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Bone Strength, Geometry, and Muscle Function
in the Lower Leg of Healthy Adolescents
Julie Briody,1 Gill A ten Hoor,1,2 Sarah P Garnett,1
Charmaine Tam,1 Chris T Cowell,1 and Craig Munns1
1The Children’s Hospital at Westmead, Westmead,
NSW, Australia
2Maastricht University, Maastricht, The Netherlands
This study aimed to (a) examine the relation between
bone strength, geometry, and muscle function in the lower
leg of healthy 17-year-old adolescents and (b) examine
the inﬂuence of birth weight, body composition, physical
activity, calcium intake, and vitamin D in mid-childhood on
bone parameters at age 17 years.
The 162 adolescents (87 girls), mean age±SD 16.8 ± 0.2
years, recruited were participants of the nepean longitudinal
study, a contemporary birth cohort. Anthropometry data
were collected using standard techniques. Bone param-
eters and cross-sectional muscle area were measured by
pQCT at the 66% distal tibia site (nondominant leg).
The polar stress strain index (pSSI), a measure of bone
strength, was calculated from pQCT data. Muscle force
and power were measured using a Leonardo Mechanog-
raphy ground reaction force plate. Body composition
(DXA), physical activity (questionnaire), calcium (food
record), and vitamin D were measured at 8 years (mid-
childhood).
TibialpQCTdatashowed thatboyshadagreaterperiost-
cal circumference (90 versus 85mm), higher cortical area
(369 versus 330mm2), and bone mineral content (BMC)
(970 versus 871mg/mm), but lower cortical density (BMD)
(1075 versus 1090mg/cm3), all P<. 001. Bone strength
(pSSI),bonestrengthadjustedfortibialength(pSSI/tlength),
muscle force, and power were also higher (P<. 001) in boys
compared to girls. Overall, assessing parameters measured
at birth, 8, and 17 years, regression analysis indicated that
42%ofthevariationinPSSI/tlengthwasexplainedbymuscle
force at 17 years and 90% of the variability of tibial BMC was
explained by sex and muscle area at 17 years and leg BMC
measured in mid-childhood. Using bivariate analysis, muscle
force at 17 years was positively associated with birth length
(r = 0.26, P = .001), DXA bone parameters (r = 0.32 to
0.58, P ≤ .001), and lean tissue mass (r = 0.65, P ≤ .001)
measured at 8 years. Similarly, muscle area was associated
with DXA bone parameters (r = 0.26 to 0.38, P ≤ .01)
and lean tissue mass (r = 0.43, P ≤ .001) measured at 8
years.
These data support the importance of the muscle-
bone unit during the growing years for bone development.
To maximize bone strength during adolescence, increasing
muscle force throughout the growing years should be
encouraged.2 International Journal of Pediatric Endocrinology
LentiviralVector-MediatedKnockdown
of SOCS3 EnhancesLeptin-InducedStat3
ActivationinRatGliomaCells
Liu Zheng Juan, Bai XueMei, Sui XiaoYan,
and Yan Dong
Department of Pediatrics, Second Hospital Aﬃliated to
Dalian Medical University, Dalian, China
Objective. The overexpression of SOCS3 gene was one of
the important mechanisms of leptin resistance through
inhibition of pathway downstream of leptin-activated JAK-
STAT signalling; therefore, suppression of SOCS3 is a
potential therapy for leptin resistance in obesity. The present
study was to investigate the role of SOCS3 knockdown
in leptin-induced Stat3 activation in vitro. Methods. We
ﬁrst constructed the lentiviral RNA interference (RNAi)
vectors of rat SOCS3 gene and evaluated the eﬀects of
silencing SOCS3 gene expression by siRNA in rat glioma
cells. Three gene-speciﬁc sequences of siRNA targets for
SOCS3 were designed, and the complementary DNA con-
taining both sense and antisense oligonucleotides was syn-
thesized. After phosphorylation and annealing, this double-
stranded DNA was cloned, respectively, to corresponding
pRNA-lentivector-VGFP to construct pRNA-Lenti-SOCS3-
VGFP recombinants with U6-containing promoter, target
sequence, and Poly terminator. Three target sequences were
correctly cloned to corresponding pRNA-lentivector-VGFP,
which was conﬁrmed by electrophoresis and DNA sequenc-
ing, and the eﬀects of RNAi to reduce gene expression were
further evaluated by real-time PCR in transfected rat glioma
cells. To examine the role of SOCS3 knockdown in leptin-
inducedStat3activation,thegliomacellswereculturedusing
DMEM containing 10% FBS and transfected, respectively,
with pRNA-Lenti-SOCS3-VGFP, or pRNA-Lenti-Control-
VGFP by Lipofectamine 2000 after 80% cell conﬂuence; 48
hours later, cells were stimulated or not with 100nM leptin
for 10 minutes, cell lysates were prepared and proteins were
quantiﬁed, and Western blot analyses were performed for
leptin-induced Stat3 phosphorylation. Results. The target
sequence of siRNA-SOCS3 was successfully cloned to pRNA-
lentivector-VGFP,andtheRNAiprotocolspeciﬁcallyreduced
expression of SOCS3 mRNA by approximately 80% com-
pared with controls in transfected rat glioma cells. Stats3
activation was signiﬁcantly greater in cells transfected with
pRNA-Lenti-SOCS3-VGFP compared with their controls.
Conclusion. SOCS3 knockdown by siRNA enhances leptin
receptor signaling, and this molecule is a potential target
for therapeutic intervention of leptin resistance and diet-
induced obesity in vivo.
AlteredChemokine Levels inChildrenwith
Type1DiabetesandItsRelationtoC-Peptide,
HbA1c, andDisease Progression
Xin Ying, Chen Xiao Juan, Yang Min,
and Tong Ya Jie
Department of Pediatrics, Shengjing Hospital of China
Medical University, Shenyang, China
Aims. Cell-mediated immunity and proinﬂammatory
cytokines are implicated in the pathogenesis of type 1
diabetes. The aim of this study was to investigate
whether circulating chemokines involved in T-helper 1
(monocyte chemoattractant protein-1 (MCP-1) and
macrophage inﬂammatory protein-1a (MIP-1a)) and T-
helper 2 (macrophage inﬂammatory protein-1β,M I P - 1 b )
autoimmunity were changed in children with type 1 diabetes
at onset and followup and to explore the associations of
MCP-1, MIP-1a, and MIP-1b with metabolic status and
beta-cell function. Methods. Serum MCP-1, MIP-1a, and
MIP-1b were measured in 50 children with newly diagnosed
Type 1 diabetes, 30 age-matched healthy children with no
familyhistoryofdiabetes.Inthediabeticchildren,additional
serum samples were obtained at 3, 6, and 12 months after
diagnosis. Serum levels of chemokine MCP-1, MIP-1a, and
MIP-1b were measured by enzyme-linked immunosorbent
assay (ELISA). At the same time fasting blood glucose, C-
peptide, and glycosylated hemoglobin (HbA1C) in diabetic
children were routinely detected. Results. Serum MCP-1,
MIP-1a levels were signiﬁcantly higher in newly diagnosed
diabetic children than in controls (P<. 05, P<. 01), but
serum MIP-1b levels in diabetic children had no signiﬁcant
diﬀerence compared with controls. In the type 1 diabetic
patients at followup, serum MCP-1 and MIP-1a were still
signiﬁcantly higher than controls at 3 and 6 months after
diagnosis (P<. 01, P<. 05) and decreased to nearly
controls at 12 months (P>. 05). While serum MIP-1b levels
did not change signiﬁcantly. MCP-1 concentrations were
negatively associated with C-peptide at 0, 3, and 6 months
after diagnosis (P<. 01, P<. 01, and P<. 05). MIP-1a
concentrations were negatively related to C-peptide in newly
diagnosed diabetic children (P<. 01). Conclusion. This study
demonstrated children with type 1 diabetes onset existence
ofTh1/Th2immuneimbalance.ChemokineMCP-1,MIP-1a
were involved in the process and progress as the condition
persists, suggesting that chemokine MCP-1, MIP-1a might
play an important role in the pathogenesis of type 1 diabetes
in children. Blockage of chemokines by therapeutic agents
may provide a new therapeutic target to ameliorate disease
progression in type 1 diabetes.
RetinalVenular Tortuosity and
UrinaryAlbuminExcretionin
YoungPersonswith Type1 Diabetes
Paul Benitez-Aguirre,1,2
Muhammad Bayu Sasongko,3,4 Maria Craig,1,2
Jie Jin Wang,3,5 Ning Cheung,3 Alicia Jenkins,6
Tien Y Wong,3,7 and Kim Donaghue1,2
1Institute of Endocrinology and Diabetes,
The Children’s Hospital at Westmead, Australia
2Discipline of Paediatrics and Child Health, The University
of Sydney, Australia
3Centre for Eye Research Australia, Royal Victorian
Eye and Ear Hospital, University of Melbourne, Australia
4Department of Ophthalmology, Gadjah Mada University,
Yogyakarta, IndonesiaInternational Journal of Pediatric Endocrinology 3
5Centre for Vision Research, University of Sydney,
Australia
6Department of Medicine, University of Melbourne,
Australia
7Singapore Eye Research Institute, National University of
Singapore, Singapore
Aims. To study the relationship between retinal venular tor-
tuosity and renal dysfunction in young persons with type 1
diabetes(T1D).Methods.Thiswasaprospectivelongitudinal
study of 536 patients with T1D of at least 2-year-duration,
aged 12 to 20 years. Retinal vascular tortuosity was measured
at baseline from retinal photographs using computer-based
analysis following a standardized protocol. Urinary albumin
excretion rate (AER) was obtained at each visit from three
consecutive timed overnight urine specimens. Longitudi-
nal analysis was performed using generalized estimating
equations with baseline arteriolar and venular tortuosity,
gender, diabetes duration, HbA1c, diastolic BP SDS and BMI
SDS as explanatory variables. Results. At baseline 412/536
(77%) participants had normal AER. Over a median (IQR)
followup period of 4 (2–6) years, 154/412 (37%) developed
incident AER elevation. In multivariate analysis reduced
retinal venular tortuosity was associated with elevated AER
at any time point (OR1.6, 95% CI 1.1–2.4, the lowest versus
highest quartile). Conclusion. Lower retinal venular tortuos-
ity was prospectively associated with early renal dysfunction.
Reduced venular tortuosity may reﬂect underlying increases
in hydrostatic pressure and oxidative stress associated with
arteriolar and venular dilatation. Retinal venular tortuosity
may be a useful noninvasive predictor of early microvascular
complications in T1D.
ClinicalandMolecular Characterizationof
NoonanSyndrome and RelatedDisorders
Han-Wook Yoo,1,2,3 Beom Hee Lee,1,2,3
Jae-Min Kim,2 Gu-Hwan Kim,2,3 Hye Young Jin,3
and Jin-Ho Choi3
1Department of Pediatrics
2Genome Research Center for Birth Defects and
Genetic Disorders
3Medical Genetics Clinic and Laboratory,
Asan Medical Center, University of
Ulsan College of Medicine, Seoul, Korea
Noonan syndrome (NS) and related disorders (NSLDs) are
caused by dysregulation or gain-of-function mutation in
a member of RAS-MAPK signaling pathway. With more
causative genes identiﬁed, their genotypic and phenotypic
heterogeneities emerge as complex and overlapped. In this
study, we analyzed genotype-phenotype correlations with
74 Korean cases with NS or NSLD. Clinical diagnosis
was NS in 56 (76%) and NSLD in 18 (24%) cases: 11
with cardiofaciocutaneous syndrome (CFC), 5 with Costello
syndrome (CS), and 2 with LEOPARD syndrome (LS).
Male predominance was noted in NS, but short stature
and delayed development were more common in NSLD.
Mutations were identiﬁed in 38 cases with NS (67.9%): 19
in PTPN11,1 1i nSOS1,4i nRAF1,1i nBRAF,a n d1i n
KRAS. Nine cases out of 11 with CFC were conﬁrmed to
carry mutations, 4 in BRAF,4i nSHOC2,a n d1i nMEK1.
All the 5 cases were with CS and 2 cases with LS harbor
mutations in HRAS and PTPN11, respectively. Four cases
with RAF1 mutation have hypertrophic cardiomyopathy.
RAS and ERK activation assays were done to verify the func-
tional perturbation after transient expression in HEK293
cells using mutant constructs. Patent ductus arteriosus was
more common in cases with PTPN11 mutation than SOS1.
Normal development and intelligence were more frequently
observed in patients with SOS1 mutation than in other
genes. There was no correlation in pulmonary stenosis,
chest deformity, abnormal genitalia, lymphedema, hearing
diﬃculty, or bleeding tendency. In conclusion, genotype-
phenotype overlap and correlations exist in NS and NSLD.
Developmental delay is an important sign for the diﬀerential
diagnosis of NS and NSLD. Further study is needed to
discover novel gene(s) responsible for NS and NSLD with
unknown genotypes.
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The Mechanism of InsulinResistance in
IntrauterineGrowth RetardationRat
Ruidan Zheng, Wujin Wang, and Xiao-ping Luo
Department of Pediatric, Tongji Hospital Aﬃliated to
Tongji Medical College, Huazhong University of Science
and Technology, Wuhan, China
Objective. As many studies show that adipose tissue plays
a very important role in insulin resistance, we developed
a catch-up growth intrauterine growth retardation (IUGR-
CG)modeltoinvestigateinsulinresistance,glucosetolerance
and the diﬀerentiation progress changes of adipose tissue in
IUGR-CG rat. Methods. Using maternal nutrition-restriction
during pregnancy to build IUGR model. 8 pups from the
normal were fed as control group and 5 newborn IUGR
pups as IUGR-CG group. Recording the body length and
body weight at 0 week, 1week, 2weeks, 3weeks, 4weeks; fast
serum glucose, insulin, triglyceride levels, and OGTT were
examined in the 3rdw. Adipocytes and preadipocytes from
the 4-week-old oﬀspring’s adipose tissue were cultured to
test the multiplication capacity and the GLUT-4 expressing
level. ShRNA of IRS-1 and IRS-2 SOCS1/3 were designed
and transferred into preadipocytes to examine C/EBP-a and
PPAR-rexpressinglevel.Result. Bodyweightandbodylength
of IUGR-CG grow faster than in the control group and
there is signiﬁcant diﬀerence between the IUGR-CG and
the control group at 4th (week 59.26 ± 3.02g, 74.69 ±
5.81g, P<. 01). Fast and OGTT serum glucose and insulin
level in IUGR-CG rats is higher than the control group
(P<. 01) Fasting plasma triglyceride (1.29 ± 0.42mmol/L),4 International Journal of Pediatric Endocrinology
insulin (7.01 ± 1.43mU/L), and insulin resistance idex
(1.32 ± 0.41) of IUGR-CG rats were signiﬁcantly higher
than AGA rats (0.75 ± 0.40mmol/L, 5.08 ± 1.35mU/L,
0.83 ± 0.20). There is no signiﬁcant diﬀerence with the
expression of GLUT4. However, preadipocytes of IUGR-
CG showed an increasing proliferation trend than AGA.
RT-PCR and Western blot showed that IRS-1, IRS-2, and
SOCS1/3 gene silencing downregulated the expression of
C/EBP-a and PPAR-r in preadipocytes. Conclusion. Insulin
resistance in IUGR-CG may be caused through the IRS1/2
and SOCS1/3 signal pathway. IRS-1, IRS-2, and SOCS1/3
expressing levels are upregulated in IUGR-CG rat, they
induced the expression of C/EBP-a, and PPAR-r, which make
IUGR-CG rat adipose tissue have a high proliferation and
diﬀerentiation capacity. The heavily increased adipose tissue
led to overweight, hypertriglyceridemia, insulin resistance,
and impaired glucose tolerance. Catch-up growth in IUGR
children may be a major risk factor or early manifestation for
later obesity, type-2 diabetes, and cardiovascular diseases.
ExerciseTrainingImprovesthe Cardiovascular
Function of Type 1 Diabetic Adolescents:
An MRI Study
Silmara Gusso,1 James C. Baldi,2 Wayne Cutﬁeld,1
and Paul Hofman1
1Liggins Institute, University of Auckland, Auckland,
New Zealand
2Department of Biological Sciences,
Northern Arizona University, Flagstaﬀ, USA
The impact of exercise training on the left ventricular
function (LVF) and femoral leg blood ﬂow (FLBF) in type 1
diabetic (T1DM) adolescents is unknown. We describe the
eﬀects of 20 weeks of exercise training on LVF and FLBF
at rest and during submaximal exercise (60% of maximal
heart rate) using magnetic resonance imaging in 38 T1DM
(20 male) and 22 nondiabetic (ND) adolescents (10 male).
Fifteen T1DM adolescents were recruited as nontraining
controls (7 male). Aerobic capacity (VO2peak)w a sr e d u c e d
in T1DM compared to controls (44.6 ± 5.7v e r s u s4 8 .3 ±
6.6mlO 2/Kgﬀm/minutes, resp., P<. 01). Baseline resting
stroke volume (SV) indexed to fat free mass was smaller
in the T1DM compared to ND adolescents (1.86 versus
2.05mL/Kgﬀm, resp., P<. 01). Resting end-diastolic (2.93
versus 3.26mL/Kgﬀm, resp., P = .01) and end-systolic
volumes were smaller in the T1DM group (1.08 versus
1.20mL, resp., P<. 05). Untrained T1DM adolescents
had a smaller SV during exercise compared to ND (1.88
versus 2.17mL, resp., P<. 01) and a smaller end-diastolic
volume (2.78 versus 3.09mL, resp., P<. 01). Baseline
FLBF was not diﬀerent between groups at rest or during
exercise; however the average area was smaller on the T1DM
during exercise (0.064 versus 0.072, resp., P<. 01). After
training, both groups increased their aerobic capacity by
an average 10% (P<. 02) and the T1DM training group
had signiﬁcantly lower body fat percentage compared to
nontraining controls (25.7 versus 28.4%, resp., P<. 01).
Resting SV did not change with training (P = .19). However,
training increased exercise SV (1.9 versus 2.07mL for T1DM
and 2.17 versus 2.32mL for ND, P<. 05). The increase
in exercise SV was achieved by a decrease in end-systolic
volumes on training groups (0.92 versus 0.80mL for T1DM
and 0.90 versus 0.84mL for ND, P<. 05). Femoral leg blood
ﬂow did not change with training; however the average area
increased in ND subjects during exercise (0.072 versus 0.074,
P<. 05). Glucose control was not improved with training
(8.8 versus 8.6% T1DM and 5.1 versus 5.1% ND, P>. 05). In
conclusion, T1DM adolescents had an impaired SV response
to exercise which was improved following twenty weeks of
exercise training. Thus, while diabetes is already limiting the
cardiac function in adolescents, exercise training may help
minimize these cardiac abnormalities.
The Role of PhospholipaseA2/
Lysophosphatidylcholine Pathway in
HepatocyteLipoapoptosis
Liu Lirui, Fu Junfen, Liang Li, and Shi Hongbo
Department of Endocrinology, the Children’s Hospital of
Zhejiang University School of Medicine, Hangzhou, China
Background. Elevated serum free fatty acids (FFAs) and
hepatocyte lipoapoptosis are important features of nonal-
coholic fatty liver disease. Excess FFAs and the abnormal
metabolites produced by FFAs are key reason for excessive
hepatocyte lipoapoptosis. However, little is known about the
underlying mechanism by which FFAs mediated lipoapop-
tosis. We presumed that the activation of phosphatidolipase
A2/lysophosphatidylcholine (PLA2/LPC) pathway may be a
keysignalingpathwayinFFAs-inducedhepatocytelipoapop-
tosis, and phosphatidolipase A2 (PLA2)m a yb eak e y
molecule in regulating hepatocyte lipoapoptosis. Objective.
To investigate the role of PLA2/LPC pathway in FFAs-
induced hepatocyte lipoapoptosis and its further molecular
mechanism. Methods. Chang cells were incubated with
diﬀerent concentration of palmitic acid (PA), together with
or without PLA2 inhibitors for 18hs. Cell viability was
assessed using the MTT assay. Cell apoptosis was determined
by Hoechst33258 staining using ﬂuorescence microscopy
and AnnexinV-PI staining by ow cytometry. Intracellular
lipids were measured by Nile red using digital ﬂuorescent
microscopy. PLA2 expression was determined by Western
blot and Q-PCR. Intracellular LPC content was measured
by an enzymatic assay. Mitochondrial function was analyzed
by detecting transmembrane potential and cytochrome C
release. JNK expression and its inhibition by SP600125 and
PLA2 inhibitors were measured by Western blot analysis of
c-Jun phosphorylation. Result. T h ee x p o s u r eo fC h a n gc e l l s
to PA induced decreased cell viability and classical apoptosis
in dose-dependent manner, and Chang cells treated with
PA showed signiﬁcant activation of PLA2,h i g hl e v e l so f
intracellular LPC content, mitochondrial transmembrane
potential loss, cytochrome C release, and JNK phosphoryla-
tion. Pretreatment Chang cells with BEL, a speciﬁc inhibitorInternational Journal of Pediatric Endocrinology 5
for iPLA2 AACOCF3 a speciﬁc inhibitor for cPLA2 or sPLA2-
IIA Inhibitor I, an inhibitor for sPLA2 protected Chang cells’
viability and signiﬁcantly decreased PA-mediated lipoapop-
tosis (P<. 05). BEL and sPLA2-IIA Inhibitor I was also
found to inhibit mitochondrial transmembrane potential
loss, cytochrome C release and JNK phosphorylation. And
pretreatment Chang cells with BEL or sPLA2-IIA Inhibitor I
decreasedintracellularLPCcontent,whileAACOCF3hadno
apparent eﬀect on intracellular LPC content in PA-induced
Chang cells, suggesting that the role of iPLA2 and sPLA2 is
more important than cPLA2 in PA-induced LPC increase.
Conclusion. These results showed that role of phospholipase
A2/lysophosphatidylcholine (PLA2/LPC) pathway appears to
be an important event in the mechanism of PA-induced hep-
atocyte lipoapoptosis. It appears that the role of PLA2/LPC
pathwayinPA-inducedhepatocytelipoapoptosis dependson
mitochondrion pathway of apoptosis and activation of JNK.
T h eR el atio n s h ipbet w ee nt h eM et abo l ic
Disturbancesandthe Content of Ghrelin in
the Brain Tissueof Young Obese Ratswith
MetabolicSyndrome
Zhang Shanshan,1 Liu Geli,1 Zhang Qiufeng,1
Guo Jing,2 and Yang Qinyan1
1Tianjin Medical University General Hospital,
Tianjin, China
2Tianjin Children Hospital, Tianjin, China
To approach the development and mechanism of metabolic
syndrome (MS) in children and adolescents, we tried to
establish the young SD rats model with metabolic syn-
drome by feeding the high fat and salt diet, which made
the rats present the characters of obesity, disturbance of
glucose metabolism, insulin resistance, disturbance of lipid
metabolism, hypertension, and so forth. Ghrelin is a kind
of peptide which can stimulate the release of growth
hormone, promote the feeding behavior, regulate the energy
metabolism, and so forth. In this research, we detected
the concentration of ghrelin in the brain tissue of diet-
controlled rats and normal rats, compared the results, and
evaluated if there was statistical signiﬁcance among the
groups. Meanwhile, we investigated the correlation between
the concentration of ghrelin and the risk factors of the
cardiovascular disease and observed the degree of their
correlation, so as to discuss relationship between the change
of ghrelin in brain tissue and the development of MS. We
divided the 40 weaned rats (including 20 males and 20
females) into 3 groups randomly and, evenly, fed them
with diﬀerent diets including normal diet (NC group),
and high fat diet (FC group), high fat and salt diet (FSC
group). After 4 weeks, We took the biochemical tests (OGTT,
insulin releasing test, and bloodlipids examination) and
measured relative items (weight, waist circumference, blood
pressure, etc.); we then got the brain tissue measured the
concentration of ghrelin by the speciﬁc ELISA kit, and
calculated the statistical signiﬁcance of the diﬀerence among
three groups. Finally, we investigated the correlation and its
degree between the concentration of ghrelin and the risk
factors of the cardiovascular disease. The results showed that
high fat and salt diet could make 7-week young rats present
the characters of MS, which meant that the young SD rats
model of metabolic syndrome was established successfully.
At the same time, the concentration of ghrelin in the brain
t i s s u eo fF S Cg r o u pw a sl o w e rw h i l et h a to fF Cg r o u pw a s
higher than that of the NC group, and the concentration
of ghrelin was negatively correlated with the weight of the
FSC and FC group. These results presented that ghrelin may
regulate the metabolism on the CNS level and there might
exist some feedback regulation of weight, blood glucose, and
insulin.
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Effects of Suckling Nutrition and Prepuberty
Nutrition on Puberty Onset and the Expression
of HypothalamicGhrelinin Female Rats
Lu-lu Cui and Pin Li
Department of Endocriology, Shanghai Children’ Hospital,
Children’s Hospital Aﬃliated to Shanghai Jiao-Tong
University, Shanghai, China
Objective. To examine the adjustment eﬀects of suckling
nutrition and prepuberty nutrition on puberty onset and the
expression of hypothalamic ghrelin by establishing diﬀerent
nutrition models of female rats. Methods. One-day-old
female Sprague Dawley rats were randomly assigned to six
groups. Each two suckling rats were fed by one lactation rat
then received a high-fat diet (HFD) after being weaned at
day 21 of age in Group A (sustained overnutrition group).
Each two suckling rats were fed by one lactation rat then
received a normal diet (NFD) after being weaned in Group
B (Infancy overnutrition group). Each ten suckling rats were
f e db yo n el a c t a t i o nr a ta n dr e c e i v e dH F Di nG r o u pC
(Prepuberty overnutrition group). Each ten suckling rats
were fed by one lactation rat and received NFD in Group D
(Normal control group). Each twenty suckling rats were fed
by one lactation rat and received NFD in Group E (Infancy
malnutrition group). Each twenty suckling rats were fed
by one lactation rat and received a low-fat diet (LFD) in
Group F (sustained malnutrition group). To comparatively
observevaginalopening time,twentyratsineachgroupwere
randomly sacriﬁced when Group B showed complete vaginal
opening and when Group D showed complete vaginal
opening. Western blot was performed in all groups and the
Ghrelin expression of hypothalamic was analyzed. Results.
(1) The comparison of vaginal opening time of six groups
is as follows: group A 29.20 ±1.96d, group B 29.50 ±1.73d,
group C, 35.80 ± 3.19d, group D 39.05 ± 1.93d, group E
41.15±2.06dandgroupF42.70±1.69d.GroupAandgroup
B showed complete vaginal opening earlier than the other
groups. It was delayed that the beginning of puberty onset of6 International Journal of Pediatric Endocrinology
groupEandgroupF(P<. 05).(2)TheexpressionofGhrelin
in hypothalamus of group A and group B was suppressed at
35 days, less than group D, group E, and group F (P<. 05).
While the expression of ghrelin in hypothalamus of group A
and group B was raised up at 42 days, in other four groups,
it was suppressed at the same time. Conclusions. This study
indicated that nutrition eﬀected the sexual development of
female rats greatly, and the eﬀects of suckling nutrition
were much greater than prepuberty nutrition. Overnutrition
was the negative feedback of the expression of ghrelin in
hypothalamus. Malnutrition promoted the expression of
ghrelin.
The Inﬂuence of Downregulation of
SOCS by RNAi on Glucose Transport of
IntrauterineGrowthRetardation Rats
Liao Lihong and Luo Xiaoping
Department of Pediatrics, Tongji Hospital, Huazhong
University of Science and Technology, Wuhan
Objective. To measure the gene expression of insulin
receptor substrate-1 (IRS-1) and suppressor of cellular
signalling (SOCS-1 and SOCS-3) in insulin resistance-
associated intrauterine growth retardation (IUGR) rats
and to evaluate the inhibition eﬀect of small hairpin
RNAs (shRNA) on the expression of SOCSs and insulin-
stimulated glucose transport in skeletal muscle cells of
IUGR-born rats. Methods. An IUGR animal model was
established by maternal food restriction in Sprague Daw-
ley rats. Length, weight, body mass index (BMI), blood
glucose, and plasma insulin were assessed at the age of
12 weeks. Levels of IRS-1, SOCS-1, and SOCS-3 mRNA
and protein in the quadriceps femoris were measured
by real-time quantitative PCR and Western blot. Con-
structed plasmids of small hairpin RNAs targeting SOCS-
1 and SOCS-3 were transfected into skeletal muscle cells
via cationic liposome lipofectamine 2000, and Western
blot and real-time quantitative PCR were used to verify
the interference eﬃciency on SOCSs protein and mRNA
expression levels. Insulin-stimulated glucose transport was
also detected via immunoﬂuorescence. Results. The insulin-
resistant IUGR rat model was successfully established. The
length of IUGR-born rats was not signiﬁcantly diﬀerent;
however, the weight, BMI, and the HOMA-IR of IUGR-
born rats were higher than the control group. The out-
comes of glucose tolerance test showed that the glucose
levels of 30 and 60 minutes were higher in IUGR-born
rats than that in the control group. The insulin level of
30 minutes was much higher in IUGR-born rats than
those in the control group. IRS-1 expression was decreased
and SOCS-1 and SOCS-3 were increased in the skeletal
muscle of IUGR rats compared to the control group. The
recombination plasmids PGPU6/GFP/Neo-SOCS-1shRNA
andPGPU6/GFP/Neo-SOCS-3shRNAweresuccessfullycon-
structed and the shRNAs eﬃciently inhibited the expres-
sion of SOCS-1 and SOCS-3. Insulin-stimulated GLUT4
translocation was also dramatically elevated. Conclusions.
Thisdataprovidesadditionalinformationonthemechanism
of insulin resistance associated with IUGR. Downregulation
of SOCS-1 and SOCS-3 ameliorates the capacity of glucose
transport and provides a potential gene therapy approach to
managing metabolic syndrome.
PosttermBirthIs Associatedwith
ObesityinAdolescent Males
Jacques Beltrand,1 Tanya Soboleva,2 Paul Shorten,2
Paul Hofman,1 Kerstin Albertsson-Wikland,3
Ze’ev Hochberg,4 and Wayne Cutﬁeld1
1The Liggins Institute, National Research Center for
Growth and Development, University Of Auckland,
New Zealand
2Ag’research, Ruakura Research Centre, Hamilton,
New Zealand
3Pediatric Growth Research Center, Sahlgrenska Academy,
G¨ oteborg University, Sweden
4Pediatric Endocrinology, Meyer Childrens’ Hospital,
Rambam Medical Center and Rappaport Family Faculty of
Medicine and research Institute, Technion-Israel Institute
of Technology, Haifa, Israel
A deleterious prenatal and/or perinatal environment may
lead to body composition and metabolic changes in child-
hood and later adult diseases. Arguably postterm (PT)
infants have been exposed to an acute suboptimal nutrition
during a prolonged gestation. The aim was to compare
longitudinal growth in PT (≥4 2w e e k so fg e s t a t i o n )w i t h
term children (T) (37–41 weeks of gestation). 525 Swedish
children, 250 boys/275 girls, with longitudinal records of
weight and height from birth until 16 years (years) of
age were analysed. 17 boys and 20 girls were PT. Growth
velocity in height and weight was determined using a
parametric mathematical model of children’s growth from
age 0 to 16. At birth, in boys, weight (PT: 3.966±0.5kg,
T: 3.640±0.5kg, P = .01) and length (PT: 52.2±1.8cm,
T: 50.9±2cm, P = .0 1 )w e r eg r e a t e ri nP Tt h a ni nT
whereas ponderal index was similar. In girls, only birth
length was longer (T: 49.5±2cm, PT: 51.5±1.9cm, P =
.002). At 16 years, despite similar heights, the PT boys were
markedly overweight (PT: 81.7±18.7kg, T: 69.9±11.5kg,
P = .02, BMI: PT: 25.4±5.5kg/m2, T: 21.7±3.1kg/m2,
P = .002). There were no diﬀerences in height or
weight at 16 years in girls. Using the mathematical model,
similar height velocities were found from birth until 16
years in both groups and both genders. However, weight
velocity was higher in PT boys during childhood (from
1.5 to 7 years of age, P = .03) and adolescence (from
1 1 . 5t o1 5y e a r so fa g e ,P = .03). Furthermore, BMI
started to be higher as early as 3 years of age in PT
boys (P = .03). The diﬀerence in BMI between PT and
T boys increased until 7 years of age when it stabilized.
It increased again during adolescence. BMI cues returned
to parallel trajectories at the end of puberty in both
groups, suggesting no further increase in BMI in PT boys.
There was a trend towards an earlier puberty onset inInternational Journal of Pediatric Endocrinology 7
PT boys (PT: 12.5±2.0 years, T: 13.5±1.4 years, P =
.01). In summary, post term males have a greater BMI at
16 years. This likely reﬂects increased adiposity through
a two-hit weight gain during childhood and adolescence.
We speculate that nutritional reprogramming by late ges-
tational placenta insuﬃciency increases the risk of later
adult obesity and a metabolic syndrome phenotype in
boys.
The Changes of Molecules in
AdipocyteInvolvedinInsulin
SignalTransduction Pathway andAdipogenic
TranscriptionFactorsinIntrauterine
Growth-RestrictedRats withCatch-Up Growth
Jinzhi Gao and Xiaoping Luo
Tongji Hospital of Tongji Medical College of Huazhong
University of Science and Technology
Objective. There is increasing evidence that intrauterine
growth-retardation (IUGR) and catch-up growth confer an
increased risk of insulin resistance in later life. To observe the
changes of molecules in adipocyte involved in insulin signal
transduction pathway and adipogenic transcription factors
to explore the possible mechanism of insulin resistance
in rats with IUGR and catch-up growth. Research Design
and Methods. We obtained timed pregnancies by vaginal
smear, and then pregnant rats received ad libitum food
(control) or were 30% food-restricted (IUGR). In lactation,
the control groups were breast-fed by one mother rat
per 10 pups, and the IUGR groups were breast-fed by
one mother rat per 5 pups in order to make catch-up
growth. Three-week-old pups were nursed and weaned to ad
libitum diet. We cultured the adipocytes (around epididymis
and kidney) from four-week-old rats and then identiﬁed
adipocyte cells with oil red O staining. We compared mRNA
levels of adipogenic transcription factors and insulin signal
transduction pathway between IUGR pups and controls by
quantitativereal-timePCR.KnockeddownIRS-1,IRS-2,and
SOCS1/3 expression by shRNA in 3T3-L1 preadipocyte and
then determined mRNA levels of adipogenic transcription
factors by quantitative real-time PCR identiﬁed whether
the preadipocytes diﬀerentiated into adipocytes or not
by oil red O staining. Results. The IUGR pups showed
upregulation of adipogenic transcription factors (PPARr,
C/EBP-a) and SOCS1/3, and downregulation of IRS-1, IRS-
2, and PI3K. Knockdown of IRS-1, IRS-2, and SOCS1/3
expression by shRNA blocks preadipocytes diﬀerentiation
and gene expression of PPARr and C/EBP-a. Conclusions.
Results from this study may imply that IUGR and catch-
up growth block the insulin signal transduction pathway,
in contrast to increasing adipogenic transcription factors.
We speculate that catch-up growth promotes the ability of
diﬀerentiation of preadipocyte, but the ability of glucose and
lipid metabolism is permanently impaired in intrauterine
with poor nutrition. The changes of molecules in adipocyte
involved in insulin signal transduction pathway and adi-
pogenic transcription factors could be the mechanism of
insulin resistance in intrauterine growth-restricted rats with
catch-up growth. The study provides new insights against
insulin resistance.
AR an d o m is edC o n tr o ll edT rialt oDet e rm in e
the Best Therapeutic Modality for Treatment of
NutritionalRickets
Varun Aggarwal,1 Anju Seth,1 Raman K Marwaha,2
Satinder Aneja,1 and Pitamber Sonkar1
1Department of Pediatrics and Radiodiagnosis,
Kalawati Saran Children’s Hospital and Lady Hardinge
Medical College, New Delhi-110001, India
2Department of Endocrinology, Thyroid Research Centre,
Institute of Nuclear Medicine & Allied Science (INMAS),
New Delhi, India
Introduction. Rickets is usually thought to be due to vitamin
Ddeﬁciency.However,recentstudieshaveimplicateddietary
deﬁciency of calcium in its etiology. Information on relative
eﬃcacy of calcium, vitamin D, or both together in treatment
of rickets is limited. Objective. To study eﬀect of treatment
with calcium, vitamin D, or a combination of these two on
healing of nutritional rickets in young children. Design. Ran-
domized controlled trial. Methods. We enrolled 67 cases of
rickets in the age group of 6 months to 5 years. The baseline
demographic (nutritional status, sun exposure (UV score),
dietary calcium, and phytate intake) and biochemical data
(serum calcium, inorganic phosphate, alkaline phosphatase,
25(OH) D3, and parathyroid hormone) were evaluated for
all cases. They were randomly allocated to receive vitamin
D (6 lakh IU single intramuscular injection), calcium
(75mg/kg elemental calcium daily), or a combination of
the above two for a period of 12 weeks. Reassessment
was done at 6 and 12 weeks for evidence of healing by
a 10-point radiological score and biochemical parameters.
Results. Mean dietary intake of calcium in all cases was
very low (204.71 ± 129.04mg/day). Mean serum 25(OH)
D3 level at baseline was in the range of mild deﬁciency
(15.94 ± 12.43ng/ml). The combined end point of normal
serum ALP and complete radiological healing at 12 weeks
of treatment was seen in 50% subjects on combination
therapy as compared to 15.7% on vitamin D alone and
11.7% in group receiving calcium alone. Conclusions. Chil-
dren with rickets had a low baseline serum vitamin D
levels and low dietary calcium intake. The best therapeutic
response was seen with a combination of both vitamin
D and calcium, than either given alone. The treatment
needs to continue beyond 12 weeks to ensure complete
healing.
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Mild Noncompliance with Growth Hormone
Therapy Is AssociatedwithPoor Growth
Wayne S Cutﬁeld,1 Jos´ e G B Derraik,1
Alistair J Gunn,2 Kyle Reid,3 and Paul L Hofman1
1Liggins Institute, University of Auckland, Auckland,
New Zealand
2Departments of Physiology and Paediatrics,
University of Auckland, Auckland, New Zealand
3Pharmaceutical Management Agency of New Zealand
(PHARMAC), Wellington, New Zealand
Background. GH therapy requires daily injections over many
years, and compliance can be diﬃcult to sustain. As growth
hormone (GH) is expensive, noncompliance is likely to lead
to suboptimal growth at considerable cost. Aims. (1) To
assess the compliance rate of children and adolescents with
GH treatment in New Zealand. (2) To determine the eﬀects
of GH treatment compliance on linear growth. Methods.
This was a national survey of GH compliance, in which all
children receiving government-funded GH for a four-month
interval were included. Compliance was deﬁned as ≥85%
adherence(nomorethanonemisseddoseaweekonaverage)
to prescribed treatment. Compliance was determined based
on two parameters: either the number of GH vials requested
by the family or the number of empty GH vials returned.
Results. 177 patients were receiving GH in the study period,
aged 12.1 ± 8.1 years. The rate of returned vials, but not
the number of vials requested, was positively associated with
HVSDS right across the compliance range (see Figure 1).
The rate of returned vials was therefore used for subsequent
analyses. 66% of patients were noncompliant, and this
outcome was not aﬀected by sex, age, or clinical diagnosis.
However, Maori ethnicity was associated with a lower rate of
compliance.
Figure 1 (not shown). Compliance with GH therapy
was compared to growth response over 6–8 months (height
velocity SDS). High (n = 30) is missing ≤1d o s eaw e e k ,
medium (n = 51) is missing >1a n d<3d o s e s / w e e k ,a n dl o w
(n = 29) is missing ≥3 doses/week. Data are mean±SEM.
(∗∗P<. 01), (∗∗∗P<. 001) versus High. Conclusions.
(1) Noncompliance with GH treatment is very common.
(2) More than one missed GH dose on average each week
adversely aﬀects growth. (3) An objective assessment of
c o m p l i a n c es u c ha sr e t u rn e dvi a l si sm u c hm o r er e l i a b l et h a n
compliance-based on parental or patient-based information.
(4) Noncompliance should be considered in all patients with
apparently suboptimal response to GH treatment.
The Effect of Long-Acting GrowthHormone
on Growth and Glucose Metabolismof
HypophysectomizedImmatureRats
Yingke Liu, Zhixin Zhang, Huimin Su,
Qiong Zhang, and Qiuling Zhao
China-Japan Friendship Hospital, Beijing, China
Objectives. The aim of this study is to observe and compare
the growth-promoting eﬀect of the long-acting growth
hormone (LGH) and short-acting growth hormone (SGH)
on hypophysectomized immature rats and to explore the
changes of glucose metabolism after LGH intervention on
these rats. Methods and Materials. Twenty-one-day-old SD
rats were used to establish the growth hormone deﬁciency
model with hypophysectomy. Two weeks after the operation
60 qualiﬁed young rats were selected and randomly
divided equally into the model group (Group M), SGH
intervention group (Group S), and LGH intervention group
(Group L). Other 20 young rats were administered a sham
surgeryasthenormalcontrolgroup(GroupN).Allthedrugs
were injected subcutaneously in the neck of the rats at the
same time of the day, 0.25mg/kg SGH daily in Group S,
1.4mg/kg LGH on the ﬁrst day and the same quantity of
normal saline on other days of the week in Group L, the
very same quantity of normal saline in Group M and Group
N daily. The body weight, body length, and tail length
were measured every other day after the administration. The
random blood glucose level was examined on the 1, 3, 5,
8, 10, 13, and 14 days at 8:00PM and the fasting blood
glucose level was detected on the 6, 11, and 15 days at
7:00 AM after 8 hours of fasting. Two weeks later 10 rats
in each group received hyperinsulin-euglycemic clamping
test while the other 10 were executed for the tibia length
and epiphyseal plate width measurement. Results. At the
end of each week, the body weight, tail length, and body
length in Group L increased (P<. 05), compared with
those in Group N and Group M, but was it not signiﬁcantly
diﬀerent (P>. 05) from that in Group S. During each
week, the body weight in Group L gained higher than that
in Group S in the ﬁrst 4 days (P<. 05), but lower in the
last 3 days (P<. 05). The length of tibia and width of
epiphyseal plate in Group L increased (P<. 05) comparing
with those in Group M and Group N, but similar with
Group S (P>. 05). The random blood glucose level in
Group L was lower than that in Group N in the 1st and
3rd day (P<. 05), but was not statistically diﬀerent with
those in Group M and Group S (P>. 05). There was no
diﬀerence (P>. 05) of random blood glucose levels among
the groups in the 5th, 8th, and 10th days. But in the 13th
and 14th day, this level in Group L was higher (P<. 05)
than that in Group N and Group M, and again similar with
Group S (P>. 05). The fasting glucose level of Group L
was lower than that in Group N (P<. 05), but it was
similar with those in Group S and Group M. The glucose
infusion rate of the hyperinsulin-euglycemic clamping test
in Group L was higher than that in Group N (P<. 05),
but was not diﬀerent from those in Group M and Group S
(P>. 05). Conclusion. During the two weeks of intervention,
we found that the LGH and SGH have similar eﬀects on
growth in the hypophysectomized immature rats, while
the growth-promoting eﬀect of LGH weakens gradually as
time approaches the end of every week. Over time, the
blood glucose levels are on the trend of rise, while the
sensitivity of LGH and SGH to insulin did not signiﬁcantly
vary.International Journal of Pediatric Endocrinology 9
FinalHeight inGirlswithIdiopathic
C e ntralP r ec ociousP ube rtyT r eat edwith
Gonadotropin-ReleasingHormone Analogue
andRecombinant Human GrowthHormone
Hua-Mei Ma, Pi-Mei Zheng, Min-Lian Du, Zhe Su,
Yan-Hong Li, Hong-Shan Chen, and Qiu-Li Chen
Department of Pediatrics, The First Aﬃliated Hospital,
Sun Yat-Sen University, China
Objective. To evaluate the long-term ﬁnal height outcome of
combined treatment with gonadotropin-releasing hormone
analogue (GnRHa) and recombinant human growth (rhGH)
in girls with central precocious puberty. Methods. Out of
forty-nine (49) girls with idiopathic CPP (treated with
GnRHa at a dose of 60∼80μg/kg every 4 weeks for at least
6 months, whose height velocity (HV) fell below 4cm/years
and showed no improvement of predicted adult height in
6 months), 26 received (GH-combined group), in addition
to GnRHa, GH at a dose of 1U/kg.W, sc, 6∼7d a y sw e e k l y ,
for 11.4±5.4(5∼26) months; 23(control group) matched for
BA, chronological age, and duration of GnRHa treatment,
who showed the same growth pattern but refused GH
treatment, served to evaluate the eﬃcacy of GH addition.
Both groups discontinued treatment at a comparable BA
(mean±SEM): 12.7 ± 1.0i nc o m b i n e dg r o u pv e r s u s1 2 .8 ±
0.8 years in the control group. Results. At the conclusion
of the study, all the girls had been followed up for 3.3 ±
1.9years and 3.2 ± 0.9years in GH-combined group and
control group, respectively, and had achieved adult height.
Adult height was considered to be attained when the growth
during the preceding year was less than 1cm, with a BA
of over 15 years. During rhGH treatment, HV of the GH-
combinedgirlsincreasedsigniﬁcantly((6.7±2.0)cm/yversus
<4cm/y baseline). GH-combined girls showed an adult
height far higher than pretreatment PAH ((157.5 ± 4.5)cm
versus (148.1 ± 4.6)cm), (P<. 01). Target height (TH:
(154.4 ± 4.6)cm) was signiﬁcantly exceeded. The control
group reached an adult height also signiﬁcantly higher than
pretreatment PAH ((154.7±5.5)cm versus (150.3±6.0)cm,
P<. 01), while TH of 155.6 ± 4.3cm just reached but
was not signiﬁcantly exceeded. The gain in centimeters
obtained, calculated between pretreatment PAH and ﬁnal
height, 9.4 ± 4.9cm in GH-combined group was much
more than 4.3 ± 4.2cm in control group (P<. 01).
Furthermore,noseveresideeﬀectshavebeenobservedeither
on bone age progression or the gynecological followup in the
GH-combined group (in comparison with control group).
Conclusion. rhGH may accelerate the linear growth and
improveadultheightofGnRHa-treatedICPPgirlswhoshow
overgrowth reduction.
PlasmaC-TypeNatriureticPeptidein
the Neonate Relation to GestationalAge and
LinearGrowth
An-Ru Wang, Bao-Sheng Yu, Ye Shan, Lan-Ying Gao,
and Yong-Quan Zhang
Department of Pediatric Endocrinology, the Second
Aﬃliated Hospital of Nanjing Medical University,
Nanjing 210003, China
Objective. C-type natriuretic (CNP) plays an essential role
in endochondral bone growth. The relationship in plasma
CNP, gestational age, and growth parameters in neonate
were analyzed in order to reveal the eﬀect of CNP on fetal
and neonatal growth, whether related to IGF-1. Methods. 20
healthy newborns from obstetrical department and 30 sick
newborns from neonatal department were enrolled. Growth
parameters include height, weight, head circumference, and
chest circumference. Plasma CNP and IGF-1 levels were
determined by radioimmunoassay. Results. Cord plasma
CNP of healthy newborns was inversely related to gestational
age and birth weight. In neonatal ward, plasma CNP at the
1st day after birth was positive related to gestational age
and all of growth parameters. Plasma CNP was correlated to
growth velocity, and also as IGF-1. Plasma CNP at the 1st
day was related to IGF-1. Conclusion. Relationship between
plasma CNP and growth parameters at the 1st day suggested
the essential role of CNP in fetal growth. Correlation of
plasma CNP and growth velocity during the ﬁrst 4 weeks of
postnatallifeindicatedtheeﬀectofCNPonneonatalgrowth.
CNP-eﬀected growth may be concerned with IGF-1.
Use Amino-TerminalPropeptideof
C-TypeNatriureticPeptidetoEvaluate
the Effectivenessof Recombinant Human
Growth Hormone Therapy in
Idiopathic Short Statureandin
IsolatedGrowth Hormone Deﬁciency
Yuan Xiao, Wei Wang, and Defen Wang
Department of Paediatrics, Ruijin Hospital, School of
Medicine, Jiaotong University, Shanghai, China
Context. C-type natriuretic peptide (CNP) is a paracrine
growth factor that plays an important role on regulating
linear growth in bone plate. The level of amino-terminal
propeptide of CNP (NTproCNP), splitting by proCNP, is
easily measured in blood and reﬂects the rate of CNP
biosynthesis. Objective. The aim of the study is to explore
thevalueofamino-terminalpropeptideofC-typenatriuretic
peptide (NTproCNP) in evaluating the eﬀectiveness of
therapy with recombinant human growth hormone (rhGH)
in patients with idiopathic short stature (ISS) and isolated
growth hormone deﬁciency (IGHD). Methods. Forty-eight
prepuberty children (44 males, 4 females), with IGHD (n =
25), mean aged (11.07 ± 1.78 years) and ISS n = 23,
mean aged (10.89 ± 1.36 years), were randomly enrolled
from Novmber 2007 to March 2009. Their heights were
under 2 SDs before treatments and were examined for
the serum concentration of insulin-like factor-I (IGF-I)
and NTproCNP. They were all treated with rhGH (0.1–
0.15IU/kgeverynight)foratleastoneyear.SerumIGF-Iand
NTproCNP levels were again measured at 6 months. After10 International Journal of Pediatric Endocrinology
1-year injection, all patients were assessed some growth-
related clinical parameters, including annual growth velocity
(GV), height SD score (HtSDS), and gain height SD score
(ΔHtSDS). Results. In GHD group, serum IGF-I SDS and
NTproCNP levels at 6 months with GH therapy were
signiﬁcantly higher than before (P<. 001, resp.), respond to
the mean HtSDS increased at one year with GH treatment.
It was showed the linear correlation between special bio-
parameter and promoting growth with GH, the GV after
therapy had a positive relationship with IGF-I SDS (r =
0.407, P = .044) and the NTproCNP (r = 0.490, P = .013),
respectively. The GH peak value had a positive relationship
with IGF-I SDS and NTproCNP before rhGH therapy (r =
0.558, P = .004, r = 0.630, P = .001, resp.); The
IGF-I SDS and NTproCNP also had a positive relation (r =
0.466, P = .019). In ISS group, the mean Ht SDS, serum
IGF-I SDS, and NTproCNP levels at 6 months of therapy
were also signiﬁcantly higher than before (P<. 001). The
linear correlation showed that the GV after therapy only
had a positive relationship with the NTproCNP (r = 0.770,
P = .001) and no relationship with ΔIGF-I SDS. The
correlation between ΔIGF-I SDS and NTproCNP was not
found. There were no signiﬁcant diﬀerences in clinical and
bio-parameters before and after therapy between ISS group
and IGHD groups. Conclusions. Serum level of NTproCNP
was a novel biomarker of growth, with increasing during
growth-promoting treatment. It may have more clinical
value in evaluation of children with short stature, predicting
and monitoring the eﬃcacy of rhGH therapy than IGF-I.
Impact of Iron-Zinc Fortiﬁed Milk on Growth
Velocity of Underweight Children, A Random-
izedControlledTrial
Annang Giri Moelyo, Endang Dewi Lestari,
Leilani Lestarina, and Harsono Salimo
Child Health Department, Faculty of Medicine, Sebelas
Maret University/Moewardi Hospital Surakarta, Indonesia
Background. Zinc, as a micronutrient, is essential for somatic
growth. It induces growth hormone (GH) dimerization that
make more stable than monomeric GH. GH is a major
hormone for growth during childhood age. Underweight
children need more, not only macronutrients but also
micronutrients, to assure optimal growth. Objective.T o
evaluate the impact of iron-zinc fortiﬁed milk supplemen-
tation on growth velocity of underweight children. Methods.
Randomized, double-blind, controlled trial, intention-to-
treat trial conducted in 10 elementary schools in Surakarta,
Indonesia from July 2007 through February 2008. A total of
217 underweight children aged 7–9 years old were recruited
in the study. Subjects who had chronic illnesses, severe
anemia, thalassemia or cow’s milk allergy were excluded.
All participants were randomly assigned to receive either
intervention milk (A) (6.3mg of iron and 1.5mg of zinc)
(n = 112) or standard milk (B) (0.02mg of iron and 0.1mg
of zinc) (n = 105). All subjects were anthropometrically
measured (weight, height, sitting height) at 0 and 6 months
of schedule, and then all plotted to CDC 2000 growth chart.
Results. Study groups were comparable at baseline. Growth
velocity of A group versus B group are 6.8 (SD 1.7) versus 6.3
(SD 2.2)cm/year (P = .05). Boys’ growth velocity of A versus
B are 6.8 (SD 1.9) versus 6.0 (SD 1.9)cm/year (P = .026).
G i r l s ’g r o w t hv e l o c i t yo fAv e r s u sBa r e6 . 8( S D1 . 5 )v e r s u s
6.5 (SD 2.4)cm/year (P = .55). In short stature subjects,
boys’ growth velocity of A versus B are 6.6 (SD 2) versus
6.0 (SD 2)cm/year (P = .22) and girls’ growth velocity
of A versus B are 7.1 (SD 1.4) versus 6.8 (SD 2.5)cm/year
(P = .54). Conclusion. Zinc-iron fortiﬁed milk gives positive
impact on growth velocity, especially boys.
T h eEf f ec to fP ar e nt alO rigino fI nt ac t
X Chromosome on Phenotypes in
Korean Patients with TurnerSyndrome
Young Ah Lee,1 Jae Hyun Kim,2 Sun Hee Lee,3
Ji Hyun Kim,4 Shin Mi Kim,1 Min Jae Kang,1
Han Hyuk Lim,5 Hye Rim Chung,6 Shoong Ho Shin,1
and Sei Won Yang1
1Seoul National University Children’s Hospital,
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4Pohang St. Mary’s Hospital
5Chungnam National University College of Medicine
6Seoul National University Bundang Hospital
The survival of 45, X fetuses and various phenotypes in
Turner syndrome (TS) can be associated with parental
origin of intact X chromosome. The aim of this study
was to evaluate the eﬀe c to fp a r e n t a lo r i g i no fi n t a c t
X on phenotypes including autoimmune thyroid disease
(AITD), congenital cardiovascular or renal anomalies, and
sensorineuronal hearing loss (SNHL) in TS patients with
45, X or X-isochromosome. A total of 49 TS patients with
45, X, (n = 34) or X-isochromosome, (n = 15, 46,
XiX or 45, X/46, XiX) were enrolled between May, 2008
and July, 2009. TS patients with 45, X without hidden Y
fragment using PCR detecting 11 Y-chromosome sequences
were included in this study. The parental origin of intact X
chromosome was identiﬁed by comparing between patient
andtheirparentsusing9highlypolymorphicXchromosome
microsatellites (DXS 1060, 8051, 1228, 1214, 986, 990, 1001,
1047, 8043). In 45, X patients, additional 3 microsatellites
(DXS 1098, 993, 991) were analyzed if only one parent
participated. Twenty-two (64.7%) of 34 patients with 45,
X and 10 (66.6%) of 15 patients with X-isochromosome
had a maternally derived intact X chromosome (Xmat).
The proportion of Xmat in survived 45, X patients was
high, (P = .044). None of patients with 45, X karyotype
had hidden X fragments using 9 or 12 X-chromosome
microsatellite marker analysis. Thirty-ﬁve (72.9%) of 48
patients were diagnosed with AITD. The Xpat group had
lower incidence of AITD than the Xmat group (50% versus
84.3%, OR = 0.16, P = .022) irrespective of age, karyotype,
regardless of GH therapy and family history of AITD. OnlyInternational Journal of Pediatric Endocrinology 11
9 (25.7%) of 35 patients with AITD had a palpable goiter.
The palpable goiter in TS patients with AITD was more
commonly present in the Xpat group than in the Xmat
group (62.5% versus 14.8%, P = .015). Neither the presence
of congenital cardiovascular anomalies nor congenital renal
anomalies was aﬀected by age, karyotype and parental origin
of intact X chromosome. The presence of SNHL without
conductive HL was associated with age (OR 1.33, P =
.016), but not karyotype and parental origin of intact X,
whether or not patients received GH therapy and duration
of sex hormone deﬁciency since 11 years of age. This study
may provide the evidence of an X-linked imprinting eﬀect
on AITD in TS patients. Although the survived 45, X
patients may have higher incidence of maternally originated
intact X chromosome, patients with Xmat may be more
prone to AITD than those with Xpat. Further study to
elucidate the mechanism of this imprinting eﬀect on AITD is
needed.
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Kisspeptin Plasma Levels in Normal Female
PubertalStages andinGirlswith
Idiopathic CentralPrecocious Puberty
Xiaoyu Ma, Jihong Ni, Yuejun Liu, Shaoke Chen,
and Wei Wang
Department of Paediatrics, Ruijin Hospital, School of
Medicine, Jiaotong University, Shanghai, China
Objective. We investigate the pattern of the plasma kissprptin
levels in various normal female pubertal Tanner stages and
inthegirlswithidiopathic centralprecociouspuberty(ICPP)
or with the premature thelarche (PT) and evaluate the
signiﬁcance of detecting the plasma kisspeptin levels as
a sensible criteria for diﬀerentiating the early diagnosis
between the ICPP and PT. Methods. Plasma kisspeptin
levels were determined in normal female pubertal girls
in Tanner stage I-V (n = 16 to 19), girls with ICPP
(n = 10) and PT (n = 12). Their levels were compared
with their signiﬁcance being analyzed statistically between
various stages of normal puberty or between groups with
ICPP and PT. The enzyme-linked immunosorbent assay
(ELISA) was used to detect the plasma kisspeptin levels.
Results. The levels of kisspeptin were signiﬁcantly higher
in the girls with ICPP than in those with PT:1.73 ±
0.23ng/ml versus 1.43 ± 0.29ng/ml (P<. 05) and it was
the highest among the normal pubertal females in Tanner
stage (1.73 ± 0.22ng/ml) and signiﬁcantly higher than all
other stages (P<. 05), while in stage (1.49 ± 0.29ng/ml
and 1.50 ± 0.36ng/ml) being higher than in stage (1.23 ±
0.30ng/ml) or 1.19 ± 0.31ng/ml (P<. 01). Conclusions.
Plasma Kisspeptin levels were the highest in Tanner stage
during normal female pubertal development and signiﬁcant
diﬀerence revealed between the girls with ICPP and with PT.
The levels of plasma kisspeptin may be suspected as a useful
criteria for distinguishing the ICPP and PT in their early
stage.
The Prevalence of Testicular AdrenalRest
Tumor andIts AssociatedFactorsin
Patients with Congenital AdrenalHyperplasia
Causedby 21-HydroxylaseDeﬁciency
Min Jae Kang, Shin Mi Kim, Young Ah Lee,
Choong Ho Shin, and Sei Won Yang
Department of Pediatrics, Seoul National University
College of Medicine, Seoul, Korea
Purpose. Congenital adrenal hyperplasia (CAH), caused by
21-hydroxylase deﬁciency, is a lifelong disorder, and issues
on quality of life, sexual function and reproductive capac-
ity should be considered in early adulthood. Particularly,
testicular adrenal rest tumor (TART) in these patients has
been known as a common and important cause of the
infertility. Therefore, in the present study we aimed to
observe the prevalence of TART, measured by testicular
ultrasound, and to analyze its factors in patients with CAH.
Patients and Methods. Testicular ultrasound was performed
in 49 male patients (salt-wasting, 37; simple-virilizing, 12)
with CAH, whose ages were between 10.6 and 27.1 years.
The prepubertal patients were excluded. We analyzed the
pastlevelsofserum17-hydroxyprogesterone(17-OHP)from
the time of ultrasound measurement tentatively to see if
patients had been in undertreatment, which was calculated
as a percentage of the number of measurement of serum
17-OHP levels higher than 10ng/mL for the total number
of measurement of serum 17-OHP during the follow-up
period. Additionally, we tentatively divided 6 years of follow-
up period just before ultrasound measurement (time 0) into
three 2-year intervals and calculated the average concentra-
tion of serum 17-OHP of each interval (0–2 year average
concentration (YAC), 2 4YAC and 4 6YAC). Results.T A R T s
were detected by testicular ultrasound in 32 of 50 patients
(65.3%). The median of maximal cross-sectional area of
TART was 0.61 cm2 (range 0.01–4.95cm2) and the median
volumewas0.297cm3 (range0.001–8.181cm3).Thepatients
with TART showed lower corrected ﬁnal adult height and
higher 2 4YAC and body mass index than without TART,
whereas other factors showed no diﬀerences. The maximal
cross-sectional area of TART was positively correlated with
undertreatment percentage (r = 0.444, P = .011), 2 4YAC
(r = 0.355, P = .046) and (4 6YAC r = 0.518, P = .003).
Conclusion. The positive rate of TART was 65.3% in male
patients with CAH, caused by 21-hydroxylase deﬁciency,
whose occurrence and progression might be associated with
the degree of disease control. Therefore, these results suggest
that strict control of this disease is mandatory and regular
check-ups with testicular ultrasound are recommended in
male patients, regardless of the type of 21-hydroxylase
deﬁciency.12 International Journal of Pediatric Endocrinology
ClinicalFeaturesinPatientswith
TrueHermaphroditism(OvotesticularDisorder
of Sex Development)
Shin Mi Kim, Min Kyung Kim, Young Ah Lee,
and Choong Ho Shin Won Yang
Seoul National University College of Medicine, Korea
Purpose. Ovotesticular disorder of sex development
(OTDSD) was deﬁned as the presence of both ovarian
and testicular tissues in the same individual. The purpose
of this study was to investigate clinical features at diagnosis
and during followup in patients with OTDSD. Methods.
A total of 21 patients with OTDSD following up 1980
and 2010 in Seoul National University Children’s Hospital
were included. We retrospectively investigated the medical
records between at diagnosis and at thelast followup.
Results. The karyotype was 46, XX (62%, n = 13), 46,
XY (29%, n = 6) and 46, XX/46, XY (9%, n = 2). The
40 gonads conﬁrmed by pathology were ovotestis (60%),
ovary (22.5%), and testis (17.5%). The location of gonads
was as follows: ovary (mostly in the left side, 88.9%; in
the abdomen or pelvis, 88.9%), testis (mostly in the right,
85.7%; in the scrotum, 57.1%). The mean age at diagnosis
was 3.4 years. The chief complaints at diagnosis were
ambiguous genitalia (hypospadia, n = 10; clitoromegaly,
n = 6, and inguinal hernia (n = 2) at initial visit and
gyecomastia (n = 2) and inguinal mass (n = 1) during
follow-up. Final gender assignment was male (n = 11)
and female (n = 10); change in gender assignment with
follow up in 4 of 21 patients was observed. Three patients
(14.2%) developed gonadoblastoma with late diagnosis of
OTDSD in adolescence and adulthood; age at gonadectomy
was 10 years, 12.9 years and 28 years of age, respectively.
Conclusions. Early diagnosis of OTDSD is required to
prevent the development of gonadoblastoma and to assign
appropriate gender assignment. Both hypospadia and
clitoromegaly were possible indications for diagnosis of
OTDSD.
MolecularAnalysisof
the DUOX2 GeneinKorean Patients with
CongenitalHypothyroidismCausedby
Dyshormonogenesis
Hye Young Jin,1 Jin-Ho Choi,1 Sun-Hee Heo,2
Bu-Won Jeon,2 and Han-Wook Yoo1,2
1Division of Pediatric Endocrinology and Metabolism,
Department of Pediatrics
2Genome Research Center for Birth Defects and Genetic
Disorders, Asan Medical Center Children’s Hospital,
University of Ulsan College of Medicine, Seoul, Korea
Purpose. Molecular studies have found that congenital
hypothyroidism (CH) is caused by genetic defects involved
in dyshormonogenesis, such as thyroid peroxidase (TPO),
thyroglobulin(TG),dualoxidase2(DUOX2),sodiumiodide
symporter (NIS), and pendrin (PDS). The DUOX2 enzyme
activity is essential for generation of H2O2, the critical step
inthyroidhormonogenesis.Previously,biallelicmutationsin
the DUOX2 gene result in severe and permanent CH, while
monoallelic mutations are associated with milder, transient
CH. This study aimed to investigate the correlation between
clinical phenotype and molecular features of the DUOX2
gene defect. Patients and Methods. Thirty seven patients
with CH with an ectopic thyroid gland were included in
this study. They had been identiﬁed by newborn screen-
ing, and conﬁrmed by serum thyroid function tests and
thyroid scan. Patients with prematurity, down syndrome,
and maternal autoimmune thyroid diseases were excluded.
All coding exons of the DUOX2 gene and their intronic
ﬂanking sequences were ampliﬁed by PCR, and directly
sequenced. Results. Twenty nine (78.3%) out of 37 patients
have permanent CH, 4 patients (10.8%) have transient
CH, while the remaining 4 patients were undetermined yet.
Seven missense mutations (p.H678R, p.R885Q, p.L1067S,
p.R1110Q,p.N43Y,p.G448R,andp.R1334W)wereidentiﬁed
in 13 (35.1%) out of 37 patients. Three mutations (N43Y,
G448R, and R1334W) were novel. Ten out of 13 patients
withDUOX2mutationshavepermanentCH,whiletheother
3 patients with DUOX2 mutations remain undetermined.
Out of 10 permanent CH patients with DUOX2 mutation,
9 patients identiﬁed compound heterozygous or homozy-
gous mutations, and one patient with permanent CH was
heterozygous for p.R885Q. Three undetermined patients
were heterozygous for p.L1067S, p.G488R, and p.R1334W.
No mutation was found in four patients with transient
CH. Conclusions. This study identiﬁed seven mutations of
the DUOX2 gene, including 3 novel mutations. Thirteen
(35.1%) out of 37 patients with CH caused by dyshormono-
genesis have DUOX2 mutation, indicating that DUOX2
mutation is a common cause of CH. Clinical phenotype
of DUOX2 mutation can be variable, suggesting existence
of alternative mechanism to replace DUOX2 or modifying
factor to regulate DUOX2 expression. Functional analysis of
novel mutations and long-term followup for undetermined
patients should be needed.
Associationofa SingleGDF5
Polymorphism with HumanWeight and
BMI in ChinesePopulation
Pei Zhou and Luo Feihong
Children’s Hospital Of Fudan University
Objective. Variation in the GDF5 gene has been reproducibly
associated with osteoarthritis (OA) and human height in
populations of UK, Finland and Sardinia. However, data
from Asian is less conclusive. To identify the associations
between GDF5 and human height, weight and BMI, we ana-
lyzed genome-wide association data from 1758 individuals
of Chinese descent. Methods. We assessed the eﬀect of GDF5
polymorphisms in a large population. A total of 862 males
and 896 females had genotype data available. Data on height
and weight were collected from participants at the time ofInternational Journal of Pediatric Endocrinology 13
blood collection. Results. Inconsistent with previous reports,
no statistically signiﬁcant association was detected between
rs6060373 and height both in males and females (P = 0.749
and 0.729 respectively). But we observed rs6060373 was
associated with weight and BMI in males (P = 0.006 and
0.006 respectively). The minor allele G was associated with
heavier stature. No associations were observed in females.
Conclusions. This population-based study shows that this
GDF5 gene variant is associated with weight and BMI in
Chinese males. And the selected SNP is not associated with
height in Chinese people. To our knowledge this is the
ﬁrst demonstration of a compelling association between
functional GDF5 SNP rs6060373 and human weight and
BMI in the Chinese population.
UrinaryGonadotropinDeterminations
duringGonadotropin-ReleasingHormone
AnalogStimulation Testing inChildren
Zhuang-jian Xu, Xi-ping Wang, Ya-ping Ma,
Wen-jie Zhang, Xing-fu Pang, Qing Wang,
Shu-yan Xie, and Ting-ting Zhang
Department of Pediatrics, The 4th Aﬃliated Hospital of
Soochow University, Wuxi 214062, Jiangsu Province,
China
Objective. To assess the utility of timed urinary Gn detections
as a substitute for serum gonadotropin determinations
during GnRHa stimulation testing in children. Methods.
Studies during 50 GnRHa stimulation tests in children
with a variety of growth or pubertal development disorders
were performed. Five consecutive timed urine samples were
collected, respectively, after triptorelin injection in all cases
(the ﬁrst was timed 1.5-hour urine, and the others were
timed 1-hour urine, resp.). LH and FSH were measured
by immunochemiluminometric assays (ICMAs). Results.
(1)The peak urinary Gn (UGn) of the consecutive timed
urine samples: the correlation coeﬃcient between the quan-
tities of peak urinary LH(ULH) and serum concentrations of
peak LH(PLH) was 0.852 in ﬁrst 3.5h after triptorelin injec-
tion, for the peak ratio of ULH concentrations/creatinine
(Cr) and serum PLH 0.774, and for (quantities of peak
ULH)/(quantities of UFSHs), UFSHs were the quantities of
urinary FSH in the same sample, and serum PLH/peak FSH
(PFSH) 0.899. In the ﬁrst 4.5h, the correlation coeﬃcient
between the quantities of peak ULH and serum PLH was
0.836, for the peak ratio of ULH concentrations/Cr and
serum PLH 0.774, for quantities of peak ULH/quantities of
UFSHs and serum PLH/PFSH 0.894. The areas under the
receiver operating characteristic (ROC)curves of quantities
of peak ULH, peak ULH concentrations/Cr, (quantities
of peak ULH)/(quantities of UFSHs) for the diagnoses of
onset of HPGA were 0.960, 0.923, and 0.907, respectively,
in ﬁrst 3.5h after triptorelin injection, and in ﬁrst 4.5h,
were 0.952, 0.928 and 0.905, respectively. Excluding the
correlation coeﬃcient between serum PLH and peak ULH
concentrations/Cr (0.816) in ﬁrst 2.5h, and between serum
PLH/PFSH and (quantities of peak ULH)/(quantities of
UFSHs) (0.904) in ﬁrst 5.5h, the above other correlation
coeﬃcients as well as the areas under the ROC curves for
quantities of peak ULH, for peak ULH concentrations/Cr,
for (quantities of peak ULH)/(quantities of UFSHs) in ﬁrst
2.5h and in ﬁrst 5.5h were less than the highest in ﬁrst 3.5h
and in ﬁrst 4.5h, respectively. (2) UGn for diﬀerent timed
urine: the correlation coeﬃcients between the quantities of
ULH and serum PLH in the timed 2.5-hour, 3.5-hour, 4.5-
hour and 5.5-hour urine were 0.815, 0.842, 0.852 and 0.814,
respectively, for the ULH concentrations/Cr and serum PLH
0.802, 0.831, 0.844, and 0.814, respectively. The areas under
the ROC curves of the quantities of ULH for the diagnoses
of onset of HPGA in the timed 2.5-hour, 3.5-hour, 4.5-
hour, and 5.5-hour urine were 0.913, 0.944, 0.958, and
0.923, respectively, for the ULH concentrations/Cr 0.911,
0.940, 0.955, and 0.919, respectively. (3) Serum spontaneous
Gn: the correlation coeﬃcient between serum PLH and
serum spontaneous LH (SLH) concentrations was 0.603,
for serum PLH/PFSH and SLH/spontaneous FSH(SFSH)
0.566; the areas under the ROC curves of serum SLH and
SLH/SFSH for the diagnoses of onset of HPGA were 0.792
and 0.675, respectively. Conclusions. Our data suggest that
urinary Gn determined by ICMA was better than serum
spontaneous Gn dectections during GnRHa stimulation
testing.
Effects of Chinese Herbsfor NourshingYinand
Removing Fire on Expression of
Gonadotropin-Releasing Hormone and
I tsR ec e pt o r ,andG r o wthH o rm o neFSHLHo f
Female RatswithEnvironmentalEndocrine
Disruptors
Qiao Lili, Sun Chunmei, Shen Weiqin,
Fan Zhirong, and Zhang Xiaoli
Objective. To investigate the eﬀects of Chinese Herbs
for Nourishing Yin and Removing Fire on expression
of Gonadotropin-releasing Hormone (GnRH) and GnRH
receptor, Growth Hormone (GH), FSHLH mRNA and
protein of female rats with mixture of octylphenol (OP)
and bisphenol A(BPA). Methods. 21d immature female
SD rats were divided into three groups: control group
(cornoil), exposure group (OP100mg/kg + BPA100mg/kg),
and treatment group (OP100mg/kg + BPA100mg/kg +
Chinese herbs), fed for 14 days, and the expression of
G n R Ha n dG n R Hr e c e p t o r ,G H F S H L Hm R N Aa n dp r o t e i n
were determined by RT-PCR and immunohistochemical
analysis. Results. The expression of GnRH and GnRH
receptor, FSH, LH mRNA and protein signiﬁcantly increased
in exposed group as compared with control group. These
indicators were reduced signiﬁcantly after given Chinese
herbs. Conclusion. Chinese herbs for Nourishing Yin and
Removing Yang can inhibit the abnormal hyper function
of hypothalamus-pituitary ovary in precocious puberty rats
inducedbyEEDSandlowertheresponsibilityofpituitarycell
to GnRH.14 International Journal of Pediatric Endocrinology
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Growth Hormone and IGF-1
Long-Term Survey of 80 Patients with
Childhood-OnsetPrimaryGrowth
Hormone Deﬁciency
Guoying Chang, Zhiya Dong, Wei Wang,
and Defen Wang
Department of Paediatrics, Ruijin Hospital,
School of Medicine, Jiaotong University, Shanghai, China
Objectives.Theaimofthestudywastoevaluatetheﬁnaladult
height (FAH), lipid proﬁle, sexual development and quality
of life in individuals with childhood-onset growth hormone
deﬁciency (CO-GHD), reassess the function of their GH-
IGF-1 axis in the transition from childhood to adulthood,
and explore eﬀective managements for diﬀerent types of
GHD in each period. Methods. 80 CO-GHD patients were
divided into 2 groups isolated growth hormone deﬁciency
(IGHD, n = 22) and multiple pituitary hormone deﬁciencies
(MPHD, n = 58). There were 62 males with age ≥18 years
(24.0 ± 5.3 years in average) and 18 females with age ≥16
years(22.2±4.8yearsinaverage).Wefollowedupclinicaland
biochemical parameters, education and occupation, rhGH
and other hormones therapy in the past. FAH was deﬁned
as bone age ≥16 years for boys and ≥14 years for girls
with the growth rate less than 1cm/year. Results.T h er h G H
replacement therapy improved the FAH of patients with
CO-GHD. FAH standard deviation scores (FAHSDs) were,
respectively, −1.19 ± 0.9, −2.64 ± 1.23 in the rhGH replace-
ment and not group (t = 4.61 P<. 01). Long- or short-
term duration of rhGH treatment during their childhood
show no statistical signiﬁcant diﬀerence in the prevalence of
occurrence of either hyperlipidemia (39.0% versus 47.4%)
or fatty liver disease (26.8% versus 31.6%). Serum IGF-1
and IGFBP-3 remained at low levels; mean IGF-1 SDS and
IGFBP-3 SDS were signiﬁcantly higher in IGHD group than
in MPHD group (−1.43 ± 0.31 versus −3.01 ± 0.66, and
−2.10±0.33 versus −3.17±0.19), respectively. Patients with
IGHDhadnormal sexualdevelopment, but79.7%inMPHD
group revealed sexual dysfunction with hypogonadotropic
hypogonadism. Conclusions. The rhGH replacement therapy
improves FAH of individuals with CO-GHD; serum IGF-
1 and IGFBP-3 levels remain low in the transition period;
GHD patients have a high risk for metabolic abnormalities
in the adulthood; the sexual development is not obviously
impaired in IGHD group, while variable hypogonadotropic
hypogonadism was apparent in all patients with MPHD.
Long-Term Followup of Two Chinese
SiblingGirlswithIsolated GrowthHormone
DeﬁciencyTypeIA
Guoying Chang, Zhiya Dong, Wei Wang,
and Defen Wang
Department of Paediatrics, Ruijin Hospital,
School of Medicine, Jiaotong University, Shanghai, China
Context. Isolated growth hormone deﬁciency type IA (IGHD
IA) is an autosomal recessive disease caused by deletion of
both growth hormone-1 alleles (GH1). We have followed
two sibling girls with IGHD IA into the adulthood; the
ﬁrst case was genetically diagnosed, and received long-term
recombinant human GH (rhGH) therapy. Objectives.T h e
aim of the study was to examine the long-term eﬃcacy
and safety of rhGH therapy for two sisters with IGHD IA,
track their sexual development and reproductive function,
and reassess the quality of life in the adulthood. Subjects.
Two Chinese sibling girls with documented IGHD IA were
enrolled in this study. Genetic analysis showing a 6.7kb
spanning deletion of GH1 gene was identiﬁed before. They
had been diagnosed at 11.7yr, 8.4yr, respectively, with the
height 89.3cm (−7.8SDs), 80.6cm (−8.8SDs), and started
rhGH substitution then. The duration of treatment was
for 6.2 and 7.3 years. In the last visit, the ages were 31
and 29 years. Methods. We retrospectively reviewed the
case notes of these 2 sisters, followed up their height,
weight, blood pressure, and sexual development, measured
fasting blood lipids, glucose, insulin, IGF-1, and IGFBP-3
and assessed educational and occupation status, and the
growth and development of their children. Results. rhGH
replacement had a signiﬁcantly eﬀe c to ng r o w t hw i t hn o
evident side eﬀects. The ﬁnal adult height was 146.1cm
(−2.6SDs) and 153.0cm (−1.3SDs), they had normal spon-
t a n e o u sp u b e r t a ld e v e l o p m e n ta n dm e n a r c h ea ta g e s1 5 . 2y r
and 14.1yr. Without rhGH treatment, pregnancy occurred
spontaneously and was complicated by gestational diabetes
mellitus (GDM). The growth and development of their
children were normal. Levels of growth factors were still low
intheadulthood,IGF-1(46.6ng/ml,52.4ng/ml)andIGFBP-
3 (2460ng/ml, 2430ng/ml). Though there was no metabolic
syndrome happened, the fasting blood glucose rose with age
(6.6mmol/L). Conclusions. Long-term therapy with rhGH
improves ﬁnal adult height of individuals with IGHD IA;
they can have normal sexual development and pregnancy,
but there is a higher risk for metabolic abnormalities in the
adulthood.
Combined Treatment withGrowth Hormone
andGonadotropin-Releasing Hormone
AnalogueinAdolescent Childrenwith
Idiopathic Short Stature
Yuechun Teng, Wei Wang, Zhiya Dong, Jihong Ni,
and Defen Wang
Department of Paediatrics, Ruijin Hospital,
School of Medicine, Jiaotong University, Shanghai, China
Background. Idiopathic short stature (ISS) characterized by
heterogeneous genetic disorders show their adult height may
havebeneﬁtbytreatmentwithrhGHaloneorcombinedwith
GnRHa when puberty developed, but still controversy on
the variable eﬀect on ﬁnal adult height gain. Objectives.T h eInternational Journal of Pediatric Endocrinology 15
aim of this study was to assess the eﬃcacy of combination
therapy with rhGH and GnRHa in Chinese children with ISS
in early puberty. Methods. 30 children with ISS (15 males,
15 females), average age 11.9 years, with a height SD score
of −2 SD or less in early puberty (Tanner stages 2-3), were
treated with GnRHa (80 100μg/kg every 28 days) and rhGH
(0.1–0.15IU/kg every night) for at least one year. 16 of them
continued treatment for two years. Annual growth velocity
(GV), bone age (BA), height SD score for CA (HtSDSCA),
height SD score for BA (HtSDSBA), and predicted adult
height (PAH) SDS were assessed. Results. The following
parameters all increased signiﬁcantly; GV 2.3 ± 1.2t o6 .7 ±
1.4cm/years(P<. 05); HtSDSCA −1.9 ± 0.4t o−1.5 ± 0.7;
HtSDSBA −2 ± 0.6t o−1.5 ± 0.4; PAHSDS −1.8 ± 0.7t o
−1.1 ± 0.7w i t hP value all <.001. BA/CA decreased from
1 ± 0.1t o0 .9 ± 0.1( P<. 05). By the end of the second year
treatment, the GV slowed from 6.7±1.4t o5 .5±1.8cm/years
(P<. 05), but was still much higher than pretreatment.
HtSDSCA increased from −1.5±0.7t o−1.3±0.5, HtSDSBA
from −1.5 ± 0.4t o−0.9 ± 0.7, and PAHSDS from −1.1 ±
0.7t o−0.6 ± 0.7; these diﬀerences were also signiﬁcant
(P<. 001). Conclusion. This result demonstrated that
this combined treatment regimen signiﬁcantly improved the
growth by delayed bone maturation and improved growth
rateinpubertalchildrenwithISS.Furtherfollowupisneeded
to verify the beneﬁcial eﬀects on ﬁnal height gain.
ComparativeEvaluationof Short-Term
PredictiveMarker Response to Growth
Hormone Treatment in Children with
GHD Born Appropriate for Gestational Age or
Small for Gestational Age:
R es ul tsf r o maPh aseIVOpe n-LabelS tud y
Wenli Lu,1 Wei Wang,1 Defeng Wang,1
Shuixian Shen,2 Xue Fan Gu,3 Xiaoping Luo,4
Chunxiu Gong,5 Minlian Du,6 Li Liang,7
Runming Jin,8 and Qing Zhou9
1Ruijin Hospital, Jiaotong University, Shanghai, China
2Children Hospital, Fudan University, Shanghai, China
3Xinhua Hospital, Jiaotong University, Shanghai, China
4Tongji Hospital, Tongji Medical College of Huazhong
University of Science Technology, Wuhan, China
5Children Hospital, Beijin University, Beijin, China
6First Aﬃliated Hospital, Zhongshan University,
Guangzhou, China
7Children Hospital, Zhejiang University, Hangzhou, China
8Xiehe Hospital, Wuhan, China
9MERCK-SERONO Pharmaceutical Ltd, Germany
Context. It is well known that GHD children born SGA
who do not catch up are at signiﬁcantly higher risk of
short stature than children born AGA. SGA children with
short stature have GH secretion abnormalities and lower
levels of IGF-I. GH therapy can improve adult height in
short stature children born SGA, but with large individual
eﬃcacy diﬀerences. There is no eﬀective and practical
prediction model for the eﬃcacy of GH treatment in
GHD children born AGA or SGA. Objective.T oe v a l u a t e
the short-term changes in GH-dependent biomarkers with
GH treatment between GH-treatment-na¨ ıve Chinese GHD
children born AGA or SGA. Methods.D a t aa r ef r o m8
centers participating in a phase IV open-label interventional
Merck Serono study of recombinant human GH (r-hGH)
treatment in GHD children. 213 GHD children, 183 AGA
(134 males, 49 females; age 10.5 ± 3.8 years) and 30 SGA
(24 males, 6 females; age 9.4 ± 4.3y e a r s ) ,w e r eg i v e n
daily GH for 4 weeks (0.1IU/kg/day). All children were
assessed pre- and posttherapy for changes in growth-related
biomarkers (IGF-I and IGFBP3) and metabolic markers
(fasting glucose, insulin, total cholesterol and HOMA-
IR). Results. The 213 GHD children had a baseline mean
GH peak level of 4.5±3.1ng/mL, 116 of whom (54.5%)
had complete GHD (<5ng/mL) and 97 (45.5%) partial
GHD (<10ng/mL). Baseline serum IGF-I SDS and IGFBP3
SDS values were signiﬁcantly lower than normal in all
children (mean values −2.0 and −1.2, resp.), but there
were no signiﬁcant diﬀerences between the two groups.
Serum IGF-I levels increased by 1.30SD (P<. 0001), and
IGFBP3 levels increased by 0.85SD (P<. 0001) in all
children from baseline to 1 month. No signiﬁcant diﬀerences
between the GHD-AGA group and the GHD-SGA group
were found in any serum biomarker or metabolic marker
changes at 1 month. Conclusions. These data show that
one month of r-hGH therapy signiﬁcantly increased serum
levels of growth-related biomarkers (IGF-I and IGFBP3)
in GHD children, but there were no diﬀerential eﬀects
of therapy on growth-related biomarker and metabolic
marker changes between GHD children born AGA or SGA.
This suggests that the eﬃcacy of r-hGH treatment may
be predicted by short-term changes in IGF-I and IGFBP3
in all GH-treated GHD children, including those born
SGA.
Association between Single Nucleotide
Polymorphisms of Growth Hormone Receptor
andthe Risk of Idiopathic Short Stature
Yi Yu,1 Wei Wang,2 Wei Huang,3 Ying Wang,3
Zhiya Dong,2 Yuan Xiao,2 and Defen Wang2
1Jiulong Hospital, Shanghai Jiaotong University,
Suzhou, China
2Ruijin Hospital, Medical School, Shanghai Jiaotong
University, Shanghai, China
3Chinese National Human Genome center Shanghai, China
Background. The linear growth of children is a complex
process, involving both the internal (genetic) and external
(environmental) factors. Children with idiopathic short
stature (ISS) reveal no obvious pathologic ﬁndings, but
some of them may present partial GH (growth hormone)
insensitivity normal or higher serum GH levels and lower
serum concentrations of insulin-like growth factor 1 (IGF-I)16 International Journal of Pediatric Endocrinology
or GH-binding protein (GHBP). It has been reported
that defects of GH receptor (GHR) gene as well as with
their polymorphism could be associated with ISS. Aim.
This study was to investigate the association of certain
single nucleotide polymorphisms (SNPs) of the GHR with
genetic susceptibility to ISS. Method.G e n o m i cD N Aw a s
extracted from peripheral blood of children with ISS (n =
199) and of normal growth and development individuals
as controls (n = 469). TagSNPs of GHR were selected
from HapMap CHB subset and genotyping were con-
ducted through the Illumina genotyping system. In single
locus analysis, the risk of short stature was statistically
a n a l y s e d .S e r u mI G F - Ia n dI G F B P - 3l e v e l sw e r em e a s u r e d
in all patients. The association between the GHR gene
polymorphisms with the height-related clinical traits was
analysed. Result. 16 SNPs at GHR gene had been selected,
but only 3 of which (rs4410646, rs10044169, and rs6182)
showed their genotype frequency in children with ISS,
and were signiﬁcantly diﬀerent from those of controls
(P<. 05). However, there are no signiﬁcant diﬀerences
in their allele frequencies between the two groups. The
genotypes of rs4410646 and rs6182 were respectively asso-
ciated with the serum IGF1 levels (P<. 05). Conclusion.
The results of our study supported the view that GHR
gene polymorphisms play a role in the pathogenesis of ISS.
Further research on the mechanism of these tagSNP may be
needed.
Analysisof Relationship betweenGrowth
Response duringGrowth Hormone Treatment
in Short Children Born withIntrauterine
GrowthRetardation andSerum Levelof
Insulin-LikeGrowthFactor-1and
Insulin-LikeGrowthFactor Binding Protein-3
Zhaowen Chen and Zheng Zheng Zhan
Jin Shan Hospital of Fudan University,
Shanghai 200540, China
Objective. Our study is to evaluate the eﬀect of growth
hormone (GH) treatment in short children born with IUGR
and to explore the relationship between pretreatment serum
level of insulin-like growth factor-1 (IGF-1), insulin-like
growth factor binding protein-3 (IGFBP-3). Method.T o
collect 50 cases of short prepubertal children born with
IUGR received growth hormone treatment at least one year
in our hospital, comparing the diﬀerences of growth velocity
before and after GH treatment and analyzing the relevance
of pretreatment serum levels of IGF-1, IGFBP-3. According
to their GH secretory status, they were divided into two sub-
groups, growth hormone deﬁciency (GHD) subgroup and
non-GHD subgroup, comparing the diﬀerences of growth
response between both groups. Result.( 1 )T h eg r o w t h
velocity of short children born with IUGR signiﬁcantly
improved afterGH treatment, 3.29400±0.65040cm/y versus
11.234 ± 1.3338cm/years. (2) Pretreatment serum level of
I G F - 1 ,I G F B P - 3b o t hh a v en e g a t i v ec o r r e l a t i o n sw i t hg r o w t h
velocity after GH treatment, (r =− 0.589 and −0.342, resp.).
(3) Comparing the diﬀerences of growth response after GH
treatment, there was no signiﬁcant diﬀerences between GHD
subgroup and non-GHD subgroup. Conclusion. (1) Good
growth response in growth velocity among short children
born with IUGR shows that GH can eﬀectively improve
the height of short children born with IUGR. (2) The
negative correlation of pre-treatment serum level of IGF-1,
IGFBP-3 with growth velocity after GH treatment, indicates
that the lower pre-treatment serum IGF-1, IGFBP-3 level,
the better clinical eﬀect of GH treatment. Pre-treatment
serum level of IGF-1 and IGFBP-3 can be considered as
makers predicting the growth response of GH treatment in
short children born with IUGR. (3) The growth response
between GHD subgroup and non-GHD subgroup shows
no signiﬁcant diﬀerence, which shows that the decision
to treat a short IUGR child with GH therapy should
not be based upon the GH response to a provocative
test.
T h eS t ud yo nt h eC h a n g eo fBo n eM a t ura tio n
SpeedandFinalAdult Heightof Childrenand
Adolescents under Treatment by
GrowthHormone
Kyung Rae Cho
Department of Pediatrics, Masan Samsung Hospital,
Sungkyunkwan University School of Medicine, Masan,
Korea
Purpose. The purpose of this study was to evaluate the trend
of the change of bone maturation speed and its eﬀect on
ﬁnal adult height in patients of idiopathic short stature.
Methods. Midparentral height, bone age, predicted adult
height, ﬁnal height, and the change of bone maturation
speed were calculated in 37 people who were diagnosed
with idiopathic short stature and treated with recombinant
human growth hormone. We analysed these factors, then
studied the correlation between the treatment period and
the change of bone maturation speed, and the relation
between the change of bone maturation speed and ﬁnal
adult height. Results. As time passes, the bone maturation
speed was accelerated by the time passage in all patients.
Predicted adult height increased until 21.2±6.3 months after
start of growth hormone treatment, thereafter decreased
gradually. If midparental height is the target height, the
ﬁnal height attained was 3.3 ± 2.7cm more. Final height
was 4.5 ± 5.7cm less than maximal predicted height, but
3.7 ± 2.2cm more than ﬁrst predicted height. Conclusion.
Even though predicted adult height will increase, then
decrease and bone maturation speed will be accelerated
in the people who were treated with recombinant human
growth hormone, ﬁnal height of patients was increased
in comparison with midparental height and ﬁrst predicted
height.International Journal of Pediatric Endocrinology 17
Novel Compound Heterozygous Mutations for
the IGF-1Receptor CausingSevere Pre-and
PostnatalGrowthFailureand
DysmorphicFacialFeatures:A FamilyStudy
Yoon Hi Cho,1 Peng Fang,2 Michael A. Derr,2
Vivian Hwa,2 Ron Rosenfeld,2 and Chris Cowell1
1Institute of Endocrinology and Diabetes,
The Children’s Hospital at Westmead, Australia
2Department of Pediatrics, Oregon Health & Science
University, Portland, Oregon 97239-3098, USA
Aim. To describe the clinical outcomes of siblings with severe
IGF-1 resistance. Method. Severe IGF-1 resistance was found
in a male proband and younger sister. Molecular analysis of
the IGF1R-gene in revealed novel compound heterozygous
mutations, E121K(exon 2) and E234K(exon 3). Parents
were heterozygous carriers (Table 1). Results. Patient 1
was born small for gestational age (SGA) at 36wks to
consanguineous Lebanese parents. At age 3.4 years, height
was 72.2cm (SDS −7.33) with height velocity 3.5cm/years,
weight 6.9kg (SDS −9.31) and head circumference 42.5cm
(SDS −5.1). Bone age was 1.8 years. GH levels were
nondeﬁcient, IGF-1 persistently elevated and IGFBP-3 was
within normal range. A one-year trial of GH therapy (14–
28IU/m2/wk) did not result in catch-up growth. At age
14 years, antibody-negative insulin-dependent diabetes was
diagnosed. He required learning support for intellectual
disability. Final height at age 20.3 years was 133.2cm.
Facialfeaturesincludebroadnasalbridge,synophrys,promi-
nent epicanthii, low set ears, thin upper lip and small
opalescent teeth. He has central adiposity and lumbar
lordosis. Patient 2 was born SGA at 38wks. Total pul-
monary anomalous venous return, diagnosed postnatally,
was repaired successfully. Severe growth failure ensued
despite stable cardiac condition. IGF-1 was 1.71U/mL
(0.15–0.7). Similar facial dysmorphic features as Patient 1
were present. Other features included left convergent stra-
bismus, ﬁfth ﬁnger clinodactyly and caf´ e-au-lait lesions.
At age 5 years, an abdominal Burkitt’s lymphoma was
diagnosed, resulting in fatal recurrence after six-months
therapy. Conclusions. Patient 1 demonstrates a novel com-
poundheterozygousmutationfortheIGF-1receptorcausing
severe pre- and postnatal growth failure and dysmorphic
facial features. Possible associations arising from this family
study include intellectual disability, nonimmune-mediated
insulin-dependent diabetes mellitus and aggressive malig-
nancy.
ClinicalandFunctional Characteristicsof
the IGF1RGeneMutationin Patients with
IntrauterineGrowthRetardation andPostnatal
Catch-UpGrowthFailure
Jin-Ho Choi,1 Min-Ji Kang,2 Maria Hong,2
Eul-Ju Seo,2 Jung-Young Park,2 Gu-Hwan Kim,2
Hye Young Jin,1 Beom-Hee Lee,2 Se-Min Lee,3
and Han-Wook Yoo1,2
1Division of Pediatric Endocrinology and Metabolism,
Department of Pediatrics
2Medical Genetics Clinic and Laboratory, Asan Medical
Center Children’s Hospital, University of Ulsan College of
Medicine, Seoul, Korea
3Department of Pediatrics, Hanyang University Guri
Hospital, Seoul, Korea
Purpose. Around 10% of infants born with intrauterine
growth retardation (IUGR) remain short, and the causes
of their growth deﬁcits are often unclear. It is postulated
that heterozygous IGF1R mutations underlie some cases of
IUGR and postnatal growth failure. The objective of this
study was to describe the clinical features of patients with
IGF1R mutation and evaluate the molecular and functional
characteristics of a novel IGF1R mutation. Methods.T h r e e
children with unexplained IUGR (birth weight < −1.5 SDS)
and persistent short stature (< −2.0 SDS) were included
in this study. Auxological and endocrinological proﬁles
including serum IGF-1 and IGFBP-3 levels, were measured.
All coding regions including intron-exon boundaries of the
IGF1R gene were PCR ampliﬁed and directly sequenced. To
study the functional eﬀect of the IGF1R gene mutation on
IGF-1 signaling, IGF1R protein expression, IGF1R phospho-
rylation,andIGF-1-dependentAktandErkphosphorylation
were measured by Western blotting using speciﬁc antibodies.
Arraycomparativegenomehybridization(CGH)wascarried
out to delineate the size and breakpoint of the cytogenetic
abnormalities in a patient with dysmorphic features and
multiple anomalies. Results. IGF1R gene analysis identiﬁed a
novel heterozygous mutation of c.330del (p.Ala110fsX20) in
exon 2, resulting in a frame shift with premature termination
of IGF1R protein. Her father and elder brother also carried
the same mutation, indicating an autosomal dominant
inheritance. The expression of IGF1Rβ protein is reduced
in patients compared with control cell lines. IGF-1-induced
autophosphorylation of P-Tyr of IGF1R and phosphoryla-
tion of downstream signaling protein Akt were increased in
a dose-dependent manner, less eﬃciently in a patient. Akt
phosphorylation in patient cells needed signiﬁcantly higher
IGF-1 concentrations than control ﬁbroblasts despite equal
amountsoftotalAktproteins.ArrayCGHofchromosome15
of a patient with dysmorphic features and multiple anoma-
lies identiﬁed a heterozygous deletion of 15q26.2 to 15qter.
Conclusions. The novel heterozygous mutation resulted in
reduced IGF1R expression and represents haploinsuﬃciency
of the IGF1R gene. The novel heterozygous mutation in the
α-subunit of the IGF1R found in three members of one
family leads to IUGR and postnatal growth. Fibroblasts from
the c.330del (p.Ala110fsX20) propositus studied in vitro
exhibited decreased IGF1R expression and IGF-1 resistance,
as assessed by IGF1R phosphorylation and postreceptor
signal transduction. The study suggests that IGF1R mutation
should be considered in diﬀerential diagnosis in familial
IUGR patients without catch-up growth.18 International Journal of Pediatric Endocrinology
Table 1
Patient 1 Patient 2 Mother Father
Genotype E121K/E234K E121K/E234K E121K E234K
Birthweight SDS −2.79 (1.55kg) SDS −3.23 (1.8kg) — —
Birth length SDS −3.53 (39cm) SDS −0.77 (47cm) — —
Clinical associations Antibody negative Burkitt’s Lymphoma Normal phenotype Normal phenotype
diabetes mellitus
Height at 4-5 years SDS −6.4S D S −3.5
Final height SDS −5.91 (133.2cm) — SDS −1.16 (155.6cm) SDS −1.44 (166.5cm)
IGF-1 (nmol/L) 95.6 (RR 17.0–60.2) — 23.8 (RR 15.1–42.1) 22.0 (RR 15.1–42.1)
IGF-BP3 (mg/L) 5.8 (RR 2.9–7.2) — 4.1 4.4
FactorsInﬂuencingGrowth Response to
Growth Hormone Therapy in Prepubertal
ChildrenwithChronic Kidney Disease
Jae Hyun Kim,1,2 Young Ah Lee,2 Min Jae Kang,2
Sei Won Yang,2 and Choong Ho Shin2
1Department of Pediatrics, Inje University,
Ilsan Paik Hospital, Goyang, Korea
2Department of Pediatrics, College of Medicine,
Seoul National University, Seoul, Korea
Purpose. Chronic kidney disease (CKD) is a cause of short
stature and recombinant human growth hormone (rhGH)
has been used to treat growth failure in CKD patients.
T h ea i mo ft h i ss t u d yw a st oe v a l u a t eg r o w t hr e s p o n s eo f
rhGHandfactorsaﬀectinggrowth-promotingeﬀecttorhGH
therapy in growth-retarded prepubertal patients with CKD.
Subjects and Methods. This study included 36 patients, who
wereprepubertalduring therhGHtherapy.Inclusion criteria
were as follows: patients on dialysis or conservatively treated
patients with glomerular ﬁltration rate of <60ml/minutes
per 1.73m2, calculated by Schwartz equation; height of −2
standard deviation score (SDS) or height velocity (HV) of
<4cm/years. All patients were treated with rhGH up to
3y e a r s .Results. Among patients, 23 were on conservative
treatment, and 13 were on dialysis at initiation of rhGH
treatment. All patients were treated with rhGH at least
for one year, 21 for two years, and 12 for three years. In
conservatively treated patients, predicted adult height (PAH)
SDS was −1.6 ± 0.7 before rhGH treatment and −0.9 ± 0.7
after rhGH treatment (P<. 001); in patients on dialysis,
PAH SDS before and after rhGH treatment was −1.8 ±
1.6a n d−1.1 ± 1.5, respectively (P = .073). However,
PAH SDS of all subjects was increased signiﬁcantly from
−1.7 ± 1.1t o−1.0 ± 1.1 after rhGH treatment (P<. 001)
(Table 2).Conclusion.InpatientswithCKD,rhGHtreatment
signiﬁcantly increased height SDS, diﬀerence in height SDS,
HV and PAH SDS in the short term. Long-term followup is
to be warranted to elucidate the eﬀect of rhGH to the ﬁnal
height.
Long-Term Effects of Recombinant Human
Growth Hormone Replacement Therapy on
Adrenal Cortical Function in Children with
Growth Hormone Deﬁciency
Qian Wang and Guimei Li
Xiaojun Sun, Lijuan Zhang Provincial Hospital Aﬃliated
to Shandong University, Jinan 250021, China
Objective. To investigate the dynamic changes of cortisol
(COR) and ACTH in growth hormone deﬁciency (GHD)
children after long-term hormone replacement therapy
(HRT). Methods. 50 growth hormone deﬁciency (GHD)
children, whose clinical information were complete and
had injected rhGH for more than 1 year were divided
into Group I (GHD) and Group (MPHD). These patients
were followed up in 3 monthly interval, serum levels of
cortisol and adrenocorticotropic hormone (ACTH) were
measured. Results. According to the data of 50 growth
hormone deﬁciency (GHD) children, 60% patient’s levels
of cortisol were decreased in group MPHD. Hydrocortisol
replacement therapy was started before or at the same time
of HRT. There was a signiﬁcant negative linear regression
between the replacement therapy dosage of hydrocortisol
and pretreatment level of COR, giving a regression equation
of dosage of hydrocortisol (mg·m-2·d-1) = 15.6–0.11×pre-
COR (pmol/L) (r =− 0.88, F = 35, P<. 01). This also
occured in isolated growth hormone deﬁciency (IGHD)
patients, but the level of COR was maintained in normal
range. The pretreatment levels of COR was positively
correlated with the peak of growth hormone (GH), serum
level of insulin-like growth factor-1 (IGF-1) and height of
anterior pituitary and negatively with pretreatment bone
age diﬀerence (CA-BA). Conclusion. Central hypoadrenalism
with symptoms or no symptoms can be observed in majority
of MPHD children, which may be exacerbated during the
process of rhGH therapy. Complete hormone replacement
therapy and regular monitoring are necessary to maintain
COR in lower limit for the best growth eﬀect of rhGH
therapy. Hydrocortisol is not needed in IGHDInternational Journal of Pediatric Endocrinology 19
Table 2: Eﬀects of 1 to 3 years of rhGH treatment on height SDS, height SDS diﬀerence and height velocity in prepubertal patients with
CKD analyzed by repeated measures ANOVA.
n rhGH treatment
Baseline 1 year 2 years 3 years
Height SDS
36 −2.7 ±0.9 a −2.1 ±1.0 b
21 −2.6 ±0.7 a −2.0 ±0.9 b −1.6 ±1.0 c
12 −2.7 ±0.9 a −2.1 ±1.0 b −1.8 ±1.1 c −1.6 ±1.1 d
Height SDS diﬀerence
36 −0.4 ±0.6 a 0.6 ±0.4 b
21 −0.2 ±0.5 a 0.7 ±0.4 b 0.3 ±0.4 c
12 −0.1 ±0.5 a 0.7 ±0.4 b 0.3 ±0.4 c 0.2 ±0.3 a,c
Height Velocity (cm/years)
36 4.5 ±1.9 a 8.0 ±1.9 b
21 4.8 ±2.0 a 8.7 ±1.9 b 7.0 ±1.7 c
12 4.6 ±2.3 a 8.3 ±1.5 b 6.5 ±1.7 c 6.0 ±1.3 a,c
Values not sharing superscript a, b, and c letters are signiﬁcantly diﬀerent from the values of other time points within each row.
C o rr el atio no fEx o n4,6,and10
Single Nucleotide Polymorphisms of
GHRGenewith Idiopathic Short Stature
Chen Linqi,1 Li Shiqin,1 Wang Ying,2 Xie Rongrong,1
Zhang Xuelan,1 and Wu Haiying1
1Suzhou Children’s Hospital, Suzhou University,
Jiangsu, China
2Shang Hai Mankind Gene Group, Shanghai, China
Objective. The GHR gene polymorphisms have been found
in idiopathic short stature. We studied the GHR (growth
hormone receptor) gene exon 4, 6, and 10 SNPs and inves-
tigated the inﬂuence of these SNPs on serum IGF-I and IGF-
BP3, their inﬂuence on the axis of GHRH-GH-IGF-1, and
height. Methods. 30 idiopathic short stature children who
were in prepuberty were recruited in Soochow University
Aﬃliated Children’s Hospital between the September of 2008
and the July of 2009; average age was (8.39 ± 2.86 years).
45 controls (these controls were separated into 2 groups,
one was normal group which contained 20 children whose
heights were normal, the other contained 25 children whose
heights were between the ISS and the normal) were collected
in Soochow University Aﬃliated Children’s Hospital at the
same time, they were all in prepuberty. We measured the
serumlevelsofIGF-1andIGF-BP3incasegroupandcontrol
group with chemiluminescence method, and contrast the
case group and control group. We drew the DNA from the
blood of the case group and control group children. Analysis
of Polymerase Chain Reaction-Single Strand Conformation
Polymorphism (PCR-SSCP) and DNA sequencing were both
used to identify mutation in the GHR gene exons 4, 6, and
10. We contrasted the polymorphism of the GHR gene exon
4, 6, and 10 between the control and case group. Using the
χ2 test to detect the sex diﬀerence genotype and the allele
frequency, using t-test and rank sum test to detect the age
IGF-1 and IGF-BP3, using the OR to describe the risk ratio
of the genotype and the allele frequency using the analysis of
variance to detect the diﬀerence on IGF-1 and IGF-BP3 in
serum among every genotype. All the data were processed
using software of SAS 8.0. Result. There is no diﬀerence
between the case group and control group in age and sex
(P>. 05). The serum level of IGF-1 of ISS was not normally
distributed, in contrast with the control group. Using t test
between the-1SD group and normal group, no diﬀerences
were found (P>. 05); using rank sum test between the ISS
group and normal group, there were diﬀerences (P<. 05);
using rank sum test between the ISS group and-1SD group,
there were diﬀerences (P<. 05); the serum level of IGF-BP3
of ISS and normal group are nonnormal distribution, and
the-1SD group is normal distribution. Using rank sum test,
there was no diﬀerence between the-1SD group and normal
group (P>. 05), there was a diﬀerence between the ISS
group and-1SD group and between the ISS group and the
normal group (P<. 0001). We did not ﬁnd any base change
on exon 4. We found a SNP on exon 6, it is 6 119 A>G
(G168G) and another SNP on exon 10, which was 10 377 G
> T(C422F). There was no diﬀerence in genotypic frequency
and allele frequency on exon 6 119SNP among these groups
P>. 05; there was no diﬀerence in genotypic frequency and
allele frequency on exon 10 377SNP among these groups
P>. 05. On exon 6 119SNP here was no diﬀerence on serum
level of IGF-1 among every genotype P>. 05. On exon
10 377SNP here was no diﬀerence on serum level of IGF-1
among every genotype P>. 05. On exon 6 119SNP there
was no diﬀerence on serum level of IGF-BP3 among every
genotypeP>. 05.Onexon10377SNPherewasnodiﬀerence
on serum level of IGF-BP3 among every genotype P>. 05.
Conclusions. The serum level of IGF-1 can be the diagnosis
index of prepubertal ISS. The serum level of IGF-BP3 can
be the diagnosis index of prepubertal ISS. The SNP on GHR
exon 6 119 is not concerned with ISS. The SNP on GHR
exon 6 119 cannot inﬂuence the serum level of IGF-1 and
IGF-BP3. The SNP on GHR exon 10 377 is not concerned
with ISS. The SNP on GHR exon 6 377 cannot inﬂuence the
serum level of IGF-1 and IGF-BP3. We should enlarge the
number of the objects of study and engineer more primers
so to make clear the reason of the decrease of IGF-1 and
IGF-BP3.20 International Journal of Pediatric Endocrinology
User Acceptance of the Easypod Growth
Hormone Autoinjection Device: Survey Results
from 824 Children andTheir Parents
Fu-Sung Lo,1 Mauro Bozzola,2 Michel Colle,3
Maria Halldin-Stenlid,4 Sylvain Larroque,5
and Monia Zignani5
1Chang-Gung Memorial Hospital Linkou Wenhua 1st Road,
Linkou, Taiwan
2Fondazione IRCCS San Matteo, University of Pavia,
Pavia, Italy
325 rue Boudet, Bordeaux, France
4Uppsala University, P.O. Box 256 SE-751 05 Uppsala,
SWEDEN
5Merck Serono S.A.-Geneva, Germany
Background. Easypod is an electronic autoinjector for GH
(Saizen, Merck Serono) administration. Aims. To assess
patient acceptance of easypod and eﬀect on adherence
to recombinant human growth hormone (r-hGH) therapy
through a large-scale survey study in 15 countries (Europe
and Latin America). Methods. Study subjects were children
using easypod for ≤3 months and their parents. After
institutional approvals were required and appropriate con-
sent/assent procedures, the survey was administered by the
nurse or investigator. Children and their parents were asked
to rate speciﬁc easypod features on 5-point scales. Self-
reported adherence to r-hGH therapy was also recorded,
with those who reported missing ≤2 injections per month
(92% of injections given) considered to be adherent to
treatment. Adherence was also assessed by downloading the
electronically recorded injection history from each easypod
device. The dose-log diary was locked for patient/parent
access during the 3-month study period. Results. A total of
824 children using easypod were surveyed (median (range)
age: 11 (1–18) years; 56% were boys); 73% were na¨ ıve
to r-hGH therapy. 39% were responsible for their own
injections (median (range) age 13 (5–18) years), parents
were responsible in 53% of cases (median (range) age 9 (1–
18) years) and 7% involved shared responsibility. Easypod
was rated as easy/very easy to use by ≥80% (ease of
use; preparation of the injection; changing cartridge and
needle; holding and gripping the device). The injection was
considered to be of short duration by 85%, as silent/almost
silent by 84% and as painless or less painful than expected
by 62% and 58%, respectively. In addition, 90% of children
consideredeasypodcomfortable/verycomfortabletouseand
92% wanted to continue to use it. For reported adherence,
52% of children missed ≥1 injection over the 3-month
period, mainly due to forgetfulness (46% of reasons given).
Overall, the electronically recorded adherence showed that
84% of children/parents were adherent (performed ≥92%
injections). Adherence was signiﬁcantly higher in treatment-
na¨ ıve children (87%) than in those previously treated (78%)
(P<. 05). For 82% of children, reported and recorded
adherences were the same. Conclusions. Children and parents
reported that easypod was easy to use. Most adhered to
therapy and wanted to continue using the device. These
results demonstrate patient acceptance and clinical interest
of an electronic injection device for daily recording and
administration of r-hGH.
ClinicalAppearance on Child and
T ee n ag eEn d o r c rin eO u tp atie n t sat
Dr.SaifulAnwar GeneralHospital,
Malang, Indonesiabetween2005 and 2009
Harjoedi Adji Tjahjono
Department of Child Health, Brawijaya University
Medical Faculty/Dr. Saiful Anwar General Hospital,
Malang Indonesia
Background. Many people and medical practitioners do not
fully understand the importance of prompt and special
treatment from pediatric endocrine specialists. Research
Objective. To ﬁnd as much relevant data as possible on
pediatric and teenage endocrinology patients at Dr. Saiful
Anwar General Hospital, Malang between 2005 and 2009.
Methods. This was a retrospective, descriptive study using
data obtained from medical records. Results.O v e r5y e a r s
there were 576 endocrine patients, of which 346 (60%) were
males and 230 (40%) were females. Ages ranged from ﬁrst
time treatment 224 patients (39%) aged from 0–5 years, 144
patients (25%) aged 5–10 years, 150 patients (26%) aged 10–
15 years and 58 (10%) aged over 15 years. Their diagnoses
found: diabetes mellitus 144 (25%), and Short stature 89
(15%), Undescended testes 56 (10%), Hypothyroid 54 (9%),
Obesity 54 (9%), Micropenis 41 (7%). Other ailments
found: Hypothyroid, Disorders of Development, Pubertal
Disorders, Hypospadia, Premature Telarche, Down’s Syn-
drome, Gynecomastia, Turner’s Syndrome, Achondropla-
sia, Osteogenesis Imperfecta, Tirotoxicosis, Marfan’s Syn-
drome, Cushing’s Syndrome and Osteoporosis. Conclusion.
The most common disorders were Diabetes Mellitus 144
(125%), Short stature 89 (15%), and Undescended Testis 46
(10%).
X-LinkedRecessiveCombinedPituitary
Hormone Deﬁciency Is Mapped to
Xp22.1-Xp21.3 inaChineseFamily
Chun Lin Wang, Zhen Shen, Li Liang,
Chao Chun Zou, Jun Fen Fu, and Guang Pin Dong
Department of Endocrinology, Children’s Hospital of
Zhejiang University School of Medicine, Hangzhou 310003,
China
Introduction. Combined pituitary hormone deﬁciency
(CPHD) is associated with deﬁciencies of growth hormone
(GH) and one or more of the other ﬁve anterior pituitary
hormones. Genetic mutations have been identiﬁed in a
modest proportion of patients with CPHD, including a
number of autosomal genes (POU1F1, HESX1, PROP1)
and X chromosome gene (SHOX, SOX3). Methods.w e
reported a three-generation family consisted of 16 subjects,International Journal of Pediatric Endocrinology 21
including 5 aﬀected males with hypothyrosis and GH
deﬁciency. Genomic DNA was extracted from venous
blood and 19 polymorphic DNA markers spread over
the X chromosome were analyzed (DXS1060, DXS8051,
DXS987, DXS1226, DXS1214, DXS1068, DXS993, DXS991,
DXS986, DXS990, DXS1106, DXS1001, DXS1047, DXS1062,
DXS1211, DXS984, DXS1205, DXS8091, DXS1073). Linkage
analysis by MERLIN software and haplotyping was done.
Results. All the aﬀected males had the same haplotype on
X chromosome and signiﬁcant LOD scores were detected
between DXS987 (Xp22.1-Xp21.3) and DXS 1226 (Xp22).
Conclusion. CPHD with this family was the X-linked
recessive inherited disease and the pathogenical gene was
mapped to Xp22.1-Xp21.3.
PEG-Rhgh Therapy for Small or
GestationalAge Ratsand Effectson
TheirMetabolicParameters
Yanping Xu,1 Huang Ke,1 Li Liang,1 Xiumin Wang,1
Jin Pei,2 and Lizhong Du1
1Department of Endocrinology, The Children’s Hospital of
Zhejiang University School of Medicine and Zhejiang Key
Laboratory for Diagnosis and Therapy of Neonatal Diseases
2Department of Biochemistry and Molecular Biology,
Pharmacy School of Jilin University, Changchun 130021,
China
Aims. To establish a rat model of small for gestational
age (SGA), to evaluate the eﬀect of the PEG-rhGH in
improving growth and to elucidate possible mechanisms
for human metabolic syndrome in SGA subjects. Methods.
Ten pregnant rats were randomly divided into two groups:
(1) oﬀspring from each undernourished rat whose birth
weight less than −2SD as SGA model (2) oﬀspring from
each standard-nourished whose birth weight between mean
±1SDascontrols.Glycometabolism,bloodpressure,glucose
tolerance test and IGF-1 levels were analyzed. Insulin,
IGF-1, PTP1B mRNAs were determined using real-time
PCR. Results. Maternal undernutrition resulted in fetal
growth retardation, inﬂuenced by decreased body weight
at parturition in the oﬀspring from SGA dams compared
to controls. SGA rats at start of treatment were lighter
and shorter than control animals. At the end of PEG-
rhGH treatment SGA animals had a greater body weight
gain. The systolic blood pressure was higher in SGA treated
with saline than that in appropriate for gestational age
(AGA) group at the end of long-term follow up. At the
same time points, SGA with saline-treated animals showed
higher glucose levels at 60min and 90min as compared
with AGA groups in glucose tolerance test. Conclusion.
Follow-up study shows that after discontinuation of PEG-
rhGH treatment, fasting levels of glucose and insulin and
IGF-I levels are comparable for PEG-rhGH treated and
untreated in SGA rats. In addition, our data suggest
that systolic BP is improved in PEG-rhGH-treated SGA
rats.
Change of Serum Fibroblast Growth
Factor 21 (FG21)and VisfatinLevels
duringR-Hgh Treatmentin Children with
Growth Hormone Deﬁciency
Li Yuchuan and Gong Chunxiu
Capital Medical University, Beijing Children’s Hospital
Objective. To study the inﬂuence of recombinant growth
hormone (rhGH) on FG21 Visfatin levels of children
with growth hormone deﬁciency (GHD). Methods.S e r u m
tryliceride (TG), total cholesterol (TC), insulin-like growth
factor-1(IGF-1),Fastinglucose,insulin,Adiponectin,Leptin
F G 2 1 ,a n dV i s f a t i nl e v e l sw e r em e a s u r e di n7 3c h i l d r e n ,
57 boys, 16 girls, aged range 4.5–16.42 years old, average
age 11.20 ± 3.2 2y e a r sw i t hG H Db e f o r ea n da f t e rr h G H
replacement therapy 6 months. Results.A f t e rr h G Hr e p l a c e -
ment therapy, the level of Adiponectin Leptin FG21 and
Visfatin levels decreased and the level of FG21 was higher.
And there was signiﬁcant diﬀerence. Conclusions.rhGH
replacement can improve the lipid proﬁle in GHD chil-
dren.
The Value of InsulinandArginineProvocation
Test and the Effect of Recombinant Human
GrowthHormone inChildren withGrowth
Hormone Deﬁciency
Liu Zheng Juan, Zhang Li, Bai Xue Mei,
and Wang Yu Chuan
Department Of Pediatrics, Second Hospital Aﬃliated To
Dalian Medical University
Objective. Growth hormone deﬁciency (GHD) is one of
the most important reasons for poor life quality. Clearly
diagnosis is essential before treatment. This study evaluated
the value of the insulin and arginine provocation test in
children with short stature and anaylized the therapeutic
eﬀect of recombinant human growth hormone (r-hGH)
in children with GH deﬁciency. Methods.G Hp r o v o c a t i o n
tests were performed with insulin and arginine in 65 short
stature children aged 5–12 years, the GH concentrations
were determined by RIA, and 35 children with peak GH
concentration less than 10ng/ml were deﬁned as GH deﬁ-
ciency and treated with r-hGH replacement therapy, with
dosage of 0.1IU/Kg·d, injected subcutaneously every night,
27 children were treated for 12 months. Body height and
body weight were monitored every month, the levels of
serum T3, T4, TSH, IGF-1, and glucose were measured
every 3 months, and the bone age was examined every
6 months. Results. The accuracy of insulin provocation
test (80%) was signiﬁcantly higher compared with arginine
provocation test (66.7%), and the accuracy of both insulin
and arginine provocation tests was 96.6%. In insulin provo-
cation test, nadir glucose level was less than 2.2mmol/liter,
which occurred during the 15–30 minutes after insulin
injection, and there was signiﬁcant positive relationship22 International Journal of Pediatric Endocrinology
between nadir glucose level and BMI. GH concentrations
peaked at 30–60 minutes after insulin injection, and 60–
90 minutes after arginine injection. The GHD children
with GH therapy for 12 months had increased in body
height and height velocity. The height velocity after 3, 6,
and 12 months therapy with GH was 13.8 ± 2.4cm/year ,
14.7 ± 2.4cm/year , and 12.5 ± 2.4cm/year , respectively .
Conclusion. The accuracy of insulin provocation test is
better than arginine provocation test, and combination of
drug provocation tests are more accurate than single drug
provocation test. The GH replacement therapy for GHD
children is eﬀective, and the body height and height velocity
are obviously increased, which is helpful for improving adult
height.
Study on the Deﬁciency of Shox Geneand
the Correlationwith Corresponing Phenotypes
of Short Stature
Yanli Cao, Min Zhu, Fang Xie, and Feng Xiong
Department of Pediatric Endocrinology,
Children’s Hospital of Chongqing Medical University
Objective. To study the deﬁciency of short stature homeobox
containing gene (SHOX) in short stature and the relation-
ship between genotypes and its corresponding phenotypes.
Methods. (1) 203 children with short stature, including
109 males, 94 females, were enrolled in Children’ Hospital
of Chongqing Medical University between July, 2008 and
October, 2009. (2) 203 and 70 fresh blood samples were
collected from patients and healthy children, respectively.
(3) Radiographs of the left forearms and wrists of patients
and healthy children were collected for the measurement
of their skeletal features. Anthropometric measures were
assessed, including height, sitting height, arm span, length
of forearm and lower leg. (4) Genomic DNAs were extracted
from fresh whole blood samples, then they were ampliﬁed
with primer pairs designed to span 5 microsatllites of SHOX
gene of patients and controls, as well as 5 SHOX exons of
all patients. (5) Compared with controls, the SHOX dele-
tions were identiﬁed by microsatellite analysis. (6) Directly
sequencing exons of SHOX gene after exclusion of the
patients without SHOX deletions, and then comparing the
SHOX gene sequences of patients with of those of Gene Bank
for the exploration of properly existed potential mutations.
(7) Comparsion of the distinctive clinical manifestation of
SHOX-deﬁcient group, non-SHOX deﬁcient participants,
and the control group with normal height was made.
Results. (1) 12 patients with SHOX gene mutations were
found (5.9%), including eleven deletions and a mutation of
exon 2 were found in 203 patients with short stature. (2)
Diﬀerences of physical signs between SHOX-deﬁcient group
and non-SHOX deﬁcient participants of all patients, and
the control group were tested by one-way ANOVA, such as
physical height, and sitting height/height, arm span/height,
forearm length/height, lower leg length/height. There were
signiﬁcant diﬀerence between SHOX-deﬁcient group and
non-SHOX deﬁcient participants, as well as between
SHOX-deﬁcient group and the control group. The sitting
height/height of patients with SHOX deﬁciency increased,
whereas their armspan/height, forearm length/height and
lower leg length/height decreased. No diﬀerences in height
were found between SHOX-deﬁcient group and non-SHOX
deﬁcient groups (P>. 05). (3) Radiographs of the left
forearms and wrists of SHOX-deﬁcient group indicated
some mild skeletal deformities like Madelung deformity in
patients with SHOX deﬁciency, but speciﬁc relationships
between genotypes and bone deformities were not seen.
Conclusions. (1) The study showed the SHOX deﬁcient
frequency of patients with short stature was 5.9%. (2)
The result of increased sitting height/physical height and
decreased armspan/height of patients with SHOX deﬁciency
suggested the ratio of increasing trunk and decreasing
mesomelic limb; with decreased forearm length/height and
lower leg length/height being characterized by the more
severely shortened forearms and lower legs. (3) There were
some mild and multiple skeletal deformities like Madelung
deformity in patients with SHOX deﬁciency, which needed
comprehensive analysis. (4) The height of short statures
patients with SHOX deﬁciency markedly varies. Most of
them had abnormal stature, although some were close to
the normal height. This suggested that a high degree of
phenotypic heterogeneity was associated with SHOX gene
deﬁciency.
Type1Diabetes
Weightand Body FatChanges inRelation to
Glucose Control before and 3 Months after
DiabetesCamp inChildrenwithType1 and
Type2DiabetesMellitus
Azriyanti Anuar Zaini,1 Muhammad Yazid Jalaludin,1
Chee Giap Tay,1 Suhaimi Hussain,2
Muhammad Hadhrami Hussain,3
Syamsul Rizal Abu Amin,4 Azril Syazwan Muhd Ali,4
Zulkarnain Jaafar,4 Rosmini Tahir,1 Adam Bujang,5
Jamaiyah H.,5 and Fatimah Harun1
1Department of Pediatrics, University Malaya
2Department of Pediatrics, University Sains Malaysia
3Ipoh General Hospital
4Department of Sport Medicine Sciences,
University Malaya
5Clinical Research Center, Kuala Lumpur Hospital
Introduction. Diabetes camp is meant to educate and impro-
vise knowledge on diabetes, self-care, and blood sugar
control in children with type 1 (T1DM) and type 2 diabetes
mellitus (T2DM). Weight management, diet education, and
exercise programme were also included to promote healthy
lifestyle. Objective. To study the children’s weight, body
mass index (BMI), and body fat changes in relation to
blood sugar control (HbA1c). Method. A 3-day diabetes
camp was held on 3rd–5th December 2009. On arrival atInternational Journal of Pediatric Endocrinology 23
camp site, weight, height and BMI of all children were
documented. Body fat measurement was performed using
body fat impedence analysis, and HbA1c was measured.
Reassessment was performed 3 months after the camp.
Result. A total of 36 children (30, 83.3% T1DM) participated
in this camp. There were 15 (41.7%) Malays, 12 (33.3%)
Chinese and 9 (25%) Indian participants. An equal number
of both gender were seen. The mean age was 13.8 (3.0)
years. Thirty-one (86%) children returned for the 3-months
post camp reassessment. Mean HbA1c pre- and postcamp
were 9.5% and 9.2% respectively. There was no signiﬁcant
weight (P = .265 in T1DM and P = .337 in T2DM),
body fat (P = .554 in T1DM and P = .385 in T2DM)
and HbA1c (P = .349 in T1DM, P = .116 in T2DM)
changes seen between pre- and post-camp measurement.
However, there was a signiﬁcant change in BMI (P =
.002) in all children. No signiﬁcant correlation was found
between HbA1c level and the children’s weight, BMI,
and body fat. Conclusion. This study showed that BMI
of all children was signiﬁcantly reduced and sustained 3
months after the camp which may suggest that they under-
stood the importance of weight management and adapting
healthy lifestyle. However, this study could not demonstrate
a better blood sugar control with the improvement of
BMI.
The Frequency and Characteristicsof
HyperglycemicHyperosmolarSyndrome in
Children andAdolescents with
DiabetesMellitus
Cao Bingyan, Gong chunxiu, Dong Qian,
and Huang Hui
Beijing Children’s Hospital aﬃliated of
Capital Medical University
Objectives. Hyperglycemic hyperosmolar syndrome (HHS)
is thought to be a rare entity in the pediatric population,
associated with signiﬁcant mortality based on case reports
in the literature. This study will report the frequency
and characteristics of HHS in children and adolescents
with diabetes mellitus in our hospital. Methods. Patients
diagnosed with type 1 and type 2 diabetes mellitus at
Beijing Children’s Hospital over a period from 1995 to 2009
were screened retrospectively for any laboratory evidence of
previous episodes of HHS. The standard diagnostic criteria
were refered from reference. Results. The records of all
patients with type 1 diabetes mellitus (T1DM) and type 2
diabetes mellitus (T2DM) diagnosed over a 15 years period
were reviewed (n = 1034,906wereT1DM,128wereT2DM).
Eleven patients were found to have HHS by diagnostic
criteria (ﬁve males, mean age at presentation 11.1 years,
age range 6.3∼17.2yr), so frequency of HHS was 1.06%.
The frequency of HHS in T2DM was a little higher than
in T1DM (1.56% versus 0.99%). 10 of 11 cases combined
with DKA simultaneously. Only 1 of 11 individuals had PH
≥ 7.25, and 2 of 11 individuals had CO2 ≥ 15mmol/L.
All eleven cases had evidence of ketonuria on presentation.
Mean eﬀectiveserum osmolality was334.18±8.82mOSM/L,
mean blood glucose was 53.19 ± 16.48mmol/L, mean PH
was 7.13 ± 1.16, mean corrected Natrium was 153.21 ±
6.37mmol/L. HHS or combined with DKA was the clin-
ical presentation at diagnosis of new onset diabetes for
all eleven children. Abdominal pain and vomiting were
common in these HHS patients (60%–70%), 80%–90% had
typical symptoms of diabetes (polyuria and polydipsia);
lethargy, weakness, confusion were also common. High-
carbohydrate drinks (2 cases with T1DM), carbohydrate
ﬂuid infusion (3 cases with T1DM), insidious onset (1
case with T2DM), and drinking less (1 case with Down
syndrome) precipitate the development of HHS in DM. The
presentation was more severe in T2DM than in T1DM, and
the mortality also higher in T2DM. Only one T2DM girl
died within the ﬁrst 24 hours. She had the highest corrected
Natrium (164.5mmol/L) and eﬀective serum osmolality
(351.4mOSM/L) and developed multisystem organ failure.
The mortality rate of HHS in this group is 9.09% (1/11). No
obvious neural system sequelae had been seen in survivors.
Conclusions. HHS is a rare entity in children. Its frequency
in diabetes is much less than DKA but more severe and
higher mortality. The frequency of HHS is higher in T2DM
than in T1DM in children. It is easily confounded by the
presence of acidosis due to the severe hypovolemia, with
a similar presentation with DKA. Corrected sodium and
eﬀective serum osmolality may correlate with the prognosis.
Fluid composition, tonicity and infusion velocity should be
carefully calculated during treatment. Increasing awareness
of HHS, the morbidity and mortality related to HHS can be
prevented.
A CaseReport of Neonatal DiabetesMellitus
withConﬁrmed Novel ABCC8 Mutationand
Improvement in Glycemic Control after Switch
from Insulin to Oral Sulphonylurea Therapy
Hung Ching Ngar and Lee Ching Yin
Department of Paediatrics and Adolescent Medicine,
Princess Margaret Hospital, Hong Kong
We report a 4-year-old girl who presented with diabetic
ketoacidosis during an admission for fever and upper respi-
ratory tract symptoms at eight months old. She was treated
with insulin infusion and then put on regular subcutaneous
insulin. She had history of hyperglycemia at 4 months of
age when she attended a hospital in Mainland China for
fever and diaper rash but mother did not seek further
medical advice afterwards. The haemoglobin A1c level at
diagnosis was 14.7% and remained about 8% when she was
treated with subcutaneous insulin at 0.2 unit per kilogram
per day. Neonatal form of diabetes mellitus was suspected.
Molecular study conﬁrmed a novel ABCC8 mutation in the
sulphonylurea receptor. The treatment was then changed
to oral sulphonylurea. The glycemic control improved and
the girl has maintained haemoglobin A1c level of 5 to
6%.24 International Journal of Pediatric Endocrinology
Lower Sex Hormone-Binding Globulin
LevelsAreAssociatedwithCardiacAutonomic
DysfunctioninGirlswithType1Diabetes
Yoon Hi Cho,1 Maria Craig,1,2,3 Shubha Srinivasan,1
Paul Benitez-Aguirre,1 and Kim Donaghue1,2
1Institute of Endocrinology and Diabetes,
The Children’s Hospital at Westmead, Australia
2Discipline of Paediatrics and Child Health,
University of Sydney, Australia
3School of Women’s and Children’s Health,
University of New South Wales, Australia
Aim. To examine the association between androgen lev-
els/insulin resistance and reduced heart rate variability
(HRV), a marker of cardiac autonomic dysfunction, in girls
with type 1 diabetes (T1DM). Methods. We report pilot
data from 53 T1DM girls, median age 15 years (range 10.5–
17.9) and duration 8 years (1.8–16.0). Heart rate variability
(HRV), deﬁned as oscillation in time intervals between con-
secutive heart beats (measuring R-R intervals = NN on a 20-
minute ECG-recording), were compared with normal values
derivedfromhealthyschool-basedfemalecontrols.Statistical
analyses used included SDNN(standard deviation NN), an
estimate of overall HRV, and root mean squared diﬀerence of
NN(RMSSD), estimate of short-term HRV. Spectral meth-
ods included low-frequency (LF)/high-frequency(HF) ratio,
the balance between sympathetic/parasympathetic controls.
Associations between SHBG/androgen levels and clinical
parameters and HRV (log-values for nonparametric data)
were analysed by linear regression. Results. Tanner staging
was T4-5 (n = 35), T2-3 (n = 7), and T1 (n = 1).
Lower SHBG was associated with longer diabetes duration,
higher BMI-SDS, total daily dose insulin/weight (TDD),
but not associated with age, waist:hip ratio, or HbA1c.
Higher testosterone levels were not associated with the above
variables. Lower SDNN was associated with higher HbA1c,
longer duration, older age, and lower SHBG. Lower RMSSD
was associated with longer duration and lower SHBG, whilst
higher LF/HF-ratio was associated with lower SHBG but not
other variables (Table 3). Conclusions. In adolescents with
T1DM, early cardiac autonomic dysfunction was associated
with low SHBG, a surrogate marker of insulin resistance.
SHBG may help to identify those at greatest risk of early
cardiac autonomic dysfunction, a known risk factor for
diabetic morbidity and mortality.
Incidenceof Type1 DiabetesinChildren
under 15 Years of Age in the Auckland Region
(New Zealand) Over a 20-Year Period
Wayne Cutﬁeld,1,2 Jos´ e Derraik,1 Alistair Gunn,3
Paul Hofman,1,2 and Craig Jeﬀeries1,2
1Liggins Institute, University of Auckland, Auckland,
New Zealand
2Paediatric Diabetes Service, Greenlane Clinical Centre,
Starship Children’s Health, Auckland, New Zealand
3Department of Physiology, University of Auckland,
Auckland, New Zealand
Introduction. A steady increase in the incidence of type 1
diabetes mellitus (T1D) is being observed worldwide, and
overseas studies suggest that this increase has been partic-
ularly pronounced among very young children (<5y e a r s
old). Objective. This study aimed to evaluate the changes
in the incidence of T1D in children under 15 years of
age in the Auckland region (New Zealand) over a 20-year
period. Methods. We performed a retrospective review of
all patients under 15 years of age that were diagnosed with
T1D over a 20-year period (1990–2009) in the Auckland
region, New Zealand. Results. There were a total of 885
new cases of T1D recorded in the region. There has been
a marked increase in the incidence of T1D (n per 100,000
people) in children in the Auckland region (+0.68/years;
r2 = 0.70; P<. 001), so that T1D incidence has risen
from 7.01 in 1990 to 19.82/100,000 in 2009. However, the
rise in T1D incidence was not even among all age groups,
being progressively greater with increasing age bands: 0–4
years (+0.37/years; r2 = 0.40; P<. 01; n = 222), 5–9 years
(+0.62/years; r2 = 0.35; P<. 01; n = 327), and 10–14 years
(+1.04/years; r2 = 0.58; P<. 001; n = 336). Conclusions.
There has been a considerable increase in the incidence of
T1D diabetes in children in the Auckland region, with a
nearly 3-fold increase over the 20-year period covered by this
study. However, unlike other studies, the greatest increase in
T1D incidence has occurred in older children, particularly
among those between 10 and 15 years of age.
10-YearReviewofType1DiabetesMellitusin
Childrenandthe ClinicalValue of
Interleukin-10inDiabeticKetoacidosis of
ChildhoodType1DiabetesMellitus
Yang-li Dai, Jun-fen Fu, Guan-ping Dong,
and Li Liang
Department of Endocrinology, The Aﬃliated Children’s
Hospital, College of Medicine, Zhejiang University,
Hangzhou 310003, China
Objective. To review the incident status of childhood type
1 diabetes mellitus hospitalized in Children’s Hospital of
Zhejiang University School of Medicine from 1999 to 2009
and to explore the clinical value of IL-10 in diabetic
ketoacidosis of childhood type 1 diabetes mellitus. Methods.
Two hundred and sixty three cases of childhood type 1
diabetes mellitus in Children’s Hospital of Zhejiang Uni-
versity School of Medicine were collected from January
1999 to February 2009. The clinical characteristics were
analysed retrospectively. Serum lipid was assessed in forty
eight diabetic children and twenty four healthy children
who were enrolled from December 2nd, 2006 to February
6th, 2009. Three subgroups were selected according to the
diagnosticcriteria:type1diabetesmellituswithketoacidosis,
type 1 diabetes mellitus without ketoacidosis, and control
group. Serum lipid, cytokines were compared in these threeInternational Journal of Pediatric Endocrinology 25
Table 3: Comparison of HRV and clinical parameters stratiﬁed for SHBG in T1DM compared to controls.
Lowest tertile SHBG in T1DM girls Higher tertiles SHBG in T1DM girls Control
HRV measures
Mean HR (bpm) 79∗∗ 71∗ 65
SDNN (ms) 63 81 91
RMSSD (ms) 53∗∗ 80 98
LF/HF ratio 1.16 0.76 0.88
Clinical parameters
Age (years) 14.8 14.3∗ 16.8
Duration (years) 9.6∗∗ 7.5
HbA1c (%) 8.8 8.3
BMI-SDS 1.23∗∗ 0.80
Insulin dose (u/kg/day) 1.21∗∗ 0.95
Androgen proﬁle
Free androgen index (%) 9∗∗ 4.6
Testosterone (nmol/L) 2.5 2.6
Androstenedione (nmol/L) 7.8 6.4
DHEAS (nmol/L) 2.8 1.4
∗∗P<. 05 lowest versus higher SHBG tertiles in T1DM girls
∗P<. 05 higher SHBG tertiles in T1DM versus non-diabetic girls.
groups. Results. The result shows female polarization. The
ratio of male to female was 0.78:1. The peak incident age
was at the age of 6 to 11.9 (55.1%, 145/263). There were
eighty six (32.7%, 86/263) children with ketoacidosis when
they were ﬁrst admitted to our hospital. The levels of serum
lipid, blood glucose and HbA1c were signiﬁcantly higher
in diabetic children with ketoacidosis than those without
ketoacidosis (P<. 05), and the increased levels of blood
glucose, serum lipid and HbA1c were risk factors of diabetic
ketoacidosis by Logistic analysis. The comparisons of 72
children with cytokines assessed:The level of serum IL-10
which was signiﬁcantly higher in diabetic children with
ketoacidosis than those without ketoacidosis (P<. 01),
whereas,nodiﬀerencesweredetectedinIL-2,IL4,IL-6,TNF-
α,I F N - γ. and Serum IL-2, IL-4, IL-6, IL-10, TNF-alfa, and
IFN-gama were signiﬁcantly higher in diabetic children than
those in healthy children (P<. 01). Conclusion. The most
common acute complications of type 1 diabetes mellitus
ketoacidosis, and disorders of glucose and lipid metabolism
in diabetic children with ketoacidosis were the risk factors
of ketoacidosis. The level of serum IL-10 was signiﬁcantly
higher in diabetic children with ketoacidosis, and IL-10 may
be a sensitive index of diabetic ketoacidosis in childhood
type 1 diabetes mellitus.
AbnormalCardiovascularFunctionin
Adolescents withType2DiabetesMayImpair
ExerciseCapacity
Teresa Pinto,1 Silmara Gusso,1 Tim Hornung,2
Chris Baldi,1 Wayne Cutﬁeld,3 and Paul Hofman1
1Liggins Institute, University of Auckland, Auckland,
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Exerciseispartofstandardrecommendationsinthemanage-
ment of Type 2 Diabetes (T2D); however maximal exercise
capacity may be limited in both adults and adolescents
with T2D irrespective of deconditioning and may be sec-
ondary to central (cardiac) and/or peripheral (vascular)
abnormalities. Aims. (1) determine exercise capacity (VO2
peak) in a group of adolescents with T2D compared to
an obese, nonT2D group and a non-obese control group,
(2) to assess cardiac function in these groups with the
use of cardiac magnetic resonance imaging (MRI) at rest
and during sub-maximal exercise, and (3) to assess femoral
artery ﬂow (FAF) at rest and immediately after-exercise
as a marker of peripheral vascular function. Methods.
13 subjects with T2D, 27 overweight or obese subjects and
19 nondiabetic, nonobese controls, aged 12–20 years were
recruited. All subjects performed an incremental exercise test
on a cycle ergometer. Body composition was determined
using dual-energy x-ray absorptiometry (DEXA). Cardiac
and femoral ﬂow MRI images were taken at rest and
during or immediately after sub-maximal exercise using
a cycle ergometer designed for use in the MRI. Results.
Maximum heart rate (HR) achieved was signiﬁcantly higher
in the control group than in the two other groups despite
comparable maximum workloads. There was no diﬀerence26 International Journal of Pediatric Endocrinology
in cardiac output (CO) indexed for fat-free mass (FFM)
between groups at rest however, during exercise CO/FFM
was signiﬁcantly lower in the T2D group compared to the
obese, and control group (P<. 01, P<. 001 resp.). SV
increased by 11.1% in the control group, 5.98% in the
obese group and 0.76% in the T2D group with exercise.
End-diastolic volume (EDV)/FFM was signiﬁcantly lower in
the T2D both at rest and with exercise. During exercise,
EDV decreased by 2.1% in the control group, 0.9% in
the obese group and 6.1% in the T2D group. End-systolic
volume (ESV)/FFM was comparable between groups at
rest but was signiﬁcantly lower in the T2D group with
exercise. The average FAF/minute and the net forward
volume both indexed for FFM were signiﬁcantly lower in the
T2D group after exercise compared to the other 2 groups.
Conclusion. Independent of obesity, T2D negatively aﬀects
bothcentralandperipheralvascularfunctionduringexercise
in adolescents. Central causes appear to be secondary to
impaired ﬁlling and possible diastolic dysfunction, while
peripheral blood ﬂow to exercising muscles may also be
impaired. Both may hinder one’s ability to engage in physical
activity.
Glycaemic Control, Frequency of
Self-MonitoringBlood Glucose andDiabetes
Knowledge inType1 DiabetesChildren
before andafter AttendingDiabetesCamp
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Background. Diabetes camp provides the opportunity to
increase patient’s self-conﬁdence and improves. the ability to
manage diabetes on their own. In small groups, participants
can learn about correct injection technique, testing and
monitoring, diet, physiology, and other issues relating to
diabetes. Aim. To evaluate the eﬀectiveness of diabetes camp
in improving glycaemic control and self-monitoring blood
glucose (SMBG) and to provide diabetes knowledge to
children with type 1 diabetes mellitus (T1DM). Method.
Children with diabetes mellitus aged 8–18 years were invited
to participate in the annual diabetes camp held on 3rd to
5th December 2009. On arrival at the camp site, diabetic
proﬁles were documented, HbA1c were measured, blood
glucometer was downloaded to assess the frequency of
SMBG, and a standard diabetes knowledge questionnaire
was distributed. Their HbA1c, frequency of SMBG and
diabetes knowledge were reevaluated at 3 months after-
camp. Results. Thirty children (13 males) participated in
this camp; 12 (40%) Malays, 11 (36.7%) Chinese, and 7
(23.3%) Indians. Mean age at diagnosis was 8.0 (3.8) years
while the duration of diabetes was 4.7 (2.7) years. Prior
to camp, mean HbA1c was 9.5% (2.1) and participants
performed SMBG 2.0 times per day on average. During
camp, hypoglycaemia episodes were common, but there
was no severe hypoglycaemia episode. Nobody had diabetic
ketoacidosis. At 3 months after the camp, mean HbA1c
was 9.9% (2.1) while mean number of SMBG dropped to
1.5 times per day. There was no signiﬁcant diﬀerence in
the percentage of hypoglycaemia, normoglycaemia or hyper-
glycaemia episodes prior to and after the camp. However,
there was a signiﬁcant improvement (P = .002) in diabetes
knowledge after the camp. Conclusion. Most of the partici-
pants had poor glycaemic control. Participating in diabetes
camp did not show signiﬁcant improvement in glycaemic
control or SMBG but did show marked improvement in
diabetes knowledge. Diabetes camp is a valuable programme
toimpartdiabetesknowledgeforbettermanagementoftheir
diabetes.
The Study on the PreventiveEffect and
Mechanismof All-TransRetinoic Acid on
Type1DiabetesMice
Xing Jie, Wang Ye, and Zhang Li
The Second Hospital of Jilin University Pediatrics
(Jilin Changchun)
Objective.Toinvestigatethepreventiveeﬀectandmechanism
of all-trans retinoic acid (ATRA) on T1DM mice model,
induced by multiple low-dose streptozotocin (STZ). Meth-
ods. Mice were randomly divided into 3 groups. Prevention
group were pre treated with ATRA subcutaneous injection,
and diabetic group and control group were treated with
the mixed solution subcutaneous injection, of 95% peanut
oil and 5% in same amount dimethyl sulfoxide. Then,
prevention group and diabetes group mice were given
intraperitoneal injection of multiple low dose STZ to induce
T1DM model, while control group was given intraperitoneal
injection of citrate buﬀer solution in the same amount.
After a week injection of STZ, we dynamically observed
the general state, weight, blood glucose level and incidence
of mice. All mice were sacriﬁced in the end of the 6th
week. The pancreas were prepared pathology to observe islet
changes, and radioimmunity analysis was used to detect the
serum insulin level, while enzyme linked immunosorbent
assay was used to determine the levels of IFN-Gamma and
IL-4. Results. Mice in prevention group had general state
similar to normal mice, decreased blood glucose, increased
serum INS, reduced IFN-Gamma levels, elevated levels of
IL-4, IFN-Gamma/IL-4 ratio decreased (compared with
diabetes group, the diﬀerence was signiﬁcant, P<. 05), to
prevent the occurrence of autoimmune insulitis. Conclusion.
ATRA has an eﬀect on preventing the incidence of T1DM
diabetes induced by multiple low-dose STZ. This eﬀect
may depend on ATRA preventing elevated levels of IFN-
Gamma and reducing IL-4 level induced by multiple low-
dose STZ.International Journal of Pediatric Endocrinology 27
AcuteMetabolic Cataractasa First
Manifestation of Type 1 Diabetes in Children:
Report of Two Cases and a Review of
the Literature
Yan-Yan Jin, Ke Huang, Chao-Chun Zou,
Li Liang, and Ji Jin
Department of Endocrinology, The Aﬃliated Children’s
Hospital, College of Medicine, Zhejiang University,
Hangzhou 310003, China
Objective. To highlight the metabolic cataract as a ﬁrst
manifestation of Type 1 Diabetes in children. Methods.
Report of two cases (4 eyes) and review of the literature.
Results. Two 11-year-old girls, met the inclusion criteria of
Type 1 Diabetes and cataract, were enrolled in our unit in
2008 and 2009. They presented cataracts 1 and 6 months
before the diagnosis of diabetes, respectively. Fundus oculi of
the second girl’s right eyes were invisible due to cataract after
mydriasis. No abnormality was found by ﬂuorescein fundus
angiography. However, Visual-Evoked Potentials (VEP) and
Electroretinogram (ERG) tests changed as follows: peak time
of 4 eyes’ P100 was slightly longer, amplitude of the a
and b wave for the ERG of the ﬁrst girl’s left eye and the
second girl’s right eye reduced. Both of them havenot been
operated on yet, although the second patient’s right eye was
advised to undergo cataract surgery. Controlling the blood
glucose levels by insulin therapy, the ﬁrst patient had a visual
acuity from 20/66 to 20/40 after 3 months, and to 20/29
after 6 months; the second girl’s left eye was from 20/50 to
20/40 and the right eye was from 20/180 to 20/125 after 6
months therapy. Literature reviewed showed only 11 cases
being reported in 6 papers to have a cataract before the
diagnosisofdiabetesandmost(10/11)ofthemhadacataract
surgery to restore vision, there was only one child completely
resolved by controlling blood glucose. Conclusions.A c u t e
metabolic cataract presented as the ﬁrst manifestation of
Type 1 Diabetes is infrequent in children, and those who
restored vision through controlling blood glucose have been
rarely reported.
ACase of ReducingInsulinRequirement in
Type1DiabetesafterHepaticojejunostomy
Ah Reum Kwon, Hyun Wook Chae, Ho-Seong Kim,
and Duk Hee Kim
Severance Hospital, Seoul, Korea
Some gastrointestinal surgical procedures can induce lose
body weight loss, therefore a vast improvement in glycemic
control has been observed in type 2 diabetes. However, it is
becoming evident that these procedures modulate the gut-
brain axis by altering the anatomy of the gut and aﬀecting
guthormones.Thesealterationsofhormonalconcentrations
may be also able to improve glycemic control. A 12-year
and 10-month old girl who has been diagnosed with type
1 diabetes 2 years ago, was admitted for abdominal pain
due to choledochal cyst, type IV-A and anomalous union
of pancreaticobile duct. Her height, weight, and BMI were
158cm, 54kg, 21.63kg, respectively, and she underente not
obese. She controlled blood glucose by 66∼72 units of
insulin per day, and the HbA1c was 11.0%. She was received
hepaticojejunostomy and was discharged after 3 weeks.
Interestingly, after discharge, she was able to control blood
glucose only 26∼32 units of insulin per day, even though
her body weight was not changed. The last HbA1c was also
8.8%. Although we were unable to identify the cause of
reducing insulin requirement, we thought that this was due
to decreased ghrelin and/or increased incretin or unknown
hormonal metabolic eﬀect by hepaticojejunostomy. There-
fore, she gained reduced insulin requirement and improved
glucose tolerance apart from treatment of choledocal cyst. To
the best of our knowledge, this is the ﬁrst case of metabolic
surgery in type 1 diabetes without obesity.
BloodGlucose ProﬁlesinDiabeticNOD Mice
UsingInsulinGlargineandAspart
Peng Shao, Guimei Li, Lijuan Zhang, Yanyan Hu,
and Caihong Liu
Provincial Hospital Aﬃliated to Shandong University,
Jinan 250021, China
Objective. To evaluate insulin glargine and aspart for their
ability to normalize the blood glucose proﬁle of dia-
betic NOD mice. Methods. Thirty newly diagnosed dia-
betic female NOD mice were randomized into 5 groups
A, B, C, D, and E (each group n = 6). Groups A,
B, C and D had free access to food and they were
given insulin glargine (I) at 9:00 subcutaneously in diﬀer-
ent doses:100IU/(god), 50IU/(god),15IU/(god) and PUBS
5μL/d, respectively. Group E was the intensive insulin
therapy group: insulin glargine as a basal replacement
was administrating subcutaneously at 9:00, and food was
given for one hour after insulin aspart (IAN) administrated
subcutaneously every four hours (begun at 0300 per day).
Also a group (Group Fa, n = 6) of age matching non-
diabetic NOD mice was included in the study. The blood
glucose value at diﬀerent time on the fourth day (24h) were
recorded, and the eﬀect of each treatment was estimated
on the 15th day. Results. The average blood glucose was
signiﬁcantly lower in intensive insulin therapy group E with
preprandial IAN plus basal I than in Group BACK and D
(P<. 05, resp.). But there was no signiﬁcant diﬀerence
when Group E was compared with Group A and Group
F( P>. 05). The ﬂuctuation of blood glucose value in
Group E was signiﬁcantly lower compared with Group A,
Ba n dC( P<. 05, resp.). The percentage of normal blood
glucose during 24 hours in intensive insulin therapy Group
E was much higher than in Group A, B, C, and D. Severe
hypoglycemia and hyperglycemia were often observed in
those single insulin glargine groups. The death rate on the
15th day of Group A, B, C, and E were 5/6, 3/6, 0/6, and 0/6,
respectively because of hypoglycemia. Conclusions.I n t e n s i v e
therapy group E with preprandially IG plus basal IG in NOD28 International Journal of Pediatric Endocrinology
mice with T1DM is superior with better glycemic control,
less hypoglycemic episodes, less blood glucose ﬂuctuates and
the higher percentage of normal blood glucose during 24
hours.
EarlyIntensiveInsulinTherapyin
DiabeticNOD MiceUsingInsulinGlargineand
AspartDecreasedInsulitisandIncreased
Bcl-2 Expression
Lijuan Zhang, Guimei Li, Peng Shao, Yanyan Hu,
and Caihong Liu
Provincial Hospital Aﬃliated to Shandong University,
Jinan 250021, China
Objective. To investigate the eﬀects of early intensive insulin
therapy on insulitis, apoptosis and regeneration of islets
Methods. Twelve newly diagnosed diabetic female NOD
mice were randomized into 2 groups: early intensive insulin
therapy group (n = 6) and PBS group (n = 6), the treatment
of these two groups was initiated within 3 days after onset of
diabetes. A PBS control group (n = 6) of age matching non-
diabetic mice was included in the study. group was sacriﬁced
on the 20th day while the other two groups were killed after
60 days of treatment. Pancreases were removed to examine
insulitis scores by HE straining, and expression of Bcl-2
and Bax on islet cells was detected by immunohistochemical
straining. Results. Diabetic symptoms were controlled by
earlyintensiveinsulintherapy.Themeanweightandinsulitis
score of intensive group were signiﬁcantly lower than that
in the after group (P = .00,.01, resp.), and there was
no signiﬁcant diﬀerence when compared the other with
group (P>. 05). The expression of Bcl-2 on islet cells
was stronger in intensive insulin therapy group than in
the other two groups (P<. 05). The Bax expression was
stronger in intensive insulin therapy group than in group
(P<. 05), but there was no signiﬁcant diﬀerence when
compared with group (P = .26). Conclusions. Early intensive
insulin therapy can decrease insulitis of islets, increase the
expression of Bcl-2 and decrease the expression of Bax on
islet.
ARand o m iz edC o ntr o lT rialo f
Intensive Diabetes Education Intervention in
ChildrenwithType1Diabetes
Xiuzhen Li, Li Liu, Liping Fan, Junqing Huang, Wen
Zhang, and Xiaojian Mao
Endocrinology Department of Guangzhou Women and
Children’s Medical Center, China
Background. Patient education is a cornerstone of treatment
in diabetes mellitus, but there is not unanimity of opinion
as to how it should be delivered. Objective. To assess the
eﬀects of an intensive diabetes education intervention on
diabetes control in children with type 1 diabetes. Methods.
34 children with type 1 diabetes for >6 months were
randomly assigned to either an intensive (n = 18) or
a current education (n = 16) group. The intensive education
group received 2 days of a diabetes education curriculum
involving a diabetes specialist, nurse, dietitian and monthly
telephone communication with the diabetes team, and
attended the diabetes camp for at least one time. The
current education group visited the diabetes clinic every 3
months providing basic information on topics related to
diabetes management. Changes in HbA1c and hypoglycemia
frequency,wererecordedbefore3monthsandafter6months
starting the intervention. Results. At baseline, there were no
diﬀerences between groups in age, sex, diabetes duration,
HbA1c and hypoglycemia frequency. In the intensive group,
HbA1c improved from 8.6 ± 0.86% at baseline to 8.1 ±
0.82 (P<. 001) at 6 month of the intervention. This
eﬀect was more distinct in patients with poor glycemic
control (HbA1c > 8.5%). In the current education group,
HbA1c did not change from baseline to 6 months (8.7 ± 0.9
versus 8.8 ± 0.9, P = .82). Hypoglycemia frequency did
not change in either group. Conclusions.H b A 1 ci m p r o v e d
signiﬁcantly after 6 months of intensive diabetes education
intervention, especially in those with poor glycemic control
(HbA1c > 8.5%).
A RetrospectiveReview of the Diabetic
KetoacidosisinTwo Regional Hospitalsin
Hong Kong
Po Yee Loung, C N Hung, and Ching Yee Lee
Department of Paediatrics and Adolescent Medicine,
Kowloon West Cluster, Hong Kong
TheincidenceofType1diabetesmellitus(DM)inourregion
was increasing over the last decade. Many of them presented
with diabetic ketoacidosis (DKA) and require admissions
to intensive care unit. DKA is associated with signiﬁcant
morbidity and mortality and probably could be prevented
by earlier diagnosis of DM and intervention. This depends
on the knowledge of the population on DM and the level of
alertnessoftheprimarycaredoctors.Weareinterestedinthe
duration of potential window period for early intervention
and secondary prevention and the possibility of reducing
the rate of DKA in newly diagnosed paediatric diabetes
patients. Questionnaires about their ﬁrst presentation were
sent to Type 1 diabetes patients during their attendance in
the diabetes clinic in two regional hospitals. Their hospital
records were reviewed for comparison to minimize recall
bias. Total number of 75 diabetic patients was analyzed
with 37 male and 38 female patients. Their mean age
at presentation was 8.9 years of age. 44 of them (60%)
presented as DKA, most of whom required admission to
the intensive care unit and insulin infusion. The common
presenting symptoms included polyuria (85.7%), polydipsia
(85.7%) and weight loss (71%). Other symptoms include
nocturia, lethargy, constipation and shortness of breath.International Journal of Pediatric Endocrinology 29
The mean duration of polydipsia and polyuria was 9.8
weeks and 6.3 weeks, respectively. They had seeked medical
attention for an average of 2.4 times (maximum of 10)
before the diagnosis was made. 49% of them had their
diagnosis made in the Accidental and Emergency Depart-
ment, 17% in the Government Clinic while 34% in the
Private Practitioners. The mean duration from the onset
of symptoms to the diagnosis, which is the window for
early detection and intervention was 6.8 weeks and the
median was 4 weeks. This was an invaluable period for
the parents and doctors to intervene and reduce the health
hazard related to DKA. Diabetic patients presented with
DKA were compared to patients without DKA regarding
the duration of their symptoms, the blood results and
other characteristics in our study. On the other hand,
about 15% patients do not have typical symptoms of
polyuria and polydipsia, especially in young children. The
diagnosis remains a challenge to the primary care doctors.
Simple urine testing in children with unexplained weight
loss or respiratory distress is extremely helpful to exclude
DM.
ThreePatients withType 1Diabetes
MellitusAssociatedwithAutoimmune
InﬂammatoryBowelDisease
Masahiro Noda,1 Kiyomi Abe,1 Keisuke Yoshii,1
Yasuhiro Naik,1 Reiko Horikawa,1 Kouichi Kamei,2
Shuichi Itou,2 Daisuke Ariyasu,3 Koji Tsubouchi,4
and Kazumoto Iijima5
1Division of Endocrinology and Metabolism,
National Center for Child Health and Development, Japan
2Division of Nephrology, National Center for Child Health
and Development, Japan
3Division of Endocrinology and Metabolism,
Tokyo Metropolitan Children’s Medical Center, Japan
4Department of Pediatrics, Chuno Kosei Hospital, Japan
5Department of Pediatrics, Kobe University Graduate
School of Medicine, Japan
Autoimmune disorders, such as thyroiditis, celiac disease,
and Addison’s disease are, known to be associated with
type 1 diabetes mellitus (T1DM). Inﬂammatory bowel
disease (IBD) is also a comorbid disorder with T1DM,
however, the cooccurrence is rare during childhood. Here
we report three patients with T1DM who developed IBD
during infancy. Case 1. A 26-year-old man, whose died at
6 months of intractable diarrhoea. He developed T1DM at
6 months old, intractable chronic diarrhoea due to food
allergy at 8 months old, and was treated with insulin
and steroid. He developed steroid-dependent nephrotic
syndromeat6yearsold. Weidentiﬁed FOXP3genemutation
(IVS1+1G > T) and diagnosed him as having IPEX (immune
dysregulation, polyendocrinopathy, enteropathy, X-linked)
syndrome. Case 2. A 13-year-old girl, whose developed
T1DM at 2 years old. She developed T1DM at the age of
ten. She showed frequent vomiting and epigastralgia, and
was found to have gastric ulcer since she was 11 years
old. She also had hypoproteinemia secondary to protein-
losing gastroenteropathy. She was diagnosed as having
autoimmune gastroenteropathy. Case 3. A 11 year-old girl.
She developed T1DM at 2 years old, Hashimoto disease at
three, and intractable diarrhoea at eleven. She was diagnosed
as having Crohn diseases by endoscopy and serological tests.
Discussion. The association of IBD is rare in T1DM during
childhood. Early onset of T1DM and IBD suggests genetic
background in immune system in these patients. T1DM
is mostly caused by polygenic reaction against pancreatic
island, while monogenic causes are found in autoimmune
polyendocrine syndrome type 1 (APS-1) and IPEX. We
found FOXP3 mutation in one patient. Early detection
and diagnosis of these conditions is essential for the better
outcome, since the bone marrow transplantation could be
another therapeutic option.
FactorsInﬂuencingChronicDiabetic
Complications inType1 Diabetes
Naree Panamonta,1 Tongchai Pratipanwut,1
and Ouyporn Panamonta2
1Department of Medicine
2Department of Pediatrics, Srinagarind Hospital,
Faculty of Medicine, Khon Kaen University,
Khon Kaen, Thailand
Although type 1 diabetes mellitus (T1DM) usually begins
in childhood and adolescence, the prevalence of cases with
complications is rising in adults as a continuum. The
objective of this study is to determine the characteristics
and factors inﬂuencing chronic complications in patients
with T1DM. During 2006-2007, 43 T1DM patients were
retrospective reviewed. Collection and analysis of demo-
graphic data, and clinical status of diabetes including
complications and treatment were performed. There were
16 males (37.2%) and 27 females (62.8%). The mean
age was17.84 ± 7.09 years (range 4.08–37.50) and the
mean age at onset was11.32 ± 5.87 years (range 0.92–
28.08) while the mean duration of DM was 6.77 ± 4.28
years (range 1.08–19.0). The mean HbA1c of the last
visit was 9.62 ± 3.07g/dL (range 5.2–17.6). Self-monitoring
of blood glucose (SMBG) was performed in 21 patients
(48.84%). Acute complications (DKA and hypoglycemia)
were documented in 29 patients (67.44%), while chronic
(microvascular and macrovascular) complications were doc-
umented in 13 patients (30.23%). Older age of onset and
longer disease duration were the factors associated with
chronic diabetic complications (P = .004 and 0.006, resp.).
The study showed no statistical signiﬁcance in the HbA1c
level, the frequency of daily insulin injections, and the
presence of SMBG between the patients with and without
complications. Females tended to have the greater risk to
develop complications even though there was no statistical
diﬀerence. Our results suggested that prompt evaluation and
proper management of DM could prevent these complica-
tions.30 International Journal of Pediatric Endocrinology
PsychologicalCharacteristics of Children and
Adolescents withType1DiabetesMellitus
Young Jun Rhie, Jeong Hee Shin, Yeon Joung Oh,
So Hee Eun, Ji Yeon Kim, and Kee Hyoung Lee
Department of Pediatrics, Korea University
College of Medicine, Korea
Objectives. Chronically ill persons have an increased risk
of greater psychological morbidity compared with general
population. Type 1 diabetes mellitus (T1DM) is a chronic
disease. Children and adolescents with T1DM are at par-
ticular risk for psychological problems which are associated
withpoormetaboliccontrolandcomplications.Thepurpose
of this study was to examine the presence of behavioural
and emotional problems in children and adolescents with
T1DM. Methods. Subjects with T1DM aged 6 to 18 years
(n = 37) and age-matched normal healthy controls (n = 36)
were evaluated using Korean Child Behaviour Checklist (K-
CBCL) and Children’s Depression Inventory (CDI). Results.
Children and adolescents with T1DM had higher scores in
CDI, compared with normal controls (13.0±8.5v e r s u s6 .3±
5.3). T1DM patients had more tendency to show depression,
social problem, attention problem, delinquent behaviour,
aggressive behaviour, internalizing problem, externalizing
problem, and total behaviour problems of K-CBCL than
controls. There were no signiﬁcant diﬀerences in CDI and
K-CBCL between well-controlled (HbA1c < 9%, n = 16)
and poorly controlled (HbA1c ≥ 9%, n = 21) patients,
and intensive (n = 13) and conventional (n = 24)
therapy patients. Conclusions. Children and adolescents with
T1DM are prone to behavioural and emotional problems.
Psychologicalevaluationandintervention arerequiredinthe
management of T1DM during childhood and adolescence.
Experienceof Basal-Bolus Administration in
Type1DiabetesMellitusAdolescent
Previously Treatedwith Conventional Therapy:
LimitedResources Perspective
Frida Soesanti, Jose RL Batubara, Bambang Tridjaja,
and Aman Pulungan
Department of Child Health, Medical School-University of
Indonesia, CiptoMangunkusumo Hospital, Indonesia
The management of type 1 DM in Indonesia is still a
big challenge caused by unavailability of insulin, limited
access to medical helps, low income, no health insurance,
and low education level. The DCCT showed that intensive
therapy (basal-bolus regimen and continuous insulin infu-
sion)slowedtheprogressionofmicrovascularcomplications,
signiﬁcantly. Institution of basal-bolus therapy requires
higher cost and understanding of insulin and carbohydrate
eﬀect on blood glucose. Thus it is a challenge to most of our
patients from low socioeconomic and lower education level.
Here we present an observational study on ﬁve adolescents
aged 15–17 years who have been diagnosed type 1 DM for
more than two years and previously treated with premixed
insulin. We compared HbA1c level, presence of hyperten-
sion, microalbuminuria, retinopathy, diabetic ketoacidosis,
insulin compliance, hypoglycemia episode, and frequency of
blood glucose monitoring 6 months prior and 6 months
after institution of basal-bolus regimen. Six months prior,
2 patients had HbA1c levels above 16%, 2 patients 13%,
and one patient 8.5%. Three patients had microalbuminuria,
two suﬀered from hypertension and 1 patient had diabetic
retinopathy. All of the patients had more than 2 episodes of
DKA and irregular blood glucose monitoring. The patients
were given rapid insulin as bolus and detemir once daily
as basal insulin. Six months after basal-bolus regimen, the
HbA1c level declined in all patients. Two patients who had
HbA1c levels above 16% gained the biggest improvement
to 7.9% and 13%, respectively. The decreasing point of
HbA1c level varied from 0.4% to 9.1%. The hypertension
was controlled, while the microalbuminuria and retinopathy
resolved. The hypoglycemia episode also decreased. Only
one patient suﬀered from DKA because of unavailability of
detemir. This study showed us that despite of the limitations
of all resources including funding, knowledge, and health
facility, the institutions of basal bolus regimen still resulted
in better glycemic control and slowed the progression of
micro vascular complications. This study has pushed us to
move forward on the management of type 1 DM to cross
boundaries to achieve optimal growth and development.
Type1DiabeteswithPremature
OvarianFailure
Hemlatha Subramaniam and Rahmah Rasat
Hospital University Kebangsaan Malaysia
Introduction. Failure of two endocrine systems is uncommon
and presents diagnostic and management challenge. We
report a case of a young woman with Type 1 Diabetes
and premature ovarian failure. Methods. A 15-year-old girl
diagnosed as Type 1 diabetes at the age 2 years presented
with poor control of diabetes and frequent hypoglycemia
for trivial activity. Developmental milestones and behaviour
are appropriate for age. No history of short stature in the
family. Patient’s mother and older sister attained menarche
at 12 years old. Results. Physical examination showed no
facial dysmorphism, with height of 141.3cm (<P3) and
weight of 43.7kg (<P25). Patient had no secondary sexual
characteristic. Karyotyping showed 46XX with no SRY gene.
Investigation revealed poor insulin reserve and elevated
HbA1c level of more than 10%. Patient is clinically and
biochemically euthyroid with no thyroid auto antibodies.
Short Synacthen test showed normal cortisol response
of >500mmol/L. Basal LH and FSH are elevated with
low estradiol which is consistent with hypergonadotrophic
hypogonadism. Ultrasound of pelvis showed atrophied
ovaries. Conclusion. Elevated gonadotrophins on more than
one occasion, in an amenorrhoeic patient, usually indicated
permanent ovarian failure. About 10–30% of women with
POF have a concurrent autoimmune disease, most commonInternational Journal of Pediatric Endocrinology 31
is hypothyroidism. Premature ovarian failure in patient with
Type 1 Diabetes is a rare occurrence.
ClinicalAppearance ofDiabeticKetoacidosis
PatientsinPediatricDepartment of Saiful
AnwarHospital, Malang, Indonesia,2005–2009
Harjoedi Adji Tjahjono
Saiful Anwar Hospital
Objective. To present the clinical appearance of diabetic
ketoacidosis in patients who were diagnosed in the Pediatric
Department of Saiful Anwar Hospital between 2005 and
2009. Methods. A descriptive study of clinical appearance
of diabetic ketoacidosis of 19 patients, 1–14 years of age,
diagnosed in Pediatric Department of Saiful Anwar Hospital
between 2005 and 2009. Results. From the 19 patients, 58%
were girls. 53% were between 5 and 10 years of age. 37%
had an equal frequency between 400–600mg/dl and 600–
800mg/dl of blood glucoses levels. 63% were undernour-
ished. About 53% had moderate DKA. 53% patients had
blood bicarbonate concentrations of 5–9, 9mmol/L. Blood
osmolarity levels were >295–400 mOsm/l in 84% patients.
53% had blood potassium levels of 3, 5–5mmol/L. 42%
patients had leucocyte counts of 10.000–<20.000/ul. The
most common symptoms of those patients were vomit-
ing, abdominal pain, decreased of consciousness, seizures,
diarrhoea, decreased of body weight, polyuria, polydipsia,
polyphagi, and febris. The majority complained of polyuria
about 16%. The majority patients of DKA who had blood
ketone levels of more than 5mmol/l were 67%. 61% had
ketonuri of 4+. The majority of those patients had anion
gap levels of about 12.0–24.0 (63%). Conclusions. Of these
19 patients the majority were girls, aged between 5 and 10
years. The majority of patients had high blood glucose levels
(between 400–600mg/dl and 600–800mg/dl). Most patients
were undernourished and had moderate DKA; the majority
hadbloodbicarbonateconcentrationsofabout5–9.9mmol/l
and high blood osmolarity levels (>295–400 mOsm/l). And
most complained of polyuria and had high blood ketone
levels (>5), potassium levels 3.5–5mmol/l, and leucocyte
counts of 10.000–20.000u/l.
Efﬁcacy and SafetyComparison between
Traditional24-Hour Fluid Therapy and
48-Hour Fluid EquilibriumTherapy on
DiabeticKetoacidosis inChildrenand
Adolescents
Di Wu, Chunxiu Gong, Bingyan Cao, and Yi Gu
Beijing Children’s Hospital, Capital Medical University
Objective. Compare the safety and eﬃcacy of a 48-hour ﬂuid
equilibrium therapy with 24 hours in Diabetic Ketoacidosis
children and adolescents with moderate and severe degree of
dehydration. Methods. Choose 36 DKA patients who were
moderate and severe degree of dehydration, divided them
into 48-hour ﬂuid equilibrium therapy group (n = 27) and
24 hours group (n = 9), to compare the time diﬀerence
of disappearance urine ketones, change of corrected sodium
and eﬀective osmolality with plasma glucose decreasing, and
prognosis of the patient with cerebral oedema and hernia.
We use statistics software SPSS16.0 to separate t-test and
X2 analysis. Result. (1) There is no statistical signiﬁcance
variance on the time of disappearance urine ketones in
both subgroup. 48-hour group: (X ± SD) 21.7 ± 9.01h,
24 h group: 19.6 ± 10.61h, (P = .582). (2) With the
plasma glucose decreasing, corrected sodium reduced 1.5 ±
5.70mmo/L in 48-hour group while12.8 ± 4.93mmo/L in
24-hour group, (P = .015), and the eﬀective osmolality
reduces, respectively 7.2 ± 11.97mosm/L in 48-hour group
and 26.5 ± 5.61mosm/L in 24-hour group, (P = .039). (3)
For 2 cases whose CT shows cerebral oedema and hernia,
the cerebral oedema and hernia of the one in 48 hours
ﬂuid administration group disappear after 38 hours, the
other in 24-hour ﬂuid administration group is dead after 11
hours of admission to hospital. Conclusion. For the patient
of DKA with moderately and severe dehydration, excessive
rates of ﬂuid administration exacerbate the risk of cerebral
oedema. For more severe DKA with more severe degree
of dehydration, 48 hours ﬂuid equilibrium therapy should
be adopted in order to avoid the risk of cerebral oedema
and herniation. During the intravenous ﬂuid, rapid decline
of corrected sodium and eﬀective osmolality may induce
cerebral oedema. So the change of corrected sodium and
eﬀective osmolality should be monitored.
CentralBrainHerniationduringTreatmentof
DiabeticKetoacidosisinChildrenwith
NewlyOnsetDiabetes
Xin Ying, Yang Min, and Tong Ya Jie
Department of Pediatrics, Shengjing Hospital of
China Medical University, Shenyang, China
Objectives. Severe cerebral oedema resulting in central brain
herniation is uncommon in DKA management, but its
mortality is very high. Early recognition and treatment of
cerebral oedema in DKA is vital for patient management.
Methods. Cases description and review of literature. Results.
A previously healthy, 7-year-old girl came to our hospital
for polydipsia, polyuria, and body weight loss for 10 days.
Laboratory analysis showed that her blood glucose level
was 15.3mmol/L, pH 7.16, BE-18.7mmol/L, ketone 2+, and
the patient was diagnosed with DKA. She was treated with
intravenous ﬂuid resuscitation and intravenous insulin. Four
hours later, her blood glucose decreased to 6.3mmol/L,
but the acidosis condition was not improved, and she
felt headache occasionally. Seven hours after therapy, the
acidosis condition still was not improved, pH 7.14, BE
−20.3mmol/L, ketone 3+, and her headache became a little
bit more severe, accomplished by vomiting. The intravenous
ﬂuids were restricted. Nine hours after therapy, she fell
into convulsions suddenly, and mannitol was administered
immediately. Fifteen minutes later, she became coma, and32 International Journal of Pediatric Endocrinology
her pupils were not symmetric, central brain herniation was
suspicious, and she was transferred to PICU. She received
a total of 950ml of normal saline and 5% dextrose with
normal saline in her ﬁrst 9 hours after admission. Her
serum natrium decreased from 139mmol/L to 128mmol/L,
and 3% natrium chloride was administered. She convulsed
again, had ﬁxed and dilated pupils and a Glasgow coma
scale of 6. She had irregular respiration and SaO2 decreased;
mechanicalventilationwasperformed.AnemergentCTscan
revealed marked low-density changes in the temporal lobe,
occipital lobe, and subfrontal area. The patient was died at
54h after admission. The second patient a 10-year-old girl
presented to an outside hospital complaining of respiratory
distress, abdominal pain, and malaise. Her blood glucose
level was 52.5mmol/L, CO2CP 8mmol/L, ketone 3+, and
she was diagnosed with DKA. The patient was treated with
intravenous insulin and ﬂuid resuscitation. Several hours
later,herbloodglucosedecreasedandacidosiswascorrected,
butshewentintoacoma.Shewastransferredtoourhospital.
On admission, the patient had ﬁxed and dilated pupils and
Glasgowcomascaleof5.CTscansoftheheadshoweddiﬀuse
low-densitychangesintherighttemporallobe,basalganglia,
and occipital lobe. During 2-week therapy, her condition
w a sn o ti m p r o v e da n dk e p to nc o m a ;h e rm u s c l et o n e
was increased, and she was discharged. Conclusion. Patients
who develop cerebral oedema in DKA management may
deteriorate rapidly; early recognition and initiating prompt
intervention are very important.
Systemic Expressionof IL-10 Gene Prevents
theOnsetofType1DiabetesinNODMice
Ai-jing Xu, Zhi-hong Chen, Fei Tian, Li-hua Yan,
and Tang Li
Department of Pediatrics, the Aﬃliated Hospital of
Qingdao Medical College, Qingdao University,
Qingdao 266003, China
Background. Studies of animals with type 1 diabetes have
revealed that auto reactive T cells that mediate islet beta
cell destruction can be manipulated by the administration of
Th(2) cytokines. Using gene delivery to express the targeted
protein can overcome the need for frequent administration
of cytokines on account of their short half-lives. In this
study, the eﬀect of IL-10 gene delivery was evaluated in
vivo using an adenovirus vector (Ad) constructed with a
murine IL-10 cDNA, and apoptosis was detected by TUNEL
assay. Methods.T oe v a l u a t ei nv i v oe ﬃcacy, Ad-mIL-10 was
intraperitoneally injected into 4-week-old and 9-week-old
NOD mice and compared to the transduction using the
vector only (Ad-EGFP) and untreated control. Immuno-
histochemistry and Western blotting analysis were used to
detect the mIL-10 expression. Blood glucose concentration
was measured twice every week. After mice were killed on
32w,seruminsulin,IL-10,IFN-gamma,TNF-alpha,andIL-6
levelweremeasuredbyenzyme-linkedimmunosorbentassay
(ELISA). Pancreatic histology was measured for determina-
tion of insulitis grades. Apoptosis was measured by using
a TUNEL assay. Expressions of Fas, Bcl-XL, and caspase-3
were estimated by Immunohistochemistry analysis. Results.
Treatment with Ad-mIL-10 resulted in the retention and
expression of the vector for longer than 5 weeks, associated
with a considerable elevation in the plasma level of IL-10,
which was not observed in Ad-EGFP-treated mice and
untreated control group. In IL-10-treated NOD mice, the
glucose level was greatly lower than Ad-EGFP-treated group
and untreated control group (P<. 05) and the insulin
level was higher than the other two group (P<. 05).
The incidence of diabetes was markedly reduced in NOD
mice injected with Ad-mIL-10 as compared with those
injected with Ad-EGFP or as compared with nontreated
NOD mice (P<. 05). The serum levels of IFN-gamma,
TNF-alpha, and IL-6 were decreased in IL-10-treated group.
The insulitis grades of IL-10-treated mice were lower than
that of Ad-EGFP-treated group (P<. 01). Treatment with
Ad-mIL-10 signiﬁcantly decreased apoptosis compared to
control (P<. 05) by TUNEL assay. Decreased expression
of Fas and caspase-3 and increased expression of bcl-xL
were observed in the presence of Ad-mIL-10. Conclusions.
This study indicates the potential for IL-10 gene therapy to
prevent type 1 diabetes and implicates that IL-10 has a dual
function, to inhibit proinﬂammatory cytokine production
and to suppress spontaneous apoptosis in vivo.
ClinicalCharacteristicsof
ChildhoodDiabetesinaSingleCenter
Jeesuk Yu, Jong Seok Oh, So Young Kang,
In Chang Seong, and Ji Yoon Park
Department of Pediatrics, College of Medicine,
Dankook University, Cheonan, Korea
Most childhood diabetes is usually thought as type 1
diabetes (T1DM), but there is an increasing tendency of
type 2 diabetes (T2DM) even in childhood. Sometimes,
it might not be easy to determine the type of diabetes
and to choose the best treatment modality. In this study,
we retrospectively reviewed the medical records of the
patients who was diagnosed as diabetes and followed at
the department of Pediatrics, Dankook University Hospital
to ﬁnd the clinical and laboratory characteristics. Total
42 patients were enrolled in this study. There was a little
female predominance (M:F 1:1.33). T1DM had an earlier
onset age, as expected. Diabetic ketoacidosis (DKA) was
the presenting symptom in 58% of T1DM, but no DKA in
T2DM as an initial symptom. Initial and follow-up HbA1c
did not show statistically signiﬁcant diﬀerences between
the group. Initial serum c-peptide or insulin levels were
lower in T1DM. Autoantibody positivity was high in T1DM,
implying it as the very valuable marker in T1DM. Obesity
was not common in childhood T2DM. Oral hypoglycaemic
agents with or without insulin were chosen as a treatment
in T2DM. In one patient who had been initially diagnosed
as having T1DM since 14 months of age, initial insulin
injection was changed to combination therapy (long-acting
insulin injection plus oral insulin secretagogue) becauseInternational Journal of Pediatric Endocrinology 33
there was no autoantibody found and the patient showed
ﬂuctuating hypoglycemia. After then, there was no more
hypoglycaemic event and HbA1c levels could be maintained
below 6.5%, suggesting the importance of speciﬁc diagnosis.
Adolescent period was thought as a very vulnerable period
to manage the diabetes requiring more intensive emotional
support including family cooperation. In this study, we
can conﬁrm that the autoantubody test is very valuable to
diagnose speciﬁc type of diabetes, and speciﬁc diagnosis is
very important for better management of the diabetes in
childhood and adolescence.
ClinicalAnalysisof 198 Casesof
ChildrenwithDiabetesMellitus
Wen Zhang, Li Liu, Xiuzhen Li, Yonglan Huang,
and Jing Cheng
Guangzhou Women and Children’s Medical Center
Objective. To investigate the clinical characteristics and
provide theoretic basis for the diagnosis and treatment.
Methods. To retrospectivelyanalyze198 new casesof children
with diabetes mellitus from January 1999 to March 2009 in
our hospital. Results. Among total 198 new cases of children
with diabetes mellitus, there were 97 boys and 101 girls
and no gender diﬀerence existed; the onset peak age was
5t o6y e a r so l da n d9t o1 1y e a r so l d ;n e wc a s e sw e r e
increasing year by year and cases of 2008 were 3.7 times
more than those of 1999; among the 198 new cases, 174
cases with type 1 diabetes mellitus were occupying 88.9%,
7 cases with type 2 diabetes mellitus occupying 3.5%, 14
cases with neonatal diabetes mellitus occupying 7.1%, and
3 case with other types occupying 1.5%. Among the new
cases with type 1 diabetes mellitus, the incidence of diabetic
ketoacidosis was 42.1%; 55 cases had infection history before
the onset of disease; the incidence of diabetic ketoacidosis
had signiﬁcant diﬀerence between the infection group and
the noninfection group (P<. 01); 23 cases there were
family history. 2 cases with hyperthyroidism, 31 cases with
temporary hypothyroidism, 30 cases with liver function
damage, 12 cases with kidney function damage, 48 cases
with dislipidemia, and 27 cases with proteinuria; the average
HbA1c was12.0% ± 1.8%; in 25 cases of type 1 diabetes
mellitus, the positive rate of islet cells antibodies (ICA) was
28%, the positive rate of insulin auto-antibody (IAA) was
20%, and the positive rate of glutamic acid decarboxylase
antibody (GADA) was 72%. Conclusion. New cases with
diabetes mellitus were increasing year by year and most cases
were type 1 diabetes mellitus; cases with neonatal diabetes
increased signiﬁcantly; children with diabetes mellitus had
also temporary hypothyroidism, liver function damage,
kidney function damage, and dislipidemia; the positive rate
of GADA was the highest in autoimmune antibodies; among
the ﬁrst-diagnosis cases with type 1 diabetes mellitus, the
incidence of diabetic ketoacidosis had signiﬁcant diﬀerence
between the infection group and the noninfection group;
diabetic ketoacidosis was the important reason of children
with type 1 diabetes mellitus going to hospital.
Type2DiabetesandObesity
MetabolicSyndrome in
7–12-Year-Old Overweight/ObeseChildren:
AHospital-BasedStudy
Azriyanti Anuar Zaini and Fatimah Harun
Department of Pediatrics, Faculty of Medicine,
University Malaya, Kuala Lumpur, Malaysia
Introduction.Themostsigniﬁcantcomplicationofchildhood
obesity is the development of metabolic syndrome leading to
cardiovascular disease and diabetes mellitus. The aim of this
study is to determine the prevalence of metabolic syndrome
and diabetes mellitus in overweight/obese children. Methods.
A total of 60 overweight/obese and 25 normal weight
children were studied. Obesity was deﬁned as those children
whose BMI was >95th centile and, overweight >85th centile
for their age and sex. All children were subjected to a
physical examination and their weights, heights, BMI, waist
circumference, and presence of acanthosis nigricans were
documented. Fasting blood glucose, fasting insulin, and lipid
proﬁle were taken. Oral glucose tolerance tests (OGTT) were
doneinoverweight/obesechildrenonly.Metabolicsyndrome
was diagnosed using the International Diabetes Federation
(IDF) deﬁnition. Results. Overweight/obese children were
signiﬁcantly taller (141.3 ± 12.4cm;P = .001), had higher
systolic blood pressure (114.5 ± 12.8mmhg; P = .049),
lower HDL (1.20 ± 0.24mmol/L; P<. 001) and fasting
insulin (16.5 ± 12.3μ/L; P<. 001) levels, had bigger waist
circumference (87.3 ± 11.5cm; P<. 001), had acanthosis
nigricans and an abnormal HOMA index. The prevalence
of metabolic syndrome in the overweight/obese children was
25%. Impaired glucose tolerance was present in 6.9% of
obese/overweight children, while 1.7% had asymptomatic
type 2 diabetes Mellitus. Conclusion.T h i ss t u d yd e m o n -
strated that a signiﬁcant number of the 7–12-year-old over-
weight/obese children had metabolic syndrome and risk of
diabetes mellitus at a very early age in life. Childhood obesity
should be regarded as a serious medical disorder. Vigorous
intervention programme either with primary measures or
pharmacotherapy should be considered to prevent diabetes.
TheRelationshipbetweentheDyslipidemiaand
EarlyVascular Lesions inObese Childrenand
Adolescents
Chao Chun Zou,1 Li Liang,1 Jun Fen Fu,1
Lan Qiu LV,2 Pei Ning Liu,3 Ke Huang,1
and Chun Lin Wang1
1The Children’s Hospital of Zhejiang University School of
Medicine
2Ninbo Women and Children’s Hospital
3Yuying Children’s Hospital of Wenzhou Medical College
Objective. Obese children and adolescents often have
abnormalities of lipid and glucose metabolism, which are34 International Journal of Pediatric Endocrinology
associated with adulthood hypertension, diabetes, and car-
diovascular disease. In this study, the blood lipids, blood
pressure, and intima media thickness (IMT) in obese
children and adolescents were measured to investigate the
relationship between the dyslipidemia and early vascular
lesions. Methods. A total of 580 obese children and adoles-
c e n t sa g e df r o m7t o1 7y e a r so fa g ew e r ee n r o l l e df r o m
3 hospitals from January 2008 to September 2009. They
were divided into 2 groups according to their blood lipoid
levels. Ortholiposis group included 100 males and 52 females
with a mean age of 10.47 years and a mean body mass
index (BMI) of 28.28kg/m2. Dyslipidemia group included
305 males and 123 females with a mean age of 10.83 years
and a mean BMI of 27.60kg/m2. Physical examination, and
measurement of blood lipid, glucose, and liver enzyme were
taken. Carotid IMT was measured for 285 subjects. Results.
(1) Hypertension was found in 12.5% (19/152) and 20.1%
(86/428) patients in ortholiposis and dyslipidemia groups,
respectively, with a statistical diﬀerence (χ2 = 4.362, P =
.037). The OR was 1.760 with 95% conﬁdence interval of
1.030–3.008. Higher prevalence of hypertension was found
in patients with dyslipidemia. (2) The left, right, and mean
common carotid IMTs of dyslipidemia group were higher
than these of ortholiposis group without statistical diﬀerence
(all P>. 05). The left, right and mean internal carotid
IMTs in dyslipidemia group were 0.66 ± 0.15mm, 0.65 ±
0.15mm and 0.65 ± 0.15mm, respectively, while these in
ortholiposis group were 0.62 ± 0.13mm, 0.60 ± 0.13mm,
and 0.61 ± 0.12, respectively with signiﬁcant diﬀerences (all
P<. 05). (3) Bivariate correlation analysis showed that
systolic blood pressure was positively correlated with age,
BMI, BMI Z score, waist circumference, hip circumference,
uric acid, alanine transarninase, triglyceride, fasting insulin,
and insulin resistance index (all P<. 05). Moreover, mean
carotid and internal carotid IMTs were positively correlated
with age, BMI, waist circumference, hip circumference, and
triglyceride (all P<. 05). Multiple linear regression analysis
showed that hip circumference and insulin resistance index
were independent determinants of systolic pressure. Waist
circumference was an independent determinant of mean
common and internal carotid IMT, and triglyceride was
an independent determinant of mean internal carotid IMT.
Conclusion. (1) Vascular lesions, including hypertension and
thicker tunica intima are common in obese children and
adolescents. (2) Vascular lesions are closely related with dys-
lipidemia, and waistcircumferenceand hypertriglyceridemia
are the risk factors.
AbnormalGlucose Homeostasis and
InsulinResistance AreHighly Prevalentin
Obese Thai Children and Adolescents
Pontipa Engkakul, Sunisa Saowan,
Preamrudee Poomthavorn,
Pat Mahachoklertwattana, and Patcharin Khlairit
Department of Pediatrics, Faculty of Medicine,
Ramathibodi Hospital, Mahidol University, Bangkok,
Thailand
Background. The prevalence of pediatric obesity has been
increasing worldwide. Obesity contributes to insulin resis-
tance, impaired glucose tolerance (IGT), dyslipidemia, and
hypertension. Metabolic syndrome (MetS) is associated with
childhoodobesity.IncomparisonwithstudiesinCaucasians,
previous studies in Asian adults showed a greater proportion
of abnormal glucose tolerance at less degree of obesity. Asian
children with obesity may carry such a high risk in devel-
oping abnormal glucose tolerance and MetS. Objective.T o
determine glucose homeostasis status and insulin sensitivity
in obese Thai children. Methods. Obese children, aged 5–
18 years, were enrolled. Weight, height, body mass index
(BMI), and waist circumference (WC) were obtained. All of
them underwent an oral glucose tolerance test (OGTT) with
glucose and insulin levels measurement. Insulin sensitivity
indices were calculated from the measured glucose and
insulin levels. MetS was diagnosed using International Dia-
betes Federation (IDF) criteria. Data are presented in mean
(SD).Results.Therewere150obesechildren(76males),aged
11.2 (2.6) years included. There were 105 children (70%)
who had already entered puberty. Weight and height Z-
scores were 5.0 (2.6) and 1.2 (1.4), respectively. BMI was
28.6 (4.8)kg/m2and BMI Z-score was 3.0 (1.4). WC was 90.5
(11.8)cm and WC percentile was at 108.1 (22.2). Median
(range) homeostasis model assessment of insulin resistance
(HOMA-IR) was 3.0 (0.4–16.3) and whole body insulin
sensitivity index (WBISI) was 2.5 (0.5–12.0). One hundred
and nineteen children (79%) had abnormal OGTT results
(81 hyperinsulinemia, 33 impaired fasting plasma glucose
and/or IGT and 5 diabetes). Thirty-eight children with IGT
and diabetes had BMIand BMIZ-scores of 28.9 (4.2) and 2.9
(1.0), respectively. There were no diﬀerences in age, gender,
pubertal status, weight, and BMIZ-scores and WC percentile
between obese children with normal and abnormal OGTT
results. However, children with abnormal OGTT result had
higher HOMA-IR and lower WBISI than those with normal
OGTT result (P<. 001). MetS was documented in 20
children. No diﬀerences in age, gender, and pubertal status
between children with MetS and non-MetS were shown.
However, MetS children had greater weight and BMI Z-
scores, fasting insulin and insulin resistance as compared
to those without MetS. Conclusion. Our study demonstrates
a frequent abnormal glucose homeostasis in obese Thai
children and adolescents as high as 80% of those screened
for. In comparison with Western studies, the lower BMI
threshold in developing an abnormal glucose homeostasis in
obese Thai children is documented.
The Prevalence of Hyperinsulinemiaand
Its Relationship toFastingBloodGlucose and
Two-Hour Plasma Glucose among Overweight
andObese FilipinoChildrenand Adolescents
Cynthia Garcia-Feliciano and Susana Padilla-Campos
Philippine General Hospital
Hyperinsulinism has been regarded to play a crucial role in
the pathogenesis of Insulin Resistance Syndrome which isInternational Journal of Pediatric Endocrinology 35
strongly associated with obesity. Understanding the impact
of hyperinsulinism and its pathogenesis is essential to
optimally address the problem. The objective of the study
is to determine the prevalence of hyperinsulinemia among
overweight and obese Filipino children and adolescents
and its relationship to fasting blood glucose (FBG) and
two-hour plasma glucose. This is a cross-sectional study
with consecutive sampling wherein overweight and obese
Filipino children and adolescents aged 10–19 years old
with BMI > 85th percentile for age and sex, weight for
height >85th percentile using the standard BMI chart set by
Center for Disease Control (CDC) were tested for fasting
and two-hour plasma glucose with simultaneous insulin
levels. Fasting lipid proﬁle was obtained in all subjects.
The prevalence of hyperinsulinemia was calculated and its
relationship to fasting and two-hour plasma glucose was
reviewed. The prevalence of hyperinsulinemia among the
overweight and obese subjects is 82% (95% CI: 67.42–
1.49). High insulin levels implying insulin resistance were
seen in 81% of subjects with normal fasting plasma glucose
and in 61% of subjects with normal two-hour plasma
glucose. There was no correlation found between blood
glucose and insulin levels. The prevalence of T2DM is
2.2% (95% CI: 0.0562–11.7704) while the prevalence of
impaired plasma glucose is 4.4% at 95% CI (0.5428–
15.1493). High density lipoproteins (HDL) were low in
100% of subjects. There was a signiﬁcant correlation found
between BMI and two-hour plasma glucose at 0.05 level
of signiﬁcance. In conclusion, the prevalence of hyperin-
sulinemia among overweight and obese subjects is 82%
at 95% CI (67.42–91.49). Since 82% of our overweight
and obese subjects have normal fasting blood glucose
associated with high insulin levels, and hyperinsulinemia
has been implicated in the metabolic syndrome, it is
recommended that simultaneous insulin levels be included
with the FBG when screening these individuals for dia-
betes.
AssociationofCRP andWhite Blood
CellCountwithComponents of
MetabolicSyndrome in Children
Fangfang Gao,1 Geli Liu,2 Qingyan Yang,2
Rongxiu Zheng,2 and Pengli Bao2
1Tianjin Medical University
2Tianjin Medical University General Hospital of Pediatrics
Objective. To investigate Association of C-reactive protein
(CRP)andwhitebloodcellcount(WBCC)withcomponents
of metabolic syndrome (MetS) in children. Methods.A
total of 70 subjects, 49 boys and 21girls aged 8–15 years,
were enrolled. The subjects were divided into four quar-
tiles according to WBCC (WBCC1–4, from the lowest to
highest WBCC) in both genders. The mean values of MetS
components for each group were compared in boys and
girls separately. Age and BMI were adjusted using a multiple
linear regression compared to WBCC and MetS-related
components of relevance. Bivariate correlation analysis was
used to compare the relationship between (CRP) and MetS.
Results. The boys had signiﬁcantly higher WBCC, CRP,
BMI, WC, and triglyceride (TG) than the girls. While there
were no signiﬁcant diﬀerences in the systolic blood pressure
(SBP), diastolic blood pressure (DBP), fasting blood glucose
(FPG), high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (HDL-C), total cholesterol
(TC). When comparing the risks of the quartiles of WBCC,
WBCC4 was signiﬁcantly higher in the BMI and WC
than WBCC1, in addition TG of WBCC4 was signiﬁcantly
higher than WBCC1 and WBCC2 while HDL-C of WBCC4
was lower than WBCC1 and WBCC2 in boys. WBCC
were positively related with BMI, WC, TG and negatively
related with HDL-C among boys, whereas in girls only BMI
and WC was positively related with WBCC. We also ﬁnd
that SBP, FPG, BMI, and WC were positively associated
with CRP among girls; whereas in boys only BMI, WC,
and TG was positively correlated with CRP. Conclusions.
Children with metabolic syndrome are in chronic inﬂam-
matory state. WBCC and CRP as inﬂammatory markers
are predictors of metabolic syndrome and cardiovascular
disease.
Changes of HVACalciumChannel
Characteristicsand theirRelationship with
Pancreatic Islet B Cell Parasecretion in
Neonatal Rat Born Small for GestationalAge
Mengzao He,1, 3 Yanyan Jin,1 Li Liang,1
Zhenyong Wu,2 Xiumin Wang,1 and Yanping Xu1
1Department of Endocrinology, The Children’s Hospital of
Zhejiang University School of Medicine
2Department of Neurobiology/Institute of Neuroscience,
Key Laboratory of Medical Neurobiology of Ministry of
Health of China, Zhejiang University School of Medicine
3Department Of Pediatrics, The Second Hospital Of
Jiaxing
Objective. To determine whether intrauterine malnourish-
ment aﬀects pancreatic islet B cell secretion and high-
voltage-activated (HVA) calcium channel characteristics in
neonatal rat born small for gestational age (SGA), then
to study the association between changes of HVA calcium
channel characteristics and B cell secretion variation in
SGA neonatal rats. Methods. SGA neonatal rat model was
created by reducing maternal total food intake to 50%
of ad libitum during pregnancy in mother rat (10g/d).
Neonatal rats obtained from pregnant rats fed ad-lib were
deﬁned as group AGA. The pups (10 per group) were killed
and their pancreases were extracted within 24 hours after
birth. Then pancreatic islets were isolated by collagenase
P digestion (1mg/ml) and single islet cells were isolated
by dispase digestion (0.3mg/ml). Whole cell patch clamp
was used to test B cell HVA calcium channel characteristics
(including calcium current density, I-V curve, activation
curve, inactivation curve) in both groups of SGA and
AGA. Capacitance variation which could reﬂect single B cell
secretion was also recorded by HEKA double patch clamp36 International Journal of Pediatric Endocrinology
system after cell being stimulated by giving a sine wave
stimulus. Results. SGA neonatal rats showed much lower
values of the HVA calcium current density in pancreatic
islet B cells than that of group AGA (−5.94 ± 0.53 ver-
sus −8.05 ± 0.73pA/pF obtained from −40mV to 0mV
depolarization, P<. 05; −6.05 ± 0.93 versus −10.69 ±
1.48pA/pF obtained from I-V curve peak value, P<. 05).
There were no statistical diﬀerences found among the other
calcium channel characteristics of the two groups. The
membrane capacitance increment of B cells was signiﬁcantly
smaller in SGA rat (4.33 ± 1.14fF/Pf) compared with that
of AGA (12.70 ± 2.51fF/Pf) after excluding the inﬂuence
of whole cell membrane capacitance deviation (P<. 05).
Conclusion. Low HVA calcium current density on B cell
membrane, which may lead to changes in calcium signalling,
plays an important role in decrease of pancreatic islet B
cell secretion in SGA neonatal rat caused by intrauterine
malnourishment.
InsulinResistance andMetabolicSyndrome in
Children withObesity
Yonglan Huang, Junqing Huang, Wenchun Lin,
Xiuzhen Li, and Li Liu
Department of Endocrinology and Metabolism,
Guangzhou Women and Children’s Medical Center,
Guangzhou, 510623, China
Objective. To observe the rates of occurrence of insulin
resistance (IR) and metabolic syndrome (MS) and the
association between IR and MS in a group of Chinese obese
children. Methods. Oral Glucose Tolerance Tests (OGTT)
were done and serum insulin measured in 76 children (49
males and 27 females) with obesity aged between 3 and 14
yearsold. Fasting blood sample wasalso obtained to measure
total cholesterol, triglycerides, HDL-C, LDL-C, uric acid,
liver function, and androgen in serum. Insulin resistance was
deﬁned as fasting levels of insulin higher than 15mU/ml,
insulin peak (post-OGTT) levels higher than 150mU/ml,
and/or insulin level higher than 75mU/ml at 120min of
OGTT. Metabolic syndrome was diagnosed if three or more
of the following criteria were present: obesity, dyslipidemia,
impaired glucose tolerance and systolic or diastolic blood
pressure above the 95th percentile. Results. In the 76 obese
children, 68.4% of them had IR, 27.6% had impaired glucose
tolerance or type II diabetes, 61.8% had dyslipidemia, 14.5%
had hypertension, 28.9% had hyperuricemia, and 26.3%
had increased ALT. Hyperandrogenism was found in 6 out
of the 27 female children. 32.9% met the criteria of MS.
The rates of impaired glucose tolerance, dyslipidemia, and
MS were 34.6%, 73.1%, and 44.2%, respectively, in children
with IR, which are signiﬁcantly higher than those without
IR (P<. 05, .01, and .01, resp.). Out of the 20 cases
with delayed or absent insulin responsive peak, 13 had
impaired glucose tolerance and 1 was diagnosed with Type
II diabetes. Conclusion. Insulin resistance and the Metabolic
Syndrome were very common in children with obesity.
The occurrence of MS is strongly and positively related to
IR.
ParentalViewson SedentaryLifestylesin
Overweight Children
Madarina Julia1 and Emy Huriyati2
1Department of Child Health, Faculty of Medicine,
Gadjah Mada University/Dr Sardjito Hospital, Yogyakarta,
Indonesia
2Department of Nutrition and Health, Faculty of Medicine,
Gadjah Mada University, Yogyakarta, Indonesia
Sedentary lifestyle is recognized as one of the risk factors
for obesity in children and, hence, should be discouraged.
Success in the promotion of active lifestyle in obese children
isdependentonhowparentsviewtheproblem.Theobjective
of the study was to assess parental views on sedentary
lifestyle in obese children in Yogyakarta, Indonesia. Subjects
were 248 overweight children aged from 7 to 13 years
old with their parents. The children’s body weights and
heights were measured in a screening for obesity in primary
school children in Yogyakarta performed in the same year
(2005). Overweight in children was deﬁned as BMI-for-
age at the 85th percentile of the CDC 2000 growth chart
or more. Data on parental body weights and heights, as
well as questionnaires on parental views, were collected
by visiting the households of the respondents. Parental
overweight was deﬁned as BMI of 25 or more. Information
on physical activity was estimated from multiple 24-hour
recalls (3 working days and one holidays) obtained from
both the children and their parents. Data were obtained
from 240 (96.8%) fathers and 247 (99.6%) mothers; 239
(96.4%) children had complete data of both parents. The
prevalence of overweight was 38.3% in fathers and 45.7%
in mothers: 46.4% had one overweight parent and 18.8
had both parents overweight. Regarding the posture of their
children, 90 (36.3%) parents did not view their children
as too fat. Only 71 (28.6%) parents thought their children
need to reduce weight, 24 (33.8%) of them thought their
children need to increase their physical activity. There
was no association between parental overweight status
and their view of their children’s posture. Mean (SD)
time spent on watching television was 2.9 (0.9)hr/day.
Selecting 88 (35.5%) parents who thought their children
spent moderate time to watch TV resulted in mean (SD)
time for watching TV of 2.8 (0.8)hr/day. Mean (SD)
time spent on overall activities performed sitting was 11.4
(0.9)hr/day, while mean (SD) time spent on a more active
life, for example, sport, walking, and cycling was 2.6
(0.9)hr/day. Median (Q1, Q3) time spent on sport was
only 0.4 (0.2, 0.7)hr/day. Selecting 113 (45.6%) parents
who thought their children spent moderate time for sports
resulted in median (Q1, Q3) time for sport of 0.6 (0.3,
0.8)hr/day. We concluded that most parents were unaware
of problems of sedentary lifestyles in their overweight
children.International Journal of Pediatric Endocrinology 37
Effectsof ExerciseTrainingon
Adiposity,MetabolicParameters,and
Adipokines inObese YoungAdults
Eun Young Kim,1 Gook Chan Jang,1
Kyung Rae Moon,1 and Kyung Hee Yi2
1Department of Pediatrics, Chosun Medical School
2Department of Pediatrics, Wonkwang University Sanbon
Medical Center
Objective. Adipokines secreted by adipose tissue are sug-
gested to play a role in the development of obesity-related
complications. Regular exercise has been shown to reduce
the risk of metabolic complications in obese subjects. The
aim of this study was to investigate the eﬀect of exercise
training on body compositions, metabolic parameters, and
adipokines in obese young adults. Methods. A total of 25
young adults (13 obese and 12 nonobese) were recruited
in the public health center of Chosun University from
January 1st to June 30th 2009. 8-week exercise training
program (60–90min/day, 3 days/week) was performed in all
participants. We measured body compositions, serum lipid
proﬁles, glucose, insulin, leptin, and adiponectin before and
after exercise in control and obese young adults. Results.( 1 )
B o d yw e i g h t( B W ) ,B M I ,b o d yf a tp e r c e n t a g e ,a n dv i s c e r a l
fat percentage were signiﬁcantly decreased in control and
o b e s eg r o u pa f t e re x e r c i s e( P<. 05). (2) In metabolic
biomarkers, serum insulin, HOMA-IR, AST, and ALT levels
were decreased in obese group than control group after
exercise (P<. 05). (3) Serum leptin concentrations were
signiﬁcantly increased in obese than control group before
exercise (P<. 05). (4) Serum leptin concentrations were
signiﬁcantly decreased after exercise in obese group after
exercise (P<. 05). (5) Leptin/adiponectin (L/A) ratio was
signiﬁcantly increased in obese than control group and
decreased in obese and control group after exercise. (6)
Changes of leptin concentrations after exercise correlated
with changes of BMI (r = 0.471, P = .013), adiponectin
(r = 0.430, P = .025), and leptin/adiponectin ratio
(r = 0.807, P<. 0001). Conclusion. Body composition,
leptin, and L/A ratio were signiﬁcantly decreased in the
obese group after exercise. After exercise, changes of lep-
tin concentrations correlated with changes of BMI and
adiponectin.
The Relation of the RBP4 Levelsand
InsulinResistance in Obese Children
Se Young Kim
Bundang Jesaeng General Hospital, DMC
Objectives. RBP4 has been proposed to be a marker for
diabetes. There are multiple mechanisms described by
which RBP4 can eﬀect changes in glucose metabolism. We
examined the serum RBP4 levels and insulin resistance in
obese children. Methods. We compared the serum RBP4
levels in obese group (BMI > 95 percentile for age, sex)
and control group (measured with ELISA kit). In both
groups, we measured fasting glucose, fasting insulin, RBP4,
AST/ALT, lipid panel, and insulin resistance by HOMA-IR.
Then we examined the correlation the serum RBP4 levels
and insulin resistance in the obese group. Results.2 0o b e s e
children and 30 controls were enrolled. In both groups,
the serum RBP4 levels were not diﬀerent. In the obese
group, serum RBP4 levels correlated positively with total
cholesterol, HDL, LDL, and TG concentrations. But that
wasnotcorrelatedwithHOMA-IR.Conclusion.Considerable
work is required to prove the value of the serum RBP4 levels
in obese children. Further methods other than ELISA would
be required.
Timingof AdiposityRebound May Not Be
RelatedtoBody WeightGainduringInfancy
andIsLateby Breast-FeedinginEarlyInfancy
Satomi Koyama,1 Go Ichikawa,1 Yuzuru Yamazaki,1
Megumi Kojima,1 Naoto Shimura,1
Toshimi Sairenchi,2 and Osamu Arisaka1
1Department of Pediatrics,
2Department of Public Health, Dokkyo Medical University,
Japan
Background. The age of adiposity rebound (AR), when body
mass index (BMI) starts to rise after infancy, is thought
to be a predictor of obesity in later life. We have already
reported that children who exhibited an earlier AR have a
higher BMI and atherogenic metabolic status at 12 years
old. It has also been reported that weight gain during early
infancy predisposes children to future obesity, and breast-
feeding is associated with a decreased incidence of obesity in
childhood. Objectives. Theaim of the studywasto investigate
whether increments of weight gain and the type of nutrition
in early infancy are related to the timing of AR. Methods.
A total of 271 children (147 boys and 124 girls) in one
community were enrolled in the study. Serial measurements
of BMI from age 4 months to 12 years old were carried
out prospectively to determine the age of AR. Body weight
increments were measured in three periods (birth −4m,
4m−8m,and8m−12m).At10yearsofage,serumlipidand
l i p o p r o t e i nl e v e l sa n db l o o dp r e s s u r e sw e r em e a s u r e d .W e
also questioned parents about nutrition in early infancy and
categorized this as breast-feeding, bottle-feeding, or mixed
feeding. Results. No signiﬁcant relationships were observed
between weight gain during any period of infancy and the
age of AR. Weight gain between birth and 4 months of age
was positively correlated only with BMI of 7 years of age.
Only 15% of children with an obesity index ≥20% at 12
yearsoldwereobeseininfancy.Breast-feedingininfancywas
associatedwithalaterageofAR.BMIthroughchildhoodwas
lower for infants fed by breast-feeding compared to those fed
bybottle-feeding.Breast-feedingtendedtodecreaseBMIand
the triglyceride level and increase HDL-C level at 10 years
old compared to bottle-feeding but the diﬀerence was not
signiﬁcant. Conclusion. Contrary to expectation it appeared38 International Journal of Pediatric Endocrinology
that body weight gain during infancy was not associated
with the timing of AR, suggesting that infantile obesity
does not relate to childhood obesity. Breast-feeding seems
to have a favorable aﬀect on prevention of future metabolic
syndrome.
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Objectives. We compared the fasting serum proinsulin levels
in lean, overweight, and obese prepubertal children with
normal glucose tolerance (NGT). We also evaluated the
relationship between fasting proinsulin level and indices
of insulin resistance (IR). Methods. One hundred nine
prepubertal children (mean age, 8.6 years) with NGT were
included. The indices of IR included the homeostasis model
assessment of IR (HOMA-IR) and adiponectin level. We
recorded the presence of 1 or more of the following
metabolic derangements: triglycerides ≥150mg/dl, HDL
cholesterol <35mg/dl, and hypertension. Results. Fasting
proinsulin levels signiﬁcantly increased with BMI category
from lean (n = 52, 7.22 ± 3.01pmol/l) to overweight
(n = 14, 12.31 ± 2.91pmol/l) to obese (n = 43,
16.51 ± 7.27pmol/l) (P<. 001), after controlling for
HOMA-IR. The ratio of the fasting levels of proinsulin
to insulin did not diﬀer signiﬁcantly between the 3
groups. Both BMI z-score and HOMA-IR were signiﬁ-
cant independent factors related to the fasting proinsulin
level (P<. 001 for each). A signiﬁcant inverse asso-
ciation was found between fasting proinsulin level and
adiponectin level (r =− 0.464, P<. 001). Children
with NGT who had at least 1 metabolic derangement
had higher proinsulin levels than those without metabolic
derangement. Conclusions. Obesity itself or obesity-related
IR may independently impose b-cell overload on prepu-
bertal children with NGT, leading to hyperproinsulinemia
without causing failure to convert proinsulin to insulin
when some degree of IR and metabolic derangement
appears.
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Objective. The single nucleotide polymorphism rs9939609,
rs1421085 of FTO gene, K121Q polymorphism of
ectonucleotide pyrophosphatase/phosphodiesterase 1 gene
(ENPP1), and SNP276 polymorphism of adiponectin gene
(AMP1) have been studied in relation to obesity, insulin
resistance and type 2 diabetes in several populations with
discrepant results. We therefore investigated the role of the
above SNP on obesity and relative trails in Chinese Han
children and adolescents. Methods. 458 obese/overweights
children and adolescents and 231 normal weight control
aged 6–18 years were recruited. Body height and weight
were measured, and body mass index (BMI) was calculated.
Serum fasting plasm glucose (FPG), fasting insulin (FIns),
triglycerid (TG), and cholesterol (TC) were measured;
HOMA-IR and QUICKI were calculated. Genomic DNA
was extracted form peripheral blood; Taqman-MGB probe
was used to determine the polymorphism. Obesity was
evaluated using IOTF BMI standard. Results. (1) The fasting
plasma glucose, insulin, TG, HOMA-IR were signiﬁcantly
higher than those in normal control group. (2) BMI existed
signiﬁcant statistical diﬀerence between the rs1421085
TC +CC, rs9939609 TA +AA genotypes when comparing
with their wild TT genotype of FTO gene (rs9939609:
P = .0003; rs1421085: P = .0005). However, FPG, Fins,
TG, TC, HOMA-IR, and QUICKI showed no signiﬁcant
statistical diﬀerence between the rs1421085 TC +CC,
rs9939609 TA +AA genotypes and their wild TT genotype.
(3) The G allele frequency of SNP276 of AMP1 gene was
69.7% which existed no signiﬁcant statistical diﬀerence
when compared with obesity (allele frequency 71.4%) and
overweight (allele frequency 72.5%) group (P = .39). (4)
The frequency of K allele was 89.4% and Q allele frequency
was 10.6% in the obese group, K allele was 90.7%, and Q
allele frequency was 9.3% in the overweight group, and K
allele was 97.9% and Q allele frequency was 12.1% in normal
control subject; there were no statistic diﬀerences among
the three groups (P = .4171). Conclusion. We report that
FTO rs9939609, rs1421085 SNP are associated with obesity
and BMI in Chinese Han children and adolescents, but
failed to ﬁnd any signiﬁcant statistical association among
the SNPs and obesity-related metabolic parameters. ENPP1
K121Q and APM1 gene SNP276 polymorphism may play
minor roles in the genetic etiology of Chinese children
obesity.International Journal of Pediatric Endocrinology 39
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Objective. The aim of this study was investigation of
clinical features, pathogenesis, laboratory examination and
early treatment of diabetes mellitus in patients with beta-
thalassemia major. Methods. Diabetes mellitus was observed
in 6 of 53 patients with beta-thalassaemia major attending
Sun Yat-sen memorial hospital. In this retrospective analysis
study, patients were examined to determine their pubertal
status and the standard deviation score for height for
evaluation of short stature. Liver enzymes, liver size and
indicators of iron overload (serum ferritin, total units of
blood transfused, splenic size, pancreas MRI) were recorded.
A fasting blood glucose, insulin level, C peptide and HbA1c
were performed. Evidence for diabetes mellitus was based on
American Diabetes Association and World Health Organiza-
tion criteria. Serum levels of calcium, phosphorous, thyroid-
stimulating hormone, totle thyroxin, luteinizing hormone,
follicular-stimulating hormone, estradiol, testosterone, cor-
tisol and ACTH were measured. Results.T h ea v e r a g ea g e
in the 6 patients was 13.36 years (11–18 years). Two
patients, at onset of clinical diabetes, presented with an
asymptomatic glycosuria and four with polydipsia, polyuria,
weight loss and ketoacidosis. The induced factors were
abscess, chest wall abscess, pneumonia and heart failure.
Serum ferritin was in the range of 4800–7148ug/L; Fast-
ing blood glucose was in the range of 8.9–43.8mmol/L,
HbA1c was in the range of 8.9–16.8%. 2 patients had
detected high insulin level (>20mu/L) suggesting insulin
resistance. 4 cases of ketoacidosis were detected insulin
level <2mu/L, C peptide mean 24pmol/L, suggesting lack
of insulin secretion. Pancreas MRI showed the signal
to reduce, which was related with iron deposition. The
puberty stage of 6 patients was in Tanner 1 to Tanner
2. 6 patients were all short stature, 4 cases of hypothy-
roidism, 2 cases of GHD. Adrenal and kidney function
was normal, mild liver function abnormalities (2 cases)
and abnormal heart function (1 case) were detected. All
patients treated with transfusion, deferoxamine, exercise,
diet control, Glucobay and insulin. Comprehensive ther-
apy was good. Conclusions. Despite therapy with defer-
oxamine to treat iron overload, the risk of secondary
endocrine dysfunction remained high. Diabetes in patients
of beta-thalassemia major were often accompanied by other
endocrine organ damaged, which occurs with iron deposi-
tion. The pathogenesis of diabetes in beta-thalassemia major
may be similar to the development of type 2 diabetes.
Early diabetes, it was insulin resistance, and ﬁnally lack
of insulin secretion induced to insulin dependent diabetes
mellitus.
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Objectives. The current worldwide increase of type 2 diabetes
mellitus (T2DM) coincides with the increase of obesity. Also,
family history of T2DM (FHD) is strongly associated with
T2DM in childen as well as adults. We evaluated insulin
resistance of obese children with FHD compared with obese
children without FHD. Methods. The study included 66
children and adolescents aged 8–15 years who were divided
into two groups according to FHD: 30 obese adolescents
with FHD and 36 obese adolescents without FHD. Anthro-
pometric measurements were obtained. Blood samples were
collected and fasting plasma glucose (FPG), serum lipids,
fastinginsulin(FI)wereassayed.Allsubjectswereperformed
oral glucose tolerance test. Results. HOMA-IR and FI levels
of obese children with FHD showed signiﬁcantly higher
than that of obese children without FHD (HOMA-IR:5.5 ±
3.4uIU/mL ∗mmol/L versus 4.0 ± 1.8uIU/mL ∗mmol/L, P<
.05). In obese children with FHD, the frequency of impaired
glucose tolerance was higher than that of obese children
without FHD (23.3% versus 5.6%). Conclusions.I no b e s e
children, especially with T2DM family history, evaluatation
of diabetes or IGT is required.
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Introduction. With the rise of obesity in pediatric population
recently, the type 2 Diabetes Mellitus (T2DM) prevalence
is also increasing. Acanthosis Nigricans (AN) is believed
to be a good clinical predictor of hyperinsulinemia, the
T2DM precursor. Previous studies showed that there were
higher AN prevalence in overweight and obese children
with family history of T2DM. Objective.T oi n v e s t i g a t e
the relation between AN and family history of T2DM in
overweight and obese children. Methods. This was a cross
sectional study conducted in junior high school children
at Wenang District, Manado. Student t-test was used to
analyze one hundred and two children with overweight
and obese that has been screened for AN and questioned
about T2DM family history. Results. AN was higher in obese
(69%) rather than overweight (44%). T2DM family history
was found in 30% obese and 31% overweight children40 International Journal of Pediatric Endocrinology
with AN. Conclusion. No signiﬁcant relation between AN
and family history of T2DM in overweight and obese
children.
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Objective. To discuss whether the concentration of the IL-6
changes in the early stage of the Metabolic Syndrome (MS).
To investigate the correlation between the concentration of
IL-6 and the risk factors of the cardiovascular disease in
MS models. Methods. 40 weaned rats, including 20 males
and 20 females, divided into 3 groups randomly. MS models
were established by high fat salt diet, obesity and lipid
metabolism disturbance models were established by high fat
diet and the control group were given common diet. After 4
weeks feeding, the weight, length, waist circumference (WC)
and blood pressure (BP) were measured of the young rats,
concentration of the lipid proﬁles like HDL, LDL, TG, TC
and the fasting blood glucose (FBG), fasting blood insulin
(FIN) were detected at the same time. Then the fat tissue
samples were weighed and the concentration of the IL-6 was
measured in the fat tissue by ELISA. After that, calculating
if there was statistical signiﬁcance between the three groups.
To investigate the correlation between the concentration of
IL-6 and the associate factors, just like HDL, LDL, FIN, TC,
TG, FBG, HOMA-IR,theweight of the fattissuesamples and
the body. Finally, calculating the degree of the correlation.
Results. The concentration of the IL-6 in the fat tissue from
the MS group, obesity with lipid disturbance group were
higher than that of the control group (P<. 05). The level
of IL-6 in MS group was higher than that in obesity with
lipid disturbance group (P<. 05). The concentration of
the IL-6 was signiﬁcantly correlated with LDL, FIN, HOMA-
IR, TC, TG, HDL, the weight of the fat tissue and body in
the MS group; IL-6 in the obesity group was signiﬁcantly
correlated with TC, HDL, TG, W, the weight of fat tissue
Conclusion. The concentration of the IL-6 in the MS and
obesity and lipid disturbance group increased indicating
IL-6 participates in the disturbance of lipid metabolism
and obesity. The diﬀerence between the MS group and
obesity with lipid disturbance group also shows that IL-6
participates in the MS process also through the other ways
besides obesity and the lipid disturbance. The level of IL-6
in the obesity with lipid disturbance group was correlated
with TC, LDL, TG, W and the weight of the fat tissue,
further indicating that IL-6 participates in the development
of obesity and disorders of lipid metabolism. IL-6 could be
an index in prediction the early pathological process of the
cardiovascular disease
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Background. The incidence of obesity in children and ado-
lescents is increasing. Obesity plays an important role in the
occurrence of cardiovascular disease. The high level of hsC-
RP is one of the strong indicators of cardiovascular events
in obese people. Regular exercise would reduce the degree
of obesity and hsC-RP level and eventually decrease the
risk of future cardiovascular disease. Objective.T oe v a l u a t e
the impact of regular physical exercise on hsC-RP levels
in adolescents with obesity. Methods. Experimental study
was conducted on 40 obesity adolescents from November
to December 2009. Samples were divided into physical
exercise group who performed physical training for one
month and control group. Level of hsC-RP was measured
before and after the study done. Data were analyzed with
chi square and t-test with a signiﬁcance level of (P<. 05).
Results. The mean of hsC-RP level in the beginning of the
study was higher in the physical exercise group than the
control (4.35mg/dL, + 3.10 versus 2.85mg/dL, + 3.10).
At the end of the study, BMI decreased in 18 samples
(90%) from exercise group and two samples (10%) from
the control (P = .000). There was a decrease in hsC-
RP level in the exercise group (2.47mg/dL, + 2, 35) and
increase in the control (3.32mg/dL, + 2.57) (P = .02).
Conclusion. There was a signiﬁcance decrease in hsC-RP level
after physical exercise in obese adolescents compared to the
control group.
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Objective. To investigate the eﬀects of food high in fat and
saltonthelevelofhypothalamicleptin,bodyfatdistribution,
blood pressure, and gluco-lipid metabolism. To analyze the
correlation between hypothalamic leptin and other indices,
then evaluate the role of leptin in the development of
metabolic syndrome. Methods. Forty young SD rats, half
males and half females, were randomly divided into three
groups: high fat and high salt group (14 cases), high fat
group, (14 cases) and control group (12 cases). After four
weeks, OGTT, hypothalamic leptin, blood pressure, blood
lipid, cortisol, body fat distribution, blood glucose, and
insulin were measured. Results. In high fat and high salt
group, body weight, waist circumference, and visceral fat
weight were signiﬁcantly higher than in control group
(P<. 05). In high fat group, body weight and visceral
fat weight were signiﬁcantly higher than in control group
(P<. 05). In high fat and high salt group, blood glucose
and serum insulin at fasting, 60 minutes, 120 minutes,International Journal of Pediatric Endocrinology 41
and 180 minutes were signiﬁcantly higher than in control
group (P<. 05). In high fat group, blood glucose at 60
minutes was signiﬁcantly higher than in control group. In
high fat and high salt group, systolic pressure, TC, TG, LDL-
C were signiﬁcantly higher than in control group (P<
.05), while HDL-C were signiﬁcantly lower than control
group (P<. 05). In high fat and high salt group, brain
leptin was signiﬁcantly lower than in high fat group and
control group (P<. 05). In high fat group, brain leptin
was signiﬁcantly lower than in control group. In high fat
and high salt group, brain leptin levels were negatively
correlated with visceral fat weight (r =− 0.453), fasting
blood glucoseserum (r =− 0.286), insulin (r =− 0.566),
systolic pressure (r =− 0.472), and TG (r =− 0.511), while
positively correlated with HDL-C (r = 0.38). In high fat
group, brain leptin levels were negatively correlated with
visceral fat weight (r =− 0.179), insulin (r =− 0.464),
blood pressure (r =− 0.286), and TG (r =− 0.607), while
positively correlated with HDL-C (r = 0.643). Conclusion.
A model of metabolic syndrome was made via food high
in fat and salt. Brain leptin levels were negatively correlated
with visceral fat weight, fasting blood glucose, serum insulin,
systolic pressure and TG, while positively correlated with
HDL-C. Metabolic syndrome is the result aﬀected by many
fators. Brain leptin may play a role in metabolic syndrome
via aﬀecting body fat distribution, blood pressure, and
glucolipid metabolization.
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Objective. The present study aimed to understand the pos-
sible correlation between serum high-sensitivity C-reactive
protein, the insulin-like growth factor binding protein-1,
and some related factors of obese children. Furthermore,
we investigated the roles of hs-CRP and IGFBP-1 in chil-
dren in predicting impaired glucose metabolism. Methods.
Fifty-nine obese children and thirty-nine nonobese healthy
controls (group 3) were enrolled into this study. The obese
individuals were subdivided into two subgroups according
to the results of OGTT: sixteen obese subjects with impaired
glycometabolism (group 1) and forty-three obese subjects
w i t h o u tI G R( g r o u p2 ) .T h el e v e l so fs e r u mp a r a m e t e r s
including hs-CRP, IGFBP-1, glucose, lipid, insulin, C-
peptide, HOMA-α,H O M A - β, and so forth were determined.
SPSS 11.0 was used for statistical analysis. Results.T h e r e
was no obvious diﬀerence among the three groups in age.
The fasting blood glucose (FBG), fasting insulin level (FIns),
fasting C-P level, HOMA-α,a n dH O M A β of the obese
children especially in the IGR group were much higher
than those of the normal ones. There was an increase
of serum hs-CRP level in obese children. The median in
group 1 was 1.35 ± 0.10mg/L, in group 2 was 2.80 ±
0.01mg/L; the level of control group was 2.80 ± 0.01mg/L.
There was a signiﬁcant decrease of serum IGFBP-1 level
in obese children. The average of group 1 and group 2
was 4.52 ± 5.31ng/mL and 7.77 ± 7.88ng/mL, respectivly;
the level of control group was 31.12 ± 23.13ng/mL. This
indicated that the changes of hs-CRP and IGFBP-1 might
happen before the changes of IGR. However, there was
no signiﬁcant diﬀerence of hs-CRP and IGFBP-1 between
these two groups in the obese subjects with or without
IGR. There was a signiﬁcant diﬀerence of HOMA-α,n o t
only between groups, but also between the obese subjects
with and without IGR. For the nonobese healthy control
group, IGFBP-1 had more primary correlation with FBG,
Fins, and HOMA-α than with age, BMI, IGF-1, and other
factors. Multiple linear regression analysis showed that
FBG, FIns, and HOMA-α were enrolled in the regression
equation. Pearson correlation analysis showed that there was
no signiﬁcant correlation between serum hs-CRP and all
parameters in obese children. On the contrary, however,
it showed that there was a moderate correlation between
serum IGFBP-1 and many parameters (such as BMI, fasting
insulin level, 2-hour insulin level, fasting C-peptide level, 2-
hour C-peptide level, WC, SBP, HOMA-α,a n dH O M A β)
in obese children. Conclusion. Along with the changes in
serum hs-CRP and IGFBP-1, there might be a chronic low-
grade inﬂammation and potential insulin resistance in obese
children prior to the presence of IGR. To some extent, the
situation of low-level serum IGFBP-1 and high-level hs-
CRP reﬂected an increased morbidity risk of IGR in obese
children, which indicated that this might be an alternative
screening method for OGTT. Independently, low IGFBP-1
is a more predictive factor of the presence of IGR and
metabolic syndrome than high-level hs-CRP. There was a
signiﬁcant diﬀerence of FIns level between group 1 and
group 2, but not for 2hIns. Therefore, it can be concluded
that IGFBP-1 is correlated primarily to the level of 2hIns,
which reﬂects that hyperinsulinemia may be a compensatory
status during the early stage of IGR. Although CRP is an
indicator of the inﬂammation, it is also sensitive to many
otherfactorssuchasinfectionaswellasobesity.Comparesto
CRP, IGFBP-1 is relatively more stable and highly sensitive to
glucose metabolism. Nevertheless, as the cost of IGFBP-1 is
much more expensive than that of hs-CRP, therefore further
research is expected.
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Xian Wu and Yu Yang
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Objective. Retinol-Binding Protein 4 (RBP-4) is a newly
discovered Adipocytokine. There are limited and contro-
versial studies concerning the relationships between RBP-4,
body mass index (BMI), and insulin resistance in obese
humans and especially in children. This study aims to42 International Journal of Pediatric Endocrinology
ﬁnd out the relationship between RBP-4 levels and obesity
and insulin resistance. Method. Choose 71 inpatients of
endocrinology department of JiangXi children’s hospital
during Mar 2008 to Mar 2009. There were 42 obese children,
among which 19 had substantial weight loss after 6 months.
Measuring weight, height, waistline, blood pressure, and
determine the serum RBP-4, fasting blood sugar, blood fat
and insulin levels, and calculate insulin resistance index
homeostasis model assessment (HOMA-IR), analysis the
correlation between RBP-4 levels, BMI, fasting glucose, and
HOMA-IR. Results. Compared with the normal body weight
children, obese children had signiﬁcantly (P<. 01) higher
RBP4 concentrations. In multiple linear regression analyses
adjusted to age, gender, and pubertal stage, RBP4 was
signiﬁcantly correlated to BMI and HOMA-IR. Conclusion.
Obese children had a higher serum RBP4 concentrations
and RBP4 levels had positive correlation with BMI and
HOMA-IR.
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Objectives. To investigate whether neonatal overfeeding
would permanently increase susceptibility to obesity, insulin
resistance, and sensitivity to high fat diet (HFD) and
potential molecular mechanisms. Methods. Pups were raised
in either 3pups/litter (chronic postnatal overfeeding, CPO)
or 10pups/litter (control, CTR). After weaning, a subset
of mice was placed onto HFD. Epididymal white adipose
tissue (WAT) and skeletal muscle (SKM) were harvested
to assess inﬂammatory and lipogenesis pathways through
approaches of histology, biochemistry, transcript, and pro-
tein expression. Results. Under HFD, CPO mice exhibited
accelerated body weight gain, rapid development of obesity
and insulin resistance, and more severe impairment in GTT
compared with CTR mice. Insulin signal pathways and
insulin response impaired more severely in WAT and SKM
from CPO-HFD mice. Increased F4/80 immunohistochem-
ical activities, increased gene expression of inﬂammatory
mediators, and sustained activation of inﬂammatory path-
way were observed in WAT from CPO-HFD. Lipogenesis
was coordinately inhibited in WAT while activated in SKM
in the presence of HFD, which in turn resulted into excess
intramyocellular lipid accumulation in SKM. Conclusion.
Postnatal exposure to overnutrition leads to a more active
inﬂammation and the oversupply of fat to SKM, which
likely increases susceptibility to insulin resistance and exac-
erbates the detrimental outcome in response to HFD in
adulthood.
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CombiningHepaticB-UltrasoundImagine
andNoninvasiveBiochemicalMarkerssuchas
Transaminases(ALT, AST) Type  c´ oP r oc o ll ag e n
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Obese Children
Xu Xiao-Hua, Fu Jun-Fen, Huang Ke,
Wang Chun-Lin, and Liang Li
Department Of Pediatrics, The First People’s Hospital Of
Huzhou
Objective. To evaluate the diagnostic value of combining
Hepatic B-ultrasound imagine and noninvasive biochemical
markers such as transaminases (ALT, AST), procollagen N
peptide (Pc c´ o) in nonalcoholic fatty liver disease (NAFLD),
and screen applicable non-invasive diagnostic markers for
compensated NAFLD in obese children. Methods. In this
study, 269 obese children and 30 healthy control group
matched in age and sex were enrolled. We measured body
mass index (BMI), waist and hip circumference, blood
pressure, blood glucose, insulin, lipid proﬁle, transaminases
(ALT, AST), serum hepatic ﬁbrosis markers hyaluronic
acid(HA), type 4 collagen (CIV), procollagen N peptide
(Pc c´ o) and laminin (LN), and hepatic B-ultrasound in all
participants.Oralglucosetolerancetestandinsulin-releasing
test were performed. Three subgroups were selected accord-
ing to the diagnostic criteria. Group 1: SOC (simple obese
children), Group 2: NAFLD-1 (US fatty liver and normal
transaminases), and Group 3: NAFLD-2 (US fatty liver
and elevated transaminases). We also classiﬁed 269 obese
children into three subgroups according to B-ultrasound
imagine examination. Group 1: SOC (normal US liver and
normal transaminases), Group 2: mild fatty liver, and Group
3:moderate and severe fatty liver. We compared body mass
index (BMI), the ratio of waist and hip circumference,
lipid proﬁle and transaminases (ALT, AST), fasting blood
glucose, insulin, serum hepatic ﬁbrosis markers, HOMA
score, and WBISI based on OGTT test in all participants and
30 healthy control. The binary Logistic regression analysis
was applied between Group SOC and Group NAFLD. We
evaluatedandcomparedallthebiochemicalmarkerswiththe
area under receiver-operating characteristics (ROC) curve.
Results. (1) Compared with group SOC, the biochemical
markers ALT, AST, TG, HA, PC, FINS, 2hINS, and WBISI
were signiﬁcantly increased in NAFLD-1 group, Compared
with group NAFLD-1, the biochemical markers ALT, PC
were signiﬁcantly increased in NAFLD-2. (2) The level of
ALT was signiﬁcantly correlated with B-ultrasound exam-
ination, and its regression coeﬃcient was 0.11 (P = 0).International Journal of Pediatric Endocrinology 43
(3) The area under the receiver-operating characteristics
(ROC) curve of ALT, AST, Pc was 0.88, 0.80, 0.70, which
showed the most value in diagnosis of NAFLD in obese
children. Conclusion. Combining Hepatic B-ultrasound and
the biochemical markers ALT, AST, PC were most useful in
diagnosis of NAFLD in obese children, which showed not
only the degree of hepatic inﬂammation but also the degree
of hepatic ﬁbrosis.
The Metabolic DisordersinChildrenwith
Abdominal andNonabdominal Obesity
Feng Xiong and Jie Yu
Children’s Hospital Of Chongqing Medical University
Objective.Toinvestigatethecharactersofmetabolicdisorders
in children with abdominal and nonabdominal obesity.
Methods. 145 obese children and 80 healthy children were
recruited. Height, body weight, waist circumference (WC),
hip circumference, and blood pressure were measured and
body mass index (BMI) were calculated. Obese children were
divided into abdominal and nonabdominal obesity group
according to BMI and WC. Blood lipids, serum glucose,
and serum insulin were measured. Results. Abdominal
obesity has an incidence of 87.59% (127 cases among 145
obese children), while nonabdominal obesity accounted for
12.41% (18 cases). Fasting blood glucose, total cholesterol
(TC), triglyceride (TG), low density lipoprotein (LDL), and
blood pressure in abdominal obesity children were higher
than nonabdominal obesity and normal children (P ±
.05). Apart from TG, there were no signiﬁcant diﬀerences
between nonabdominal obesity and normal group. Among
127 abdominal obesity children, There were 77 cases of
insulin resistance, 14 cases of impaired fasting glucose, 7
cases of damage carbohydrate tolerance, 24 cases of high
TG Hyperlipemia, 13 cases of hypercholesterinemia, 10 cases
of high LDL hyperlipidemia, and 15 cases of hypertension,
only two cases of insulin resistance were observed in non-
abdominal obesity. Conclusion. Abdominal obesity is the
leading type of children obesity and is more susceptible
to abnormality of metabolism than nonabdominal obe-
sity.
The Relationship between Evaluationof
Glucose Intolerance in Obese Children and
PositiveFamily Historyof
Type2DiabetesMellitus
Hui Yao, Shi-xiu Kang, and Juanjuan Ding
Wuhan Children’s Hospital
Objectives. There is an increasing trend in the prevalence of
type 2 diabetes mellitus (DM2) in childhood and adoles-
cence, while a positive family history of DM2, and obesity
is the most important risk factor. The inﬂuence of family
history and obesity on glucose intolerance was the aim of
this study. Methods. A total of 65 children and adolescents
aged 7–12 years (mean 10.3 ± 1.5 years) were included in
the study. All children and adolescents were divided into
three groups according to positive family history of DM2
and obesity, and an oral glucose tolerance test (OGTT)
was performed for all Prediabetes was deﬁned as impaired
fasting glucose tolerance (IGT) and/or impaired fasting
glucose (IFG). Insulin secretion and insulin resistance were
estimated using the insulinogenic index and the homeostatic
model assessment for insulin resistance (HOMA-IR) and
Matsuda index, respectively. Results.T h ep r e v a l e n c eo f
prediabetes was 15.4% in the whole group, while it was
25.0% in obese children who also had a positive family
history of DM2. The frequency of hyperinsulinism was
36.9% in all groups, 50% in the group of obese children
with a positive family history of DM2. Conclusions.T h e
risk of prediabetes in children is highest in obese children
who also had a positive family history of DM2. There
is a need for a lifelong preventive program starting in
childhood to avoid DM2 and decrease cardiovascular risk
factors.
Effect of IntrauterineGrowth Retardation
on Beta-CellRegulating Factors:
PDX-1, HNF-1 Alpha, and HNF-4Alpha
Zhang Jie, Xin Ying, and Li Shuqin
Department of Pediatrics, Shengjing hospital aﬃliated to
China medical university, Shenyang, China
Objectives. Studies indicated that intrauterine growth retar-
dation (IUGR) is related to the occurrence of diabetes
mellitus. This study investigated the relationship of PDX-1,
HNF-1 alpha, and HNF-4 alpha with beta cell to explore the
possible role of these factors in the occurrence of diabetes
mellitus.Methods.ThemurinemodelofIUGRwasemployed
by low-protein diet. There is also temporal and spatial
expression of PDX-1 in the pancreas as well as HNF-1
alpha and HNF-4 alpha in the liver of the newborn rats, 3-
week-old and 8-week-old rats, using Western-blot analysis,
immno-histochemistry staining, and real-time PCR. Results.
Western-blot analysis and immnohistochemistry staining
revealed that signals speciﬁc for PDX-1 in the pancreas
decreased in the newborn rats and 3-week-old rats and
increased in the 8-week-old rats. There was signiﬁcant
diﬀerence between the IUGR and normal rats (P<. 05).
Western-blot analysis and immnohistochemistry staining
revealedthattheexpressionlevelofHNF-1alphaandHNF-4
alpha in the livers of IUGR rats was signiﬁcantly lower than
that in the normal rats (P<. 05) including newborn, 3-
week-old, and 8-week-old rats. The results by real-time PCR
were consistent with Western-blot analysis and immnohis-
tochemistry staining. Conclusions. The decreased expression
level of PDX-1 in the pancreas of IUGR rats is likely to
result from the weakened regulation of HNF-1 alpha and
HNF-4 alpha in the liver and contribute to the dysplasia of
beta cells in pancreas, and it accordingly leads to diabetes
mellitus.44 International Journal of Pediatric Endocrinology
InbornErrorsofMetabolism
Enzyme Replacement Therapy for
MucopolysaccharidosisVI
(Maroteaux-LamySyndrome):
ExperienceinHong Kong
Wai Man But,1 Man Yee Wong,1
Jasmine Chi Kwan Chow,1 Winnie Kwai Yu Chan,1
Wai Tai Ko,1 Shun Ping Wu,1 May Ling Wong,1
Ting Yat Miu,1 Wing Yee Tse,1
Winnie Wai Yee Hung,2 and Tsz Wo Fan3
1Department of Paediatrics, Queen Elizabeth Hospital,
Hong Kong
2Department of Physiotherapy, Queen Elizabeth Hospital,
Hong Kong
3Department of Radiology & Imaging,
Queen Elizabeth Hopsital, Hong Kong
Background. Mucopolysaccharidosis VI (MPS VI; Maro-
teaux-Lamy syndrome) is a very rare inherited lysosomal
storage disease caused by deﬁcient activity of the enzyme N-
acetylgalactosamine 4-sulfatase (arysulfatase B). Inevitably,
the disease leads to signiﬁcant functional impairment and
shortened lifespan although intelligence is usually preserved.
In the past, there is no satisfactory treatment although a few
have beneﬁted from bone marrow transplantation. Enzyme
replacement therapy generates hope in the outlook for
patients with MPS VI. Objective.W er e p o r to u re x p e r i e n c e
of the use of recombinant human arylsulfatase B (rhASB)
as enzyme replacement therapy for MPS VI. Methods.A
prospective study in which two patients with advanced
MPS VI were enrolled to evaluate the eﬃcacy and safety of
weekly infusions of rhASB 1.0mg/kg. The primary eﬃcacy
variables were the distance walked in a 6-minute walk
test (6MWT), forced vital capacity and ejection fraction.
The secondary eﬃcacy variables were the number of stairs
climbed in a 3-minute stair climb (3MSC), joint mobility,
the level of urinary glycosaminoglycan (GAG) excretion,
autocontinuous positive airway pressure (CPAP) study, and
liver size. Results. After 24 weeks of treatment, patient A
walked 40 meters (36%), and patient B walked 66 meters
(58%) more in the 6 MWT than in the baseline. Additional
improvements were observed after receiving 48 weeks of
rhASB. Patient A walked 142 meters (129%) more in the
6 MWT and 33 stairs (60%) more in the 3MSC than
baseline while patient B walked 198 meters (174%) more
in the 6 MWT and 77 stairs (140%) more in the 3MSC.
Both showed signiﬁcant decline in urinary GAG excretion
after 12 weeks of treatment which remained low after 48
weeks.Improvementsinjointrangeofmotionwereobserved
in both patients. The other eﬃcacy variables remained
static. There were no drug-related adverse events or allergic
reactions reported during and after infusions of rhASB.
Conclusions. rhASB signiﬁcantly improves endurance and
reduces urinary GAG excretion. There are improvements
in range of joint movement after treatment. The drug is
generally safe and well tolerated.
RingChromosome 15 Syndrome:
A Case Report and LiteratureReview
Fang Xu,1,2 Chao Chun Zou,1 Li Liang,1
and Xian Mei Huang2
1Department of Endocrinology, the Children’s Hospital of
Zhejiang University School of Medicine
2Department of Pediatrics, the First People Hospital of
Hangzhou
Objective. To report the clinical features, diagnosis, and
management of ring chromosome 15 syndrome. Methods.
There are case report and literatures review. Results. A 4.5-
year-old girl was admitted to our unit because of short
stature. She was 86cm in height and 9kg in weight. Apart
from short stature, sparse temporal hair, right simian crease,
many irregular caf´ e-au-lait spots were observed on the chest,
abdomen, and inner thigh (Figure 1). No mental retardation
was found. Magnetic resonance imaging (MRI) scan of the
brain as well as abdominal and cardiac ultrasonography were
normal. Pelvicultrasound showed that gonadwasnot found.
Growthhormone(GH)provocativetestsshowednormalGH
peak. Cytogenetic analysis revealed a karyotype with 46, XX,
r (15) pattern. Recombination human GH (rhGH) with a
dose of 0.1U/kg-1·d-1 was administered for 4 months with
height increment of 3cm, Figure 1 (not shown). Clinical
features of the patient. (a) Short stature and sparse temporal
hair.(b)Rightsimiancrease.(c)and(d)Manyirregularcaf´ e-
au-lait spots on the chest, abdomen, and inner thigh. (Please
see poster for ﬁgures). Conclusion. These results showed
that ring chromosome 15 syndrome should be considered
in patients with short stature and caf´ e-au-lait spots. Timely
recognitionandhereditarytendencycounselingarerequired.
rhGH therapy improved growth and ﬁnal height.
Clinical,Biochemical, and
MolecularAnalysisof
Combined Methylmalonic Acidemia and
Hyperhomocysteinemia(cblC Type)inChina
Wang Fei,1 Lianshu Han,1 Yangyan Lin,2
Xuefan Gu,1 Jun Ye,1 Wenjuan Qiu,1 Huiwen Zhang,1
Yafen Zhang,1 Xiaolan Gao,1 and Yu Wang1
1Shanghai Children’s Hospital Aﬃliated To
Jiaotong University (Worked)
2Shanghai Institute For Pediatric Research,
Xinhua Hospital (Studied)
The most common inborn error of cobalamin metabolism
in China is the cblC type, characterized by combined
methylmalonic acidemia and hyperhomocysteinemia. The
clinical presentation is relatively nonspeciﬁc such as feeding
diﬃculty, recurrent vomiting, hypotonia, lethargy, seizures,
progressive developmental delay and mental retardation,
together with anemia, and metabolic acidosis; more speciﬁcInternational Journal of Pediatric Endocrinology 45
biochemical ﬁndings include high levels of C3 (propionyl-
carnitine), C3/C0 (free carnitine), and C3/C2 (acetylcar-
nitine) measured by tandem mass spectrometry (MS/MS),
elevation of MMA measured by gas-chromatography mass
spectrometry (GC-MS), and increased total homocysteine
with normal or decreased methionine. In this study, we
report 50 Chinese patients with combined methylmalonic
acidemia and hyperhomocysteinemia. Fourty six belonged
to the cblC complementation group. Mutation analysis of
the MMACHC gene was performed to characterize the
mutational spectrum of cblC deﬁciency in China. A total
of 17 diﬀerent mutations were found in the MMACHC
gene. Most of them clustered in exons 3 and 4, account-
ing for 91.3% of all mutant alleles. Two mutations were
novel, namely c.315C > G (p.Y105X) and c.470G > C
(p. W157S). In terms of genotype-phenotype correlation,
the c.609G > A mutation was associated with early-onset
disease when homozygous. Unlike previous reports from
other populations, c.609G > A (p.W203X) was the most
frequent cblC mutation detected in China, aﬀecting 51
of 92 MMACHC alleles (55.4%). The high prevalence of
this nonsense mutation could have potential therapeutic
signiﬁcance for Chinese cblC patients. Besides traditional
approaches consisting of hydroxocobalamin injections, car-
nitine, betaine, and protein restriction, novel drugs that
target premature termination codons may have a role in
the future.
4905 InpatientNewborns Screeningfor
InheritedMetabolic Disease
Liu Haihong, Yang Yao, and He xiyu
The Military General Hospital of Beijing PLA
Objective. The feasibility of “second generation newborn
screening” by tandem mass spectrometry was evaluated
for the diagnosis of inherited metabolic diseases. The
feasibility of newborn screening for inherited metabolic
diseases in patients hospitalized is also investigated based on
the experimental data. Methods. 4905 inpatient newborns,
including 1723 premature newborns and 3182 full-term
newborns, were selected from February 2009 to February
2010. The newborns were admitted to hospital as pre-
mature newborns, pneumonia, hyperbilirubinemia, hypoxic
ischemic encephalopathy, diarrhoea, and so on. The tandem
mass spectrometry was being used for amino acid and
carnitine analysis by using dried blood-spot specimens
routinely collected from newborns. Urine screening by
the gas chromatography/mass spectrometry was conducted
combined for the ﬁnal diagnosed of inherited metabolic
disease. Results. A total of 21 cases were diagnosis of
inherited metabolic disease, including 8 full-term newborns
and13prematurenewborns.Thetypeofinheritedmetabolic
disease and the corresponding number of cases are as
follows: 5 cases of methylmalonic aciduria, 5 cases of
hyperphenylalaninemia, 3 cases of short-chain fatty acid
metabolism disorders, 2 cases of carnitine transport defect,
2 cases of isovaleric acidemia, 2 cases of tyrosinemia, and
2 cases of long-chain fatty acid metabolism disorder. Of
the 21 inpatients, 13 cases with premature infant were
hospitalized, and 4 cases with pneumonia were hospitalized,
4caseswithhyperbilirubinemiawerehospitalized.Theabove
data show that the incidence of inherited metabolic disease
in inpatient newborns in our hospital was 4.28 ‰and is
higher than the total incidence of inherited metabolic disease
of 0.67‰. At the same time, the number of premature
newborns for inherited metabolic disease is higher than
that of patients with full-term newborns. Conclusion.T h e
patients for diagnosis of inherited metabolic disease were
hospitalized for common diseases. There were also no
suspected clinical symptoms of inherited metabolic disease.
It is suggested that the early diagnosis of asymptomatic
newborns is important for the treatment. It is necessary
to perform the newborn screening for inherited metabolic
disease in inpatient newborns because of the high incidence
of inherited metabolic disease in newborns hospitalized
although the newborn screening was not developed nation-
wide.
SixYearsof ExpandedNewborn Screeningin
China withTandem Mass Spectrometry
Results and Outcome
Lian-shu Han, Jun Ye, Wen-juan Qiu, Hui-wen Zhang,
Xiao-lan Gao, Yu Wang, Wen-jun Ji, Jing Jin,
Xiao-yan Li, and Xue-fan Gu
Department of Pediatric Endocrinology and
Genetic Metabolism, Xinhua Hospital, Shanghai Jiaotong
University School of Medicine, Shanghai Institute for
Pediatric Research, Shanghai
Objectives. The aims of this study were to determine the
prevalence of amino acids disorders, organic acidemias,
and fatty acid oxidation disorders in China by newborn
screening using tandem mass spectrometry (MS/MS) and
to assess the outcome of the patients that were diagnosed.
Methods. From January 2003 to June 2010, 270 067 neonates
were collected in Shanghai. About 20 kinds of amino acids,
free carnitine, and 40 kinds of acylcarnitines in their dry
blood spots were tested by MS/MS for screening 40 kinds
of amino acids disorders, organic acidemias, and fatty acid
oxidation disorders. The positive neonates were conﬁrmed
with gas chromatography mass spectrometry (GC-MS) or
genemutationtest.Themeanperiod ofclinical followupwas
28.7monthsperchild(13days∼84months).Results.I nt otal,
74caseswerediagnosedwith15kindsofdiseases.Theoverall
prevalence was 1/3650. Among these cases, 41 cases (55.4%)
were diagnosed with 7 kinds of amino acids disorders
(29 with hyperphenylalaninemia, 3 with maple syrup urine
disease, 3 with hypermethioninemia m, 2 with citrullinemia
type II, 2 with tyrosinemia type II, 1 with homocystinuria,
and 1 with Arginemia); 19 cases (25.7%) were diagnosed
with 4 kinds of organic acidemias (9 with 3-methyl crotonyl-
CoA carboxylase deﬁciency, 8 with methylmalonic acidemia,
1 with propionic acidemia, and 1 with glutaric acidemia
type I); 14 cases (18.9%) were diagnosed with 3 kinds46 International Journal of Pediatric Endocrinology
of fatty acid disorders (8 Carnitine uptake defect, 3 with
short-chain acyl-CoA dehydrogenase deﬁciency, and 3 with
medium-chain acyl-CoA dehydrogenase deﬁciency). During
the follow-up period, all cases with 3-methyl crotonyl-CoA
carboxylase deﬁciency, short-chain acyl-CoA dehydrogenase
deﬁciency,andmedium-chainacyl-CoAdehydrogenasedeﬁ-
ciency, 6 cases with Carnitine uptake defect, and 4 cases
with methylmalonic acidemia have no symptoms without
treatment. Two cases with MSUD and propionic acidemia
died at the age of a few days. Other cases have a good
outcome with treatment. Conclusions. Newborn screening
with MS/MS was valuable in the early diagnosis of severe
and treatable for amino acid diseases, organic acidemias, and
fatty acidoxidation disorders. These diseases were not rare in
China. It was desirable that all newborns were screened with
this method.
Diagnosisof TyrosinemiaType 1by
DeterminationofSuccinylacetoneinDried
Blood Spots usingTandem Mass Spectrometry
andTreatment withNitisinone
Lian-shu Han, Yu Wang, Wen-jun Ji, Jun Ye,
Wen-juan Qiu, and Xue-fan Gu
Department of Pediatric Endocrinology and Genetic
Metabolism, Xinhua Hospital, Shanghai Jiaotong
University School of Medicine, Shanghai Institute for
Pediatric Research, Shanghai
Objective. To establish the method of determining the
succinylacetonelevelindriedbloodspotsusingtandemmass
spectrometry for diagnosis of tyrosinemia type 1 and to
evaluate the treatment eﬀect of nitisinone for tyrosinemia
type 1. Methods. After the diameter of 3mm dry blood spots
was collected from 20 patients suspected with tyrosinemia
and 1600 healthy children (as controls) were punched into
wells of 96-well plate, 100μL 80% acetonitrile were added
into each well, which contains hydrazine monohydrate
and the internal standard C5-succinylacetone (SUAC). The
eluates were transferred to another 96-well plate and dried
under heated nitrogen, after the plate was incubated for
30 minutes at 65◦C. The residual hydrazine reagent was
removed by the addition of 100μL methanol to each well
and evaporation under heated nitrogen. The mobile phase
(80% acetonitrile) was added to each well, and 20μL
samples were tested by tandem mass spectrometry for
determining the level of SUAC. Two patients were treated
with nitisinone (1mg/Kg/d) and feed with formula free
of tyrosine and Phenylalanine. Results. The SUAC levels
of nine patients were increased (7.26–31.09μmol/L). The
mean level of SUAC in 1600 controls was 2.68 (0.96–
5.34)μmol/L. These patients were diagnosed as tyrosinemia
type 1 with the symptoms of jaundice and hepatomegaly.
Their tyrosine levels in blood were from 190 to 543μmol/L.
Among them, two patients were treated with nitisinone
and feed with formula free of tyrosine and Phenylalanine.
After one month, their symptoms became better than before
treatment. The SUAC levels decreased to normal (2.60,
3.20μmol/L), but the tyrosine level increased. Conclusion.
Determination of SUAC in dry blood spots using tandem
mass spectrometry was a good method for the diagnosis
of tyrosinemia type 1. Nitisinone had a quick eﬀect to
decreasetheSUAClevelinbloodofpatientswithtyrosinemia
type 1.
HyperthyroidisminaGirlwith
Down’sSyndrome
Hui Huang and Yu Yang
Children’s Hospital Of Jiangxi Province
We describe the occurrence of hyperthyroidism and con-
genital heart disease in a 7-year-old girl with Down’s syn-
drome. Thyroid disorders can occur in children with Down’s
syndrome while hypothyroidism occurs more frequently.
There is no report about Down’s syndrome associated with
hyperthyroidism in China. The report of DS associated with
hyperthyroidism and congenital heart disease is rare in other
countries. We report this patient with thyroid disorders and
Down’s syndrome and emphasize the importance of periodic
evaluation of thyroid function in children with Down’s
syndrome, instead of only detecting hypothyroidism.
ClinicalCharactersofMucopolysaccharidoses:
22-CaseReport
Yonglan Huang, Sheyong Li, Xiaoyuan Zhao,
and Li Liu
Department of Endocrinology and Metabolism, Guangzhou
Women and Children’s Medical Center, Guangzhou
Objective. The objective of this study is to observe the
diﬀerentiation of the clinical characteristics of various
subtypes of mucopolysaccharidosis (MPS). Methods.F r o m
June 2008 to May 2010, twenty-two patients in our center
were highly suspected to be suﬀering from MPS. Their ages
range from 0.4 to 8.4 years old and averaged 3.0 years old.
All the X-ray inspections of their bones exhibited MPS-
like pathological changes. In all cases, urinary glycosamino-
glycans (GAGs) content was detected by dimethylmethy-
lene blue-tris spectrophotometry, and agar electrophoresis
was applied for qualitative analysis. Fluorescence enzyme
assays in leukocytes of peripheral blood for α-L-iduronidase
(MPS I), iduronate sulfatase (MPS II), arylsulfatse B (MPS
VI), β-D-glucuronidase (MPS VII), and β-D-galactosidase
( M P SI V B )w e r ed o n ei no u rc e n t e rf o r2 0c a s e s .T h e
other two patients were diagnosed as MPS IVA with enzyme
assay in Beijing. Results. GAG levels as well as the ratios of
GAG/creatinine in urine were obviously elevated in 19 cases,
with urine GAG levels ranging from 127.7 to 775.6mg/L
and averaging 268.7 ± 152.4mg/L. Dermatan sulfate and/or
chondroitin sulfate were detected by electrophoresis in these
19 patients. Three patients had normal urinary GAG, and
2 of them were diagnosed as MPS IVA with enzyme assay
in Beijing. Enzyme assay results of 20 patients in our centerInternational Journal of Pediatric Endocrinology 47
showed 4 cases with type I, 6 with type II, 3 with type VI,
and one with type VII. Six cases cannot be classiﬁed. All
classiﬁed cases had typical clinical features of MPS and high
urinary GAG excretion. The 6 unclassiﬁed patients exhibited
similar clinical features, characterized primarily by growth
retardation, skeletaldysplasia, andnormalintelligencedevel-
opment, which are similar to the clinical features of the
cases diagnosed as type IVA in Beijing. Conclusion. Urinary
GAG quantitative and qualitative analyses are still eﬀective
screening procedures for mucopolysaccharidosis except for
type IV patients. Total urine GAGs in patients with MPS
IVA are close to the normal range, so it is diﬃcult to
distinguish this type of MPS based on urine GAG excretion.
Type II is still the most common type of MPS in this
study.
Enzyme Replacement Therapy in
PatientsWho HaveMucopolysaccharidosis and
A r eY oung e rthan5Y earsOld
Se Hwa Kim, Sung Won Park, Young Bae Sohn,
Sung Yoon Cho, Seon Tae Jee, and Dong-Kyu Jin
Department of Pediatrics, Samsung Medical Center,
Sungkyunkwan University School of Medicine, Seoul,
Korea
Enzyme replacement of therapy (ERT) is one of the most
promising therapeutic strategies for the treatment of lyso-
somal storage disorders. ERT is available in three types of
Mucopolysaccharidosis (MPS): MPS I (Aludrazyme), MPS
II (Elaprase), and MPS VI (Naglazyme) for patients who
are over 5-year-old. But recently, early diagnosis can be
done by expert clinicians and even in prenatal case. We
describe the case of ERT under 5 years old MPS patients.
Up to June, 2010 in Samsung Medical Center, there were
6 patients who were diagnosed as MPS and started ERT
under 5 years old. 3 patients were MPS I, and other 3
patients were MPS II. 2 patients who was diagnosed as
MPS I were female, and others were male. Their ages at
diagnosis were 4 to 37 months old (4, 13, 16, 25, 27,
37 months old), and they are now 9 to 60 months old
(9, 39, 32, 81, 60 months old). The youngest patient was
started ERT at 4 month-old and others were started at
their 13 to 49 months old (13, 29, 27, 28, 49 months old).
First manifested symptoms of patients were macrocephaly,
kyphosis, and coarse face appearance. Especially, in 2 of
them, one was MPS I and the other was MPS II who
had an elder brother with same disease. And the youngest
one was diagnosed by the iduronate-2-sulfatase (IDS) gene
analysis from chorionic villi sampling. His mother knew
that she was a heterozygous carrier of IDS gene mutation
because her younger brother died from MPS II. All of them
were conﬁrmed as MPS by the enzyme assay in leukocytes
and ﬁbroblast skin culture. We started ERT with α-L-
iduronidase (Aldurazyme) to MPS I and did recombinant
human iduronate-2-sulfatase (Elaprase) to MPS II patients
as recommended dose for those over 5 years old. But for
MPS II patient who was 4 months old, we started ERT by
recombinant human IDS (Elaprase) with reduced dose of
0.1mg/kg and increased dose every 2 weeks by 0.1mg/kg up
to 0.5mg/kg IV infusion. During ERT, all patients had no
adverse eﬀects, and the excretion of GAGs was decreased. We
have evaluated other clinical symptoms such as liver/spleen
volume, heart function, and neurologic evaluation. We
describe a successful ERT to MPS I and MPS II patients
under 5 years old without any adverse events. It indicates
that ERT in young children is well tolerated and that it has
several eﬀects which may confer clinical beneﬁts with long-
term therapy.
The Genotypeand Phenotypeof Phenylalanine
HydroxylaseinPatientswith Phenylketonuria
Song Li,1 Dang Li-heng,1 Meng Ying-tao,1
and Fu Bo-jing2
1Pediatric Research Institute, Tianjin Children’s Hospital,
300074, China
2The Center Of Women And Children’s Health In Tianjin
300070, China.
Objective. To investigate the correlation of genotype and
phenotype of phenylalanine hydroxylase (PAH) in patients
with phenylketonuria, expecting it to be helpful for manage-
ment and genetic counseling. Methods. All of 13 exons and
ﬂanking introns of PAH gene from 101 patients with high
blood phenylalanine lever (>120μmol/L) at initial diagnosis
were ampliﬁed by polymerase chain reaction and analyzed
bysingle-strandconformationpolymorphism(SSCP),dena-
turing high-performance liquid chromatography (DHPLC)
and DNA sequencing. The correlation between genotype
and biochemical phenotype was observed by comparison.
Results. A total of nine homoallelic mutant PAH genotypes
were found (9%) including 3 R111X/R111X, 1 IVS4nt-
1g>a/IVS4nt-1g>a, 3 R243Q/R243Q, and 2 V399V/V399V
genotypes. Eight of them (8/9) belong to classic PKU
phenotypes except 1 R243Q/R243Q genotype, which ﬁts
moderate PKU phenotype. Among ninety-one heteroallelic
mutant PAH genotypes (90.1%), 53 kinds of mutations
corresponded to 61 classic PKU phenotypes; 29 moderate
PKU phenotypes and 1 mild PKU phenotype besides
nonmutation were found in one case. Heteroallelic mutant
PAH genotypes R111X/R243Q and Y204C/R243Q were
observed in both classic PKU and moderate PKU phe-
notypes. Conclusions. In the present, ninety percent of
genotypes were compound heterozygous. The independent
assortment of mutation alleles results in the complicat-
ing relationship between genotype and phenotype. One
should be cautious when evaluating the prognosis based
on genotype during genetic counseling. The phenomenon
which is the same genotype but with the diﬀerent bio-
chemical phenotype hints that some other inﬂuential factors
might not be found during phenylalanine metabolic pro-
cess.48 International Journal of Pediatric Endocrinology
RecurrentSevereKetoacidosisCausedby
SCOT Deﬁciency: A Case Report
Li Liu, Xiaohong Zhang, Xiuzhen Li, and Jing Cheng
Department Of Endocine And Metabolism,
Guangzhou Women And Children’s Medical Center
A 3-years-old boy had recurrent ketoacidosis six times
triggered by only mild fever since 8 months old age.
Each time he falls into deep breath, disturbance of con-
sciousness, blood PH 6.9–7.1, BE-15–25mmol/l, HCO3-3–
7mmol/l, beta-hydroxybutyrate 3–5mmo/l, and lactic acid
10–12mmol/l, urine organic acid analysis only sees a lot of
ketones. Triglyceride, glucose, ammonia, bilirubin, liver, and
muscle enzymes are all normal, with no visceral enlargement
and fatty. No positive ﬁnding was found in cranial MRI.
And he could recovery from his severe situation within 1
to 2 days with timely enough sodium bicarbonate correct
acid, expansion, and glucose infusion. And there was no
psychomotor retardation. His SCOT Gene was analyzed and
found to be skipping of exon 12. Detection in DNA level
showed a single-base substitution (c1147G > A) in exon
12. The pre-mRNA secondary structure analysis revealed a
change of pre-mRNA secondary structure after substitution
while the ESE analysis showed that the purine-rich region
was unlikely acting as ESEs, which was not reported before,
and at the same time the 50 normal controls had no such
mutation. We concluded that SCOT gene c1147G > Am i g h t
cause skipping of exon 12, SCOT deﬁciency, and recurrent
severe ketoscidosis.
Sitosterolemia in Infants and Children
Dau-Ming Niu,1,2 Kah-Wai Chong,1 Ju-Hui Hsu,2
Tina Jui-Ting Wu,2 Hsiao-Chi Yu,2
Cheng-Hung Huang,2 Ming-Yu Lo,2 Ching Fai Kwok,3
Lisa E. Kratz,5 and Low-Tone Ho4
1Institute of Clinical Medicine, School of Medicine,
National Yang-Ming University
2Departments of Pediatrics
3Medicine, and
4Medical Research and Education, Taipei Veterans General
Hospital, Taipei, Taiwan, R.O.C.
5Kennedy Krieger Institute, Baltimore, USA.
The clinical observation and treatment of young children
with sitosterolemia have rarely been reported. We report
clinical, biochemical, and molecular genetic observations
and treatment outcomes for 5 Chinese children presenting
with sitosterolemia from 4 separate families in whom we
identiﬁed 2 new (Y329X, G269R) and 3 known (R446X,
N437K, R389H) mutations in the ABCG5 gene. The R389H
mutation was found in 50% of alleles. Three of these ﬁve
patients received cholestyramine therapy with a very good
response. However, all of the patients discontinued this
therapy because of poor compliance. Finally, all of these
ﬁve patients were on ezetimibe therapy and had satisfactory
total serum cholesterol levels though their plant sterols
levels were still higher than normal. Another noteworthy
ﬁnding is that a female infant had a serum cholesterol level
of 654mg/dl at 7 months of age, despite being breast fed
(with very tiny amounts of plant sterols) since birth and
undergoing 4 months of ezetimibe administration. Although
she failed to respond to ezetimibe during this period, she did
show improvement when the therapy was started again at 2
years of age. It is possible that another 23-month-old female
patient also responded more slowly to ezetimibe treatment
than older patients.
Studieson ClinicalManifestation and
SLC25A13 GeneMutationof ChinesePatients
withNeonatal IntrahepaticCholestasis
Causedby CitrinDeﬁciency
Wenjuan Qiu, Yazhi Xing, Je Ye, Lianshu Han,
Huiwen Zhang, and Xuefan Gu
Department of Pediatric Endocrinology and Metabolic
disease, Xinhua Hospital Aﬃliated to Shanghai Jiaotong
University, Shanghai Institute for Pediatric Research
Objectives. To investigate the clinical and laboratory fea-
tures of neonatal intrahepatic cholestasis caused by citrin
deﬁciency (NICCD) and to characterize the molecular basis
of this disease and prognosis. Methods. Thirty-one patients
were detected because of idiopathic intrahepatic cholestasis
and jaundice. Eighteen exons of SLC25A13 gene were ana-
lyzed. Mutations are veriﬁed by bidirectional sequencing of
the whole detected exons. The clinical features, blood amino
acid and acylcarnitine proﬁles, urinary organic proﬁles, and
other laboratory data were reviewed and analyzed. Results.
The NICCD patients showed low birth weight, and the
average time of onset including jaundice and hepatomygly
was 25 days. Laboratory data showed liver dysfunction,
hyperbilirubinemia, hypoproteinemia, high levels of α-
fetoprotein, prolonged prothrombin time, hypoglycemia,
andhyperammoniemia.MS-MSanalysisofthebloodsample
revealed speciﬁcal elevation of citrulline and other amino
acids. GC-MS analysis of the urine sample showed elevated
4-hydroxyl phenylpyruvic acid and 4-hydroxyl phenyllactic
acid. 15 diﬀerent mutations of SLC25A13 gene were iden-
tiﬁed, including 7 new mutations: G386V, K453R, D350N,
R467X, 1192-1193delT, 1092-1095delT, and IVS11+5G > C.
51 mutated alleles were identiﬁed in the 56 alleles (91.1%).
851del4, 1638ins23, and IVS6+5G > A mutations were the
most frequent mutations in Chinese people, accounting for
39.2%, 17.7%, and 14.7% of the total alleles examined,
respectively. 4 in the 31 patients have poor prognosis, 3
died, and 1 implemented liver transplantation. No obvious
relationship wasfoundbetweenthegenotypeandphenotype
in NICCD. Conclusions. 15 mutations were found in 31
Chinese patients from 28 families, including 7 new muta-
tions. 851del4, 1638ins23, and IVS6+5G > A mutations
are frequent mutations in Chinese NICCD. There is no
obvious relationship between the genotype and phenotype
of NICCD. Not all of NICCD patients have optimisticInternational Journal of Pediatric Endocrinology 49
prognosis, and the poor prognosis may be associated with
delayed treatment.
GeneMutationAnalysisinFifteen
ChineseChildren with Wilsons’s Disease
Huiying Sheng, Li Liu, Xiuzhen Li, Jing Cheng,
and Youlan Huang
Department of Endocrine and Metabolism,
Guangzhou Women and Children’s Medical Center
Objective. To conﬁrm the diagnosis of Wilsons’s disease
(WD) on the gene level and explore the mutation in Chi-
nese Children by PCR-based restriction mapping analysis.
Methods.E x o n8 ,e x o n1 2 ,a n de x o n1 3o fA T P 7 Bg e n e
were ampliﬁed by PCR from genomic DNA, digested with
restriction enzymes Msp I, Tai I, and BstDs I, respectively
and analyzed by 1.8% gel electrophoresis of the cleavage
products. The exons of gene mutation were conﬁrmed by
direct sequencing. Results. Arg778Leu of exon 8 was detected
in 26.7% (4/15) patients. 1 patient was homozygous, and 3
patients were heterozygous for this mutation. Thr935Met of
exon 12 was detected in 20% (3/15) patients, and 2 cases
were heterozygous for this mutation. None of patients had
Pro992Leu of exon13. Among them, 1 case was compound
heterozygous mutation with Arg778Leu/Thr935Met. The
result of this method was the same as that of the DNA
sequencing. Three family trees were built and analyzed by
detecting these gene mutations. Conclusion. The method of
restriction mapping can identify high-frequency mutational
sites of WD gene accurately and rapidly and help to
diagnose suspicious WD cases and their family members.
The mutations of Arg778Leu and Thr935Met are “hot-spot”
mutations in Chinese WD patients, whereas the Pro992Met
w o u l db ec o n ﬁ r m e db ym o r es a m p l e s .
Cytogeneticand MolecularGeneticAnalysisof
Down’sSyndrome:287 Cases
Cui Song, Feng Xiong, and Min Zhu
Special care ward, Children’s Hospital,
Chongqing Medical University
Objective. To better understand the karyotype distribution
of the patients with Down’s syndrome (DS) who have been
ﬁnally diagnosed in our hospital. To compare the strengths
of G-banding karyotype analysis and FISH (Fluorescence
In Situ Hybridization, FISH) in diagnosing the DS patients
with the chromosome mosaicism and calculating the per-
centage of abnormal karyotypes. Methods. Blood of the
patients who were likely to suﬀer from DS was selected
for G-banding karyotype analysis to describe the karyotype
distribution. 5 of the ﬁnally diagnosed patients with the
chromosome mosaicism were randomly selected for FISH to
compare the percentage of abnormal karyotypes of the two
methods. Results. 287 DS patients were diagnosed, 91.29%
of whom had the simple karyotype. Among the patients
with the translocation karyotype, 11 D/G translocation
karyotypes were detected, accounting for 73.33%, while 4
G/G translocation karyotypes were diagnosed, constituting
26.67%. One patient with both the translocation karyotype
and the mosaicism karyotype was detected in our research,
which was uncommon in recent report. The results of FISH
and G-banding karyotype analysis were consistent. There
was no signiﬁcant diﬀerence of the abnormal karyotype
rates for DS patients with the chromosome mosaicism by
G-banding karyotype analysis and FISH. Conclusions.T h e
simple karyotype is the main karyotype of the DS patients in
our research. Among the translocation karyotype, the D/G
kind is common. DS patients can be diagnosed eﬃciently
by G-banding karyotype analysis, but we still suggest using
FISH to get the proportion of the abnormal cell for the
patients who have less triploid cells and slighter clinical
manifestation.
Spectrumof InbornErrorsof Metabolism in
VietnamesePatients: ClinicalPresentationand
Results of Treatment
Nguyen Thi Hoan,1 Vu Chi Dung,1
Nguyen Ngoc Khanh,1 Bui Phuong Thao,1
Can Thi Bich Ngoc,1 Khu Th Khanh Dung,1
Nguyen Thu Nhan,1 Seiji Yamaguchi,2
and Nguyen Thanh Liem1
1National Hospital of Pediatrics, Hanoi, Vietnam
2Department of Pediatrics, Shimane University School of
Medicine, Japan
As hospitalizations for traditional pediatric illnesses have
declined during the last century, due primarily to improved
treatment of infectious diseases, the contribution of other
disorders has gained prominence. Biochemical genetics, with
its various inherited metabolic disorders (inborn errors
of metabolism: IEM), has become more important in the
routine care of hospitalized pediatric patients. We aim to
study spectrum of IEMs, clinical characteristics, prevalence
of IEMs, and survival rate of children with IEMs at National
Hospital of Pediatrics (NHP) in Hanoi, Vietnam. 650
patients with suspected IEMs were examined and treated
at NHP from 2005 to May, 2010. Quantitative analysis of
blood amino acids and acylcarnitine using Tandem MS and
urine organic acids using GC/MS was done in Shimane
University, Japan. IEMs were identiﬁed in 81 cases (12.5%)
of suspected patients. IEMs occupied 0.033% of inpatients at
NHP. Age ranged from 2 days to 18 years. Among 81 patients
with IEMs, 54/81 cases (66.7%) were organic acidemia,
17/81 cases (21%) were aminoacidopathy, and 10/81 cases
(12.3%) were fatty acid oxidation disorders. In organic
academia, lethargy and metabolic acidosis were common
features (88.9%). Mental retardation and encephalopathy
were frequent symptoms in cases with aminoacidopathy
(41.2% and 58.2%, resp.) and in cases with fatty acid
oxidation (30% and 60%, resp.). Nearly, the half of the
cases had familial history with one or more siblings with
similar presentation. Treatment saved lives without mental50 International Journal of Pediatric Endocrinology
and motor development delay in 23.5% cases. Among 81
cases, 23.5% had mental and motor development delay. 17
patients of 54 cases with organic academia were without
complication. In aminoacidopathy, 9/12 cases with MSUD
died; 5 cases with PKU had mental delay. This study shows
that organic acidemia is the most common of IEMs at NHP.
Associationsof Methylation Statusin
the MTHFR Promoterregionwith
CongenitalHeart Diseases
Zhang Wendi and Luo Xiaoping
Department of Pediatrics, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and Technology
Objective. The etiogenic mechanisms of congenital heart
diseases (CHDs) are still poorly known. Singlenucleotide
polymorphisms (SNPs) in the Methylenetetrahydrofolate
reductase (Methylene tetrahydrofolate reductase, MTHFR)
gene have been revealed to be involved in CHDs; however,
other mechanisms of pathogenesis, for example, promoter
region hypermethylation, may also play an important role.
Therefore, in our study, we compared the methylation
status of the promoter region of MTHFR in children with
CHDs with children without congenital birth defects. We
did it in order to get the message of the relation of
the methylation status of the promoter region of MTHFR
and CHDs. Methods. We collected peripheral venous blood
samples of 53 patients with CHDs and 80 healthy children
without congenital birth defects (controls) and abstracted
DNA from leukocytes. Then, the DNA was modiﬁed by
sodium bisulﬁte and analyzed by Methylation Speciﬁc PCR
(MSP) ampliﬁcation, which use primers that hybridize to
the CpG islands in the promoter region of MTHFR. And
the relation between the methylation status of the promoter
region of MTHFR and CHDs was analyzed by case-control
study. Results. In peripheral venous blood, the analysis result
of MSP revealed that the complete methylation ratio in case
(2/53, 3.77%) is slightly higher than control (2/80, 2.50%);
the incomplete methylation ratio in case (13/53, 24.53%) is
also slightly higher than control (9/80, 11.25%). But there
is no statistical signiﬁcance between them (P = .110).
Conclusions. There are no diﬀerences between children with
CHDs and children without congenital birth defects about
the methylation status of the promoter region of MTHFR.
The causative mechanisms of CHDs are not due to the
hypermethylation status of the promoter region of MTHFR.
Effects of the Mitochondrial Respiratory
ChainComplexii in Rat CardiacMuscleby
Methylmalonic Acid
Qin Yi, Fengyan Tian, Hong Wei, Yan Liang,
Qin Ning, and Xiaoping Luo
Department of Pediatrics, Tongji Hospital,
Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430030, China
Objective. To clarify the underlying mechanisms involved
in the mitochondrial respiratory chain by methylmalonic
acid using mitochondria from cardiac muscle of young rats.
Methods. Mitochondria were extracted from cardiac muscle
of 30-days-old SD rats and incubated by diﬀerent concen-
trations of methylmalonic acid (0mM, 1mM, 2.5mM, and
5mM) and diﬀerent times (30 minutes, 2h, 4h and 8h).
The mitochondrial respiratory chain complexII enzymatic
activity and expression of ﬂavoprotein subunit 70 (FP)
and iron-sulfur protein subunit 30 (IP) in complexII were,
respectively, detected using spectrophotometric method and
Western blot. Results. (1). Enzymatic activity of mitochon-
drial respiratory chain complexII. (1) When exposed to
methylmalonic acid for 30 minutes and 2h, respectively,
complexII activity in diﬀerent concentrations groups had no
signiﬁcant diﬀerence with that in control group. (2) When
exposed to methylmalonic acid for 4h, complexII activity
in three treatment groups decreased signiﬁcantly compared
with the control group. (3) When exposed to methylmalonic
acid for 8h, complexII activity in 1mM group had no
signiﬁcant diﬀerence with that in control group; but in
2.5mM and 5mM groups, complexII activity decreased
signiﬁcantly; (4) complexII activity remained stable when
exposed to 30 minutes, 2h, and 4h; when the incubation
time prolonged to 8h, complexII activity decreased signiﬁ-
cantly. (2). Expression of FP and IP in Western blot (1) when
exposed to methylmalonic acid for 30 minutes, expression of
FP and IP in treatment groups had no signiﬁcant diﬀerence
with those in control group; (2) when exposed for 2h,
expression of IP in treatment groups had no signiﬁcant
diﬀerence with those in control group, but expression of FP
decreased signiﬁcantly; (3) when exposed for 4h, expression
of IP in treatment groups had no signiﬁcant diﬀerence
with those in control group, but expression of FP decreased
signiﬁcantly; (4) when the incubation time prolonged to
8h, expression of FP decreased signiﬁcantly in treatment
groups; expression of IP in 1mM group had no signiﬁcant
diﬀerence with that in control group, but in 2.5mM and
5mM groups, it decreased signiﬁcantly. Conclusions.T i m e -
dependent and concentration-dependent inhibition of respi-
ratory chain complexII enzymatic activities and expression
of protein subunits by methylmalonic acid found in rat heart
mitochondria may suggest a direct inhibition mechanism of
methymalonic acid on the respiratory chain complexII.
A Case Report of Niemann-Pick Type C Disease
Yining Zhang,1 Hongwei Du,1 Shanyu Li,1
Lijie Wang,2 and Li Shibo2
1Endocrinology and Metabolism Department, Pediatrics,
First Hospital of Jilin University Changchun
2The Department of Pediatrics, The university of
Oklahoma Health Science Center
A 12-year-old Chinese boy born to consanguineous par-
ents presented with progressive neurological regression and
hepatomegaly noticed after 8 year of age. Bone marrow
examination revealed presence of storage cells suggestive ofInternational Journal of Pediatric Endocrinology 51
Gauchers or Niemann Pick. Conﬁrmatory study by lysoso-
mal enzyme from leucocytes was normal for β-Glucosidase
and sphingomyelinase speciﬁc for Gauchers and Niemann
Pick type A or B, respectively. Further study was carried out
onGenetictestingfortheboyandhisparents.Themutations
in NPC1 were detected in the boy conﬁrming the diagnosis
of Neimann-Pick type C (NPC), a rare autosomal recessive
disorder. Meanwhile, his parents were conﬁrmed as NPC
carriers. The mutations found were Mother: g 46639C>C/T;
p 927A>A/V; Father: g 46636C>C/T; p 936A>A/V; patient: g
46639C>C/T; 46636C>C/T; p 927A>A/V, 936A>A/V.
Thyroid Disorders
Children Beyond 5 Yearsof Age:
AreWeStillDiagnosingCongenital
HypothyroidismSoLate?
Anju Seth, Varun Aggarwal, and Anu Maheshwari
Department of Pediatrics, Kalawati Saran Children’s
Hospital and Lady Hardinge Medical College,
New Delhi-110001, India
Background. India lacks a neonatal screening program for
detection of congenital hypothyroidism (CH) leading to a
delay in its diagnosis. Tardiness in diagnosis and treatment
of CH leads to signiﬁcant neurological morbidity. Objective.
To determine the frequency of undiagnosed and untreated
congenital hypothyroidism in children presenting after 5
years of age. Methods. Retrospective analysis of records of
children with hypothyroidism who were more than 5 years
of age at presentation to Pediatric Endocrinology clinic
at Kalawati Saran Children’s hospital, New Delhi, India,
between October 1997 and April 2010. Results. During the
study period, 320 children were diagnosed with hypothy-
roidism. Among these, 94 (29.3%) were older than 5 years
of age at presentation. In this group of subjects, CH was
diagnosed in 34 (36.1%) and acquired hypothyroidism (AH)
in 60 (63.9%). Female preponderance was more commonly
seen in AH (83.3%) as compared to CH (61.7%). Symptoms
of CH were noted at a mean age of 35.3 ± 25.9 months
(range 12–132 months). However, the children were brought
for evaluation at our center at the age of 86.6 ± 35.3
months (range 60–216 months). The mean gap between
onset of symptoms and diagnosis was nearly 51 months.
However, the mean duration of symptoms before diagnosis
in children with AH was signiﬁcantly shorter (8 months,
P<. 001). The main presenting complaints in children with
CH and AH were growth delay (100%) and thyroid swelling
(65%), respectively. Anterior fontanel was still open in 10
children with CH while one child also had open posterior
fontanel. Mean fT4 values of CH and AH at presentation
were 0.23 and 0.34ng/dL, respectively (P = .19). Children
with CH had signiﬁcantly higher TSH values (377.4mIU/L)
as compared to those with AH (151.4mIU/L) (P = .002)
and had signiﬁcantly delayed bone age (mean chronological
age minus bone age 4.9 years in CH versus 2.0 years in AH,
P<. 01). The most common cause of congenital hypothy-
roidismwasthyroiddysgenesis(51.8%),followedbyagenesis
(25.9%) and dyshormonogenesis (22.2%). Conclusions.I n
The absence of a universal screening program, diagnosis of
CH, an important causeof preventable mental retardation, is
often delayed in India, even in the capital city. Until universal
screening is implemented, a high awareness of this disorder
among physicians is crucial to facilitate early diagnosis.
VariedClinicalPresentationsof
Van Wyk Grumbach Syndrome
Ahila Ayyavoo1 and Palany Raghupathy1,2,3,4
1G. Kuppuswamy Naidu Memorial Hospital,
Coimbatore, India
2Sagar Hospital, Indira Gandhi Institute of Child Health
3Kempegowda Institute of Medical Sciences
4Bangalore, India
Sexual precocity, hypothyroidism, and large cystic ovaries in
young girls, though unusual, were seen in eight girls over
a 5-year period. This paper describes varying clinical man-
ifestations in eight girls presenting with van Wyk Grumbach
syndrome (vWGS) and their response to thyroxine therapy.
Clinical, biochemical and imaging features of eight children
with vWGS treated during 2005–2009 and followup results
of therapy are presented. Age at presentation ranged from 6
to 11 years. At ﬁrst visit, clinical features of hypothyroidism
were evident in 8/8 girls, short stature (height: <3c) 6/8,
early thelarche 8/8, sexual hair 0/8, and precocious menarche
(mean age at onset: 6.38 years) 7/8. One girl aged 11
presentedwiththelarche,largeabdominalmassesandascites.
Two girls investigated with MRI brain scan for precocious
puberty were referred as pituitary tumours; one of them
(aged 6.5 years) had Down syndrome. Bone age was delayed
in all though they had precocious puberty. Biochemical
hypothyroidism was documented in all; TSH ranged from
118 to 4236mIU/ml. Ovarian hyperstimulation was demon-
strated by ultrasonogram in all girls and very large ovarian
cysts in two. One of them presented acutely with torsion
of enlarged ovaries and required excision of a gangrenous
ovary. Another girl was referred with a diagnosis of ovarian
carcinoma. All girls improved with thyroxine therapy—loss
of body weight upto 20%; improved height velocity (mean:
9.5cm/years),goodcatch-upgrowth,andcrossovertohigher
centiles were noted in all, and signs of hypothyroidism
abatedwell.Fourgirlsattainedpubertyappropriately(mean:
12.6 years). All had regression of ovarian size. All were
investigated earlier for precocious puberty, short stature
or obesity and obvious hypothyroidism had been missed.
Complications such as growth retardation in all, torsion of
the ovary, the diagnosis of pituitary tumour (thyrotroph
hyperplasia) in two girls and ovarian carcinoma in one may
have been avoided by early recognition and treatment of
vWGS. This condition may be easily treated simply with
thyroxine replacement producing an assured outcome of
excellentresults,namely,arrestofpuberty,improvedphysical
growth and overall well-being.52 International Journal of Pediatric Endocrinology
MulticysticOvariesinaGirlwith
PrimaryHypothyroidism
Sioksoan Chan-Cua
Department of Pediatrics, University of the Philippines,
Manila Doctors Hospital, Manila, Philippines
A girl presented with obesity and short stature, associated
with recurrent abdominal pain, postprandial vomiting and
constipation. She has gained much weight since age 4 years.
Vaginal bleeding ﬁrst occurred at the age of 8 years and
her abdomen has increased signiﬁcantly in size about a
month prior to consultation. At the age of 11 years and 4
months, her height was 106.4cm (height age of 4.8 years)
and body mass index was 34 (>+3SD, WHO reference).
Her blood pressure was 107/77mmHg. She had dry skin,
with pustules and abscess in the extremities, and acanthosis
nigricans in neck, axilla, elbows, knuckles and knees. She
had no palpable thyroid gland. Her breast development
was at Tanner stage 4 and nipples were hyperpigmented.
Her abdomen was globular and circumference was 91cm.
Her bone age was 4.5 years at chronological age of 11
year 4 months. Thyroid ultrasonography showed small-sized
thyroid gland, both lobes appeared small and displaced
cephalad in the anterior neck at the midline. Abdominal X-
rays showed segmental ileus. Initial pelvic ultrasonography
showed bilaterally enlarged ovaries with multiple enlarged
follicular cysts. Blood tests showed low free T4 level,
0.16ng/dl, high TSH level, 98.79uIU/ml, elevated prolactin
level, 71.81ng/ml, FSH, 7.05mIU/ml, low LH, 0.10mIU/ml,
estradiol, 171pg/dl, low IGF-1 level, 64.9ng/ml and growth
hormone 0.12ng/ml, dyslipidemia—high serum cholesterol,
10.06mmol/L (390mg/dl), LDL, 7.64mmol/L (294mg/dl)
and triglycerides, 2.6mmol/L (230mg/dl) and elevated liver
enzymes (SGPT, 89U/L and SGOT, 78U/L). Levothyroxine
therapy was started at 200mcg/day (5mcg/kg/day) for the
primary hypothyroidism. After 4.5 months, her BMI was
reduced to 21.7 and her growth velocity increased to
11cm/years. Restoration of euthyroid state was associated
with decreased abdominal circumference and resolution of
the ovarian cysts as well as normalization of biochemical
parameters. This case emphasizes the need to consider
hypothyroidism in the short girl with ovarian cysts. Right
diagnosis with the initiation of levothyroxine therapy can
reverse the symptoms and avoid unnecessary surgery on the
ovaries.
The Therapy of Low-Dose Levothyroxine to
Central Nervous System Infection
Agung Tanurahardja, Antonius Pudjiadi,
Aman Pulungan, Pramita Gayatri, and Risma Kaban
Indonesian Pediatric Society
Objective. To study the therapeutical eﬀect of low-dose
levothyroxine (2∼3μg/kg.d) in the infection of central ner-
vous system (CNS) with hypofunction of thyroid. Method.
Clinicaldataof50patientswithCNSinfectionwereanalyzed
Free triiodothyronine (F13), triiodothyronine (T3), free
thyroxin (FI’4), thyroxine (T4), and thyroid stimulating
hormone (TSH) were determined, low-dose levothyroxine
wasusedtotreatedsuchpatientsandthemindandcognition
were test every day. They were divided into two groups
randomly, one was given Levothyroxine, the other nothing.
Results. Low FT3 was 66.7% in the abnormal thyroid func-
tion; it was obviously lower than the normal (P<. 05). The
mind and cognition of patients with Levothyroxine became
better than without treated. Conclusion. Levothyroxine can
promote patients’ mind and cognition to become better; it
needs to be used early in CNS infection with hypofunction
of thyroid.
A15-Year-OldGirlwithGraves’Disease
AssociatedwithMoyamoya Disease
Chong Kun Cheon and Su Yung Kim
Department of Pediatrics, Children’s Hospital,
Pusan National University, Beomeo-ri, Mulgeum-eup,
Yangsan-si, Gyeongnam, 626-770, Korea
Background. Thyroid hormone excess in Graves’ disease
is harmful to arterial walls because it may alter vascular
reactivity, and Graves’ disease is often accompanied by many
cardiovascular symptoms. There have been few reported
cases of the coexistence of Graves’ disease and moyamoya
disease. Clinical Case. A 15-year-old girl who had suﬀered
from Graves’ disease for seven years visited our hospital with
central type right facial palsy. She presented with a clinical
picture of hyperthyroidism, goiter and ischemic attack
consisting of right-side hemiparesis. Thyroid function tests
demonstrated suppressed thyroid-stimulating hormone and
elevated thyroid hormone levels. The patient was diagnosed
with Moyamoya disease with typical stenosis of the ICA
and MCA, based on MRI scans and cerebral angiography.
Single photon emission computed tomographic (SPECT)
scans revealed cerebral hypoperfusion of the left frontal lobe,
left thalamus without vascular reserve. The patient under-
went cranial revascularization by encephalo-duro-arterio-
synangiosis (EDAS). After surgery, the patient’s symptoms
improved, and the power of the right upper and lower
extremities recovered. Conclusion. To our knowledge, this is
the ﬁrst case of Moyamoya disease associated with thyrotox-
icosis in a young girl in Korea. Moyamoya disease should
be considered in the diﬀerential diagnosis of cerebrovascular
events in patients with Graves’ disease.
A Caseof Melkersson-Rosenthal Syndrome in
aGirlwithHashimoto’s Thyroiditis
Chong Kun Cheon and Su Yung Kim
Department of Pediatrics, Children’s Hospital,
Pusan National University, Beomeo-ri, Mulgeum-eup,
Yangsan-si, Gyeongnam, 626-770, Korea
Background. Melkersson-Rosenthal syndrome (MRS) is a
rare disorder of unknown etiology. MRS is classically deﬁnedInternational Journal of Pediatric Endocrinology 53
as a triad of recurrent orofacial edema, relapsing paralysis of
the facial nerve, and ﬁssured tongue. It frequently occurs in
the ﬁrst two decades of life. The incidence of this syndrome
is estimated to be about 0.08%. A link between MRS
and immunological disorders such as sarcoidosis, Crohn’s
disease, unilateral anterior uveitis and multiple sclerosis was
documented. However, there have been few reported cases
of the coexistence of Hashimoto’s thyroiditis and MRS.
We present here a case of MRS with the classical triad
of symptoms and Hashimoto’s thyroiditis. Clinical Case.
A 10-year-old girl who had suﬀered from Hashimoto’s
thyroiditis for one year visited our hospital with peripheral
type right-sided facial palsy. Antithyroperoxidase antibodies
(anti-TPO) were highly elevated and thyroid function tests
had evidenced a clinically signiﬁcant hypothyroidism. The
patient had a history of right-sided facial paralysis at the
age of 9. The physical examination showed that the patient
had a ﬁssured tongue, right seventh nerve paralysis and mild
orofacial edema. The examination of all other systems was
normal. Nerve conduction study revealed paralysis of the
right facial nerve. No pathological ﬁndings were detected
on cranial MRI scan. After oral steroid therapy, the patient’s
symptoms improved. Conclusions. The presence of the anti-
TPO antibodies in the case reported here could suggest
a possible correlation between immunological alteration
characteristic of autoimmune thyroiditis and MRS. MRS
shouldbeconsideredinthediﬀerentialdiagnosisofrelapsing
paralysis of the facial nerve in patients with Hashimoto’s
thyroiditis. To our knowledge, this is the ﬁrst case of
MRS associated with Hashimoto’s thyroiditis in a young
girl.
Neonatal Screeningfor Congenital
Hypothyroidism:Twelve Years of Experience in
HatYaiHospital
Pathikan Dissaneevate and Jeerawan Wannaro
Department of Pediatrics, Hat Yai Hospital,
Songkhla, Thailand
Objectives. To evaluate the incidence of congenital hypothy-
roidism (CH) in neonates born at Hat Yai Hospital. Methods.
TSH screening for CH, using dried blood spot at the aged
of 2 days or older, was introduced in Hat Yai Hospital since
1998. From January 1998 to March 2010, 77, 242 neonates
born at Hat Yai Hospital were screened for CH at the aged
of 2-3 days. Infants with elevated TSH level of greater than
25mU/L were recalled for evaluated serum total T4, total
T3 and TSH level. Thyroid scan and uptake were performed
in aﬀected infant after treatment at the aged of 2-3 years.
Results. The coverage rate of TSH screening was 81% in
1998 and increased to 99.9% in 2010. The average recall
rate was 0.2 percent. Elevated TSH more than 25mU/L was
found in 172 neonates. Of these, 165 were repeated for TT4
or FT4, TT3 and TSH and only 21 were conﬁrmed CH.
The incidence of CH was 1:3, 678 live-births. All aﬀected
infants were asymptomatic. Thyroid scan was performed
in 15 infants which showed abnormal in 6 cases, ectopic
thyroid in 5 neonates and thyroid dysgenesis in 1 neonate.
Six infants were suggested as having thyroid dyshormono-
genesis. When primary CH was conﬁrmed, the treatment
with thyroxine will be started. Conclusion. The incidence
of CH at Hat Yai Hospital is 1:3, 678 live births. The
cutoﬀ value of serum TSH was 25mU/L. Routine neonatal
screening for CH and early treatment should be estab-
lished and continued to detect and prevent the intellectual
handicap.
Thyroid Dysfunction Detected in
Intensively Cared Neonates for
More Than 1 Month
Heon-Seok Han and Jae Hong Yu
Department of Pediatrics, Chungbuk National University
Hospital, Joy children’s Hospital
Objective. To evaluate the incidence, time of detection,
classiﬁcation and the risk factors of thyroid dysfunction in
very low birth weight (VLBW) and sick infants in order to
help with the diagnosis and treatment of thyroid dysfunction
in the neonatal intensive care unit (NICU). Methods.W e
reviewed medical records of 67 infants, who were admitted
for more than 1 month in the NICU at Chungbuk National
University Hospital from July 2006 through June 2009. At
least two thyroid function tests (TFT) were performed in
these infants, an initial screening within 2 weeks of age and
a repeated TFT after 2 weeks of age. They were grouped
as VLBW (birth weight <1, 500g, n = 40) and non-very
low birth weight (NVLBW, birth weight ≥1, 500g, n =
27). Results. At initial screening test, abnormal TFT was
detected in 10 infants (9 VLBW, 1 NVLBW), including 1
primary hypothyroidism (PH), 2 hypothyroxinemia, and
7 hyperthyrotropinemia. Nine of them showed subsequent
abnormal TFT, and 1 hypothyroxinemic VLBW changed
to normal at followup. Additional 33 infants (22 VLBW,
11 NBLBW) showed abnormal subsequent test mostly at
2–6 weeks of age (90.9%), resulting abnormal TFT in 42
(62.7%) infants with 30 (75.0%) in VLBW. The types of
thyroid dysfunction (Table 4)w e r eP Hw i t hm a r k e dT S H
rise (n = 7 ) ,P Hw i t hd e l a y e dm i l dT S Hr i s e( n = 14),
hypothyroxinemia (n = 7), and euthyroid sick syndrome
(n = 14). Among 42 infants with thyroid dysfunction 15
(35.7%) were treated with thyroxine. Only the birth weight
was signiﬁcantly related to the risk of thyroid dysfunction
(P<. 05). Conclusion. Thyroid dysfunction was very
common in sick infants in NICU, especially in the VLBW.
Frequently they were not detected at the initial screening,
but detected at later repeated tests. The repeated thyroid
function tests should be performed in NICU infants for
later detection of thyroid dysfunction after 2–4 weeks of
age.54 International Journal of Pediatric Endocrinology
Table 4: Classiﬁcation of thyroid dysfunction in subsequent followup test.
Classiﬁcation VLBW NVLBW Total
Thyroid dysfunction, no. (%) 30 (75.0%) 12 (44.4%) 42 (67.7%)
PH with delayed marked TSH rise 6 (6∗)1 ( 1 ∗)7 ( 7 ∗)
PH with delayed mild TSH rise
2(a) decreased FT4: mild PH 2 (1∗)1 ( 1 ∗)3 ( 2 ∗)
2(b) normal FT4: hyperthyrotropinemia 7 (3∗)4 ( 1 ∗)1 1 ( 4 ∗)
Hypothyroxinemia 5 (1∗)2 ( 1 ∗)7 ( 2 ∗)
Euthyroid sick syndrome 10 4 14
Thyroid supplementation, no. (%) 11 (36.7%) 4 (33.3%) 15 (35.7%)
Values are represented as number and percent.∗Number of infants with thyroxine supplementation.
ChronicKidney Diseaseina Childwith
HashimotoThyroiditis
Zuhrotul Aini,1 Risky Vitria Prasetyo,1
Achmad Yuniari Heryana,2 Muhammad Faizi,2
Ninik Asmaningsih Soemiarso,1 Netty Harjantien,2
and Mohammad Sjaifullah Noer1
1Division of Nephrology
2Division of Endocrinology, Department of Child Health,
Faculty of Medicine, University of Airlangga,
dr. Soetomo Hospital Surabaya
Background. Hashimoto thyroiditis is the most common
cause of acquired hypothyroid. Severe hypothyroidism is
associated with signiﬁcant eﬀects on the kidney due to low
cardiac output, decrease in renal blood ﬂow and glomerular
ﬁltration rate. Undiagnosed and untreated hypothyroid can
cause chronic complication such as chronic kidney disease
(CKD). Objective. To report a case of CKD in a child
due to Hashimoto thyroiditis focusing on diagnosis and
management. Case Report. A 7-year-old girl was referred
with suspicion of hepatorenal syndrome. She suﬀered from
vomiting for 1 month and easy fatigability, lack of appetite
and constipation for 1 year. She had poor growth, and
her height was not progressing since she was 4 years old.
On physical examination we found short stature (weight
at 25th percentile, height at less than 3rd percentile), dull
expression, myxedema and dry skin. There was no goiter.
Her blood pressure was 140/90mmHg. Laboratory test
revealed ALT 58IU, AST 47IU, BUN 21.0mg/dl, creatinine
2.2mg/dl, GFR 23ml/mn/1.73m2,T 41 . 0 μg/dl (4.6–11),
FT4 0.4ng/dl (0.8–2.0) and TSH more than 26μIU/ml
(0.4–7.0). Antithyroperoxidase antibody was 6315.92IU/ml
(<56IU/ml) and antithyroglobulin positive was 1:2.560
(N: negative). Abdominal USG revealed bilateral chronic
parenchym kidney disease. Thyroid USG revealed shrunken
thyroid lobes. The patients improved clinical and laboratory
ﬁndings after treatment with levothyroxin and conserva-
tive treatment of CKD. Conclusion. Delayed diagnosis of
hypothyroid can cause complications such as CKD that are
usually overlooked and may result in potential diagnostic
pitfalls.Thyroidhormonetherapyledtosigniﬁcantimprove-
ment in thyroid and renal functions in our patient.
Receiver Operating Characteristic Analysis of
Cord Blood TSH for the Screening of
PrimaryCongenital Hypothyroidism
Suhaimi Hussain, Yazid Jalaludin, and Fatimah Harun
Pediatric Department, University Hospital, Jalan Hospital
Objective. To determine the safe cut oﬀ point for the
screening of congenital hypothyroidism using ROC anal-
ysis. Methods. All newborns were screened for congenital
hypothyroidism using cord blood TSH. TSH is analyzed by
chemiluminescent method. Normally when the TSH is more
than 20mIU/L, the repeated test for TSH and freeT4 will
be done. When the test is abnormal the baby will be called
for conﬁrmation with venous blood for thyroid functions.
ROC curves were calculated for cord blood TSH. Results.S i x
thousand eight hundred and sixty two (n = 6862) samples
were analysed. The mean/median/standard deviation of TSH
were7.31/5.80/5.703.WhenthecutoﬀvalueofTSHusedwas
57, the area under the curve was 0.9 ± 0.130 (SE) (95% CI
0.644–1.156). With cut oﬀ value of TSH 20, the area under
the curve was 0.553 ± 0.041, (95% CI 0.472–0.633). It was
noted that the lower the cutoﬀ value for TSH, the area under
the curve will be less accurate in discriminating cases and
the control. Conclusion. Using cord blood TSH level of 20
is adequate and safe to screen congenital hypothyroidism in
our population.
ConcurrentOccurrence of
ChronicLymphocyticThyroiditiswith
Hypothyroidismand GrowthHormone
Deﬁciency in a Turner’s Syndrome Patient
Wu Jin, Xiang ChengFa, Sun XiaoMei, and Yang Fan
Department of Pediatrics, Second Hospital of West China,
Sichuan University, Chengdu, China
Background. Concurrent deﬁciencies of three hormones in
patients with Turner Syndrome have been rarely reported.
Here we describe a case of a young girl who had Turner’s
syndrome with concomitant chronic lymphocytic thyroidi-
tis, growth hormone deﬁciency, and hypothyroidism with
cardiopericarditis. Case. An 11-year-old girl was referred toInternational Journal of Pediatric Endocrinology 55
the outpatient clinic because of short stature, ochronosis and
cardiopalmus. Her ultrasound revealed absence of ovarian
tissue. Karyotype examination suggested Turner’s syndrome
with sex-hormone deﬁciency. She was found to have an
abnormal thyroid gland and elevated thyroid-stimulating
hormone (TSH). A positive thyroid autoantibody titer con-
ﬁrmed the diagnosis of chronic lymphocytic thyroiditis with
hypothyroidism. Furthermore, her growth hormone levels
were well below normal. Diagnosis. A multiendocrine dis-
order, that is, Turner’s syndrome with chronic lymphocytic
thyroiditis, growth hormone deﬁciency, and hypothyroidism
withcardiopericarditiswasdiagnosed.Growthhormoneand
thyroxin substitution therapy was suggested.
PrimaryHypothyroidismMasqueradingas
PituitaryTumor
Ansu Mali Joshi,1 VP Jyotsna,1 Emmy Grewal,1
Raju Sharma,2 and Ariachery C Ammini1
1Departments of Endocrinology and
2Radiology AIIMS, New Delhi, India
Introduction. Hypothyroidism is a common endocrine dis-
order which usually presents with growth deceleration in
children. Here we present a case of primary hypothyroidism
presenting with a large pituitary mass at the age of 16. Case
Report. Ms R.S., 16 years, was referred to us for management
of pituitary macroadenoma. She gave history of headache
oﬀ and on for the past 8 years and blurring of vision for
2 months. She also complained of increasing lethargy, cold
intolerance, constipation and hoarseness of voice for the
previous 6 years. She had attained menarche at 13 years of
age. Physical examination revealed height of 140cm (mid-
parental height 154.5cm) and weight 35kg. Her pulse was
70/minutes, BP was 120/70mmHg, skin was dry and rough.
She was pale, and thyroid was not palpable. Visual acuity
and visual ﬁeld were normal. Deep tendon reﬂexes were
delayed. Other systemic examination was essentially normal.
Her hemoglobin was 9 gm%. Total T4 was 0.64μg/dl and
TSH was >100μU/ml. LH 4.3mIU/ml, FSH 5.5mIU/ml,
ACTH 17pg/ml, prolactin 67.6ng/ml, cortisol 14.1g/dl.
ECG showed low voltage complexes. MRI sella showed
enlarged pituitary gland measuring 2.99×2.78cm×1.89cm
with suprasellar extension with multiple cystic areas. She
was started on thyroxin 25g/day and gradually increased to
75g/day. On followup at 4 months, total T4 was 11g/dl and
TSH was 1.39IU/ml. Serum prolactin was within normal
limits. MRI done at this time showed signiﬁcant reduction
in size. Discussion. Pituitary enlargement in patients with
long-standing primary hypothyroidism is well known. The
present case was unique for the fact that the mass had
heterogeneous appearance with cystic areas making it diﬃ-
cult to diﬀerentiate from a pituitary tumor. The reduction
in size following thyroxin substitution suggests that it was
thyrotroph hyperplasia.
Remission Predictors of
GravesDiseasein Children
Shin Mi Kim,1 Sei Won Yang,1 Choong Ho Shin,1
Young Ah Lee,1 Min Jae Kang,1 and Jin Soon Hwang2
1Seoul National University College of Medicine
2Ajou University School Medicine
Objectives. Antithyroid drug treatment is usually recom-
mended as the initial treatment for children with Graves’
disease. However, achieving remission with medical therapy
usually requires many years of treatment, the risk for adverse
reactions is relatively high and relapse is common after
medication discontinuation. So there is debate about how
Graves disease should be treated in children. The aim of this
study was to identify predictors of remission after 2 years
of antithyroid medication use. Methods.W er e t r o s p e c t i v e l y
studied children who had Graves disease and were treated
with antithyroid medication. We compared children who
achieved remission after 2 years with those who had per-
sistent disease to determine which variables were associated
with remission. Results. Forty-one patients were enrolled, of
which 5 (12.2%) achieved remission and 36 (87.8%) could
not achieve remission until the last visit. There were no
signiﬁcant diﬀerences in T3, free T4, antimicrosomal anti-
body (AMA), and TSH-binding inhibitory immunoglobulin
(TBII) between the two groups at presentation. However,
the remission group had signiﬁcantly higher titer of TSH
than did the no-remission group at presentation (0.11±0.04
versus 0.04±0.04 mIU/L,P = .04). And the remissiongroup
had signiﬁcantly lower titer of antithyroglobulin antibody
(ATA) than did the no-remission group (189.6±103.2v e r s u s
520.4 ± 677.1U/ml, P = .01). The no-remission group
had higher ATA concentrations after 3 months of treatment
with antithyroid medication than did the remission group
(583.3 ± 763.9U/ml versus 211.2 ± 147.0U/ml,P = .02).
Conclusion. TSH, ATA concentrations at presentation and
ATA concentration after 3 months of treatment can be
predictors of remission in children with Graves disease after
2 years of antithyroid medication use.
Long-Term Followup Study of Newborns with
TSH Elevation without Low T4 in
Neonatal Screening
Su-Young Kim and Sang-In Bae
Pusan National University Children’s Hospital, Yangsan,
Korea
There have been few studies about long-term followup of
babies with TSH elevation without low T4 in neonatal
screening.Weaimedtohelpdiagnosisandtreatmentofthose
babies. We retrospectively reviewed medical records of 16
male and 26 female neonates whose T4 was normal and TSH
were elevated in neonatal screening. Mean T4 and TSH were
8.61±1.55μg/dl, 49.66±36.56μU/dl respectively. Untreated
patients were ﬁfteen in whom TSH titers were normalized56 International Journal of Pediatric Endocrinology
within 1.5 months (8 patients), 3 months (5 patients), 6
months (1 patient), and 9 months (1 patient) of age. Twenty-
seven patients were treated with thyroid hormone, among
whom 11 patients were oldes than 3 years of age at the
study point. Among those 11 patients, 6 patients could stop
thyroid hormone therapy after trial oﬀ, but 5 are still on the
thyroid hormone replacement. Those 5 patients had ectopic
thyroids (4 patients) or hypoplastic thyroid (1 patient), all
of who had been detected at radionuclide thyroid scan done
at neonatal period. In conclusion, in many patients with
hyperthyrotropinemiawithouthypothyroxinemia,TSHlevel
become normalized within 9 months of age, although we
should wait for more studies about long-term prognosis of
those without hormone replacement. Radionuclide thyroid
scan would be helpful to decide whether patients really need
hormone replacement therapy.
SeizureandEncephalopathy Associatedwith
Thyroid Storm in Children
Hae Sang Lee and Jin Soon Hwang
Department of Pediatrics, Ajou Unviersity School of
Medicine, Ajou University Hospital, Suwon, Korea
Objective. Thyroid storm is a rare occurrence in children.
T h eo c c u r r e n c eo fs e i z u r e sw i t ht h y r o i ds t o r mi sv e r yr a r e .
The aim of the study was to evaluate three cases of thyroid
storm in patients who presented with seizures. Methods.W e
retrospectively reviewed the medical records of 46 hyperthy-
roidism patients who were hospitalized at our pediatric unit
between2003and2009.Wereporttheclinicalandlaboratory
ﬁndings of three patients with thyroid storm who had a
seizure in the absence of a history of neurologic disease.
Results. Case 1 was an 11-year-old girl who presented with
a headache, abdominal pain, diarrhea, vomiting, and fever.
Three days after admission, she suﬀered two generalized
tonic-clonic seizures lasting for about 30 seconds and ﬁve
minutes, respectively. Case 2 was a 10-year-old boy who
presented with fever, palpitation, and irritability. On the day
of admission, he had tonic-clonic movements for about ﬁve
minutes. Case 3 was a 14-year-old boy who was diagnosed
with hyperthyroidism one year prior to admission. However,
he was not taking antithyroid drugs. He was admitted with
a complex partial seizure that lasted for about 10 minutes.
The serum thyroid hormone levels of all patients were
elevated. Acute medical management with propylthiouracil,
Lugol’s solution, hydrocortisone, and propranolol led to
complete resolution of the symptoms. Conclusion. Patients
with thyroid storm may be predisposed to the development
of neuropsychiatric change. Early recognition and multidrug
treatment of thyroid storm are essential to reduce morbidity
and mortality from this disorder.
Relationship of Congenital Hypothyroidism
andTSH Receptor GeneMutationandClinical
Phenotype
Liu Xiaa, Liu Xiaohonga, and Wang Shayanb
Shenzhen Children’s Hospital 518 026,
Shenzhen People’s Hospital 518000
Objective. Congenital Hypothyroidism is one of the most
common pediatric endocrine diseases and congenital
metabolic defects. It is one of the main causes of mental
retardation of children. Relationship of congenital hypothy-
roidism and thyroid-stimulating hormone receptor (TSHR)
gene mutation has been studied in order to explore the
molecular biology basis of thyroid disease. of hypothy-
roidism and the relationship between hypothyroidism and
TSHR gene mutation has been studied by detecting gene
m u t a t i o n so fe x o n1 0a n de x o n6o nT S H R .T h em o l e c u l a r
mechanism of congenital CH has been further clariﬁed.
Methods. Extracting DNA of white blood cells from 40
congenital hypothyroidism patients diagnosed in our hos-
pital, and enlarging its TSHR gene primers. Compare the
sequences obtained with the standard sequence of human
TSHR gene in the Gene Bank and test their sequences.
Results. Hypothyroidism patients have been examined by
color Doppler, among which 8 patients have been examined
by isotope scanning. Among 40 hypothyroidism patients,
14 cases (35%) are thyroid hypoplastic, 8 cases (20%) are
thyroid absent, 6 cases (15%) are thyroid enlarged, 5 cases
(12.5%) are thyroid Cystic, 4 cases (10.5%) are thyroid
ectopic, and 3 cases (7.5%) are with normal thyroid. Results
Positive and negative sequence test results of TSHR gene
mutation: Codon 727 of hypothyroidism patients numbered
1, 2, 3, 4, 5, 6, 10, 11, 14, 15, 16, 17, 18, 20, 21, 22, 24, 25,
26, 27 has been changed from GAC to GAG; 727 amino acid
substitution: Asp72→Glu, D727E homozygous mutation,
while the hypothyroidism patients number 7, 8, 9, 12, 13,
19, 23 are heterozygous mutations. Conclusion.T S H Rg e n e
mutation of 27 CH patients has been studied and it was
found that the TSHR 727 codons have changed from GAC
to GAG, 727 amino acid Asp727 have been substituted to
Glu, among which 20 were homozygous mutants, 7 were
heterozygous mutation. The results further elucidate the
molecular mechanism of congenital CH and provides a new
way of thinking.
AnEchocardiographic Studyof
CardiacChangesinCongenitalHypothyroidism
andthe Response to Treatment
Shanshan Mao, Zhefeng Yuan, and Chaochun Zou
Department of Endocrinology, The Children’s Hospital of
Zhejiang University School of Medicine
Congenital hypothyroidism (CH) is a common endocrine
disease of pediatrics, which results in severe mental retar-
dation and growth failure as well as other functional
impairment because of the deﬁciency of thyroid hormone
during human perinatal development. Recent research has
demonstrated that cardiac function is impaired in chil-
dren with CH, which can be fully or partly reversed by
levothyroxine (L-T4) substitution therapy. However, only
few, contradictory data are available on cardiac function inInternational Journal of Pediatric Endocrinology 57
neonates with CH. The aim of this study was to investigate
the eﬀects of L-T4 substitution therapy on left and right
ventricular function in neonates with CH, measured with
Quantitative tissue velocity imaging (QTVI) and pulsed-
wave Doppler echocardiography (PWD). Fifty full-term
neonates with CH aged 17∼28 days before and after 1 month
of levothyroxine substitution therapy as well as 35 normal
neonates aged 17∼28 days underwent PWD and QTVI. On
QTVI,peakmitralandtricuspidannularsystolic(S)velocity,
peak early (E) and late (A) mitral and tricuspid annular
diastolic velocity were measured, and the E/A ratio was
calculated. All the biochemical tests and echocardiographic
evaluations were reevaluated after 1 month of replacement
therapy. In CH neonates, QTVI showed that CH neonates
had signiﬁcantly lower S, E, and E/A of both left and
right ventricles (P<. 001, resp.). However, A of left and
right ventricles did not diﬀer signiﬁcantly. After 1 month
of substitutive therapy, CH neonates showed a signiﬁcant
increaseofSandEandasubsequentincreaseoftheE/Aratio
(P<. 001, resp.). In conclusion, our ﬁndings demonstrated
that CH is associated with impaired left systolic and diastolic
function in addition to impaired right systolic and diastolic
function. Early L-T4 replacement therapy should be advised
for these neonates with the aim to correct preclinical cardiac
dysfunction.
Near-FatalUterineBleeding in
a Congenital HypothyroidAdolescent
Catherine Anne G. Pangilinan
University of the Philippines, Philippine General Hospital
Abnormal uterine bleeding is an infrequent but serious
complication of inadequately treated hypothyroidism. This
is a case of a 16-year-old girl who was brought to the
emergency room because of seizure. The patient is a
diagnosed case of Congenital Hypothyroidism since one
month of age by newborn screening. She is maintained
on levothyroxine but with poor compliance because of
ﬁnancial constraints. She presented with one week his-
tory of menorrhagia consuming ﬁve to six fully soaked
pads per day associated with pallor and generalized body
weakness. Five days after the onset of menses, she had
four episodes of generalized tonic-clonic seizures, each
lasting for 30 seconds, which prompted the consultancy.
On admission, she was lethargic, clammy, and hypotensive
with BP: 60/40mmHg, CR: 140/minutes, RR: 40/minutes
and with poor pulses. Neurologic exam was normal. ABG
showed metabolic acidosis. Oxygen supplementation and
initial ﬂuid resuscitation were done. Plasma expanders,
dopamine and dobutamine were likewise started with
gradual improvement of vital signs. CBC showed severe
anemia (Hgb: 32g/dl, Hct: 0.09) warranting pRBC trans-
fusion. Transabdominal ultrasound revealed hematometra
with thinned-out endometrium. Conjugated estrogen, fer-
rous sulfate and tranexamic acid were likewise given. On
further examination of the patient, she was noted to be
severely stunted (Wt: 30kg and Ht: 120cm, both <P5),
with periorbital edema, depressed nose bridge, underde-
veloped breasts and genitalia (Tanner Stage 2) and very
dry skin. The parents claimed that the patient is also
mentally-retarded. Thyroid function tests were consistent
with hypothyroidism (TSH: >100, NV: 0.3–3.8miu/L; FT4:
5.6, NV: 11–24pmol/L). L-thyroxine at 100mcg/day was
started. There was a decrease in the menstrual blood ﬂow
noted on the 3rd hospital day, with cessation of the bleeding
on the 5th day. There was no recurrence of the seizure and
vital signs stabilized. The patient was gradually weaned from
inotropes and IV ﬂuids and was subsequently discharged
improved.
ThyrotoxicHypokalemic Paralysis:
ACaseR e po rt
Catherine Anne G. Pangilinan
University of the Philippines, Philippine General Hospital
Thyrotoxic Hypokalemic Paralysis is an uncommon
endocrine emergency which presents as recurrent sudden-
onset muscle weakness associated with hypokalemia in a
hyperthyroid patient. Although the exact mechanism is
still unclear, thyrotoxicosis is thought to alter the plasma
membrane permeability to sodium and potassium, a
function linked to the Na+-K+ ATPase activity. There is
a strong male preponderance, more commonly aﬀecting
hyperthyroid patients of Asian descent. Most reported cases
present between ages of 20 and 39 years. This is a case of a
17-year-old male who was brought to the ER with a chief
complaint of inability to ambulate. He is a diagnosed case
of Graves’ Disease since three months prior to consult with
initial presentation of gradually-enlarging anterior neck
mass. He was started on methimazole but was discontinued
two weeks ago due to ﬁnancial constraints. He presented
with one-week history of progressive weakness of both
lower extremities. This was associated with palpitations,
hyperdefecation (at least 3 bowel movements/day), heat
intolerance, and tremors. A day prior to admission, he
w a su n a b l et or i s ef r o mb e da n dt oa m b u l a t e .H ec a m e
in wheelchair-borne, agitated with BP: 100/60mmHg,
CR: 130/minutes, RR: 25/minutes, afebrile. Pertinent PE
ﬁndings include exophthalmos, diﬀusely enlarged thyroid
gland and tremors. The heart, lungs and abdomen were
essentially normal. Neurologic examination revealed
symmetrical proximal muscle weakness associated with
tenderness, more prominent on the lower extremities. There
was no atrophy or fasciculation of the involved muscles.
Laboratory workups showed hypokalemia (2.4mmol/L,
NV: 3.5–5.10mmol/L). CBC and other electrolytes were
within the normal range. ECG showed sinus tachycardia,
ST segment changes and presence of U waves. Thyroid
function test revealed a hyperthyroid state (TSH: 0.26, NV:
0.39–6.0uiu/mL; FT4: 8.21, NV: 0.8–2.0ng/dl). Assessment
made was Thyrotoxic Hypokalemic Paralysis. IV correction
of hypokalemia was initiated. Methimazole and propranolol
were given. There was signiﬁcant clinical improvement
after one day. Repeating serum potassium was within58 International Journal of Pediatric Endocrinology
normal range (3.5mmol/L). The patient was discharged
improved and able to walk. He was advised to continue
methimazole. Repeating TSH and FT4 done after one
month showed normal values (0.33uiu/ml and 1.36ng/dl,
resp.). The patient has then lost to followup. After ﬁve
months, he was readmitted for muscle weakness and
diﬃculty ambulating. He also complained of palpitations
and diﬃculty in breathing. He claimed that methimazole
was discontinued for more than a month. Blood tests again
showed hypokalemia. He subsequently improved after
being given potassium and resuming methimazole and
propranolol.
PediatricPrimaryThyroid Carcinoma:
An InstitutionalExperience in India
Leena Priyambada,1 Anna Simon,1 Sudipta Sen,2
Jacob Chacko,2 and Aravindan Nair3
1Division of Pediatric Endocrinology, Department of
2Pediatric Surgery
3Endocrine Surgery; Christian Medical College,
Vellore, India
Thyroid cancer is quite rare in the pediatric age group,
even though it is the most common endocrine malignancies.
The incidence of these malignancies is increasing over the
years. We describe here the clinical presentation, course
and factors associated with disease outcome in children
and adolescents with primary thyroid carcinoma. Methods.
Data of all patients younger than 18 years presenting with
primary thyroid carcinoma between 2003 and 2009 were
analysed retrospectively. Results. Thirty-one patients at a
mean age of diagnosis of 13.5 + 3.2 years were included
in the study. A female predominance (64%) was seen,
especiallyinpatientsolderthan10years.Noneofthepatients
(except for medullary carcinoma with a family history of
MEN2) had a suggestive risk factor. More than 90% of
patients presented with a painless thyroid swelling (median
duration of 6 months). The regional lymph nodes were
involved in 64% of patients. Distant spread (asymptomatic
pulmonary metastases) was seen in 13%. All patients were
euthyroid. Preoperative FNAC was either false negative or
inconclusive in 55% of the cases. Histopathologically, the
majority were papillary (61%), 25% were follicular variant
of papillary, 10% were follicular and 3% were medullary
carcinomas. Associated thyroiditis on histopathology was
seen, especially in patients with recurrent disease. Thyroid
antibodies were positive in only one of the 15 cases
done. Surgery was the initial treatment modality in all
patients. Total thyroidectomy was done for all patients,
with additional modiﬁed radical neck dissection in 35%
of the cases. Residual malignancy on postoperative iodine
scan was seen in >90% of the cases. 80% underwent
Iodine ablation. 13% of patients received external beam
radiotherapy for extensive regional metastasis. The followup
duration ranged from 6 to 84 months in 90% of the
patients. Recurrence, commonly nodal, was seen in 16%
of patients. In 25% patients disease persisted, commonly
evidenced by elevated thyroglobulin or as persisting lung
metastases. Persistence of disease was associated with a
male predominance (62%), lymph node and lung metas-
tases, papillary tumors, multicentricity and extrathyroidal
extension on biopsy. Patients with follicular variant of
papillary carcinoma had a favourable outcome. Conclusion.
Pediatric primary thyroid carcinoma commonly presents as
asymptomatic neck swelling and nodal metastases. Absence
of risk factors and lack of sensitivity of FNAC adds to
delay in diagnosis. A high incidence of residual malignancy
necessitates postoperative iodine scan in all patients. More
than a third of the patients have either recurrence or
persistence of disease, hence prolonged careful follow up
is necessary. Male gender, multicentricity, extrathyroidal
extension on histopathology, and lung metastases may be
associated with worse outcome.
Thyroid Hormone Receptor Gene Analysis on
Two ChineseFamilieswithResistance to
Thyroid Hormone
Qian Dong, Chun-xiu Gong, Yi Gu, and Chang Su
The Capital Medical University,
Beijing Children’s Hospital, Beijing 100045, China
Background. Resistance to thyroid hormone (RTH) is a dom-
inantly inherited syndrome of reduced tissue responsiveness
to thyroid hormone usually due to mutations located in
the ligand-binding domain and adjacent hinge region of the
thyroid hormone receptor β (TRβ). Objective.W ed e s c r i b e
the clinical and laboratory characteristics and the genetic
analysis of patients with this rare disorder from two Chinese
children and their families. Methods. We detected the thyroid
function test (TFT), the complete blood cell count (CBC),
blood biochemistry markers, magnetic resonance imaging
scan (MRI) of pituitary and electrocardiogram (ECK) for
the two patients. We also detected the TFT of their family
members as well. Direct DNA sequencing of the TRβ gene
was done for people with abnormal TFT. Results. All the
two RTH children had goiter, associated with irritability,
aggressiveness, and profuse sudoresis, but only one had
proptosis. The TFT showed high levels of circulating free-
thyroid hormones (FT4 and FT3) and normal- or high-TSH
concentrations. Other blood biochemistry examinations
werealmostnormal.Allthetwochildrenusedbromocriptine
and the clinical presentations got improved obviously and
no advert eﬀect. We identiﬁed a novel missense mutation,
A317D, located in exon 9 of the gene in one child and his
mother, but his mother showed no clinical presentation.
The other child and his parents were found no mutation
in the TRβ gene. Conclusion. The present report shows
that there is a novo mutation found in the TRβ in one
case and his mother. The other child with RTH found no
mutation. And this research veriﬁed the phenomena that
there is a heterogeneous within the same mutation of RTH
patient.International Journal of Pediatric Endocrinology 59
Newborn Thyroid Screening in
a Tertiary CareHospitalin
SouthIndia Involvinga LargeBirth Cohort
Anna Simon, Palani Raghupathy, A. K. Jana,
F. S. Geethanjali, and Sarah Mathai
Departments of Child Health and Clinical Biochemistry,
Christian Medical College, Vellore, South India
Background. Neonatal thyroid screening is part of the
national screening programme in most developed countries,
but not as yet available in developing countries. Early
diagnosis and early treatment can prevent most of the
consequences of congenital hypothyroidism (CH). Methods.
All babies >26 weeks gestational age born between July
2001 and June 2009 with cord blood TSH >25mIU/ml were
recalled for repeating thyroid function tests after 72 hours.
Primary hypothyroidism was conﬁrmed based on elevated
TSH levels and low FT4 values. Tc99m thyroid nuclear
scan was done in all babies with primary hypothyroidism
conﬁrmed on blood tests. Perchlorate discharge test was
done in babies with suspected dyshormonogenesis. Results.
63, 853 samples of cord blood TSH were collected. Of the
1718 samples which were repeated 52 were conﬁrmed to
have CH. The mean recall rate was 2.7%. Missed repeat
samples (1%) were due to either neonatal deaths or failure
of parents to return for repeat test. Congenital hypothy-
roidism was conﬁrmed in 52 babies and the hospital based
incidence was 1: 1228. There was no female preponderance
(52%). 38.5% of those conﬁrmed with CH had thyroid
dyshormonogenesis, 27% agenesis, 15.5% hypoplasia and
(15.5%) ectopia. Transient hypothyroidism was diagnosed in
1 of the 52 conﬁrmed cases. 5 babies were diagnosed with
central hypothyroidism who had very low initial cord blood
TSH (<0.1mIU/ml) and on repeated sampling had low TSH
and FT4. 52% of babies with conﬁrmed CH had treatment
initiated within the ﬁrst week, 27% within 2 weeks and
21% within 4 weeks after birth. Conclusion. The incidence
of congenital hypothyroidism in this study is higher than
most reported studies. High incidence rates for CH reported
in this hospital-based study suggest the need for a national
programme in India for screening for CH. Cord blood
TSH remains the preferred screening method in developing
countries where most mothers and babies are discharged
within a day after delivery.
MulticysticOvariesdue toHypothyroidism:
ACase of Van Wyk-GrumbachSyndrome
Rashida Vasanwala,1 Fabian Yap,1 Jeremy Ho,2
and Ong Lin Yin2
1Department of Paediatric Endocrinology,
KK Women’s and Children’s Hospital, Singapore
2Department of Paediatric Surgery,
KK Women’s and Children’s Hospital, Singapore
Background. Ovarian hyperstimulation is a recognized com-
plication of longstanding hypothyroidism. In 1960 Van Wyk
and Grumbach described a syndrome of juvenile hypothy-
roidism, precocious puberty and ovarian enlargement. Sev-
eral theories have been proposed to explain precocious
puberty caused by hypothyroidism. Van Wyk and Grum-
bach suggested increased pituitary production of not only
thyroid stimulating hormone but also follicle-stimulating
and luteinizing hormones and prolactin when there was no
negative feedback from thyroid hormones. The mechanism
was dubbed “hormonal overlap in pituitary feedback.” The
current most widely accepted theory is that high levels of
thyroid-stimulatinghormoneactonfollicle-stimulatinghor-
monereceptorsbecauseofmolecularsimilaritiesbetweenthe
two hormones, This mechanism, known as “speciﬁcity spill
over” has been demonstrated in vitro. Ovarian stimulation
in the hypothyroid child may result in oestrogen production,
breast development, endometrial proliferation and vaginal
bleeding. These ﬁndings undergo complete regression with
thyroidhormonereplacementtherapy.Objective.T odescribe
a case of bilateral large multicystic ovaries in a young child
who presented to paediatric surgical unit and underwent
left salphingo-oophorectomy and right ovarian cystectomy.
The casewasa possible diagnostic dilemma, with subsequent
diagnosis of primary hypothyroidism. Methods.W ep r e s e n t
the clinical, radiological, biochemical and histopathological
ﬁndings in a patient with megaovaries who underwent
unilateral oophorectomy. Result. The patient, 5-years-old
girl presented with per-vaginal bleeding, abdominal disten-
sion and abdominal pain. The CT scan of the abdomen
showed bilateral adnexal masses likely ovarian in origin
and neoplastic in nature given their size and complexity.
The surgical intervention was a consequence of torsion of
left megaovary necessitating oophorectomy. Histopoatho-
logical report commented that both ovaries contained large
luteinized follicular cysts with haemorrhagic infarction of
left tube and ovary with no viable tissue. Endocrinological
evaluation showed that there was no history suggestive of
hypothyroidism. Examination revealed prominent nipple-
aerolar complex but neither breast buds, nor signs of vir-
ilisation and cliteromegaly. Patient was clinically euthyroid.
Her gonadotropin response to LHRH was prepubertal, she
had elevated levels of oestradiol, prolactin and CA-125, with
normal levels of alpha fetoprotein and beta-HCG. The thy-
roid function test revealed severe primary hypothyroidism
with very high TSH levels. She was started on thyroid hor-
mone replacement. Conclusion. The association of primary
hypothyroidism with cystic ovarian enlargement and preco-
cious puberty is important to recognize. In the absence of
suspected torsion, surgery is unnecessary, as cyst regression
occurs after appropriate thyroid hormone replacement.
Signiﬁcance of Bone Age Inspection in
Children with Hypothyroidism
Yan Xiaoli, Wang Zhihua, Li Xiaoqing,
and Pan Qiuhong
Xi’an children’s hospital, Xi’an 710003, China
Objective. To observe the bone age development in children
with hypothyroidism and explore the potential applications60 International Journal of Pediatric Endocrinology
in diagnosis and therapy of hypothyroidism. Methods.W e
observed 37 children’s X-ray ﬁlms of left hands and wrists
and applied method for assessing bone age of Chinese chil-
drentoscoretheirboneage.Results.Theboneageofchildren
with hypothyroidism is younger than their chronological
age and the bone age caught up the chronological age
after treatment in the followed 3 years. Conclusions.B o n e
age inspection has important instructional signiﬁcance in
diagnosis and treatment of hypothyroidism in children.
ClinicalSigniﬁcanceof Measurementsof
SerumGh andIgf-1 inChildren with
CongenitalHypothyroidism
Xiaoli Yan, Zhihua Wang, Xiaoqing Li,
and Qiuhong Pan
Xi’an children’s hospital, Xi’an 710003, China
Objective. To detect the serum growth hormone (GH),
insulin-like growth factor-1(IGF-1) levels in children with
congenital hypothyroidism (CH) and explore the change
regulation of GH-IGF axis and thyroxine. Methods.S e r u m
levels of GH, IGF-1 T3, T4, FT3, FT4 and TSH of 30
children with CH were detected before and after levothy-
roxine sodium treatment by means of chemiluminescence
immunoassay and 28 normal children were the control
group. Results. Serum GH, IGF-1 levels in children with CH
were lower, and there were statistical signiﬁcance compared
with that of control group. The serum GH, IGF-1 levels
were normal after thyroxine substitute therapy, in addition,
there were statistical signiﬁcance between before and after
treatment. Conclusions. The GH-IGF axis is insuﬃcient
in CH children, which is one of the major reasons for
stature short. Early thyroxine substitute medication helps
children with CH to maintain normal growth and develop-
ment.
Analysisof the Behavior Problem and
InterferenceFactorsinPreschoolChildrenwith
Early-TreatedCongenital Hypothyroidism
Zhang- liqin and Fu Ping Zhou ji-yong
Qingdao Women and Children’s Medical Health Center,
Qingdao 266011, Shandong, China
Objective. To evaluate behavior Problem and interference
factors in preschool children with early-treated congenital
hypothyroidism (CH), reduce the behavior problem so as to
improve living quality of CH. Methods. A historical cohort
study was performed in 4–6 years old children with CH
detected by neonatal screening in Qingdao. 47 children
with permanent CH were studied and compared to 58
matched normal children born at the same time. Behavior
problem of the children was evaluated on the Achenbach
Child Behavior Checklist (CBCL), The related factors of
the two groups were investigated by self-made question-
naires, children temperament assessment battery, Family
Environment Scale-Chinese Version (FES-CV) respectively.
Results. In preschool, the behavior problem incidence of
CH children was higher than normal children. The type
of temperament, and family environment were important
inﬂuencing factors in CH. Conclusion. Though CH children
have been early-diagnosed and early-treated, the present
ﬁndings strongly suggest that the behavior problem inci-
dence of CH children was higher than normal children,
psychological assessment and consulation must be done so
as to they could grow healthy.
Adrenal Disorders
GrowingNumbersof Children with
CAHinVietnam?
Vu Chi Dung,1 Bui Phuong Thao,1
Khu Thi Khanh Dung,1 Can Thi Bich Ngoc,1
Nguyen Ngoc Khanh,1 Nguyen Thi Hoan,1
Nguyen Thanh Liem,1 Kate Armstrong,2
Maria Craig,3 and Garry Warne4
1National Hospital of Pediatrics, Hanoi
2CLAN (Caring & Living As Neighbours)
3The Children’s Hospital at Westmead, Sydney
4Royal Children’s Hospital Melbourne
Objectives. The National Hospital of Pediatrics (NHP) in
Hanoi is an 850 bed tertiary referral centre servicing
approximately 30 million people from Northern provinces
of Vietnam. Congenital Adrenal Hyperplasia (CAH) was
ﬁrst diagnosed in Hanoi in 1976. This audit was under-
taken to analyze anecdotal reports of increasing patient
numbers. The incidence of CAH in Vietnam is not known
currently, although pilot Newborn Screening (NBS) trials
are continuing in HCMC. Methods.R e t r o s p e c t i v er e v i e w
of all CAH patients registered at NHP from 1999–2009.
Ethical clearance was granted by the NHP Directorate.
Results. At the start of 1999 there were 71 children with
CAH managed at NHP. By December 2009 this increased
to 494 (47% male and 53% female; 72% salt wasting
CAH), representing a more than ﬁve fold increase over
11 years. Number of new cases doubled from 30 to 60 in
2009. Most children (72%) were diagnosed at less than 12
months of age (39% at less than 1 month of age); 70%
(348/494) of all children were younger than 10 years. Formal
mortality ﬁgures were low (6 known deaths), although
loss to follow-up unknown. There are data to suggest
persisting mortality from undiagnosed CAH (evidenced by
low ethnic minority group representation; few children from
remote provinces; higher average income of CAH families;
gender ratio shift; reports of sibling deaths). Patient to
paediatric endocrinologist (494:6) ratios at NHP are very
high compared with higher income countries. Conclusions.
The caseload of CAH at NHP has increased since 1999
and additional capacity is needed for patient care given
high patient to staﬀ ratios. Whilst initiatives such as:
aﬀordable access to medication; introduction of 17-OHP
testing; translation of educational materials; and resourceInternational Journal of Pediatric Endocrinology 61
nurse training to promote family education have focused
on improving quality of life for children living with CAH
in Vietnam, objective clinical benchmarks to track progress
over time are required. Introduction of NBS would enable
more accurate estimation of CAH incidence, reduce infant
mortality and minimize trauma to aﬀected infants and their
families.
Screening for Mutations in DAX1 (NR0B1)
andSF1(NR5A1)Genein16Boyswith
PrimaryAdrenalFailure
Guoying Chang, Zhiya Dong, Wei Wang,
and Defen Wang
Department of Paediatrics, Ruijin Hospital, School of
Medicine, Jiaotong University, Shanghai, China
Context. Primary adrenal failure is a life-threatening condi-
tion that can be caused by a range of etiologies, including
autoimmune, metabolic, and developmental disorders. The
nuclear receptors DAX1 (NR0B1) and steroidogenic factor-
1 (SF1, NR5A1) play an important role in adrenal devel-
opment and function, and mutations in these transcription
factors have been found in patients with adrenal hypoplasia.
Objective. To investigate the prevalence of DAX1 and SF1
gene mutations in 16 primary adrenal failure male patients
associated or not with hypogonadism and/or disorder of sex
development. Subjects.At o t a lo f1 6b o y sw e r ed i a g n o s e da s
primary adrenal failure of unknown etiology characterized
by their clinical manifestations (except one associated with
hypospadia). The age at ﬁrst presentation was from newborn
to 10 years old (average 4.5 ± 3.9 years). The diagnosis
was conﬁrmed by laboratory ﬁndings, in addition with the
geneticstudiestoassesstheprevalenceofDAX1andSF1gene
m u t a t i o n si no u rgr o u p .T h ep a t i e n t sr a n g e di na g ef r o mo n e
to 25yr in the last follow-up, of which, 9 cases under puberty,
2 cases with normal sexual development, and 5 cases with
puberty delayed. Replacement treatment with glucocorticoid
was maintained in all the patients. Methods. Genomic DNA
(from peripheral blood leukocytes) was obtained from all
the patients and their related suspected family members.
The full coding regions and intron-exon boundaries of
DAX1 (exon1, 2) or SF1 gene (exon2–7) were ampliﬁed
with PCR, then directly sequenced. DAX1 gene mutations
were screened for all the patients and those who were
negative undergone SF1 gene screening. Results.( 1 )G e n e t i c
screening: Five frameshift mutations (304delC, R98E; 341-
342delCT, S111X; 746delG, R244L; 663-664delCA, T218E;
853delG, W253C), one missense mutation (T785C, L262P,
two patients) and one nonsense mutation (424→T, E137X)
w e r ef o u n di nD A X 1g e n e ,a n do n l yo n em u t a t i o ni d e n t i ﬁ e d
in SF1 gene (624→G, G146A). The mutations underlined
were novel and the others have been reported previously.
(2) Prevalence of DAX1 gene mutations was 50% (8/16)
in our patients, 5 of the positive cases (5/8) show positive
family history veriﬁed by genetic studies, and 4 cases
(4/8) with under developed puberty. SF1 gene mutation
occurred in the patient with hypospadia. Conclusions.D A X 1
genetic defects are a relatively frequent cause of primary
adrenal failure while SF1 gene mutations relatively rare
and more likely to be associated with disorders of sexual
development.
Update of ClinicalPhenotypeand
MutationDatabase: Identiﬁcation of
a Novel Mutation of the StAR Gene in
Korean Patientswith Congenital Lipoid
AdrenalHyperplasia
Jin-Ho Choi,1 Hye-Young Jin,1 Beom-Hee Lee,2
Gu-Hwan Kim,2 Jung Hyun Lee,3 Hae Soon Kim,4
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Inha University, Incheon, Korea
Purpose. The steroidogenic acute regulatory (StAR) protein
plays a crucial role in steroidogenesis, as it promotes the
transfer of cholesterol from outer to inner mitochondrial
membrane. Mutations in the gene encoding StAR cause
congenital lipoid adrenal hyperplasia (CLAH), a disease that
is the most severe form of congenital adrenal hyperpla-
sia characterized by a deﬁciency of adrenal and gonadal
steroid hormones. In this study, we updated the clinical
characteristics and mutation spectrum of the StAR gene in
Korean patients with CLAH. Methods. Seventeen unrelated
Korean patients were referred to Medical Genetics Clinic
and Laboratory, Asan Medical Center for molecular analysis
of the StAR gene. Clinical features (skin hyperpigmenta-
tion, external genitalia, salt-losing phenomenon, karyotype,
adrenal imaging, etc.) and endocrine data (ACTH, renin,
17-OHP, DHEA-S, and adrenal androgen) were collected
retrospectively. After obtaining informed consent, genomic
DNA was extracted from peripheralblood leukocytes. Seven
exons of the StAR gene and their intronic ﬂanking sequences62 International Journal of Pediatric Endocrinology
were ampliﬁed by PCR, and subsequently sequenced using
ABI3100 Genetic analyzer. Results. All patients developed
hyperpigmentation and adrenal insuﬃciency in the neonatal
period. Ten out of 17 patients were genetically males,
although they had female external genitalia. The basal ACTH
levels and plasma renin activity were extremely high in
all patients. Fourteen patients were homozygous for the
p.Q258X mutation, and three patients were compound
heterozygotes of p.Q258X/p.L98R, p.Q258X/p.A218V, and
p.A218V/c.745–6 810del. The p.Q258X mutant allele was
identiﬁed in 30 out of 34 alleles (88.2%). The c.653C>T
(p.A218V) mutation was detected in 2 out of 34 alle-
les (5.9%). The p.L98R and c.745–6 810del mutations
were found in one out of 34 alleles (2.9%), respectively.
Conclusions. We identiﬁed four diﬀerent mutations in
the StAR gene. Three mutations have been previously
reported and one mutation is a novel mutation (c.745–
6 810del). As previously reported, the p.Q258X mutation
in the StAR gene is the most common in Korean pop-
ulation by a founder eﬀect. In vitro expression analysis
of the novel mutation and long-term follow-up should
be needed for evaluation of genotype-phonotype correla-
tion.
TesticularAdrenalRestTumorsinaPatientwith
UntreatedCongenital AdrenalHyperplasia
Hye Young Jin,1 Han-Wook Yoo,1,2 Gu-Hwan Kim,2
and Jin-Ho Choi1
1Division of Pediatric Endocrinology and Metabolism,
Department of Pediatrics,
2Medical Genetics Clinic and Laboratory, Asan Medical
Center Children’s Hospital, University of Ulsan College of
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Background. Testicular adrenal rest tumors (TARTs) are
considered aberrant adrenal tissue that has become hyper-
plastic because of elevated adrenocorticotropic hormone
(ACTH)inmalepatientswithcongenitaladrenalhyperplasia
(CAH). Case. A 6-year-old boy presented with testicular
enlargement, pubic hair. His height and weight were 124cm
(2.31 SDS) and 27kg (2.63 SDS), respectively. The volume
of each testes was 7mL, the stretched penile length was
7cm, and his bone age was 13 years by Greulich and
Pyle’s method, which was remarkably advanced for his
chronological age. His serum 17-hydroxypregnenolone (17-
OHP) and testosterone levels were elevated to 480ng/mL
(normalrange:0.32–3ng/mL)and2.0ng/mL(normalrange:
0.03–0.1ng/mL), respectively. He was diagnosed with CAH
complicated by precocious puberty. However, he was not
followed-up. At age 17 years, he visited the outpatient
clinic because of testicular enlargement and short stature.
His right and left testicles were 10 × 6cm and 7.5 ×
4.5cm, respectively. His height was 155.1cm −2.90 SDS).
The diagnosis of CAH due to 21 hydroxylase deﬁciency
was conﬁrmed by mutation analysis of CYP21A2. Testicular
biopsyshowedlarge,polygonal,eosinophiliccellswithround
nuclei and prominent nucleoli, suggesting that the tumors
were TARTs. He was treated with dexamethasone for 3 weeks
and the tumors regressed. Dexamethasone was changed to
prednisolone and 9α-ﬂudrocortisone, and reduced testis size
has been maintained. Conclusion. In patients with CAH,
poor compliance with treatment increases plasma ACTH
levels, accelerating the development of TART. Although
TARTs are usually benign, they may obstruct the semi-
niferous tubule, leading to possible gonadal dysfunction.
Early detection of TARTs is important in preventing irre-
versible testicular damage. Patients with CAH should be
regularly examined by digital palpation and radiological
methods such as ultrasonography, to detect small-sized
tumors. We describe here a patient with untreated CAH
who developed TARTs, which regressed with dexamethasone
therapy.
AdrenalInsufﬁciency Presentingwith
R ecurr e ntSe izur esinanI nfant
Ansu Mali Joshi, Rajesh Khadgawat, VP Jyotsna,
and A C Ammini
Department of Endocrinology, AIIMS, New Delhi, India
Introduction.Primaryadrenalinsuﬃciencyisanuncommon,
but well recognized cause for hypoglycemia in infants.
Presented here is case of a child who presented with
seizures and hypoglycemia due to adrenal insuﬃciency.
Baby J.K. was the ﬁrst born child of a non consan-
guineous marriage. This was a full term normal vaginal
delivery, conducted at home, birth weight was 2.1kg.
He was apparently normal except for dark complexion.
Few weeks later he started having seizures and investiga-
tions revealed hypoglycemia and elevated plasma ACTH
(>2000pg/ml). With hydrocortisone supplementation both
seizures and hypoglycemia stopped. He is now 3 years
old, developmental milestones are within normal limits.
Schirmer’s test was negative. CECT abdomen revealed
normal adrenal glands. Common causes of adrenal insuf-
ﬁciency in neonates are congenital adrenal hyperplasia, X-
linked congenital adrenal hypoplasia, peroxisomal disor-
ders, familial glucocorticoid deﬁciency, Allgrove syndrome
or triple A syndrome (alacrima, achalasia, and adrenal
insuﬃciency), and acquired conditions such as adrenal
hemorrhage, trauma and infections. The present case is
possibly a case of Familial Glucocorticoid Deﬁciency (FGD).
FGD is an autosomal recessive disorder, ﬁrst described in
1959, and since then about 50 cases have been reported from
around the world including Caucasian, African-American,
and East Indian populations. The age of presentation varies
from birth to 9 years of age. Unlike classical Addison’s
disease, patients with FGD never develop mineralocorticoid
deﬁciency.International Journal of Pediatric Endocrinology 63
Interesting Case of Hyperpigmentation in
Two Siblings
Deepak Khandelwal,1 Sunil Mishra,1
Rajesh Khadgawat,1 AC Ammini,1
and Adrian J.L. Clark2
1Department of Endocrinology and Metabolism,
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2Molecular Endocrinology, John Vane Science Centre,
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Adrenal insuﬃciency in childhood is a rare condition.
Familial glucocorticoid deﬁciency (FGD), also known as
hereditary unresponsiveness to ACTH or isolated gluco-
corticoid deﬁciency is a rare autosomal recessive disorder
that is characterized by severe cortisol deﬁciency, high
plasma ACTH levels and typically, a well-preserved rennin
angiotensin-aldosterone axis and hence normal mineralo-
corticoid levels. FGD is a rare cause of adrenal insuﬃciency
in childhood. We are reporting experience of FGD in two
siblings. Our index case, a 3.5 years old male child of
Asian-Indian origin presented to the dermatology outdoor
with diﬀuse hyperpigmentation. After ruling out non-
endocrinal causes of hyperpigmentation, he was detected
to have very high ACTH levels (3320pg/ml) and referred
to endocrinology. Parents denied any history suggestive of
hypoadrenalism, apart from hyperpigmentation. There was
no history of fungal infection, alopecia, or tetany. There
was no past history of tuberculosis. Genital examination
was unequivocally male with both testes descended, without
axillary or pubic hair. Endocrine evaluation revealed 8.00 am
serum cortisol 5.4ug/dl (normal range 6.2–9.4ug/dl) with
plasma ACTH level 3320pg/ml (normal range 6–56pg/ml).
Stimulation with synthetic ACTH (Synacthen 250 ug) failed
to increase serum cortisol further (5.2ug/dl). Post-exercise
andfurosemidestimulatedserumaldosteronelevelincreased
twice the basal values. CT scan of abdomen revealed normal
size adrenal glands without any hyperplasia, atrophy or
calciﬁcation. All possible causes of primary hypoadrenalism
were excluded. Family screening showed normal 8 AM
s e r u mc o r t i s o l( 9 . 6u g / d l )w i t hh i g hl e v e lo fp l a s m aA C T H
(260pg/ml) in younger sister (aged one year) but without
any hyperpigmentation or any other complaint. Test for
anti-adrenal antibodies were negative in both siblings and
parents. Mutation analysis did not show any mutation in
melanocortin-2 receptor (MC2R) or melanocortin receptor
accessory protein (MRAP) gene. Both of them are regularly
taking treatment (3 years in index case and one and half
year in sister) and growing normally. Hyperpigmentation
has been markedly decreased. Cases illustrates occurrence of
hypoadrenalism in two siblings at very young age with very
high ACTH levels and without any detectable mutations.
AGirlwithCentralPrecociousPuberty
following SurgicalRemoval of
VirilizingAdrenocorticalTumor
Tippayakarn Klomchan, Suttipong Wacharasindhu,
Vichit Supornsilchai, and Taninee Sahakitrungruang
Division of Pediatric Endorinology, Department of
Pediatrics, Faculty of Medicine, Chulalongkorn University,
Bangkok, Thailand
Adrenocortical carcinoma, an extremely rare neoplasm in
children, may be presented with virilization alone as pseu-
doprecocious pubertyorincombinationwithglucocorticoid
and minerocorticoid excess as cushing syndrome. We report
a-2.6-year old girl with adrenocortical carcinoma. She had
clitoromegaly, pubic hair, deep voice and accelerated growth
for 1 year. Short ACTH stimulation test was reported normal
cortisol response and slightly elevation of 17OHP. Serum
DHEAS was extremely high. The bone age was advanced to
6.8 years old according to Greulich and Pyle. An abdominal
computed tomography revealed a large left adrenal mass.
She underwent complete surgical resection and no evidence
of metastasis was found. The pathological diagnosis was
adrenocortical carcinoma. The virilized symptoms were
gradually improved within 1 year and a DHEAS level was
rapidly decreased to normal range in 4 months. Her breast
developed as Tanner 2 when she was 4 year old. The GnRH
stimulation test showed peak FSH of 14.8IU/L and LH
15.3IU/L. The tumor markers showed AFP<0.5IU/mL and
Beta hCG<5mU/mL and ultrasonography revealed pubertal
sizeandshapeofuterusandovaries.Thisconditionissimilar
to that is found in some patient with congenital adrenal
hyperplasia especially after glucocorticoid replacement. The
exact mechanism remained unknown. The gonadotropin
releasing hormone agonist was given monthly to delay
pubertal progression. In conclusion, an isosexual pubertal
sign should be closely monitored after the treatment of
virilizing adrenocortical tumor to prevent the progression of
puberty especially in girl and attain ﬁnal adult hight with
GnRHa injection.
Analysisthe CardiovascularRiskFactorof
Obesity ChildrenwithNonalcoholic Fatty
LiverDisease
Jiang Li-hong, Liu Ge-li, and Zheng Rong-xiu
Tianjin medical university general hospital,
pediatric department
Objective. To explore the cardiovascular risk factor of obesity
children with nonalcoholic fatty liver disease (NAFLD).
Methods. 186 obesity children were divided in to two
groups: 114 obesity children with NAFLD (NAFLD group)
and 72 was obesity children without NAFLD (WNAFLD
group). Body mass index, liver B-mode ultrasound examina-
tion, triglycerides (TG), low density lipidprotein-chelesteral
(LDL-C), high density lipidprotein-chelesteral (HDL-C)
and high-sensitive C-reactive protein (hs-CRP) were per-
formed for all of the cases. Results. (1) The incidence
of obesity children with NAFLD was 61.3% (114/186).64 International Journal of Pediatric Endocrinology
BMI, HDL-C and LDL-C of NAFLD group were 29.75 ±
3.83, 1.16 ± 0.87mmol/L, and 2.34 ± 0.92mmol/L. BMI,
HDL-C and LDL-C of WNAFLD group were 28.53 ±
4.49, 1.22 ± 0.76mmol/L, and 2.53 ± 0.81mmol/L. There
were no diﬀerences between two groups (P>. 05). hs-
CRP and TG of NAFLD group were 7.84 ± 2.62mg/L
and 1.53 ± 0.85mmol/L. hs-CRP and TG of WNAFLD
group were 3.86 ± 1.57mg/L and 1.28 ± 0.48mmol/L.
There were signiﬁcant diﬀerent between these two groups
respectively. Conclusion. The cardiovascular risk factors
of obese children are not as same as the obese adults.
Obese children with NAFLD are at higher risk of car-
diovascular diseases. hs-CRP is one helpful indicator to
detect cardiovascular diseases for obesity children with
NAFLD.
PrevalenceandRiskFactor ofMetabolic
Syndrome inChildhood-Onset Young Adults
withHypopituitarism
Han Hyuk Lim,1 Min Jae Kang,2 Young Ah Lee,2
Choong Ho Shin,2 and Sei Won Yang2
1Department of pediatrics, School of medicine,
Chungnam national university, Daejeon, the South Korea
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Purpose. This study evaluated the prevalence of metabolic
syndrome (MetS) and the risk factors of metabolic derange-
ment for childhood-onset young adults with hypopitu-
itarism (COAHP). Methods. Thirty patients with COAHP
with hormone replacement therapy aged 20 to 29 years
who visited Seoul National University Children’s Hospital
between September 2009 and February 2010 were enrolled.
Laboratory tests for metabolic syndrome including height,
weight, waist circumference (WC), and the hip circum-
ference were performed. The clinical and hormonal fea-
tures were reviewed, retrospectively. We evaluated metabolic
derangement of enrolled patients and healthy adults aged 20’
(data from Korean National Health and Nutrition Exami-
nation Survey (KNHANES), 2005) by National Cholesterol
Education Program-the Adult Treatment Panel III (NCEP-
ATP III). Results. In comparison with KNHANES, the
patients with COAHP had more signiﬁcantly WC size,
hypertension, and hypertriglyceridemia. It was signiﬁcant
correlation between the duration of illness and the central
obesity (r2 = 0.546, P = .003). The prevalence of
MetS in COAHP was 10% (versus 2, 3% in KNHANES).
The incidence of central obesity and prevalence of MetS
was higher than KNHANES (P<. 001 and P = .042,
resp.). Conclusion. The longer duration of illness not the
older age is risk factor for cenral obesity. The insulin
resistance caused by central obesity is known key for
metabolic syndrome. We should regularly check the WC for
preventingMetS,particulary,inCOAHPwithlonghistoryof
illness.
MolecularAnalysisofthe Cyp11b1Gene
Loke Kah Yin,1 Cindy Ho Wei-Li,2
Yvonne Lim Yijuan,2 and Poh Kok Seng Larry1
1Department of Paediatrics,
National University of Singapore
2University Children’s Medical Institute,
National University Hospital
Congenital adrenal hyperplasia is commonly caused by 21-
hydroxylase deﬁciency (90–95%) and 11 beta-hydroxylase
deﬁciency (5–8%). Their identical presentation of genital
ambiguity (females) and pseudoprecocious puberty (males)
can lead to misdiagnosis since hypertension, the clinical hall
mark of 11 beta-hydroxylase deﬁciency, is variable and the
biochemical conﬁrmation of elevated precursor metabolites
(deoxycortisol/deoxycorticosterone) is not readily available
locally. We report the results of molecular characteriza-
tion of 11 beta-hydroxylase deﬁciency in 6 patients from
unrelated pedigrees (Singapore, Malaysia, India, Nigeria),
suspected of having 11 beta-hydroxylase deﬁciency. All
males presented with pseudoprecocious puberty, while the
females had virilised external genitalia at birth. Only 1 male
presented with hypertension at diagnosis, aged 5 years, and
one female had hypertension when she was non-compliant
during adolescence. All the other patients did not have
hypertension, but had normal CYP21 gene analysis. The
CYP11B1 gene was ampliﬁed by polymerase chain reaction,
andtheampliconsweresequenced.Wild-typeCYP11B1gene
was ampliﬁed from normal human fetal adrenal total cDNA
andclonedintothepBUDCE4mammalianexpressionvector
for the functional expression studies. The DNA could not
be ampliﬁed in two patients, suggesting a large deletion of
the CYP11B1 gene. A total of 4 mutations were discovered
in the other 4 patients, including 2 previously described
mutations (Q338X and Q356X) and 2 novel mutations
(R374W and R454C). The novel mutations were constructed
using site-directed mutagenesis, and the constructs were co-
transfected with the wild-type CYP21B expression vector
into HEK293 cells, prior to the addition of tritium labeled
17-hydroxyprogesterone substrate. After incubation for 24
to 48 hours, there was full conversion of 11-deoxycortisol
to cortisol by the wild type 11 beta-hydroxylase enzyme,
but there was no conversion with the R374 and R454
mutants, conﬁrming their role in the pathogenicity of 11
beta-hydroxylase deﬁcieny. To our knowledge, this is the
ﬁrst report of novel mutations arising from the Singaporean,
Malaysian, Indian and Nigerian population. Molecular diag-
nosis can provide an alternative conﬁrmation of 11 beta-
hydroxylase deﬁciency in patients who have a normal CYP21
gene in the absence of hypertension, and would allow for
early and eﬀective management of hypertension.International Journal of Pediatric Endocrinology 65
Congenital Adrenal Hyperplasia—Gender
Dysphoria
Siska Mayasari Lubis,1 Frida Soesanti,2
Aman B Pulungan,2 Bambang Tridjaja AAP,2
and Jose RL Batubara2
1Pediatric Endocrinology Division,
Child Health Department, Medical School, University of
Sumatera Utara, H.Adam Malik Hospital, Medan
2Medical School, University of Indonesia,
Cipto Mangunkusumo Hospital, Jakarta
Background. Congenital adrenal hyperplasia (CAH) is
characterized by an impaired biosynthesis of cortisol
and aldosterone and an increased secretion of 17α-
hydroxyprogesterone (17OHP) and androgens. Clinically,
almost all forms can be allocated to three forms; the salt
wasting (SW), the simple virilizing, and the nonclassic (NC)
forms. Patients require long-term glucocorticoid treatment.
Late diagnosis may result in death during an SW crisis
or in prolonged incorrect gender assignment. Objective:
To report a case of late diagnosis of congenital adrenal
hyperplasia, simple virilizing form in a 16 years old girl with
gender dysphoria. Case: This girl was born with ambiguous
genitalia and said to be a girl and further raised as a
girl. She grew, developed and act as a girl. There was no
intervention for her ambiguous genitalia. Since one year
ago she started acting and feel like a boy. She insisted her
name change to a boy’s name. Because of these reasons, her
parents took her to our division to investigate her gender
assignment. Physical examination showed a male habitus,
body weight: 40kg (<P3), height: 149cm (<P3). Her skin
looked darker than her parents, with acne, heavy voice, and
hirsutism. External genitalia showed clitoromegaly, pubertal
stage: A2M1P3 (Tanner scale), and no history of menarche.
Analysis chromosome: 46 XX, SRY gene: negative. Serum
17 OHP: 302, 60nmol/L. Pelvic USG: showed uterus and
ovarium, there were no right and left testicles, Bone age:
average girl. We diagnosed: CAH, simple virilizing form.
Unfortunately, the diagnosis was very late and it has revert
the patient to be a boy and refused all of the treatments. So,
we consulted her to psychiatry department to evaluate the
genderidentityofthispatient. Conclusion.Thispatientneeds
more psychoeducation and psychotherapy to make sure her
gender identity.
CongenitalAdrenal Hyperplasiain Indonesia:
AR etr ospecti v eA nalysis
Siska Mayasari Lubis,1 Frida Soesanti,2
Jose RL Batubara,2 Bambang Tridjaja AAP,2
and Aman B Pulungan2
1Pediatric Endocrinology Division, Child Health
Department Medical School, University of
Sumatera Utara, H.Adam Malik Hospital, Medan
2Medical School, University of Indonesia,
Cipto Mangunkusumo Hospital, Jakarta
Background. Congenital adrenal hyperplasia (CAH) is a
recessively inherited disorder in the biosynthesis of adrenal
steroids with an incidence of 1 in 5000–18000 newborns
of a mixed population. Up two thirds of the cases suﬀer
from the more severe salt-losing form of the disease. This
is the ﬁrst report of CAH cases in Indonesia and there
is no neonatal screening program for CAH in Indonesia.
Objective. To review retrospectively the presentation of all
known patients with CAH under the care of pediatricians
at Hospitals in Indonesia between 1995 until 2010. Methods.
T h i sw a sar e t r o s p e c t i v es t u d y ,w er e v i e w e da l lt h eb a b i e s
and children who came to Hospitals in Indonesia with
diagnosis congenital adrenal hyperplasia that reported by
pediatricians. The following information was collected:
patient’s sex, body mass index (BMI), age at diagnosis,
CAH type, parents’ ethnic and earning, presenting clin-
ical features, family history, health funding, supporting
examinations (17 hydroxyprogesterone (17 OHP), plasma
renin activity (PRA), testosterone, bone age, chromosome
analysis, genitalia USG), and treatments (Hydrocortisone,
Fluorinef, and surgical intervention). Results. One hundred
and ten patients with CAH who were diagnosed between
1995 and 2010 were included in order to be analyzed. In
some cases not all the information was available. There
were 16 males and 83 females (male:female ratio 1:5), 11
(10%) patients were incorrectly assigned sex. The age at
diagnosis was between since newborn until 29 years. The
CAH cases were most common happened in Jawa ethnic.
Two cases (1, 8%) had a history of sibling death in the
neonatal period, three (2.7%) cases similar features were
present in older siblings and one patient has CAH carier
parent. Unfortunately, we didnot have data about parental
consanguinity. Salt wasting, simple virilization and non-
classical CAH was found in 85 (77, 3%), 21 (19, 1.0%) and
4 (3, 6%) patients, respectively. Twenty seven (24, 5%) of
themhadadrenalcrisis,54(49%)hadambiguousgenitalia,5
(4, 5%) had precocious puberty, 1 (0, 8%) had amenorrhea,
4 (3, 6%) had hypertension, and 10 (9%) had failure to
thrive. The parents earning for some patients were about
less than 1 million rupiahs, and it had been the big problem
not only for patients but also for the doctors, because
for some patients they took the medicines irregularly and
someparentsrefusedtobecheckedsupportingexaminations
for CAH, such as 17 OHP, chromosome analysis, PRA,
because they didnot have enough money, and only about
14 (12, 7%) had ﬁnancial insurance. Sixty seven (60,
9%) of patients underwent surgical interventions of their
externalgenitalia.Conclusion.Newbornswithdevelopmental
anomalies of the external genitalia should be diagnosed as
early as possible so that medical, psychological, and social
complications are minimized. A neonatal screening program
for such a disorder can identify infants at risk for the
development of life-threatening adrenal crisis and prevent
incorrect sex assignment of aﬀected female infants with
intersex.66 International Journal of Pediatric Endocrinology
Autosomal Recessive
Pseudohypoaldosteronism Type 1 in
aNeonate with 3 Deaths of Siblings
Palinee Nantarakchaikul, Preamrudee Poomthavorn,
and Pat Mahachoklertwattana
Division of Endocrinology, Department of Pediatrics,
Faculty of Medicine, Ramathibodi Hospital,
Mahidol University, Bangkok, 10400 Thailand
Autosomal recessive pseudohypoaldosteronism type 1
(arPHA1) is a rare genetic disease. It is characterized
by renal salt wasting, dehydration, hyperkalemia and
metabolic acidosis during the neonatal period. Resistance
to aldosterone underlies the clinical presentation. Markedly
elevated serum aldosterone level and plasma renin activity
(PRA) are thus hallmarks of the disease. Unawareness of
the condition makes the diagnosis diﬃcult. We report a
female neonate with arPHA1 who presented with renal
salt wasting at the ﬁrst week of life. She was born at
term with an uneventful pregnancy with a birthweight
of 3.5kg. No history of parental consanguinity was
noted. She had 3 earlier born siblings with diﬀerent
sexes died of “suspected” sepsis during the ﬁrst weeks of
lives. Physical examination was unremarkable. Owing to
the sibling deaths history, she had been admitted since
birth for closed observation and investigations of an
inborn error of metabolism. She developed lethargy and
poor feeding with dehydration on day 6 of life despite
apparently healthy looking and normal serum electrolytes
prior. Investigations showed serum electrolytes of Na
112, K 12, Cl 84, and CO2 7.4mmol/L. Blood urea
nitrogen and serum creatinine were elevated at 34 and
0.6mg/dL, respectively. Plasma glucose level was 105mg/dL.
Septic workup results were all negative. Primary adrenal
insuﬃciency as a cause of hyponatremic, hyperkalemic
and metabolic acidosis was suspected. However, serum
cortisol level was appropriately raised at 44mcg/dL.
Simultaneous serum aldosterone was markedly elevated
at 21, 187pg/mL (normal, 50–1, 750) and PRA was
10.7ng/mL/h (normal, 1.5–5.7). Pseudohypoaldosteronism
was promptly diagnosed. Preliminary genetic study
demonstrated a deletion of the gene encoding one of
the subunits of epithelial Na channel (ENac) but no
mineralocorticoid receptor gene mutation was found.
Therefore, arPHA1 was the most likely diagnosis. She
had been treated with large dose of Na and bicarbonate
supplementation with potassium-binding resin since the
diagnosis. She has now been followed for 5 years with
normal growth and development albeit having frequent
episodes of hyponatremic, hyperkalemic and metabolic
acidosis during febrile illnesses. This report highlights
the importance of suspicion of pseudohypoaldosteronism
diagnosis in a neonate with renal salt wasting syndrome.
Prompt treatment and long-term follow-up are essential for
saving life and having a good outcome.
PregnancyandDeliveryin3Women with
Congenital Hyperplasiadueto
21-HydroxylaseDeﬁciency
Satsuki Nishigaki,1 Yusuke Mizuno,1 Kazuyuki Waki,1
Masahiro Noda,1 Yasuhiro Naiki,1 Toshiaki Tanaka,2
Ayako Tanae,3 and Reiko Horikawa1
1Division of Endocrinology and Metabolism,
National Center for Child Health and Development,
2Tanaka Growth Clinic, Department of pediatrics,
Shonankamakura General Hospital
Context. Fertility rate in women with congenital adrenal
hyperplasia (CAH) has been reported to be lower than in
general population. However, recent studies suggested that
the pregnancy outcome of mothers and children would not
diﬀer in those with CAH from general population, once
they achieved pregnancies and were treated adequately. We
report three cases with 21-hydroxylase deﬁciency (21OHD)
treated at our institution from childhood, who experienced
pregnancy and delivery. Cases. Three women with simple
virilizing (SV) form 21OHD conceived and delivered a total
of 5 children. Two cases underwent genital reconstruction at
age of one and four, respectively. In all three, the menstrual
cycles were regular and 17-hydroxyprogesterone (17OHP)
levels were controlled within 0.2∼4ng/ml before pregnancy.
All were able to achieve spontaneous pregnancy. Two cases
were treated with dexamethasone before pregnancy, and
switched to predonisone after becoming pregnant. One
case treated with paramethasone received same medication.
During pregnancy, maternal serum 17OHP and testosterone
levels were monitored and controlled within normal preg-
nant range by adjusting the glucocorticoid dosage. The max-
imum predonisone dose needed was 7mg/day in one case.
The pregnancies were uncomplicated in both mothers and
fetuses. Two patients underwent elective Caesarean sections
because of prior vaginal reconstruction and expected risk of
adrenal failure caused by delivery stress. While, one patient
hadavaginaldelivery.Stressdoseglucocorticoidwasgivenat
the time of delivery, and there were no labor complications.
All of their babies were born in normal-weight and free from
complications and malformations. Among 5 children, three
were boys and two were girls. None of the girls had apparent
virilization; slightly wide vagino-anal length was observed in
o n eg i r l .T h eg r o w t ha n dd e v e l o p m e n th a v eb e e nn o r m a l
in all children. Discussion. We report three women with SV
form 21OHD who experienced successful pregnancies. The
appropriate medical and surgical management from infancy
enables spontaneous pregnancy and vaginal delivery. For
the management of pregnancy in 21OHD, it is essential to
use non-permeable steroids through placenta for prevention
of fetal excessive steroid exposure, and the adjustment of
steroid dosage by monitoring maternal serum 17OHP and
testosterone levels for prevention of virilization in female
fetus. The optimizing dosage of corticosteroid should be
individualized. The improvement of pregnancy rate in salt-
wasting 21OHD remains an issue to be solved.International Journal of Pediatric Endocrinology 67
Carrier Frequency of Congenital Adrenal
Hyperplasia(21-hydroxylasedeﬁciency) in
Korean Children withthe Majorityof
EarlyPuberties
Phil Soo Oh,1 Hui Kwon Kim,1 Hong Jin Lee,1
and Jae Hoon Shin2
1Pediatrics, Hallym University Medical Center,
Chuncheon, Korea
2Pediatrics, Hanyang University Medical Center,
Seoul, Korea
Objective. Nowadays, many Koreans are concerned with the
phenomenon of early puberty. And I know a few reports
of congenital adrenal hyperplasia (CAH) carrier frequency
in some populations. So, prospectively I scheduled to know
the CAH (21-hydroxylase deﬁciency) carrier frequency in
Korean children with the majority of early puberties. Meth-
ods. I started to gather the study group since July, 2008. So
far, ACTH stimulation tests have been done for 171 Korean
children (female 161, male 10) with the majority of early
puberties and the results of 17-OH-progesterone (17OHP)
andcortisolhavebeenanalyzedwithboneageevaluationetc.
Results. I found about 10 heterozygote CAH carriers in the
studygroup.AndIcouldﬁndaninterestingaspectof17OHP
results. Almost always the cortisol responses after ACTH
stimulation were elevated, but the 17OHP responses were
not. In many children, 17OHP were not suﬃciently elevated,
oreventhesameordecreasedresponsescouldbeseenamong
them. Conclusions. I think that the heterozygote CAH (21-
hydroxylasedeﬁciency)carrierfrequencywouldbeabout5%
in Korean children with the majority of early puberties. And
it seems that another mechanism(s)/pathway(s) of ACTH
stimulation for cortisol could be present.
AnUnusualCaseof HypoglycaemicSeizurein
a Male Term Chinese Neonate
Grace WK Poon, PT Cheung, KW Chan,
Joanna YL Tung, Anne MK Kwok, and Louis CK Low
Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
Introduction. X-linked adrenal hypoplasia congenita (X-
linked AHC) is a rare cause of adrenal insuﬃciency in
male infants presenting in the neonatal period. It results
from a deletion or point mutation of the NR0B1 (nuclear
receptor subfamily 0, group B, member 1) gene which
encodes an orphan nuclear receptor DAX1 (dosage-sensitive
sex reversal-adrenal hypoplasia congenita critical region
on the X chromosome, gene 1) that is expressed in the
hypothalamus, pituitary gland, adrenal gland and gonads.
Case Report. A normal-sized male term infant initially
developed cyanosis and seizure on day 2 of life. He was
found to have hypoglycaemia and high C-reactive protein
and was treated as clinical sepsis. The plasma electrolytes,
CXR, echocardiogram and USG brain were all normal and
sepsisscreeningincludingbloodandcerebrospinalﬂuidwere
negative for bacterial culture. He was discharged after one
week of intravenous antibiotics but was readmitted to hospi-
tal 10 days later with shock and acute adrenal insuﬃciency,
characterized by severe hyponatraemia, hyperkalaemia and
metabolic acidosis. He required ﬂuid resuscitation as well
as full ventilatory and inotropic support. Clinically he had
no hyperpigmentation. The serum cortisol level was low
(132nmol/L) at the time of stress; together with a normal
plasma 17-hydroxyprogesterone (12nmol/L) and normal
USG adrenals, 21-hydroxylase deﬁciency was excluded. His
normal male external genitalia excluded 3b-hydroxysteroid
dehydrogenase deﬁciency or a deﬁciency of steroidogenic
acute regulatory protein (StAR). His plasma renin activ-
ity was high (>50ng/ml/hr) whilst the aldosterone level
was normal (255pmol/L), suggesting a biosynthetic defect
of aldosterone. The clinical picture was compatible with
congenital adrenal hypoplasia and the baby recovered well
with hydrocortisone, mineralocorticoid replacement and salt
supplement. Genetic analysis: PCR-based cycle sequencing
of the 2 exons of the NR0B1 gene was performed on
peripheral blood leucocyte-derived DNA from the proband.
The baby was found to be hemizygous for a known mutation
c.1292delG (TAGTA>TATA), leading to frameshifting and a
premature stop codon (p.S431fs436X) 1. Conclusion. Despite
its rarity, it is essential for paediatricians to maintain
vigilance over the possible diagnosis of X-linked AHC in
male infants presenting with severe adrenal insuﬃciency in
the newborn period. Aﬀected male may also present later
in childhood or adolescence with delayed puberty from
hypogonadotropic hypogonadism. Female carriers do not
develop adrenal insuﬃciency but may present with delayed
puberty. Genetic analysis may aid the anticipation of clinical
problem in such patients; it may also be valuable in carrier
identiﬁcation and prenatal counselling.
CushingSyndrome in King Culalongkorn
Memorial Hospital: A CaseSeries
Rottanat Rugpolmuang
Endocrine Unit, Department Of Pediatrics,
Chulalongkorn University
Endogenous Cushing syndrome in childhood and ado-
lescence is rare. Six children, 2 girls and 4 boys, were
diagnosed as having Cushing syndrome and admitted to
King Chulalongkorn Memorial Hospital between 2006 and
2010. Four of 6 were diagnosed as Cushing disease and 2
of 6 as adrenocortical carcinoma. The clinical presentations,
investigations, management and therapeutic outcome were
retrospectively reviewed. The clinical data were shown in
the table. In addition to the typical clinical features of
cushing syndrome, patient with adrenocortical carcinoma
alwayspresentwithheterosexualprecociouspuberty.Theage
of onset of adrenocortical carcinoma group were younger
(6–12 years) than that of cushing disease (12–14 years).
Loss of circardian rhythm and cortisol unsuppressible from
LDDST (Low dose dexamethasone suppression test) were68 International Journal of Pediatric Endocrinology
demonstrated in all patients. One of 4 patients with cushing
disease can not be suppressed by the HDDST (high dose
dexamethasone suppression test). One of 4 can not be seen
by the Pituitary imaging but the tumor was localized by
the bilateral inferior petrosal sinus sampling (BIPSS). One
patient with Pituitary macroadenoma has a consequences as
diabetes insipidus and the others were normal after surgical
resection. All the patients with adrenocortical carcinoma
were treated by surgical removal and chemotherapy. No
evidence of metastasis were found in the patients with
adrenocortical carcinoma, but one patient needed to be
reoperation due to the tumor recurrence. There were no
clinical overt signs of adrenal insuﬃciency due to all of them
were replaced with glucocorticoid and gradually decreased
to physiologic requirement for at least 6–9 months after
treatment.
Partial Defect in the Cholesterol
Side-ChainCleavage Enzyme P450scc
(CYP11A1)PresentingasNon-Classic
CongenitalLipoid AdrenalHyperplasia
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and Walter L. Miller1
1Department of Pediatrics (TS, WLM), University of
California, San Francisco, San Francisco, CA 94143;
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Context. The cholesterol side-chain cleavage enzyme
(P450scc), encoded by the CYP11A1 gene, converts
cholesterol to pregnenolone to initiate steroidogenesis.
Genetic defects in P450scc cause a rare autosomal recessive
disorder that is clinically indistinguishable from congenital
lipoid adrenal hyperplasia (lipoid CAH). Non-classic lipoid
CAH is a recently recognized disorder caused by mutations
in the steroidogenic acute regulatory protein (StAR) that
retain partial function. Objective. We describe two siblings
who appeared to have non-classic lipoid CAH but had
P450scc mutations that retain partial function. Patients and
Methods. A 46, XY male presented with underdeveloped
genitalia and partial adrenal insuﬃciency; his 46, XX sister
presented with adrenal insuﬃciency. Hormonal studies
suggested partial primary adrenal and gonadal insuﬃciency.
Sequencing of the StAR gene was normal, but mutations
were found in the CYP11A1 gene. Mutations were re-
created in the F2 plasmid expressing a fusion protein of the
cholesterol side chain cleavage system. P450scc activity was
measured as pregnenolone production in transfected COS-1
cells. Results. The patients were compound heterozygous
for the previously-described frameshift mutation 835delA
(0% activity) and the novel missense mutation A269V,
which retained 18.1% activity of the wild-type F2 protein.
Conclusions. There is a broad clinical spectrum of P450scc
deﬁciency. Partial loss-of-function CYP11A1 mutation
can present with clinical and hormonal phenotypes
indistinguishable from non-classic lipoid CAH.
A LongitudinalStudy on Adrenarche
Progressin49 GirlswithIdiopathic Central
PrecociousPuberty(Icpp)andElevated
DehydroepiandrosteroneSulfate(Dheas)
before and during GnrhAnalogue Treatment
Zhe Su
The First Aﬃliated Hospital of Sun Yat-Sen University,
Guangzhou, P R China
Objectives. To explore the relationship between andrenarche
and gonadarche. Methods. One hundred and sixty one girls
with ICPP were evaluated. We followed up 49 of them
whose serums DHEAS Z score for chronological age (CA)
were higher than +2SD at diagnosis. Physical examinations
including pubertal stage were repeated at 3–6-month inter-
val. Serum DHEAS levels were monitored yearly. They were
followed up for an average period of 3.26 years after GnRH
analogue (GnRHa) treatment. We were able to follow up 16
patients until more than one year after discontinuation of
GnRHa treatment. Results. All the 49 girls with ICPP and
elevated serum DHEAS were older than 6 years old. Before
GnRHa treatment, the 49 girls presented younger average
age at attainment of pubic hair stage 2 (PH2) and pubic
hair stage 3 (PH3) than normal 8.07 ± 0.98 years versus
11.16 ± 1.15 years and 8.82 ± 0.5 1y e a r sv e r s u s1 2 .40 ± 1.28
years, respectively, (P<. 01). During GnRHa treatment, the
intervals between PH2 and PH3, PH3 and pubic hair stage 4
(PH4), breast stage 2 (B2) and PH2 were longer than normal
1.69 ± 0.6 7y e a r sv e r s u s0 .83 ± 0.52 years, 1.64 ± 1.07 years
versus0.60±0.30yearsand3.62±1.40yearsversus0.76±0.99
years, respectively, (P<. 01). The intervals between PH2
and PH3, B2 and PH2 during GnRHa treatment were also
longer than that before GnRHa treatment 1.69 ± 0.67 years
versus 1.05 ± 0.33 years, 3.62 ± 1.40 years versus 1.13 ± 0.91
years, respectively, (P<. 01). The ΔDHEAS SDS per year
during GnRHa treatment were (−0.57 ± 1.12, n = 49),
(−0.61 ± 0.88, n = 49), (−0.75 ± 0.95, n = 24), (−0.84 ±
0.89, n = 7) respectively. It increased signiﬁcantly after
GnRHa cessation, (0.78 ± 1.64 n = 16). Conclusion.I tw a s
observed that gonadarche after 6 year old may lead to earlier
adrenarche. GnRHa treatment may slow down adrenarche
progress except for suppressing the hypothalamus-pituitary-
gonadal axis.
Expressionsof SEDLGeneandIts Encoded
P r ot e inSedlininaV arietyo fT iss uesinM ic e
Feng Xion, Na Hu, and Fei Lao
Children’s Hospital of Chongqing Medical University
Objective. To investigate the expressions of SEDL gene and
its encoded protein sedlin in a variety of tissues in mice.International Journal of Pediatric Endocrinology 69
Methods. Real-Time PCR and Western Blot were used to
detect the expression levels of the SEDL mRNA and sedlin
protein in 9 tissues in mice, respectively. And the expression
levels of them in bone tissues in mice of 1, 2 and 4-week-old
were also measured in the same way. Results. (1) Expressions
of SEDL gene and its corresponding sedlin protein existed
in 9 tissues detected in mice. The relative expression levels
of SEDL mRNA and sedlin protein in tissues in mice were
signiﬁcantly diﬀerent (P<. 0001), and with a high level
in bone. (2) In bone tissues of age varied mice, the relative
expression levels of SEDL gene and sedlin were obviously
diﬀerent (P<. 01), and age-related changes in expressions
were identical with each other. Conclusion. The expression
of SEDL gene and sedlin were consistent in tested tissues.
Expression levels of them were diﬀerent among tissues and
with a high level in bone. In bone tissues of mice, the
expressions of SEDL gene and sedlin had the same changes
with time.
AStudyontheContentsofCalcium,Magnesium
in Northeast Children’s Hair
Guo Xuwei, Zhang yining, Li Yanchun, and Li Shanyu
The First Aﬃliated Hospital, Jilin University
Objective. Calcium is the most occupied inorganic elements
in human body and it is one of the essential nutrients
and closely related with the activities of human life and
disease. Metabolism of calcium and magnesium should not
be separated. Calcium involves in several of physiological
functions, such as nerve excitability, muscle contraction,
heart activity and blood clotting regardless of its small
volume in a body. Calcium is an essential material for
life activities since it participates in the whole activities
of human life. The aim of this study is to determine the
levelsofcalcium,magnesiuminnortheastchildren’shairand
t h er e s u l tm a yh e l pu st om a k em o r er a t i o n a ln u t r i t i o n a l
guide for children. Method. In Jilin Province, the volume of
calcium and magnesium in hairs are determined by plasma
generator from 9158 healthy children that are between three
and seven years old. Results. Data shows that the contents
of calcium and magnesium in the hair of mostly children
in Jilin Province are low than normal level. 77.5% of the
children is lack of calcium whereas 26.2% of the children
shows magnesium deﬁciency. Calcium deﬁciency is parallel
with magnesium deﬁciency. Conclusion. in Jilin province,
the long winter, lack of sunlight exposure and low calcium
and magnesium in food attribute to sub-clinical state of
many children. Children in Jilin province need much more
outdoor activities and increase calcium intake (at least intake
recommended daily dosage) even for those lack of clinical
manifestations.
PituitaryDisorders
ALargeDeletionofProp1GeneinPatientswith
Combined PituitaryHormone Deﬁciency from
TwoUnrelatedChinese
Zhang Huiwen,1 Wang Yi,1 Han Lianshu,1
Gu Xuefan,1 and Shi Dingping2
1Xinhua Hospital, Shanghai Institute For
Pediatric Research, Shanghai Jiaotong University School
Of Medicine
2Beijing Children Growth Expert Clinic
Background. Combined pituitary hormone deﬁciency
(CPHD) has an estimated prevalence of 1:8000. Familial
CPHD is more likely to have a genetic cause than sporadic
CPHD. Mutations in PROP1 gene encoding pituitary-
speciﬁc transcriptional factor is the most common cause for
CPHD. Herein, we investigated whether PROP1 plays a role
in two Chinese familial cases of CPHD. Methods. PROP1
gene and adjacent 5  and 3  boundaries from genomic
samples from two unrelated families were ampliﬁed by
polymerase chain reactions (PCR), and directly sequenced
to investigate molecular variations and deﬁne the extension
of potential deletion. Quantitative real-time (RT-PCR)
were also conducted to analyze the copy-number of PROP1
gene in the mother of proband. The relationship of the
two distantly located families was further analyzed using
micorsatellite markers ﬂanking the deleted region. Results.
As e g m e n to f∼53.2Kb, comprehending PROP1 and
another gene encoding a hypothetical protein Q6ZTH3,
was deleted in both pedigrees families. The mother of one
of the probands was hemizygote for this large deletion
by RT-PCR, which conﬁrmed to the assumption that the
aﬀected children inherited each of the deletion allele from
their consanguineous parents. The diﬀerences of most
microsatellites surrounding the absent segment indicated
two pedigrees in our study were genetically unrelated.
Conclusion. We report the largest genomic deletion including
PROP1 gene associated with CPHD. The hypothetical
protein Q6ZTH3 is unlikely exert an indispensable function
during embryogenesis or organogenesis. The segment 7.7 Kb
upstream to the transcription of PROP1 probably harbors
a fragile-site for occurrence of breakpoints, although, the
deﬁnite site of breaking is still elusive.
CaseSerieson PediatricProlactinoma
Joanna Tung, Grace Poon, Anne Kwok,
Pik To Cheung, and Louis Low
Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
Introduction. Prolactinomas are the most common
hormone-secreting pituitary tumors and they have been
reported in patients from the age of 2 to 80. Although they
are uncommon in children and adolescent, they represent
50% of all pituitary adenomas and 2% of all intracranial70 International Journal of Pediatric Endocrinology
tumors. Methods. We retrospectively reviewed the clinical
presentation, response to medical treatment and long
term outcome of 5 Chinese adolescents (4 female, 1 male)
with prolactinoma, diagnosed at the age of 12–16 years.
Results. The mean duration of follow up was 5 years (2 to 8
years). Only 2 of the 5 patients presented with neurological
symptoms including headache and visual disturbance. 3
of the 4 female patients were post-menarcheal and they
presented with secondary amenorrhea. 2 out of these 3
girls had galactorrhoea. Growth arrest was not observed
in any of the patients and pubertal development was
normal in all patients. All patients had macroprolactinoma
and the mean size was 19.8mm (range: 10–39mm) at
presentation while the mean serum prolactin at diagnosis
was 41660miu/L (range: 1843–179070miu/L). Only one
patient had impairment of other pituitary hormones on
presentation. One patient received transphenoidal surgical
resection of the prolactinoma before medical treatment and
she developed growth hormones deﬁciency post-operatively.
Allpatientsweretreatedwithbromocriptineatdosesranging
from 2.5mg to 15mg per day. All patients achieved normal
serum levels of prolactin but 2 patients were subsequently
switched to carbergoline because of intolerable side eﬀects
of bromocriptine including postural dizziness and nausea.
Carbergoline was well tolerated and normal serum levels
of prolactin were achieved at a dose of 0.75 to 1.75mg per
week orally. After 2–8 years of treatment, 2 patients achieved
complete resolution of tumor on magnetic resonance
imaging (MRI). Another 2 patients showed signiﬁcant
reduction of the tumor size, whilst the remaining one patient
showed no interval change. Conclusion. Medical treatment
with dopamine agonist is safe and eﬀective in paediatric
patients with prolactinoma and should be considered as the
ﬁrst line of therapy.
EndocrineTumors
Two Casesof GigantismCausedby
GrowthHormone SecretingPituitaryAdenoma
Chan Jong Kim, Hwa Jin Cho, and Young Jong Woo
Department of Pediatrics, Chonnam National University
Medical School & Hospital, Gwangju, South Korea
Introduction. Gigantism indicates growth hormone (GH)
excess that occurs during childhood when open epiphyseal
growth plates allow for excessive linear growth. Gigantism
may begin at any age prior to epiphyseal fusion. The
incidence of gigantism is extremely rare with approximately
100 reported cases to date. Cases. Case one was a 15-year-old
boy who came to our hospital for his tall stature and growth
acceleration. On physical examination, all growth parame-
ters were aﬀected: his height and weight were 198.4cm (>97
percentile), and 84.2kg (>97 percentile), respectively, and
his head circumference was 58.5cm (>97 percentile). He
has been noted to have disproportionately large hands and
feet, but there was no evidence of frontal bossing, prominent
jaw, or other coarse facial features. On admission, he had
donehormonalstudieswhichshowedGH22.7ng/mL,IGF-1
(somatomedin-C) 740.0ng/mL, and IGFBP-3 6301.6ng/mL,
andhisGHwasnotsuppressedon75goralglucosetolerance
test (OGTT). Brain magnetic resonance imaging (MRI)
showed 12mm macroadenoma in pituitary gland. The
tumorwastotallyremovedbytranssphenoidalapproach,and
microscopic ﬁndings revealed the tumor turned out to be
growth hormone secreting type of pituitary adenoma. After
the surgery, GH level was 9.4ng/mL, and 75g OGTT showed
suppressed growth hormones. Case two was a 14-year-old
boy complained tall stature. His height and weight were
197.3cm (>97 percentile) and 101.5kg (>97 percentile),
respectively, and his head circumference was 58.6cm (>97
percentile). Endocrine evaluation revealed GH 7.1ng/mL,
IGF-1 518.0ng/mL, and IGFBP-3 3450.0ng/mL, and GH
was not suppressed on 75g OGTT (peak GH 18.8ng/mL).
BrainMRIshowed6mmmicroadenomainleftsidepituitary
gland. The tumor was totally removed, and microscopic
ﬁndings showed growth hormone secreting type of pituitary
adenoma. After the surgery, GH was 0.2ng/ml, and 75g
OGTT showed suppressed growth hormones. Conclusion.
The authors report two cases of gigantism which were due
to the growth hormone secreting type of pituitary adenoma
requiring transsphenoidal surgery.
InsulinomaPresentingas Hypersomnolence
Catherine Anne G. Pangilinan
University of the Philipppines—Philippine General Hospital
Insulinomas manifest with neuroglycopenic symptoms
induced by hypoglycemia. Most cases often initially present
with neuropsychiatric symptoms and are often misdiag-
nosed. This is a case of an 18-year-old girl who presented
with 5-year history of increased sleeping time (at least 14
hours/day) associated with diﬃculty waking up. The patient
was initially managed by a psychiatrist as a case of Primary
Hypersomnolence after Cranial CT scan, and EEG showed
normal results. She was given mirtazapine for one month
which was later shifted to ﬂuoxetine with no improvement
of symptoms. After three years, she started to develop occa-
sional episodes of generalized tonic-clonic seizures lasting
for 10–15 seconds, occurring at least two to three times a
month. A repeat EEG showed focal slowing over the left
frontal, temporal, and parietal regions suggesting cortical
dysfunction but with no epileptiform discharges. Cranial
MRI done was unremarkable. The patient was ﬁrst seen
by the endocrinology service during an ER admission for
seizure.Atthattime,thepatientwasafebrile,withstablevital
signs but was noted to hypoglycemic (CBG: <20mg/dl). She
wasdrowsyanddisorientedpostictallywhichimprovedupon
administration of D50 water. On further evaluation, patient
was observed to have a regressed, slow-mannered speech.
She also had poor memory and concentration. Hormonal
workup of critical samples obtained revealed an elevated
insulin level (62.5, NV: 5–35uiu/mL with simultaneous RBS
5.2mg/dL), elevated cortisol (820, NV: 160–620nmol/L),
and elevated Growth Hormone (70.9, NV: 0–14uiu/ml).International Journal of Pediatric Endocrinology 71
Urine ketone was negative. Holoabdominal ultrasound was
normal. Abdominal CT Scan revealed a fatty liver with
a mildly prominent pancreatic body; cannot rule out an
underlying mass lesion. MRI of the Abdomen showed a well-
deﬁned tumor mass in the pancreatic body measuring 2.9 ×
3.1 ×2.6cm,toconsideranisletcelltumor.CBGmonitoring
in the ward revealed hypoglycemic episodes. Cornstarch was
supplemented to diet. The patient subsequently underwent
distal pancreatectomy with splenectomy. Intraoperatively,
a2 . 0× 3.0 × 3.0cm mass at the body of the pancreas
was identiﬁed and excised. Histopathologic ﬁndings were
consistent with insulinoma. CBG postop ranged between
147–260mg/dL. Human Regular Insulin was given but was
discontinued on the 6th postop day with normalization of
blood glucose levels. The patient had improved well-being
after the surgery. There was resolution of the hypersomno-
lenceandhadnorecurrenceofseizures.Shewasalsoreferred
to a speech therapist for improvement of speech.
DiagnosticValue of Serum Levels of
β-HumanChorionic Gonadotropin (β-hcG)
Combined with β-hcG in CerebrospinalFluid
for Determinationof Locations of Germinomas
inChildrenwithPrecociousPuberty
YanHong Li, Zhe Su, HuaMei Ma, HongShan Chen,
YuFen Gu, and MinLian Du
The First Aﬃliated Hospital of Sun Yat-Sen University,
GuangZhou, China, 510080
Objective. To study the clinical manifestations of germinoma
in children with precocious puberty and to evaluate the
diagnostic value of serum levels of β-human chorionic
gonadotropin (β-hcG) combined with detections of β-hcG
in cerebrospinal ﬂuid (CSF). Method. 12 male children with
germinomas conﬁrmed by pathology from Jan, 2005 to Dec,
2009, in the ﬁrst aﬃliated hospital of Sun Yat-Sen University,
Guangzhou, aged from 4.15 to 10.18 years, were enrolled in
our study. Patients were classiﬁed into two groups according
to tumor locations: intracranial group and nonintracranial
group. Levels of β-hcG in serum as well as in CSF were
detected before the initiation of therapy. Age and gender
matched 5 children undergoing lumbar puncture for other
diseases who were set as control group of the determinations
of β-hcG in CSF. Levels of β-hcG and testosterone in
serum and CSF were compared between intracranial group
and nonintracranial group, and levels of β-hcG in CSF
were compared between nonintracranial group and control
group. Results. 12 children showed low response to LHRH
stimulation tests but elevated serum levels of testosterone:
29.49 ± 70.79ng/ml. The ﬁrst clinical manifestation in
children with non-intracranial or pineal geminomas was
precocious puberty, while it was hemiparesis in children
with basal ganglia germinomas. Serum levels of β-hcG were
elevated in both intracranial and non-intracranial group,
and no diﬀerences were found between groups 113.41 ±
112.6551.96 ± 24.12 (P = .644). No relations were found
between serum levels of β-hcG and ages, tumor locations,
courses of the patients r = 0.366, P = .24, r =− 0.276,
(P = .384), r =− 0.323, (P = .306). Levels of β-hcG
in CSF were signiﬁcantly higher in intracranial group than
that in non-intracranial group 355.70 ± 345.98, 1.30 ± 0.17
(P = .009). Children with nonintracranial germinomas had
similar levels of β-hcG in CSF as that in control group
1.30 ± 0.17, 1.20 ± 0.01 (P = .571). Conclusion.D e t e c t i o n
of serum levels of β-hcG combined with β-hcG levels in CSF
is useful for determination of the locations of germinomas in
children with precocious puberty.
TheEtiology andClinicalCharacteristicsof
DiabetesInsipidusinChildren
XiaoJing Liu, HuaMei Ma, Zhe Su, MeiNa Liu,
and YanHong Li
The First Aﬃliated Hospital of Sun Yat-Sen University,
GuangZhou, China, 510080
Objective. To study the etiology and clinical features of
diabetes insipidus (DI) in children. Methods. From 1997 to
2009, 52 children (44 boys, 8 girls, aged 7.9 years) were
conﬁrmed as DI in the ﬁrst aﬃliated hospital, Sun Yat-
Sen University. Clinical data was learned retrospectively.
Results. In our whole group, 7 (13.5%) were conﬁrmed as
nephrogenic diabetes insipidus (NDI), while 45 (86.5%)
were conﬁrmed as central diabetes insipidus (CDI). In
children with CDI, 29 (64.4%, 29/45) were idiopathic, 16
(35.6%, 16/45) were organic, secondary to brain tumors (11
cases), autoimmune diseases (1 case), and central nervous
system leukemia (1 case). Short stature was more common
in children with idiopathic CDI than that in children with
organic CDI (15/29 versus 3/16). 35 children with CDI
underwent head MRI scans. Conclusion. Idiopathic CDI still
accounts for a large proportion in DI in children. Brain
tumorsaretheleadingcauseoforganicDI.MRIscansofsella
region can help to achieve a correct diagnosis at ﬁrst visit.
Disorders of Sex Development
Glucocorticoid Therapy for Girlswith
Cogenital AdrenalHyperplasia:
Effect on Appearance of ExternalGenitalia
Ariachery Ammini and Rajeev Khanna
AIIMS, New Delhi
Girls with congenital adrenal hyperplasia are born with
malformed external genitalia. Antenatal glucocorticoid ther-
apy does decrease the extent of malformation. We have
observed that postnatal steroid therapy, started during early
infancy, can also bring about growth and development of
female external genitalia. Presented here is a case to illustrate
the morphogenesis of genitalia with medical treatment.
Case Report. Baby L S was assigned male sex at birth
although urethral opening was at the base of phallus. During72 International Journal of Pediatric Endocrinology
the second week of life, he was hospitalized because of
vomiting.Investigationsdoneduringthisadmissionrevealed
that the karyotype was 46, XX, and the child had salt
wasting form of congenital adrenal hyperplasia. Treatment
was started with hydrocortisone and ﬂudrocortisone, and
parentswereadvisedtorearthechildasafemale.Photograph
to show appearance of genitalia at 1, 6, and 9 months after
initiating therapy will be presented to document genital
development with medical therapy alone. Discussion.W e
had speculated, based on observations on human fetuses,
that feminization of external genitalia took place during the
3rd trimester of gestation under the inﬂuence of estrogen
from fetal ovaries. Genital malformations observed in girls
with ambiguous genitalia are due to lack of progression of
feminization due to inadequate fetal ovarian functions and
continuing androgen excess. Subsequently, studies in girls
with aromatase deﬁciency and estrogen receptor defects have
alsosuggestedroleofestrogeninfemalegenitaldevelopment.
The present study documents postnatal growth and devel-
opment of external genitalia with steroid supplementation.
This has important implications fortiming of girls born with
genital ambiguity.
EndocrinologicalProblems in
Turner’s Syndrome
Rui Min Chen, Xiang Quan Lin, and Xiao Hong Yang
Fuzhou Children’s Hospital Of Fujian
Objectives. Evaluating the endocrinological problems in
Turner’s syndrome (TS). Methods. 49 patients with TS
diagnosed in our clinic in 1998∼2009 by karyotype, growth
hormone stimulation, IGF1, TPO and Tg antibodies, sTSH,
FT3, FT4, fasting glucose (GS), A1c (if GS high), insulin,
FSH, LH, ultrasound (ovaries, uterus, and thyroid), bone
age, and pituitary MRI (if growth hormone deﬁciency).
Results. Chronological mean age: 11.5 (3.6∼16.8) years,
height –3.9 (−0.39 ∼− 6.25) SD, bone age 9.5 (2∼13.6)
years, >13.5 years no puberty signs (13/15, 87%), obesity
(6/49,12.2%),andoverweight(6/49,12.2%).Distributionof
karyotype: X monosomy −45, X (21/49, 42.9%), mosaicism
(16/49, 32.7%): including 45X/46, XX, 45, X/46, X, +mar,
45XO/47, XXX, 45X/46, XX/47, XXX, 45X/46X, dufX)
(q24), 45X/46X, i(X), 45X/X, idic(X) (q24), 45X/46, XY,
45X/X, idic(X) (q24); aberration of X structure (10/49,
20.4%): 46X, i(X), 46X, del(X) (q22), and others. Growth
hormone deﬁciency (25/47, 53.2%), IGF1 (207±130)ng/ml,
Hashimotothyroiditis(6/26,23.1%),hyperthyroidism(2/47,
4.3%), hypothyroidism (2/47, 4.3%), diabetes (1/49, 2%),
and insulin (12.6 ± 5.7)IU/L, LH (13.2 ± 11.1)IU/L,
FSH (77.9 ± 51.5)IU/L. Pituitary MRI abnormalities (5/18,
27.8%): including small (2/18, 11.1%), small cyst (1/18,
5.6%), and empty sella turcica (1/18, 5.6%), and pituitary
tumor or pituitary hyperplasia (1/18, 5.6%)? Conclusions.
Endocrinological problems are common in TS. Patients with
TS are at risk for some endocrinological problems that
r e q u i r ec a r ee a r l y .
ANovelMicroRNATargetingGas6Regulates
VascularSmooth MuscleCellsApoptosis in
Mice andContributes to ArteryCalciﬁcation in
Childrenwith ChronicKidney Disease
Rong-Rong Cui and Ding-An Mao
Pediatric Department, The Second Xiangya Hospital Of
Central South University
Vascular smooth muscle cells (VSMCs) apoptosis plays a key
role in artery calciﬁcation, while arterial medial calciﬁcation
is a major complication in children with chronic kidney
disease (CKD) and a strong predictor of cardiovascular and
all-cause mortality. MicroRNAs (miRNAs) interfere with
translation of speciﬁc target mRNAs and are thought to
thereby regulate many cellular processes. Recent studies
have suggested that miRNAs might play a role in VSMCs
apoptosis and artery calciﬁcation. Here, we identify a new
miRNA (miR-X) in primary mouse VSMCs that promotes
VSMCs apoptosis by repressing Gas6 expression at the
posttranscriptionallevel.OverexpressionofmiR-Xenhanced
the apoptosis of mouse VSMCs whereas inhibition of miR-X
expression attenuated it. Gas6, an inhibitor of cell apoptosis,
was conﬁrmed to be a target of miR-X. In calciﬁcation-
prone DBA/2 mice, CKD was induced by renal ablation of
varyingmagnitudesplusphosphatefeeding.Invivosilencing
of miR-X in calciﬁcation-prone DBA/2 mice enhanced
Gas6 expression, inhibited VSMCs apoptosis, and inhibited
artery calciﬁcation. Importantly, miR-X was found to be
conserved in humans, and a homozygous mutation in pre-
miR-X that caused over expression of miR-X was shown to
cause artery calciﬁcation in 2 related children. Consistent
with the mouse data, Gas6 levels were inhibited in the 2
aﬀectedindividuals.Thus,ourstudiesshowthatmiR-Xplays
an important physiological role in VSMCs apoptosis and
contributes to artery calciﬁcation in children with chronic
kidney disease.
WT1 Mutationas a Cause of
46XY DSD andWilm’s Tumor:
A Case Report and LiteratureReview
Jun Fen Fu, Yang Li Dai, Fang Hong, Shan Xu,
and Zheng Shen
The Children’s Hospital Of Zhejiang University School Of
Medicine
The Wilms’ Tumor gene is thought to have tumor suppressor
activity and to play an important role in the develop-
ment and subsequent normal function of the urogenital
system. WT1 mutations will impair Gonadal and urinary
tract development and have been demonstrated to cause
syndromes of WAGR, Denys-Drash, and Fraiser. Here, we
describe a 14-year-9-month nonmosaic XY sex-reversed
female with pure gonadal dysgenesis (46, XY karyotype,
completely female external genitalia, normal Mullerian
ducts, absence of Wolﬃan ducts, and streak gonads) whoInternational Journal of Pediatric Endocrinology 73
had Wilm’s tumor when she was seven years old and was
referred for the assessment of primary amenorrhea and no
breast development. We sequenced the genomic DNA of
all the 10 exons of the WT1 gene which mutations may
happen in proposita. A new de novo insertion mutation
in the 1st exon was found. A T is replaced by G in
codon 558 at position 139, resulting in the replacement
of the phenylalanine by the serine and creation of a stop
codon and a truncated protein. This insertion mutation
has not been described earlier and was not detected in
the patient’s parents and her male siblings and other 25
normal controls. The present data provide further evidence
to support the functional importance of WT-1gene in sex
diﬀerentiation.
46 XY Sex Reversal with Hypertension
Cindy Ho Wei-Li, Yvonne Lim Yijuan,
and Loke Kah Yin
University Children’s Medical Institute,
National University Hospital, Singapore
Patients with 46 XY sex reversal are occasionally encoun-
tered, and possible diﬀerential diagnoses include complete
androgen insensitivity syndrome, complete gonadal dys-
genesis, testosterone biosynthetic defects, and 17 alpha-
hydroxylase deﬁciency. We report a “girl” who had discor-
dance between the prenatal 46 XY karyotype performed
through amniocentesis and the female genitalia noticed
at birth. She was initially erroneously thought to have
androgen insensitivity syndrome at birth, as there was
some testosterone production with the HCG stimulation
test although there were no common mutations discovered
on screening the androgen receptor gene. She subsequently
presented with gastroenteritis at the age of 9 years and
was found to have persistent hypokalaemia associated with
hypertension (BP: 135/90mmHg). Biochemical investiga-
tions revealed markedly elevated levels of plasma ACTH,
serum progesterone, deoxycorticosterone, corticosterone,
and aldosterone levels, which were consistent with 17 alpha
hydroxylase deﬁciency, a rare cause of congenital adrenal
hyperplasia resulting in female phenotype in a 46 XY
genetically male individual. Genetic analysis conﬁrmed a
known homozygous deletion of codon 487–489 in the
CYP17 gene in the propositus, and the parents of the
propositus were found to be carriers of the mutation.
She was treated with hydrocortisone with normalisation
of her blood pressure and hypokalaemia and improve-
ment of her biochemical parameters. She also under-
went surgical removal of her testes with refashioning of
the lower vaginal tract. Histopathology of the left testis
demonstrated features consistent with cryptorchid testes
with suggestion of focal intratubular germ cell neoplasia.
Persistent hypokalaemia should prompt an assessment of
blood pressure, as associated hypertension would suggest
mineralocorticoid excess. In patients with 46XY sex reversal,
the presence of hypokalaemia and hypertension should
suggest a diagnosis of 17 alpha-hydroxylase deﬁciency. Early
diagnosis is essential so as to treat the hypertension and
hypokalaemia and prevent their sequelae and to allow for
early surgical removal of the testes which are at risk of
malignancy.
Molecular Detectionof X or Y Sequences in
TurnerSyndrome Patients with45, X or
Those withMarker Chromosome
Jun Fen Fu, Yang Li Dai, Fang Hong, Shan Xu,
and Zheng Shen
The Children’s Hospital Of Zhejiang University School Of
Medicine
The signiﬁcances of the detection of hidden X or Y sequences
in Turner syndrome (TS) were as follows: the issue of hidden
mosaicism related to fetal survival in 45, X patients, and
the risk of gonadoblastoma was associated with the presence
of Y sequences in TS patients. The aim of this study was
to detect X or Y sequences in TS patients with 45, X or
thosewithmarkerchromosomeusingmolecularanalysis.We
investigated clinical ﬁndings of TS patients with gonadoblas-
toma and whether particular Y sequences were related to the
development of virilization or gonadoblastoma. A total of 59
patients were included: 45, X (n = 39), 45, X/46, X, +mar
(n = 18),and46,X,der(X)(X:Y)(n = 2).ThePCRusing11
primers (PABY, SRY, ZFY, TSPY, DYS270, DYS280, DYS209,
DYS1, YBMY, DYZ1, and DYS249) was performed to detect
Y sequences. The conﬁrmation of X sequences was analyzed
by comparing between patients and their parents using 9 or
12 highly polymorphic X chromosome microsatellites (DXS
1060,8051,1228,1214,986,990,1001,1047,8043,1098,993,
and 991). One (2.6%) of 39 patients initially identiﬁed with
45, X karyotype was found to be positive for Y sequences,
butnonehadhiddenXsequences.ThepatientwithhiddenY
sequences was revealed to have 45, X/46, X, +mar karyotype.
Origin of marker chromosome in 19 TS patients including
one aforementioned was as follows: Y (n = 8, 42%), X
(n = 2, 10.5%), and undetermined (n = 9). Gonadectomy
was undertaken in 6 of 9 patients with Y sequences and
5 of 6 gonadectomized patients had developed virilization
(3 at birth, 2 in the second decade). Two patients who
developed virilization in the second decade were diagnosed
with gonadoblastoma (Figure). The remaining 3 TS patients
with Y sequences had been thoroughly monitored. We did
notﬁndanyassociationofgonadoblastomawithparticularY
sequences, because most TS patients with Y origin of marker
chromosome had SRY, TSPY, and centromeric DYS270 genes
regardless of gonadoblastoma. In conclusion, we found
that molecular X or Y screening has a supportive role in
helping to ascertain initial karyotype. About half of marker
chromosome in TS was revealed to be derived from the
Y chromosome. If TS patients show progressive vilization
and gonadal mass during followup, it may be an ominous
sign of gonadoblastoma. Careful monitoring of TS patients
with Y sequences who did not submit gonadectomy is
mandatory.74 International Journal of Pediatric Endocrinology
Molecular Defects of Indonesian
5-Alpha Reductase-Deﬁcient Patients
Nanis Sacharina Marzuki,1, 3 Lita Putri Suciati,1
and Mewahyu Tridjaja Dewi1
1Eijkman Institute for Molecular Biology, Jakarta,
Indonesia
2Department of Child Health, Faculty of Medicine,
University of Indonesia
3Pediatric Endocrinology Chapter,
Indonesian Pediatric Society
Background. Steroid 5-alpha reductase 2 deﬁciency is an
autosomal recessive disorder with clinical spectrum ranges
from a male phenotype with hypospadia to a female
p h e n o t y p ew i t hn o r m a lW o l ﬃan structures. Over 50 dif-
ferent mutations, mostly missense or nonsense mutations,
distributed over the gene have been reported in patients
with 5 alpha-reductase 2 deﬁciency. Several mutations were
described in speciﬁc populations, including New Guinea
highlands, Dominican Republic, Turkey, and Egypt. Objec-
tive. The study was performed to characterise the molecular
defectsofSRD5A2geneinIndonesianpatientswithclinically
suspected of 5 alpha reductase deﬁciency. Methods. Three 46,
XY DSD patients from 2 unrelated families, with clinically
suspected of 5-alpha-reductase deﬁciency, and the parents
were analysed. The DNAs were extracted from lymphocytes
using standard procedures, and subsequently, the 5 exons
of SRD5A2 gene were sequenced using speciﬁc primers.
Results. All patients (aged 13–18 years old) presented with
ambiguous genitalia, which were noted since birth, and had
marked masculinisation as they entered pubertal age. Two
novel mutations were detected in this series, of patients and
their parents, which are p.34Fs and g.699-1 G > T. The other
mutationdetectedwasp.R227Q,whichcommonlydescribed
in Far East Asian population. Diﬀerent from other reports,
in our series three mutations were found in each patient.
Whether the p.R227Q mutation is considered a polymor-
phism or a mutation in Indonesian population warrants
further study. Conclusion. Two unreported mutations of
RSD5A2 gene were detected in Indonesian 5 alpha reductase
deﬁcient patients and their parents.
PersistentMullerianDuctSyndrome with
SevereHypospadia:Possibilityof
a Complex Sex Disorder?
Frida Soesanti, Bambang Tridjaja, Arry Rodjani,
Aman Pulungan, and Jose RL Batubara
Department of Child Health, Department of Urology,
Medical School-University of Indonesia,
CiptoMangunkusumo Hospital, Indonesia
Background. Persistent Mullerian duct syndrome is a rare
disorder characterized by the presence of Mullerian deriva-
tive in otherwise normal male. It is an autosomal recessive
inherited disorder caused by the mutations of the AMH or
AMH type II receptor gene. Here, we presented a case of
PMDS with severe hypospadia: is it possible for a combined
sex disorder? Case. A one-year-and-two-month-old boy
presenting with right nonpalpable testis, right inguinal
hernia, and perineal hypospadia. The left testis was within
the left scrotum. He was born and raised as a boy. Pregnancy
and birth history were normal. No consanguinity or family
history of disorders of sex development. No other physical
abnormalities were found. Developmental milestones were
normal. Karyotyping from peripheral blood revealed 46, XY.
Mullerianinhibiting substancelevelwas15ng/mL (ref:48.2–
336ng/mL),BasalLH3.6mIU/mL,FSH0.4mIU/mL,testos-
terone <2ng/mL, DHEA <6ng/dL, and androstenedione
18ng/dL. Testosterone level, DHEA, and androstenedione
after HCG test stimulation were 357.2ng/mL, 56ng/dL,
and 35ng/dL, respectively. Exploration during herniotomy
and laparoscopy revealed remnant uterus, fallopian tube,
ﬁmbriae,andastructuremimickingovarian.Gonadalbiopsy
from the right gonad revealed testicular tissue, and no
ovarian tissue was found. Karyotyping examination from the
right gonad revealed 96% of 46, XY and 4% of 45, X. He was
diagnosed with 46, XY DSD with persistent Mullerian duct
syndrome. He wasplanned to undergo surgeryto remove the
Mullerian duct structure and orchidopexy, continued with
reconstruction of hypospadia. Conclusions. This case showed
us a very rare male sex disorder of persistent Mullerian
duct syndrome presenting with severe hypospadia. Further
eﬀort needs to be done to ﬁnd out any possibility of other
underlying etiology of sex disorder in this patient instead of
PMDS alone.
A Case of Congenital Lipoid Adrenal
Hyperplasia
Joanna Tung, Grace Poon, Anne Kwok,
Pik To Cheung, and Louis Low
Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
Introduction. Congenital lipoid adrenal hyperplasia (lipoid
CAH) is a rare cause of adrenal insuﬃciency caused by
mutations in the steroidogenic acute regulatory (StAR) or
P450 side chain cleavage enzyme (CYP 11A1) genes. Aﬀected
patients have impaired synthesis of all adrenal and gonadal
steroid hormones, and they are all phenotypically female
regardless of their genetic sex. Case Report. A Chinese
term neonate with normal birth weight was noted to
have generalized hyperpigmentation. She developed adrenal
insuﬃciency with severe hyponatremia, hyperkalaemia, and
metabolic acidosis within the ﬁrst week of life. She had
normal female external genitalia with no sign of virilization.
Serum cortisol was low at 84nmol/L with elevated serum
adrenocorticotropic hormone (ACTH) up to 1635pg/ml at
the time of stress, suggestive of glucocorticoid deﬁciency.
Aldosterone was in the high normal range of 900pmol/L,
but plasma renin activity was raised to more than
20ng/ml/hour, suggesting impairment of mineralcorticoidInternational Journal of Pediatric Endocrinology 75
production. Serum 17-hydroxyprogesterone was not ele-
vated at 0.6nmol, excluding the classical congenital adrenal
hyperplasia caused by 21-hydroxylase deﬁciency. Ultrasound
showed bilateral enlarged adrenals. The condition improved
with hydrocortisone and ﬂudrocortisone replacement. She
remained well until the age of 12, when she was found to
have delayed puberty. Hormonal workup showed elevated
gonadotrophins. Her karyotype subsequently came back to
be 46XY. She underwent laparoscopy, and no uterus was
found. Bilateral gonadectomy was done, and the histology
showed atrophic testes with no malignant change. Testicular
tissues with sertoli cells and rare spermatogonia were seen
within atrophic seminiferous tubules. Epididymis and vas
deferens were both present. Molecular analysis of the StAR
gene showed that she was homozygous for a known non-
sense mutation Q258X. Conclusion. In managing newborn
with apparent female phenotype and adrenal insuﬃciency,
karyotype should always be checked as the development
of adrenal and gonad are closely related. The possibility
of sex reversal and the diagnosis of lipoid CAH should
be considered in such situation. The correct delineation
of internal pelvic organs using reliable imaging modalities
or even laparoscopy, together with careful interpretation of
all clinical and laboratory ﬁndings are crucial to accurate
diagnosis and subsequent management.
Effect of Estradiol on Secretion of
KisspeptinfromFemale Rat Hypothalamus
andon SexualMaturation
Bao Sheng Yu,1 Li Xiaonan,2 Pan Xiaoqin,2
Yong quan Zhang,1 Shan Ye,1 and Chen Ronghua2
1Department of Pediatric Endocrinology,
the Second Aﬀ iliated Hospital of Nanjing Medical
University, Nanjing 210011, China
2Pediatric Institiue, Nanjing Medical University,
Nanjing 210029, China
Objective. To investigate the eﬀect of estradiol on secretion
of kisspeptin from female rat hypothalamus and on sexual
maturation. Methods. The 50 rats were randomizied into 5
groups: the rats of group E1 and E2 received a daily s.c.
administration of estradiol (1mg/kg/day) for 5 (PNDs 15–
19) and 13 days (PNDs 15–27), respectively, the rats of
group C1 and C2 received a daily s.c. administration of
vehicle for 5 (PNDs 15–19) and 13 days (PNDs 15–27),
respectively, and the rats of natural 35d group were without
any treatment. All of these rats were examined daily for
imperforation of the vaginal membrane to determine age
at vaginal opening (OV) until killed at PND28 (group E1
and E2, C1 and C2) and PND 35 (natural 35d group).
Sample of blood and hypothalamic explants were collected.
Hypothalamic explants were incubated in DMEM, 30-
minute preincubation period preceded the experimental use
of the explants, and then incubated with fresh plain media
for 6 hours and with fresh plain media plus 60 mM KCL
for another 1 hours. Media and serum were frozend until
assayed for kisspeptin by RIA. Results.( 1 )T h ea g eo fO V
of rats in group E1 (25.1 ± 1.1d )a n dE 2( 2 4 .7 ± 0.9d )
was signiﬁcantly advanced in comparision to the natural
35d group (33.8 ± 1.0 d). (2) The secretion of kisspeptin
(pg/ml/h) from hypothalamus in group E1 (4.31 ± 0.72)
and E2 (4.10 ± 0.17) was higher than those in group C1
(3.44 ± 0.34) and C2 (4.31 ± 0.72) (P<. 05), but there
was no diﬀerence in secretion of kisspeptin between E1, E2
and the natural 35d group (P>. 05). All groups responded
to 60mM KCL with signiﬁcantly increase in kisspeptin
secretion. (3) The serum estradiol concentration in group
E1, E2, and E2 was higher than those in group C1, C2,
and E1, but again without statistically signiﬁcant (P>. 05).
Conclusion. External estradiol used in a speciﬁc development
period in female rat may induce sexual maturation, which
are involved in the increased secretion of kisspeptin from
hypothalamus.
A Caseof SRY-NegativeOvotesticular Disorder
of SexualDevelopment
Yvonne Lim Yijuan, Cindy Ho Wei-li,
and Loke Kah Yin
University Children’s Medical Institute,
National University Hospital, Singapore
Ovotesticular disorders of sexual development (DSD) (for-
merly known as true hermaphrodites) are very rare. More
than 400 cases have been reported worldwide. Despite the
well-known fact that the SRY gene is known to initiate testis
formation and subsequent male diﬀerentiation in mammals,
about 20% of the 46 XX ovotesticular DSD lack the SRY
gene. A baby was noted to have ambiguous genitalia at
birth, consisting of a phallus measuring 2.5cm in length,
with a diameter of 1cm, associated with a single urethral
opening at the tip of the phallus, and a right palpable
gonad. Exploratory laparotomy revealed a left streak gonad
histologically proven as an ovary, a left fallopian tube,
and a left hemiuterus, associated with a right gonad in
the right hemiscrotum, which was histologically proven to
be a testis. The chromosomal karyotype was 46 XX and
the SRY gene was absent in both the peripheral blood
and both gonads, conﬁrming the diagnosis to be 46 XX
SRY-negative ovotesticular DSD. The child was reared as a
girl, with surgical removal of the testes and male internal
structures. The female structures were left intact. 46 XX
SRY-negative ovotesticular disorders of sexual development
can be caused by unrecognized genetic mosaicism in the
gonad (which was excluded on chromosomal karyotyping
of both gonads), or a mutation of an autosomal gene which
permits testicular diﬀerentiation without the SRY gene. Lack
of the SRY gene despite virilisation in this case indicates that
other candidate genes are involved in male diﬀerentiation,
of which one possibility is the SOX9 gene. Duplication of
the SOX9 gene has been suggested in a case of 46 XX SRY-
negativeovotesticularDSDandcampomelicdysplasia,which
was not present in our patient. Another case report describes
a family of XX sex reversal in the absence of SRY or a
SOX9 mutation, suggesting a mutation at a sex-determining76 International Journal of Pediatric Endocrinology
locus other than SRY and SOX9 as the cause for the XX sex
reversal trait. It is clear that normal testicular development
involves an exquisitely regulated network of gene expression
and protein-protein interactions and that further research
mayuncovertheothercandidategeneswhichareresponsible
f o rm a l es e x u a ld i ﬀerentiation.
Disorders of Bone Calciumand
Phosphate Metabolism
Etiology of NutritionalRickets:
ACaseC o ntr o lS tud y
Anju Seth,1 Varun Aggarwal,1 Raman K Marwaha,2
Satinder Aneja,1 and Pitamber Sonkar1
1Department of Pediatrics and Radiodiagnosis∗,
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Objective. To study the role of calcium and vitamin D
deﬁciencyinetiologyofnutritionalricketsinyoungchildren.
Design.C a s ec o n t r o ls t u d y .Introduction. Rickets is conven-
tionally thought to be due to vitamin D deﬁciency. Studies
from some tropical countries have postulated low dietary
calcium as the cause of nutritional rickets. Both Vitamin D
and dietary calcium deﬁciency are highly prevalent in India.
Information on their relative contribution in the etiology of
rickets in Indian children is limited. Methods.W ec o m p a r e d
67 children with nutritional rickets with 68- age and sex-
matched healthy controls. The baseline demographic (nutri-
tional status, sun exposure (UV score), dietary calcium, and
phytate intake) and biochemical parameters (serum calcium,
inorganic phosphate, alkaline phosphatase, 25(OH) D3, and
parathyroid hormone) were compared among the cases and
controls. Results.M e a n( ±S.D.) intake of calcium was found
to be signiﬁcantly lower in cases as compared to controls
204.71 ± 129.04 versus 453.27 ± 234.1mg/day ,(P<. 0001).
The diet of cases also had a signiﬁcantly lower dairy calcium
and higher phytate content as compared to the controls.
Mean serum 25(OH) D3 levels in both cases and controls
were in the range of mild deﬁciency 15.94 ± 12.43ng/ml
and 19.9 ± 13.4ng/ml,respectively ,(P = .08). There was no
signiﬁcant diﬀerence in the mean serum 25(OH) D3 levels
and UV score among the cases and controls. In cases with
rickets, regression analysis showed a signiﬁcant correlation
(r =− 0.279, P = .0278) between dietary calcium intake
and radiological score used to quantify severity of rickets.
Conclusions. The results of the study indicate that while
vitamin D deﬁciency is prevalent in young children, its
prevalence is not diﬀerent among cases of rickets and healthy
controls. On the other hand, dietary calcium, especially
dairy calcium intake, is signiﬁcantly lower among children
with rickets as compared to controls. Thus, it seems that in
our population, rickets develops when calcium deﬁciency is
superimposed upon a low/borderline Vitamin D status.
ClinicalPresentationofPrimaryHyperparathy-
roidismin Adolescent Age Group
Krishna Biswas, Richa Arora, Divendu Bhushan,
Shruti Sharma, Vindu Amitabh, A.S. Chawla,
and Rohini C.S. Bal
V.M. Medical College & Safdarjang Hospital
Primary hyperparathyroidism is an uncommon condition
in pediatric and adolescent age group. Here, we report
4 such cases who presented between 13–16 years of age
in last 2 years. All the four of them are male. The ﬁrst
patient, aged 13 years, presented with repeated episodes
of pancreatitis followed by multiple bony lytic lesions,
particularly involving the neck of femur making him unable
to walk. The second patient, aged 14 years, presented
with generalized bodyache followed by an episode of acute
abdominal pain suggestive of pancreatitis. Serum amylase
was raised, and serum calcium was 11.5mg/dl. The third
patient, aged 16 years, had multiple joint pain with diﬃculty
in walking. He was investigated as radiological features show
multiple lytic bony lesions, particularly involving the neck
and shaft of the femurs. The fourth patient, aged 13 years,
presented with short stature and found to have multiple
renal calculi on screening ultrasound. The serum calcium
was more than 11mg/dl in all the 4 cases going as high up
to 15mg/dl on repeated testing. Serum PTH were 636pg/ml,
2696pg/ml,1274pg/ml, and118pg/ml,respectively(normal
range(15–68)).Parathyroidadenomaswerelocalizedby99m
Technetium Sestamibi scan in all four. In patients nos. 1 and
3, who had predominantly bony lesions, 25(OH) vitamin D
were low. Postoperatively, all patients went to hypocalcaemia
and required calcium supplementation. However, in patient
no.1,thebonylesiondidnotdisappearcompletelyevenafter
1 year of calcium and vitamin D supplementation. Though
asymptomatic hyperparathyroidism is common in adult age
group, in pediatric and adolescent age group, the clinical
manifestations are prominent and varied. An early index
of suspicion and investigations made accordingly leads to
prompt diagnosis.
Studyon Effect andMechanism of
VitaminA Deﬁciency on Skeletal Development
of Male Growing Rats
Xing Jie, Zhang Li, and Tian Xin
The Second Hospital of Jilin University Pediatrics
(Jilin Changchun) 130041
Objective. To investigate the eﬀectandmechanism ofvitamin
A deﬁciency on skeletal development of male growing rats.
Methods. 24 male Wistar rats of 21–23 days after birth were
randomly divided into 3 groups, severe vitamin A deﬁciency
(SVAD) group, marginal vitamin A deﬁciency (MVAD)
group, and control group (CN). All rats were fed 10 weeks.
Level of vitamin A in serum was determined using the HPLC
method, while levels of growth hormone (GH) insulin-likeInternational Journal of Pediatric Endocrinology 77
growth factor (IGF-1) were detected with radioimmunoas-
say. The femur length of all rats was measured and modiﬁed.
Gomori special staining was used to establish the cartilage
morphology of femoral growth plate. Results.( 1 )L e v e l so f
serum vitamin A of 3 groups had statistically diﬀerences
(P<. 01). The levels of serum vitamin A of SVAD group
were signiﬁcantly lower than those of CN group and MVAD
group, and MVAD group was signiﬁcantly lower than the
CN group. (2) The femur length of SVAD group was lower
than that of CN group and MVAD group whereas there
were no statistical diﬀerences between MVAD group and
CN group (P0.05). (3) GH and IGF-1 levels in serum were
lowered due to the lack of VA in SVAD group, MVAD group,
and CN group; GH and IGF-1 levels of SVAD group were
signiﬁcantlylowerthanthoseofCNgroupandMVADgroup
(P<. 01, P<. 05). (4) Epiphyseal cartilage cell in CN
group had obvious proliferation and diﬀerentiation, clear
structural levels, large cartilage lacuna, and more common
mitotic. However, SVAD group had a smaller hypertrophic
zone, a relatively extended still area, disorder structure, small
cartilage lacuna, and unclear showed cartilage capsule. Also,
ithadmoredysplasiacartilagecells,mostofwhichwerenaive
and less obvious mitotic. Less distinct bone formation could
be seen, while bone marrow ﬁbrosis could be observed. But
that situation of MVAD group was improved. Conclusions.
VAD may aﬀect GH secretion of the anterior pituitary
eosinophils, and then the liver synthesizes decreased IGF-1,
resulting in endochondral bone synthesis disordered.
GenotypeandPhenotypeFindingsin
Childhood Onset Hypophosphatasia in
Chinese: ACaseSeries
Anne Kwok,1 Oliver Ma,2 Simon Siu,2
Pik To Cheung,1 Grace Poon,1 Joanna Tung,1
Sidney Tam,2 and Louis Low1
1Department of Paediatrics and Adolescent Medicine,
Division of Clinical Biochemistry, Department of Pathology
2Queen Mary Hospital, The University of Hong Kong
Introduction.Hypophosphatasia isaninbornmetabolic bone
disease caused by a loss-of-function mutation in ALPL gene,
which encodes the enzyme tissue-nonspeciﬁc alkaline phos-
phatase (TNSALP). TNSALP deﬁciency results in substrate
accumulation (including phosphoethanolamine, pyridoxal-
5 phosphate, and inorganic pyrophosphate), aﬀecting both
skeletal and dental mineralization. Hypophosphatasia varies
greatly in clinical presentations and is classiﬁed into 6
forms according to age at diagnosis and clinical severity.
More than 200 mutations are reported. Such a great allelic
heterogeneity may contribute to the wide variability of
clinical manifestations. Methods. We describe the clinical
picture and ALPL gene mutations in 4 Chinese patients with
childhood onset hypophosphatasia. Case Reports. Patient 1
is a 3.5-year-old Chinese boy. He presented with exfoliation
of deciduous teeth at 16 months of age. His mother had
history of mandibular pain and shed her permanent teeth at
20 years of age, and this case was labeled as periodontitis.
His maternal grandfather, granduncles, and grandaunts had
all of their teeth shed by their 30–40s. Patient 1 was well
otherwise, with height and weight both between the 75th to
90th percentile. He did not have any bone pain, deformity,
or any history of fracture. But his skeletal X-ray at 3 years
of age already showed osteopenia. Patients 2–4 were siblings.
Patient 2 was the index patient. He was 4 years and 10
months old at the time of study. He ﬁrst presented with
exfoliation of deciduous teeth at 12 months of age. In
retrospect, his 7-year-old elder brother (patient 3) also shed
his deciduous teeth early since 4 years of age. Patient 4, his
16-month-old youngersister, wasdiagnosed subsequentlyby
screening at 18 months of age. She was totally asymptomatic
so far. All 3 sibs enjoyed normal growth and development.
Both their height and weight were at 75th percentile. They
did not suﬀer from any bone pain, deformity, or fracture.
Father was asymptomatic. But paternal grandfather reported
shedding of all his permanent teeth in his 30–40s. He
was previously diagnosed to have low bone mineral density
and was advised to do weight-bearing exercise and increase
calcium intake. All patients had low serum ALP, high plasma
pyridoxal 5 -phosphate and urine phosphoethanolamine,
and ALPL gene mutations (Table 5). Patients 2–4’s father
and paternal grandfather also carry the same c.346 G > A
heterozygous mutation. Conclusions. Premature exfoliation
ofdeciduousteethandlowserumALPshouldalertclinicians
to the possibility of hypophosphatasia. Genetic diagnosis
and family screening is important to identify undiagnosed
aﬀected family members.
Experienceof IntravenousPamidronate
Treatment for Children with
Osteogenesis Imperfect
Yasuhiro Naiki, Masahiro Noda, Satsuki Nishigaki,
Yusuke Mizno, Kazuyuki Waki, and Reiko Horikawa
National Center for Child Health and Development
Bisphosphonate is an only eﬀective treatment for osteoge-
nesis imperfecta (OI) because of its suppression eﬀect on
osteoclast. We treated 8 patients who suﬀered from OI (7 of
type III and 1 of type IV) with intravenous pamidronate and
evaluated its eﬀects on bone and growth. 8 patients (mean
age at initiation of treatment, 2 year 1 month old: range, 1
month to 6 year 5 month old: 5 boys and 3 girls) during 38
months (11 to 69 months) of pamidronate treatment. The
intervals of the treatment were one month except for a case
of neonate, which interval is two months. All patients but
type IV decreased frequency of bone fracture without severe
adverse event even if treatment is started as early as 1 month
of age. During this treatment, BMD increased in all patients
but was not normalized except for one case. The changes
of bone markers were signiﬁcant statistically. Age-matched
SD score of height was worsen through therapy in one case
without change of IGF-1. Renal calculus was observed in
one case. Our experience suggests that cyclical pamidronate
treatment is eﬀective for patients even in neonatal period.78 International Journal of Pediatric Endocrinology
Table 5
Patient ALP∗ P5P∗ PEL:Cr∗ ALPL gene∧
1 95 736 52.1 a novel sequence change—signiﬁcance to be conﬁrmed
2 90 256 63.3 heterozygous mutation for c.346 G > A, p.A99T in exon 5
3 94 166 38 heterozygous mutation for c.346 G > A, p.A99T in exon 5
4 94 292 72.6 heterozygous mutation for c.346 G > A, p.A99T in exon 5
∗ALP: serum alkaline phosphate-normal: 145–420U/L
∗P5P: plasma pyridoxal 5 -phosphate—normal: <109nmol/L
∗PEL: Cr: urine phosphoethanolamine to creatinine ratio—normal: 2–17umol/mmol Cr
∧ALPL gene analysis was performed by PCR-based direct sequencing of ALPL gene on peripheral blood leucocyte-derived DNA.
Report of a RareCase of
VitaminD-Dependent Rickets Type II
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Introduction. Vitamin D-dependent rickets type II (VDDR
II)isarareautosomalrecessivedisordercausedbymutations
in the vitamin D receptor (VDR) gene that results in
resistance to the active hormone 1, 25-dihydroxyvitamin D3.
We report a nine-year old girl with refractory rickets and
alopecia. She had markedly elevated 1, 25-dihydroxyvitamin
D3 but low 25 hydroxyvitamin D level. The diagnosis of
VDRR II was conﬁrmed by molecular analysis of the VDR
gene. Case Report. AS, nine-year old girl, is the fourth
progeny of a ﬁrst cousin marriage. She was born term with
birth weight of 3.3kg. At one month of age, she went
through cultural ritual of hair shaving and subsequently
noted absence of hair growth. Patient had no eyebrows
but eyelashes were present. Despite an adequate diet, AS
failed to thrive. She walked unaided at two years old but
she refused to bear weight from age of three. When ﬁrst
presented at 4.5 years old, she had features of active rickets
withricketyrosary,bilateralwristandankleswelling,bowing
of both femurs with genu valgum. Radiography showed
diﬀuse osteopenia and classical changes of rickets. Biochem-
ical studies revealed hypocalcaemia, hypophosphataemia,
markedly elevated alkaline phosphatase and parathyroid
hormone. 25 (OH) Vit D level was 15.6nmol/l (60–160)
and 1, 25-dihydroxyvitamin D3 was 442nmol/l (50–160).
She was started on Rocaltriol and calcium supplements.
Unfortunately, she defaulted followup for three years but
continued to receive the same medications from a local
hospital. She became stronger and started walking again at
six years old. However, the rickety features persisted with
only slight improvement in biochemical parameters. Cur-
rently, she was on high dose of one alpha calcidol, calcium
supplement and Vitamin D. Molecular analysis of the VDR
gene revealed a homozygous missense mutation R391C in
exon 9 of the ligand-binding domain (LBD). This mutation
had been reported not only reduced the ability of LBD to
bind with 1, 25-dihydroxyvitamin D3 but also impaired the
subsequent step of VDR heterodimerization with retinoid
X receptor (RXR). Without VDR-RXR heterodimer, the
ensuing activation of Vitamin D Response Element (VDRE)
of the target genes is impaired. Conclusion. VDDR II is a rare
disorder. Presence of alopecia is associated with more severe
degree of vitamin D resistance. The concomitant presence
of vitamin D deﬁciency with VDDR II, though rare, had
been reported. In view of this speciﬁc mutation, it remains
a therapeutic challenge as patient is yet to respond fully to
treatment.
HyperplasticCallusFormationin
OsteogenesisImperfectaTypeV
Hooi Leng Ooi and Loo Ling Wu
Paediatric Endocrinology Unit, Department of Paediatrics,
University Kebangsaan Malaysia Medical Centre,
Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras,
Kuala Lumpur, Malaysia.
Introduction. Osteogenesis imperfecta (OI) is the most
common hereditary bone disease resulting in osteoporosis in
childhood. It is characterized by bone fragility and reduced
bone mass that results in multiple fractures with deformities.
OI type V is a newly described form of brittle bone disease
since 2000. One of the hallmarks of OI type V is hyperplastic
callus (HPC) formation at fractures and osteotomy sites.
We report a 10-year-old girl with OI type V complicated
with recurrent HPC formations over the years. Case Report.
SA, 10-year old girl, was ﬁrst seen in our clinic at four
years old with history of recurrent fractures since birth.
She was born at term via spontaneous vaginal delivery with
birth weight of 3.25kg. She had fractures of right humerus
and bilateral clavicles at birth. She failed to thrive and
subsequently noted to have scoliosis. She had no blue sclera,
dentinogenesis imperfecta or family history of bone disor-
ders. Her biochemistries were normal but vitamin D level
was not done. Radiography showed generalised osteopenia
with L3 compression fracture. She was started on cyclical
intravenous pamidronate since 5 years 8 months old. Over
the years, there were three episodes of long bone fractures
that resulted in HPC formation, that is, right humeral
fracture at birth, left femoral fracture at 2.5 years and right
femoral fracture at 7 years 10 months old. HPC formationInternational Journal of Pediatric Endocrinology 79
at birth and 2.5 years only evidence on radiographs, but the
right femoral HPC formation at 7 years 10 months resulted
in severe right thigh swelling which was warm and tender
with normal overlying skin. It was associated with pain
and reduced mobility. Initially, the HPC was enlarging and
alkaline phosphatase was elevated. Subsequently, it stabilised
but serial radiographs over two-year period showed minimal
sign of callus regression despite improvement in pain and
size of swelling. During this period, patient continued to
receive pamidronate therapy. Conclusion. HPC formation,
though usually treated conservatively, is a potentially serious
complication as it can lead to signiﬁcant morbidity. Natural
history of HPC was not well understood; some regressed
completely but some could progress to result in alteration
of bone architecture and subsequent bone deformity. In
view of minimal regression, longer followup is required to
determine the ﬁnal outcome of this patient. The role of
pamidronate in HPC and its healing process need to be
further elucidated.
HypercalcemiaComplicating Malignant
Rhabdoid Tumor
Catherine Anne G. Pangilinan
University of the Philippines-Philippine General Hospital
Hypercalcemia complicating malignancy is a frequent ﬁnd-
ing but little is known regarding its occurrence among chil-
dren. Acute leukemias, Hodgkin’s Disease, non-Hodgkin’s
Lymphoma, andcertainsolid tumors such asrhabdomyosar-
coma, rhabdoid tumor, hepatoblastoma, and neuroblas-
toma have been associated to it. Clinical manifestations
of hypercalcemia usually occur late in the course with
the tumor already known in most cases. Cancer-associated
hypercalcemia may be due to elaboration of humoral factors
produced by tumors aﬀecting the calcium metabolism in the
bone, kidney, and intestines with the Parathyroid Hormone-
related Protein (PTH-RP) being thought to play a major
role. A 2.5-year-old girl with a large posterior thoracic wall
mass admitted for surgery was referred for evaluation of
hypercalcemia. This was associated with occasional episodes
ofvomiting,polydipsia,polyuria,andnocturia.Thiswasﬁrst
noted at seven months as a bean-sized, ﬁrm, nonmovable
mass at the right suprascapular area which progressively
enlarged. Excision of the mass was done upon consult at
one year of age. Assessment made was hemangioma. No
histopathologic study was done, however. Six months later,
there was recurrence of the mass prompting consult at
our institution. Chest CT Scan revealed a large posterior
thoracic wall mass conﬁned to the subcutaneous layer
measuring 13.8cm × 12.6cm × 6.1cm. Lab work-ups done
revealed hypercalcemia (Total Calcium: 4.35mmol/L, NV:
2.12–2.52mmol/L; Ionized Calcium 2.33mmol/L, NV: 1.1–
1.4mmol/L), hypophosphatemia (0.35mmol/L, NV: 0.81–
1.58), normal magnesium, alkaline phosphatase, BUN,
and creatinine. PTH: 65ng/ml NV: 10–40ng/ml. Urinaly-
sis, KUB ultrasound, and skeletal survey were essentially
unremarkable. ECG revealed shortened QTc. During the
admission, patient was hyperhydrated with D5 0.9% NSS
at 3L/BSA and was later started on prednisone with no
signiﬁcantdecreaseincalciumlevel.Excisionoftherecurrent
mass was subsequently done with histopathologic studies
revealing malignant rhabdoid tumor. Calcium levels nor-
malized beginning Day 2 postoperatively. Chemotherapy
with vincristine, cyclophosphamide and ifosfamide was
initiated. Serial determinations of total calcium were within
normal range. Four months after, the back mass recurred.
There was also note of a progressively enlarging metastatic
mass at the left temporal area which later involved the
orbital ﬂoor. The patient was readmitted at the ward ﬁve
months after for vomiting. Total Calcium was elevated
(5.7mmol/L). IV hydration and furomeside were started
with gradual decrease in the calcium level (5.25, 3.99, 3.34,
and2.38mmol/L).Chemotherapywasresumed.Thepatient,
however, developed nosocomial pneumonia which led to her
demise.
Autosomal Dominant Familial
Hyperparatyroidism
Sudeep Siwach, Andrew Cotterill, Gary Leung,
John Cardinal, David McIntyre, Ivan McGown,
Harold Jeupner, and Mark Harris
1Mater Childrens Hospital, Brisbane
Objective. A family is described which has a unique auto-
somal dominant hypoparathyroidism with normal DNA
sequence for calcium sensing receptor and preproPTH gene.
Case Report. The index case is a 14yr 9m boy who was
diagnosed to have type 1 diabetes in 1993. He developed
epilepsy in 1998 and received Carbamazepine for about 1
year. No recurrence of epilepsy was noticed. On one of his
visit to endocrine clinic, he complained of tremulousness
and muscle cramp involving his calf muscles. Clinical
examination was unremarkable. His mother, a 40-year-
old lady, revealed that she was taking treatment with 1,
25 (OH) Vit D and calcium carbonate for hypocalcemia
since the age of 18 years. She was ﬁrst diagnosed to
have hypocalcemia when she was pregnant with her ﬁrst
daughter. She suﬀered from seizures as a child. Seizures
spontaneously stopped as she grew older. Index case had
no clinical evidence of hypocalcemia. Biochemistry: Ionised
Ca 1.04mmol/L (1.2–1.3); PTH 1.2pmol/L (1–7); 25OH
Vit D 78nmol/L (25–150). Urinary calcium excretion
was 0.14mmol/L (low) and Ca/Cr<0.1 His 1st degree
cousin, a 10-month-old baby, had similar biochemistry:
ionized Ca 1.1mmol/L; PTH 1.7pmol/L and 25O Vit D
99nmol/L. Seven out of 10 children are also aﬀected and
2 maternal cousins have hypocalcemia and hypoparathy-
roidism. Impression. Autosomal dominant hypoparathy-
roidism with normal calcium-sensing receptor and pre-
pro-PTH genes cased by Denovo mutation in this family
DNA sequencing is currently being performed with pending
results.80 International Journal of Pediatric Endocrinology
Autosomal DominantHypocalcemiaCausedby
anActivatingMutationof the Calcium-Sensing
Receptor Gene
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Hypoparathyroidism is an abnormality of calcium
metabolism characterized by low serum levels of
parathyroid hormone in spite of hypocalcemia. The
causes of hypoparathyroidism are numerous. Activating
mutations in the calcium-sensing receptor (CaSR) gene are
well-known causes of familial isolated hypoparathyroidism,
also known as autosomal dominant hypocalcemia (ADH).
Here, we describe three members of a Korean family with
a heterozygous Pro221Leu mutation causing ADH. A
2-month-old male visited our clinic due to hypocalcemic
seizure occurred at 10 days after birth. The serum level
of calcium was 6.3mg/dl (reference range 8.4–10.2),
and phosphorus was 8.7mg/dl (reference range 2.5–
4.5). He had a family history of hypocalcemia. His
grandfather had a history of hypocalcemic seizure with
basal ganglia calciﬁcation. His father had generalized
seizure caused by hypocalcemia at the age of 20 years,
and his aunt had intermittent numbness and periodic
paralysis started at the age of 10 years which was also caused
by hypocalcemia. On physical exam, the baby appeared
well without any dysmorphic feature. The laboratory test
showed hypocalcemia, hypophosphatemia, decreased 1,25-
dihydroxycholeccalciferol, and decreased PTH. The direct
sequencing of CaSR gene of all four aﬀected family members
showed a C to T transition at nucleotide 662 resulting in
heterozygous Pro221Leu missense mutation in exon 3 which
was reported resulting in activating mutation of CaSR. All
of the four aﬀected family members are now on treatment
with vitamin D and calcium carbonate. It is important to
distinguish hypocalcemia due to an activating mutation
of CaSR from isolated hypoparathyroidism because ADH
patients can develop nephrocalcinosis and renal impairment
during treatment with calcium and vitamin D.
Hypocalcaemia,Hyperparathyroidism,
andVitaminDDeﬁciency ina Caseof
Neonatal Mucolipodosis II
Lim Song Hai, Fabian Yap, and Rashida Vasanwala
KK Women and Children Hospital, Singapore
Mucolipodosis II (ML II or I-cell disease) of neonatal-onset
is well known to have characteristic bony changes mimicking
rickets, which is in distinct contrast to the typical dysostosis
multiplex found in those who present at an older age.
Hyperparathyroidism is a common feature in all neonatal-
onset ML II and widely thought to be secondary to impaired
calcium transport to the fetus across the placenta such that
severehypocalcemiaisnotatypicalﬁnding.WhilevitaminD
deﬁciency is not universal, vitamin D is the preferred treat-
ment to hasten the resolution of hyperparathyroidism and
bone changes. However, a unique observation in neonatal-
onset ML II is the complete resolution of radiological
“rickety” changes whether or not vitamin D treatment is
instituted.Wereportacaseofanewbornwhopresentedwith
radiological evidence of rickets, hypocalcaemia, and low 25-
hydroxyvitamin D, features typically seen in children with
vitamin D deﬁciency. However, based on the severe skeletal
changes at birth, we pursued potential diﬀerentials which
eventually revealed an underlying diagnosis of ML II. We
reexamine the approach to a newborn with “rickety” bone
changes and review previous reports of neonatal-onset ML
II. We conclude that hypocalcaemia secondary to vitamin D
deﬁciency may coexist in neonatal-onset ML II, potentially
delaying the diagnosis of the underlying bone disease. The
role of vitamin D in this lysosomal storage osteopathy
remains unknown.
Two Siblings with a Novel Nonsense Mutation,
p.R50X, inthe VitaminD Receptor Gene
Vichit Supornsilchai,1 Yodporn Hiranras,1
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We report 2 aﬀected children with hereditary vitamin D
resistant rickets (HVDRR) from the same family, one at
the age of 10 years and 9 months and the other at 9
monthsofage.ClinicalandX-rayﬁndingswerereviewedand
compared to the previous reports. RNA and genomic DNA
were extracted from peripheral blood leukocytes. Mutation
analysis by PCR-sequencing the entire coding region of
the vitamin D receptor (VDR) gene was performed. A
homozygous C to T transition in exon 5 of the VDR gene
(c.148C>T) resulting in a stop codon at amino acid position
50 (p.R50X) was identiﬁed in the proband and his younger
sister. Both of their asymptomatic parents were heterozygous
for the mutation. The proband had most of the clinical
features of HVDRR including total alopecia. The infrequent
features including a later onset of hypocalcemic symptoms
and normophosphatemia were also observed. In conclusion,
we report two siblings with a novel nonsense mutation,
p.R50X, in the VDR gene. Hypocalcemic symptoms at a laterInternational Journal of Pediatric Endocrinology 81
onset and normophosphatemia, rarely found in HVDRR
were present in the proband. This study also emphasizes
an important role of genetic testing for early diagnosis and
genetic counseling.
Effectof Glucocorticoids on
Bone Status in Children Sufferingfrom
InﬂammatoryBowelDisease
Sona Tomkova,1 Emese Majorova,2 Juraj Payer,3
and Peter Vanuga4
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Background. The decreased bone density is present in
children with inﬂammatory bowel disease. The growth
of bones and changes of its metabolism are inﬂuenced
by malabsorption, corticosteroid treatment, by energy and
protein imbalance, low level of IGF and with loss of
micronutrients through bowel. Objectives.O u rg o a lw a s
to determine the density of bone (BMD) in children
with inﬂammatory bowel disease and group comparison
of patients with corticosteroid treatment and without of
corticosteroids. We performed prospective cohort study in
50 children (28 boys and 22) girls, mean age of this group
was 13,8 years. We followed up this group for 7 years,
and at least 2 densitometry measurement was performed.
Methods. Lumbar spine mineral density (BMD) was assesed
by Dual Energy X-ray Absorptiometry (DEXA, Hologic).
Low density was considered as: −2,0 and more Z score. The
results of measurement was compared with reference values
adjusted for age and gender and explicated as ±2SD. The
bone age was determinated according with Tanner W2, as x-
ray of left wrest. As bone markers vitamin D3, Ca, ionized
Ca, crossinks telopeptide of collagen I were examinated,
the Pearson correlation and single and pair T-Test were
used for statistical analysis. Results and Conlusion.B o n e
mineral density was signiﬁcantly reduced in both groups
(boys and girls) comparing to reference values. No statis-
tical diﬀerence was found between treated and untreated
groups (corticosteroids). Comparison of BMD versus CTx
showed strong statistical signiﬁcance among groups. Major-
ity of bone markers were in normal value for gender and
age.
2Cases of Osteogenesis imperfecta Type V—to
Treat or not to Treat?
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Introduction. Osteogenesis imperfecta type (OI) V is a
distinct clinical entity with its unique clinical, radiological
and histological features. Case Report. We report 2 Chinese
children with OI type V. Both of them presented with
repeated episodes of bony fractures since early childhood
and both had the classical radiological ﬁndings of OI
type V with calciﬁcation of the radioulnar interosseous
membrane and subluxation of the proximal radioulnar
joint. They had absence of blue sclera, normal hearing,
and normal dentition. One of them continued to suf-
fer from recurrent bone fractures after puberty. He was
started on intravenous pamidronate treatment every 3 to 4
monthly for 1 year, and he had no further fracture since
the commencement of treatment. The other patient had
repeated fractures since early childhood but his condition
improved since the onset of puberty. He developed painful
hypertrophic callus 3 months after anterior closing wedge
osteotomy on his right distal femur at the age of 13 years.
Pamidronate treatment was not started in view of uncertain
eﬀect of antiresorptive agents on the natural history of
hypertrophic callus, and the relatively mild disease at the
time. Conclusion. Although bisphosphonates treatment is
a well-established therapy for patients with osteogenesis
impefecta type I, III, and IV, there is limited information
on its eﬀect on OI type V, particularly in patients with
hypertrophic callus. Its clinical beneﬁts should be weighed
against its potential complications in every individual
case.
PamidronateUse in Children with
Bone Disorders
Joanna Tung, Grace Poon, Anne Kwok,
Pik To Cheung, and Louis Low
Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
Introduction. The use of intravenous pamidronate therapy
has been suggested in a variety of bone disorders in
children. The main objective of the study is to assess the
eﬀect of pamidronate treatment in Chinese children with
bone disorders. Methods. A retrospective chart review was
undertakenonpaediatricpatientswhoreceivedpamidronate
treatment in a single centre. 11 patients (3 male, 8 female)
were included in the study and their average age was
10.6 years (3.4 to 16.3 years) at the start of treatment. 4
patients that had idiopathic juvenile osteoporosis, 2 with
osteoporosis pseudoglioma syndrome, 2 with ﬁbrous dys-
plasia, 1 with steroid induced osteoporosis, 1 with epilepsy-
related osteoporosis, and 1 with osteogenesis imperfecta
were included. These children had either a history of
recurrent bone fractures or nerve roots encroachment by
dysplasticbones.Intravenouspamidronatewasadministered82 International Journal of Pediatric Endocrinology
at a dose of 1mg/kg/dose for 3 consecutive days at 3-
to 7-month intervals, over a period of 1.5–7 years. Their
clinical status, biochemical characteristics including bone
turnover markers, and their bone mineral density were
assessed regularly during treatment. Results.S e r i a ld u a lX -
ray adsorptiometry (DEXA) scan was performed in 10
out of the 11 subjects. The bone mineral densities were
all below normal at presentation with a z-score ranging
from 1.5 to 5.8 SDS. Signiﬁcant improvement in bone
mineral densities was observed, with a mean annualized
percentage gain of 9.49% ± 6.12%, which is beyond the
expected increase of 3–5% per year in normal growth. In
addition, a decrease in fracture was observed in patients who
had recurrent fractures. One patient with ﬁbrous dysplasia
presenting with nerve root encroachment had increased in
bone mineral density but she suﬀered from another episode
of nerve root encroachment despite treatment. Delayed bone
healings after lower limb osteotomy was observed in 2
patients with juvenile idiopathic osteoporosis. No delayed
bone healing after fractures was observed. The patients
otherwiseexperiencedfewadverseeﬀects,andthesideeﬀects
were limited to mild acute phase reaction during the ﬁrst
infusion. Conclusion. Intravenous pamidronate treatment is
safe and eﬀective in children with primary osteoporosis and
secondary osteoporosis in decreasing fracture incidence and
increasing bone mineral density in the ﬁrst 3 to 4 years of
treatment. Our experience on its use in ﬁbrous dysplasia is
not conclusive.
ClinicalFollowup of 8 Casesof Osteogenesis
Imperfecta TreatedwithBisphosphonates
Veena Nair, Preeti Dabadghao,
and Vijayalakshmi Bhatia
Department of Endocrinology, Sanjay Gandhi
Postgraduate Institute of Medical Sciences, Lucknow, India
Background. Osteogenesis imperfecta (OI) is a genetic dis-
order of increased bone fragility with severe long term
morbidity and poor quality of life. Physical rehabilitation
and orthopedic care are the mainstay of management
along with bisphosphonate therapy. Objective.T or e v i e w
the clinical outcome in 8 children with moderate to
severe OI treated with bisphosphonates. Methods.C a s e
records of children with OI during the last 10 years
were reviewed. Radiological imaging was done in all cases.
Baseline BMD could be done only in 4 children and
followup BMD in 3 due to ﬁnancial constraints. Six patients
were treated with cyclic pamidronate infusion and 2, for
logistic issues, with oral Alendronate. Orthopedic and
physiotherapy inputs were suboptimally available. Results.
Total 8 patients (4 females) were followed up for a median
period of 3 years (range 1–5 years). The median age of
presentation was 3 years, and the onset of fractures was
22 days of life. Fracture rates decreased, and all chil-
dren showed improvement in bone pain and mobility; 3
patients underwent intramedullary roding of femur. One
girl had painful femoral swelling (which was diagnosed
as hyperplastic callus) and calciﬁcation of inter osseous
membrane of forearm suggesting Type V OI (Table 6).
Conclusions. Our patients clearly showed beneﬁcial eﬀect
of bisphosphonate on bone pain and fragility. Those who
received simultaneous orthopedic care had better functional
outcome. Oral alendronate may be a feasible option when
pamidronate treatment is not possible in terms of availabil-
ity/aﬀordability.
VietnamesePatientswith Osteogenesis
Imperfecta:ClinicalFeaturesof104Cases and
Results of Treatment
Dung Chi Vu, Ngoc Can Thi Bich,
Khanh Nguyen Ngoc, Thao Bui Phuong,
Hoan Nguyen Thi, Khu Thi Khanh Dung,
and Nguyen Thanh Liem
National Hospital of Pediatrics, Hanoi, Vietnam
Osteogenesis Imperfecta (OI) is a heritable disorder charac-
terized by bone fragility due to impairment in bone quantity
and quality, which may present with a wide range of disease
severities. Despite its prevalence, information regarding the
clinicalfeaturesofthisgeneticdisorderislackinginVietnam.
Thus this study aimed at characterizing the clinical feature
and treating of OI patients in Vietnam so that a practical
correlation could be established for distinguishing diﬀerent
clinical subtypes of OI. Review of medical record indentiﬁed
104 patients with OI during the study period from January
2000 to October 2009. Diagnosis and classiﬁcation, using the
classiﬁcation system of Sillence et al. were based on clinical
andradiologycharacteristics.Treatmentwithbiphosphonate
a n df o l l o wu pw e r ep e r f o r m e du s i n gp r o t o c o lo fR a u c h
(2003). We also analyzed the data of these patients among
diﬀerent subtypes, including clinical presentations, physical
examination, and bone mineral density ﬁndings. There were
60 males and 44 females with age ranging from 1 day to
15 years. Among these patients, 18 were classiﬁed as type
I, 8 as type II, 66 as type III, and 12 as type IV. Height
SDSs were −1 ± 1.99 in type I, −4.47 ± 2.39 in type III,
and −1.6 ± 3.17 in type IV. The clinical feature of blue
sclera was present in 89% patients of type I, 88% of type
II, 86% of type III, 86% of type IV. Annual fracture rate
was 4 ± 2.9i nt y p eI ,9 .8 ± 6.4 in type II, 6.1 ± 4.3i nt y p e
III, 4.6 ± 3.4 in type IV. In type IV patients, 41.6% had
family history of OI, compare to 0% in type II, 16.7% in
type I, and 13.6% in type III. Biphosphonate was used to
treat 30 patients with an average time of 13 ± 0.8 months.
After 3 cycles of treatment, 100% patients had improved
the radiology feature, reduced bone pain and improved
in mobility. No patient experienced new fractures after 12
months of treatment. The study indicated that there is a
wide range of clinical severities among Vietnamese patients
with OI, and biophosphonate has eﬀects on treatment of
OI.International Journal of Pediatric Endocrinology 83
Table 6
A g ea tl a s tf o l l o w A g ea tf r a c t u r e A g ea tb i s p h o s p h o n a t e Drug No. rate/year before No. rate/year Mobility
up (years)/Sex onset initiation treatment on follow up
10/F 5 days 7 years Alendronate 3 1$ Sits supported
3.5/M Birth 45 days Pamidronate — 2 Stands supported
7∗/F 45 days 4 years Pamidronate 5-6 0 Sits unsupported
7/F 1.5 years 5 years Pamidronate 1-2 2 Walks supported
9/F 20 days 2 years Alendronate/ 63 Sits unsupported§,C
Pamidronate no.
4/M 3 months 1.5 years Pamidronate 2-3 2 Stands supported
7/M 22 days 5 years Pamidronate 3-4 0-1 Walks unsupported§
4.5/M 1.5 years 3.5 years Pamidronate 3 2 Walks unsupported§
∗Type V OI $: lost to followup after 3 years, #: on Pamidronate during last 6 months follow up.
§: underwent intramedullary roding.
C: had attained walking with support, present deterioration due to the recent fracture femur.
ARecurrentMutationc.617G >Ain
the ACVR1GeneCausesFibrodysplasia
Ossiﬁcans ProgressivainaChinese Patient
Chen Xiuli, Cao Lingfeng, Xi Li, Pei Zhou, Lu Wei,
Zhang Miaoying, Cheng Ruoqian, Zheng Zhangqian,
Shen Shuixian, Yang Yi, and Luo Feihong
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Fibrodysplasia ossiﬁcans progressive is a rare autosomal
dominant disorder characterized by progressive heterotopic
ossiﬁcation and congenital malformation of the great toes.
Recently,FOPhasbeenassociatedwithaspeciﬁcmutationof
ACVR1, the gene coding for a bone morphogenetic protein
type I receptor. One heterozygous mutation (c.617G > A,
p.R206H) in ACVR gene was identiﬁed in all sporadic and
familial FOP cases with classic phenotype. We report the
ﬁrst Chinese uighur FOP patient with heterozygous de novo
mutation of ACVR1 gene.
Report of FiveChinesePatients with
ProgressivePseudorheumatoid Dysplasia:
From ClinicalDiagnosisto MolecularStudies
Jun Ye, Hui-wen Zhang, Wen-juan Qiu, Lian-shu Han,
Ya-fen Zhang, Zhu-wen Gong, and Xue-fan Gu
The department of Pediatric Endocrinology and Genetic
Metabolism, Shanghai Institute for Pediatric Research,
Xinhua Hospital, Shanghai Jiao Tong University School of
Medicine, Shanghai, China
Progressive pseudorheumatoid dysplasia (PPD) is a rare
autosomal recessive inherited disease characterized by
generalized bone-cartilage dysplasia, which has been
attributed to mutations in the gene encoding WISP3.
The aim of this study is to recognize PPD from clinical
manifestations and imaging characteristics of bones and
to investigate the gene mutations of WISP3 in Chinese
patients with PPD. Five patients from ﬁve unrelated Chinese
families, who presented with waddling gait, progressive
swelling, pain, and restriction of movements of several
joints including interphalangeal joints, visited our clinics
at the age of 9–15 years old. The radiographic imaging
revealed no erosive arthropathy, but platyspondyly, ovoid,
or wedged anterior end-plate of vertebral bodies in all
patients, coxa vara, widened epiphyses, or metaphyses
including capital femoral, metacarpophalangeal and
interphalangeal joints in some patients. Normal laboratory
values were found for the erythrocyte sedimentation rate
and C-reactive protein, rheumatoid factors, and so on,
in all patients. So ﬁve patients were diagnosed as PPD
according to clinical symptoms, signs and the ﬁndings of
radiographic imaging. The molecular study showed ﬁve
patients carry c.624 625insA/c.729 735delGAGAAAA,
c.624 625insA/c.866 867insA, c.866 867
insA/c.866 867insA, Q46X/C114W, and C223G/C114W
mutations, respectively, on exon 4 (40%), exon 2 (30%) and
exon 5 (30%), of the WISP3 gene. All six diﬀerent mutations
above found in this study have not been previously reported.
The illustrative patients here serve to remind physicians to
carefully examine the entire skeleton including spine and
not to oncentrate only on extremities skeleton in order to
prevent misdiagnosis. The mutation analysis of WISP3 gene
can help to conﬁrm the clinical and radiograph diagnosis for
PPD.
Hypoglycaemia
Reversal of Sensorimotor Peripheral
Neuropathy and Refractory Hypertensionwith
SurgicalCureof Insulinomain
a10-Year-Old-Girl
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Introduction. Insulinomas present rarely in children. Here
we present a case of insulinoma with peripheral neuropathy
and hypertension in a child. Case Report.A n u ,a1 0 - y e a r - o l d
girl presented to the neurology department with history of
episodic irrational behavior and seizures for 12 months and
features suggestive of sensorimotor peripheral neuropathy
for one and a half months Evaluation in the hospital revealed
hypertension, peripheral symmetrical sensory motor neu-
ropathy, and hyperinsulinemic hypoglycemia. MRI revealed
a tumor 1.3cm in size in the body of pancreas. She required
multiple drugs for control of hypertension. Surgical removal
of insulinoma led to resolution of hypoglycemic episodes.
Drugs for hypertension could be tapered oﬀ by the 3rd
month, and at one year follow up her muscle weakness
has almost completely recovered. Conclusion. Reversal of
hypertension and neuropathy with removal of insulinoma
suggests that both these were caused by hypoglycemia,
hyperinsulinemia, or a combination of both. To the best
of our knowledge, this is the ﬁrst case of insulinoma with
neuropathy and hypertension in a child.
CongenitalHyperinsulinism:
AVietnameseCase witha Novel Mutationof
Abcc8 Gene
Nguyen Ngoc Khanh,1 Vu Chi Dung,1
Nguyen Thi Hoan,1 Can Thi Bich Ngoc,1
Nguyen Thanh Liem,1 Khu Thi Khanh Dung,1
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Background Congenital hyperinsulinism (CHI) is one of
common causes of severe and persistent hypoglycemia in
the newborn period. The incidence of sporadic and familial
formsis1in50000children.AsCHIisamajorriskfactorfor
brain injury and subsequent neurodevelopment handicap,
the identiﬁcation, rapid diagnosis and prompt management
of patients with CHI are essential if brain damage is to
be avoided. Advances in molecular genetics, radiological
imagining techniques (18FDOPA-PET), and laparoscopic
surgery have completely changed the clinical approach and
treatment to patients with CHI. Case Report.T h et e r mg i r l
with birth weight of 3.8kg was caesarean section from the
mother without any evidence of maternal hyperglycemia.
She is the ﬁrst child, born to nonconsanguinity parents,
and had no perinatal asphyxia. 1 day after birth, she had
poor feeding, convulsion, lethargy, then admitted in our
hospital on the clinical condition of lethargy, poor feeding,
no convulsion, no respiratory failure (SpO2: 97%), nor-
mothermia, warm extremities, macrosomia, and no hepato-
spleenomegaly. The investigations showed severe hypo-
glycemia (0.1mmol/L), hyperinsulinemia (217MUI/ml),
normoamonemia (40μg/dL). The rest of investigations such
as cortisol 8 am, arterial blood gas, transaminase, ure,
creatinine, electrolyte, lactate, urine ketone, and abdominal
ultrasound were unremarkable. Immediately, she was treated
with glucose infusion 9–12mg/kg/minutes, then diazoxide
(6–12mg/kg/day) after 10 days of admission. But her
blood glucose concentration had been still low (ranged 1–
5mmol/l). Then, the patient was performed near-total pan-
createctomy after 20 days of admission. We had to continue
highrateofglucoseinfusion(10mg/kg/minutes)tomaintain
normoglycemia during 2 days after the surgery. Her blood
glucose level became normal level without glucose infusion
after 7 days of the surgery. A compound heterozygote for
two missense mutations, F686I and F686S, in exon 15 of
the ABCC8 gene was identiﬁed. The T>A mutation (from
her father) at nucleotide 2056 (c.2056T>A) results in the
substitutionofisoleusineforphenylalanineatcodon686and
has not been reported previously. The T>C mutation (from
her mother) at nucleotide 2057 (c.2057T>C) result in the
substitution of serine for phenylalanine at codon 686 and
has been previously reported. Now, she is 3 months of age
and normal development and normoglycemia. Conclusion.
This is the ﬁrst case of CHI in Vietnamwas analyzed ABBC8
and KCNJ11 gene. A novel mutation of ABCC8 (c.2056T>A)
was identiﬁed. The autosomal recessive CHI result in severe
and persistent hypoglycemia and often require performed
pancreatectomy to maintain normoglycemia.
ClinicalAnalysisof 40 CasesHyperinsulinemic
Hypoglycemia of Infancy
Chang Su, Chunxiu Gong, and Changhong Li
1Beijing Children’s Hospital Aﬃliated to The Capital
Medical University
2The Children’s Hospital of Philadelphia
Objective. we reviewed the diagnosis and treatment of
40 infancies with hyperinsulinemic hypoglycemia (HH)
in order to learn from HH and reduce misdiagnosis.
Methods. Reviewing on clinical presentation, laboratory data
and management retrospectively. Results.S e xr a t i oo fb o y s
to girls was 25:15. The most common chief complaint
was convulsion, 92.5%. 17.5% patients were misdiagnosis
as epilepsy or hypocalcemic convulsions at ﬁrst medical
visit. 50% patients had disorders in perinatal period. 40%
were large for gestational age. 58 times image studies in
40 patients did not show any positive results. We used
frequent feeding combined with drug treatment to those
patients. Hypoglycemic attacks reduced from up to 5 times
per day to 1 time after several months, at median age
of 20 months old (upper quartile 20 months old, lower
quartile 14 months old). 24 were treated with diazoxide,
and 13 (54%) of them had good response. Followingup,
57% (20/35) patients had mental retardation. 25.7% (9/35)
patientsspontaneouslyremisedatdiﬀerentages.Conclusions.
Hyperinsulinemic hypoglycemia had atypical symptoms.
Misdiagnosis of HH was very common. Blood glucose must
be tested in infants with convulsion. Any perinatal disorder
and macrosomia was necessary for blood glucose and insulin
checking. Hypoglycemic attack would alleviate with the age
increasing. Diazoxide was eﬀective for more than half cases.
Some cases could have spontaneous resolution. NeuropathyInternational Journal of Pediatric Endocrinology 85
complications were high. The only way to prevent central
nervous system damage was diagnosis and treatment earlier.
Wesuggestfoodmanagementcombinedwithdrugtreatment
for patients, as well as closely blood glucose monitoring.
HbA1c should be an indicator of this disease.
AnUnexpectedHistologicalFindingof
a Case of Congenital Hyperinsulinism
Joanna Tung, Grace Poon, Anne Kwok,
Pik To Cheung, and Louis Low
Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
Introduction. Congenital hyperinsulinism refers to inherited
disorders of dysregulated insulin secretion and it is a
common cause of severe and persistent hypoglycemia in
the neonatal and infancy period. Histologically, persistent
disease can grossly be divided into the diﬀuse and focal
forms. The preoperative diﬀerentiation of these two forms is
importantsincethesurgicalmanagementisentirelydiﬀerent
and patients with focal disease can be completely cured by
limited resection of the pancreas. Case Report We report a
case of congenital hyperinsulinism. The child had persistent
hypoglycemia despite dietary manipulations and was resis-
tant to medical therapy with diazoxide, hydrochlorothiazide,
and octreotide. Magnetic resonance imaging (MRI) did not
identifyanyfocallesioninthepancreasbutfurtherinvestiga-
tion with 18 ﬂuoro-L-Dopa positron emission tomography
(PET) showed a focus of moderately intense abnormal
isotope activity in the pancreatic head. Initially, limited
resection of the pancreas was planned, but eventually, a
98% subtotal pancreatectomy was done due to technical
reasons. Histological analysis subsequently showed a focus
of adenomatous hyperplasia in the proximal one third of
the pancreatic specimen but large islet cell nuclei are also
seen in the other pancreatic areas, which was suggestive of
diﬀuse hyperinsulinism. Conclusion. This case highlights the
importance of intraoperative biopsy at various sites of the
pancreas and careful interpretation of Dopa-PET ﬁndings in
order to minimize the need of multiple surgeries.
PersistentHyperinsulinemicHypoglycemia in
the Neonate with the Mutationof
the Gene ABCC8
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Persistent hyperinsulinism is known as the most severe form
of hypoglycemia in early infancy. It is especially dangerous
due to the low plasma ketone as well as hypoglycemia, the
condition which magniﬁes the risk of brain damage. Those
infantswiththemostsevereformshaveatendencytopresent
earliest. There are several genes which cause the hyperin-
sulinemic hypoglycaemia including ABCC8, KCNJ11, GCK,
and GLUD1. Here is a term neonate who was born with the
birth weight of 4.965g and gestational age of 37 + 5 weeks.
Therewasnohistoryofmaternaldiabetes.Initialbloodsugar
test (BST) showed 25mg/dL, and it was wax and wane in
spite of the continuous infusion of higher concentration
of glucose and active feeding. The laboratory results were
as follows: serum glucose 36mg/dL, insulin 76.1uIU/mL,
c-peptide 10.1ng/ml, ACTH 187.1pg/mL (normal 6–60),
cortisol 14.2ug/dL, and free fatty acid 169umoL/L (normal
176–586). Serum ketone was negative at that time. We
started medication with diazoxide, but the response was
not complete, so subcutaneous injection of the octreotide
was also added. The BST became stabilized, and after then
we could stop diazoxide medication. During the followup,
intermittently asymptomatic low blood sugar levels were
noted, but they improved very rapidly after active feeding
or sometimes with glucagon injection without any severe
symptomatic hypoglycaemia. We maintained frequent and
active feeding every 2-3 hours and octreotide injection three
times a day (initially 4 times a day). Now he is over 4
months of age, and he can control his head and is trying
to roll over. Genetic screening for Beckwith Wiedemann
syndromeshowednoabnormality.Mutationalanalysisofthe
genes KCNJ11, GCK, and GLUD1 revealed no abnormality,
but we could ﬁnd one mutation in the gene ABCC8 (c.
3748C>T,p.Arg1250X).Herewereportaneonatepresenting
as the persistent hyperinsulinemic hypoglycaemia with the
mutation of the gene ABCC8.
Disorders of Puberty
PrecociousPubertyandGelasticSeizures
witha HypothalamicHamartoma
Aditiawati Anang
Endocrinology Division Departement of Child Health,
Faculty of Medicine Sriwijaya University/Moh. Hoesi
Hospital Palembang, Indonesia
Background. Sexual precocity can result from primary
dysfunction of the neuroendocrine system within the brain.
Hypothalamic hamartoma (HH) is a rare congenital non-
neoplastic heterotopia consisting of neuron, glial cells, and
ﬁber bundles. Clinically, most patients with HH present with
precocious puberty and/or gelastic epilepsy. Objective.T o
report a rare case of hypothalamic hamartoma in 5-year
7-month old boy. Case Report. A boy with 5-years and 7-
month, BW 30kg, height 130cm, admitted on June 12th
2008 with main complaint hair growth in pubic area and
episodes of unprovoked stereotyped laughter lasting for few
seconds since 4 months old. there was stage of puberty as
hair growth in pubic area with enlarged penis and large testis
for his age (A1P2G3-4). There were no other neurological86 International Journal of Pediatric Endocrinology
deﬁcits, LH: 0.85mIU/mL, FSH 0.5mIU/ml, Testosterone
239,20ng/dL, FT4 1,110ng/dL, TSH 2.228 IU. EEG is
normal, bone age (Greulich and Pyle): advanced growth,
appropriate with an 8-years 6-month-old boy. CT Scan:
suspecttubercineriumhamartoma.(MRI):Themorphology
is suggestive of tuber cinerium hamartoma. After 1 year
of receiving topiramate 2 × 20mg and leuprolin 3.37mg
injection intramuscular every month, the patient was clin-
ically improved, no tumor enlargement using MRI, and
body height increase to 140cm. Conclusion. Hypothalamic
hamartoma needs speciﬁc attention due the possibility of
precocious puberty and gelastic seizures that require early
management. These conditions could result in cognitive and
behaviour disoders that will psycholocally impact on the
family and the patient.
GeneticResearch AssociatedwithCentral
PrecociousPubertyandTimingof Puberty
Sung Yoon Cho,1 SungWon Park,1 Young Bae Sohn,1
Se hwa Kim,1 Seung-Tae Lee,2,3 Jong-Won Kim,2,3
and Dong-Kyu Jin1
1Department of Pediatrics, Samsung Medical Center,
Sungkyunkwan University School of Medicine, Seoul,
Korea
2Center for Genome Research, Samsung Biomedical
Research Institute, Samsung Medical Center, Seoul, Korea
3Department of Laboratory Medicine, Samsung Medical
Center, Sungkyunkwan University School of Medicine,
Seoul, Korea
Background. Recently, variation in LIN28B was supposed
as a control factor of the timing of major developmental
events. And LIN28B was reported to be associated with
timing of puberty in humans. Objective. The objective of
the study was to investigate of genetic cause in precocious
puberty and evaluate the variation in the LIN28B gene in
196 subjects with early pubertal development and compared
with control subjects. Methods. For this study, 5 males
and 191 females with early pubertal development were
included. Control subjects were women under 30 years
old, who know their age of menarche and have normal
adult height. Early pubertal development was deﬁned by
appearance of breast development before the age of 9 years
and in males when testicular enlargement was present before
the age of 10 years. Through the literature review, we
selected 22 single nucleotide polymorphisms (SNPs) which
were previously reported to be signiﬁcantly associated with
precocious puberty with P-values below 5 × 10–8. The
target SNPs were genotyped by the Sequenom MALDI-
TOF genotyping system. Diﬀerences in genotype frequencies
were statistically analyzed in dominant, recessive, genotype,
and allelic modes. Result. Two SNPs near the LIN28B
gene, rs2095812, and rs314268, were signiﬁcantly associated
with precocious puberty when analyzed in recessive mode
(P = .032 and .024, resp.). Of them, rs314268 was also
signiﬁcantly associated in genotype mode (P = .042), while
rs2095812 showed a borderline signiﬁcance (P = .059).
Conclusions. Our results show that SNPs near the LIN28B
gene do underlie early pubertal development. They are
associated as recessive mode, and one of them also associated
in genotype mode.
PrimaryOvarianDysfunctionafter
HematopoieticStem CellTransplantation
duringChildhood
Won Kyoung Cho, So Huyn Park, Seung Hoon Hahn,
Min Ho Jung, and Byung-Kyu Suh
Pediatrics, College of Medicine,
The Catholic University of Korea, Seoul, Korea
Background. Survival rates after hematopoietic stem cell
transplantation for hematological malignancies during
childhood over the past decades have advanced. And there is
much concern about the eﬀects on gonad during treatment
for hematological malignancies. Limited data are available
regardingovarianfailureaftercancertreatmentduringchild-
hood. We evaluated the incidence of and patient/treatment
factorsassociatedwithovarianfailureinpediatriccancersur-
vivors. Methods. 35 girls who were over 12 years and referred
to evaluate ovarian function among patients underwent
HSCT, at the Catholic HSCT Center between March, 2008
and March, 2010 were included. They were between 12.0 and
20.6yearsold(average14.7±2.1)atlastvisit.Theoccurrence
of menarche and basal serum follicular stimulating hormone
(FSH) concentrations was assessed retrospectively. Primary
ovarianfailurewasdiagnosedifbasalFSHlevelwas>20IU/L
with hypoestrogenism. Results. Of thirty ﬁve girls who
underwent HSCT, twenty three patients (65.7%) developed
primary ovarian failure. The interval between HSCT and
last visit was 1.15–11.58 years (average 5.91 ± 2.94). Age
at HSCT was signiﬁcantly older in girls with primary
ovarian failure than normal (9.62 ± 3.05 versus 7.12 ± 2.23,
P = .010). Chi-square showed that primary ovarian failure
was less likely if patient receive a total body irradiation
(patients who receive a total body irradiation compared with
patients who do not, 47%(8/17) versus 83% (15/18), (P =
.028), but there was no signiﬁcant diﬀerence in Busulfan
and cyclophosphamide-based chemotherapy. A univariate
logistic regression analysis for detect pretransplantation risk
factors revealed relations of the age at HSCT (OR: 1.395,
95% conﬁdence interval (CI): (1.04–1.88, P = .028),
TBI (OR: 0.18, 95% conﬁdence interval (CI): (0.04–0.85,
P = .030), and diagnosis of myeloid leukemia (OR: 5.67,
95% conﬁdence interval (CI): (1.24–25.88, P = .025)
with primary ovarian failure. Conclusions.W eo b s e r v e d
primary ovarian failure in 65.7% of patients following HSCT
and favourable prognosis of ovarian function in girls who
underwent HSCT at young age. These results emphasize the
regular ovarian function test of these patients in order to
detect ovarian failure. The preparative regimen consisted
of total body irradiation (n = 17, 12Gy, 2Gy/fraction,
two fraction/day for 3 days), Busulfan-based chemotherapy
(n = 5, 130mg/m2 for once daily intravenously for 4 days,
total 520mg/m2), cyclophosphamide-based chemotherapyInternational Journal of Pediatric Endocrinology 87
(n = 12, 50–60mg/kg once daily intravenously for 2–4 days,
total 120–200mg/kg), and others (n = 1, mephalan-based
chemotherapy).
PrecociousPubertyinaGirlwith
SuprasellarGerminoma:A CaseReport
Yodporn Hiranras, Vichit Supornsilpchai,
and Suttipong Wacharasindhu
Division of Endocrinology and Metabolism, Department of
Pediatrics, Faculty of Medicine, Chulalongkorn University
Primary intracranial germ cell tumor in childhood is rare
and usually localized in the pineal and the suprasellar
region. Although precocious puberty is common in boys
with human chorionic gonadotropin (hCG) secreting brain
tumor, it is extremely rare in girls. There have been few
reports in which a human chorionic gonadotropin-(hCG)-
producing tumor associated with precocious puberty in
female. We report a 7 2/12-year-old girl with suprasellar
germinoma who developed isosexual precocity. The patient
presented with evidence of polyuria, polydipsia, visual
disturbance, ptosis and was noted to have breast bud.
The serum hCG level was 243.2mIU/ml. Both luteinizing
hormone (LH) and follicle-stimulating hormone (FSH)
were below detectable level. After gonadotropin releasing-
hormone stimulation test, LH and FSH remained below
detectable level. Serum estradiol was elevated. The breast
enlargement and bleeding per vagina were observed during
admission. Pelvic ultrasonography revealed normal study.
After chemotherapy, the breasts were decreased in size.
The present case illustrates the development of isosexual
precocious puberty in girl with hCG-producing suprasellar
germinoma. It is speculated that FSH-like activity of human
chorionic gonadotropin may play a role in the development
of precocious puberty in this case.
OnsetofSecondary SexualMaturityin
Obese Boys: A LongitudinalStudy
Modella Rahmi Femina, Madarina Julia,
and Soeroyo Machfudz
Department of Child Health, Faculty of Medicine,
Gadjah Mada University/Dr. Sardjito Hospital,
Yogyakarta, Indonesia
Obesity was associated with early onset of sexual maturity
in girls; however, results of studies in boys were conﬂicting.
Early onset of sexual maturity is a concern because of its
association with shorter ﬁnal height. The objective of the
study was to assess the onset of secondary sexual maturity
in obese urban Indonesian boys, compared to nonobese boys
as controls. The study recruited 133 obese and 133 nonobese
boys in Yogyakarta, matched for age and school. Obesity was
deﬁned as BMI for age above the 95th of the CDC 2000
reference standard. All boys were between 9 and 10 years
old and had not begin their secondary sexual development
assessed with testicular volume of 2mL or less and Tanner
staging of pubic hair P1 at baseline. At baseline, 99.2% boys
had testicular volume of 1mL; only 2 nonobese boys had
testicular volume of 2mL. nonobese boys were slightly taller
than the obese boys, mean (SD) height of 137.9 (1.8)cm
versus 136.2 (8.7), P = .03. Staging of pubic hair and
testicular volume were examined every 4 months in two
years, that is, 6 visits. Onset of secondary sexual maturity
was deﬁned as testicular volume of 4mL or more, or the
appearance of pubic hair stage P2. By the end of study, 106
(79.7%) obese boys attained testicular volume of 4mL or
more versus 85 (63.9%) in nonobese boys, RR (95%CI) of
1.8 (1.2–2.7), P = .004. For pubic hair, 81 (60.9%) obese
boys attained P2 versus 37 (27.8%) in nonobese boys, RR
(95%CI) of 1.8 (1.5–2.3), P<. 001. Survival analysis showed
that the median (95%CI) duration for achieving testicular
volume of 4mL or more was 20.0 (19.3–20.7) months in
obese boys versus 24.0 months in nonobese boys, P = .007.
Since the mean age at baseline was 9.3 years, it corresponded
to the age of 11.0 and 11.3 years. For pubic hair staging, the
median (95%CI) duration for achieving P2 was 16.0 (15.2–
16.8) months in obese boys versus 20.0 (18.9–21.1) months
in nonobese boys; it corresponded to age of 10.6 and 11.0
years. Our study concludes that obesity is associated with
earlier onset of sexual maturity in boys, which may lead to
shorter ﬁnal height since both groups had similar heights at
baseline.
A Correlation between Age of Menarche and
Anthropometric MeasuresinAdolescents and
Young Women
Hae Soon Kim, Hanwool Kim, Hyejin Lee,
Ji Young Oh, and Yeon-Ah Sung
Department of Pediatrics and internal Medicine,
Ewha Womans University School of Medicine, Seoul, Korea
Purpose.Toevaluatethecorrelationbetweenageofmenarche
and anthropometric measures in adolescents and young
women. Method. We surveyed 8.330 fertile women, aged
between 15 and 29, to ﬁnd out anthropometric measures
and age of menarche. They were assorted into “adolescents”
(15–18 years) and “adults” (19–29 years), then each group
was categorized into “early menarche” (∼10 years), “mid
menarche” (11∼14 years), and “late menarche” (∼15 years),
compared with anthropometric measures. Results.T h em e a n
age was 17.2 ± 2.4 years of age in adolescents and 21.0 ±
2.1 years of age in adults. The mean age of menarche was
12.55 ± 1.2 years in adolescents and 12.53 ± 1.2y e a r si n
adults. There was no signiﬁcant diﬀerence between the two
groups. The height of the two groups showed no diﬀerence
(161.8 ± 4.9cm in adolescents, 162.3 ± 4.7cm in adults;
P = .52). The body mass index and waist circumference
were signiﬁcantly diﬀerent between the two groups (20.1 ±
2.4kg/m 2,6 8 .2 ± 5.8cm in adolescents; 19.8 ± 2.0kg/m 2,
67.7 ± 4.7cm in adults). In adults, the mean height of
early, mid, and late menarche woman was 161.3 ± 4.5cm,
162.3±4.1cm, and 163.8±4.9cm. The waist circumferences88 International Journal of Pediatric Endocrinology
in those groups were estimated at 69.8 ± 5.5cm, 67.7 ±
4.7cm,66.6 ± 4.5cm. Also, the body mass index was 20.9 ±
2.3kg/m 2,1 9 .7 ± 2.0kg/m 2,1 9 .2 ± 0.8kg/m 2. There were
signiﬁcant diﬀerences among the three groups (P<. 001).
The age of menarche in adolescents and results had a
positive correlation with height, but a negative correlation
with weight, body mass index and waist circumference
(P<. 001). According to timing of menarche, prevalence
of oligomenorrhea was signiﬁcantly diﬀerent as 6.1%, 8.5%,
13.4% in adolescents, 5.1%, 7.6%, 15.3%. Conclusion.T h e
earlier onset of menarche is correlated with bigger waist
circumference and body mass index. It suggests that the age
of menarche is related to height and obesity.
The Value of MRI and IGF-1in
the DifferentialDiagnosisbetweenICPPand
ICPPComplicated withGH Deﬁciency Girls
Caihong Liu, Guimei Li, Xin Qiao, and Yanyan Hu
Provincial Hospital Aﬃliated to Shandong University,
Jinan 250021, China
Objective. To analyze the sensitive indicators of diﬀerential
diagnosis between idiopathic central precocious puberty
(ICPP) and ICPP associated with growth hormone deﬁ-
ciency (GHD). Methods. 36 ICPP girls and 16 ICPP girls
associatedwithGHD(ICPP+GHD)wereenrolledandallof
them underwent magnetic resonance imaging (MRI) scans
of the hypothalamic-pituitary area, the B-mode uItrasound
of ovaries and uterus, bone age (BA), fasting blood IGF-1,
FSH, LH, E2, To, PRL, FT3, FT4, TSH, and the peak of LH,
and LH/FSH after the stimulation of GnRH, Growth hor-
mone concentrations were measured in patients suspected
with ICPP + GHD after GH stimulation test. 30 healthy
prepuberty girls were selected as the control group. Results.
Bone age was signiﬁcantly advanced in ICPP group than in
ICPP + GHD group, pituitary height, IGF-1, and the peak
of LH and LH/FSH were signiﬁcantly higher in ICPP group
than in ICPP + GHD group, compared with the control
group, pituitary height and IGF-1 in the ICPP group were
signiﬁcantly higher, and they were signiﬁcantly lower in the
ICPP + GHD group. Conclusion. MRI and IGF-1 are helpful
in the diﬀerential diagnosis between ICPP girls and ICPP
complicated with GHD girls.
The Value of MRI and IGF-1in
the EarlyDiagnosisofGirlswith
Idiopathic CentralPrecocious Puberty
Yanyan Hu, Guimei Li, and Xin Qiao
Provincial Hospital Aﬃliated to Shandong University,
Jinan 250021, China
Objective. To observe the value of magnetic resonance
imaging (MRI) and insulin-like growth factor-1 (IGF-1) in
the early diagnosis of girls with idiopathic central precocious
puberty (ICPP) and to analyze the relevance between MRI
and traditional indicators. Methods. Selected 36 typical ICPP
and 8 early ICPP, IGF-1, LH, FSH, E2, FT3, FT4, TSH
at fast time, and the peaks of LH, and LH/FSH after the
stimulation of GnRH were examined, all of the patients with
CPP underwent MRI scans of the hypothalamic-pituitary
area, the B-mode uItrasound of ovaries and uterus, and
bone age BA, 30 healthy prepuberty and age-matched girls as
the control group. Results. Pituitary height and IGF-1 were
signiﬁcantly higher in both typical and early ICPP group
than in control group (P<. 01), there were no signiﬁcant
diﬀerence between the typical and early ICPP; CA, (BA-
CA), peak LH, and LH/FSH, E2 in typical ICPP group
were signiﬁcantly higher than those in the group of early
ICPP, P<. 01 Gonadotropin-releasing hormone analogue
(GnRHa) showed signiﬁcant eﬀect in the treatment of early
ICPP. Pituitary height showed a signiﬁcant linear positive
correlation with (BA-CA), IGF-1, LH, and LH/FSH, GnRH-
stimulated peak LH, and LH/FSH, E2, (resp., r = 0.45, 0.65,
0.54, 0.45, 0.58, 0.57, 0.54, P<. 05–.01). Elster grades of
anterior pituitary had a signiﬁcant positive correlation with
Tanner stages (r = 0.54, P<. 001). The children with ICPP
whichpituitaryshowedmildconvexityandsphericalonMRI
accounted for 86.4%. Conclusion. MRI and IGF-1 are helpful
in the early diagnosis of ICPP girls. MRI is closely related
to the clinical manifestations and the functions of pituitary-
gonad axis.
The Growth-Promoting Efﬁcacy of
Gonadotropin-Releasing Hormone Analogues
on Idiopathic CentralPrecocious Puberty Girls
Xie Liling, Yang Yu, Yang Li, Jiangwei Ke, Xian Wei,
Haiying Zhou, Lirong Yu, Dongguang Zhang,
and Yi Yuan
Children’s Hospital Of Jiangxi Province
Objective. To observe the gonadotropin releasing hor-
mone analogue (GnRH-a) on idiopathic central precocious
puberty (ICPP) and projected adult height of girls growing
inﬂuence. Methods. 200 patients with idiopathic central
precocious puberty (ICPP) girls were treated with GnRHa
treatment, 1 injection every 4 weeks, the ﬁrst 3 times
100μg/kg, after 60∼80μg/kg, for 12 to 36 months (average
21.1 ± 7.43 months) of treatment, bone age (BA), growth
rate (GV), predicted adult height (PAH), and changes in
sexual characteristics, height growth forecast value of the
correlation with the course. The slower growth rate after
treatment of bone age results, bone age (BA) growth of
less than the age (CA) growth of 6 months after treatment,
12, 24, and 36 months BA/CA ratios were 0.86 ± 0.39,
0.61 ± 0.28, 0.48 ± 0.32, 0.22 ± 0.26, and 1.73 ± 0.25
before treatment were signiﬁcantly diﬀerent (P<. 01).
The ﬁrst year after treatment, the growth rate (GV1) was
6.4 ± 1.25CM, the second annual growth rate (GV2) for
the 5.3 ± 1.38CM, the third annual growth rate (GV3)
was 4.5 ± 1.32CM; predicted adult height (PAH) before
treatment was 151.26 ± 4.63CM, 6 months after treatment,
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152.29 ± 3.91, 153.13 ± 4.33, 154.58 ± 5.09, 156.31 ± 5.34,
compared with before treatment were signiﬁcantly diﬀerent
(P<. 01), the third year of net PAH before treatment
was 5.21 ± 1.02CM, close to the target height 156.39 ±
4.24 (P>. 05). PAH growth in value and duration
were signiﬁcantly correlated (r = 0.75, P<. 01), 3
months after treatment serum levels of Estrogen and LH,
FSH peaks were reduced to pre-puberty, breast star back.
Conclusion.G n R H ac a ne ﬀectively inhibit the growth of
secondary sexual characteristics and bone age, to improve
the prediction of adult height ICPP girls; when GnRHa
treatment is longer, the growth of the value predicted adult
height is greater; GnRHa treatment combined with growth
hormone can more eﬀectively improve the prediction adult
height.
ReproductiveAxis,Uterus and
OvarianVolume andMenstrualCycle
after Long-Term Therapy with
Gonadotropin-ReleasingHormone Agonist in
Girlswith CentralPrecocious Puberty
Marta Snajderova,1 Daniela Zemkova,1
and Leos Teslik2
1Department of Paediatrics, 2nd Medical School and
University Hospital-Motol, Prague, Czech Republic
2Department of Gynaecology and Obstetrics,
2nd Medical School and University Hospital-Motol,
Prague, Czech Republic
Gonadotropin-releasing hormone analogs (GnRHa) are
standard of care for central precocious puberty (CPP). Only
a few data on the development of girls with CPP after long-
termtherapyareavailable.Weareinterestedintheregulation
of reproductive axis and sexual development in girls with
central precocious puberty after therapy. Thirty two girls
with CPP (n = 19 idiopathic CPP; n = 13 organic CPP), at
the end of therapy aged 11.1 ± 1.1 years (mean ±SD) (range
9.3–14.1), treated 3.1 ± 1.3 years (range 1.0–7.2 years) with
D-Trp6-GnRH agonist were observed. Volumes of uterus,
ovaries, and standard GnRH test (LHmax/FSHmax) were
assessed at the end of therapy, 3, 12, 24, and 36 months
thereafter (GnRH test only until menarche) and results were
compared with previous time. Menstrual cycle was analysed
12, 24, and 36 months after therapy withdrawal. Similar
trends in gonadotropin levels, ovarian, and uterus volume
were found both in girls with idiopathic (ICPP) and organic
(OCPP) central precocious puberty. LHmax/FSHmax at the
end of therapy 0.3 ± 0.3 increased within 3 months to
1.2 ± 0.7( P<. 001); compared with previous time) and
to 3.0 ± 3.2( P<. 01) 12 months after therapy. Ovarian
volume 2.2 ± 0.9ccm at the end of therapy increased within
3 months to 3.3 ± 2.0ccm (P<. 01) and at 12 months
to 4.4 ± 1.8ccm (P<. 05). No signiﬁcant changes were
found 24 and 36 months since therapy withdrawal. Uterus
volume 4.2±17ccm at the end of long-term GnRHa therapy
increased within 3 months to 11.6 ± 9.6ccm(P<. 01), at
12 months to 21.1 ± 9.4ccm (P<. 01), at 24 months to
37.8 ± 16.9ccm (P<. 05), and 36 months after the end
of therapy to 39.6 ± 17.7ccm (ns). Menarche was reached
at the mean age 12.7 ± 1.2y e a r s( b o n ea g e1 3 .7 ± 0.9
years), 1.5 ± 0.8 years after the end of therapy, earlier in
ICPP group (1.4 ± 0.6 )y e a r sv e r s u s1 .7 ± 1.1y e a r si n
OCPP group; (P<. 01). Irregular menstrual cycle was
detected in 11% of girls 36 months after therapy withdrawal,
more frequently within OCPP group. Volumes of uterus and
ovaries correspond with the rapid increase of gonadotropin
levels during the ﬁrst year of posttreatment period. In the
post treatment period, development of uterus corresponds
with the biological age. We conclude that suppression of
pituitary-gonadal axis after depot long-term GnRHa therapy
in girls with central precocious puberty is fully reversible.
Incidence of irregular menses did not diﬀer signiﬁcantly
compared with general population.
ConsecutiveGonadotropin Determinationsin
UrinebyImmunochemiluminometric Assays
duringGonadotropin-ReleasingHormone
Analog StimulationTesting inChildren
Zhuang-jian Xu, Xi-ping Wang, Ya-ping Ma,
Wen-jie Zhang, Xing-fu Pang, Qing Wang,
Shu-yan Xie, and Ting-ting Zhang
Department of Pediatrics, The 4th Aﬃliated Hospital of
Soochow University, Wuxi, 214062, Jiangsu Province,
China
Objective. To observe gonadotropin excretion in urine by
immunochemiluminometric assays (ICMA) during GnRHa
stimulation testing in order to provide urinary gonadotropin
(UGn) basic data for studying diagnosis of HPGA. Methods.
Twenty four GnRHa stimulation testing in children who
suﬀered from disorders of growth or pubertal development
were performed in hospital. Nine consecutive timed urine
samples (the ﬁrst was timed 1.5-hour urine, and the others
were, resp., timed 1-hour) were collected, respectively, after
injecting triptorelin in 24 tests. Overnight urine before
injecting triptorelin and 3 consecutive overnight urine after
injecting triptorelin were collected, respectively, in 16/24
tests. The LH, and FSH were assayed by ICMA, and
urinary gonadotropin (UGn) concentrations were corrected
by creatinine (Cr). Results. (1) The excreting phase for the
peak urinary LH (ULH) among 9 consecutive timed urine
sampels: The upper 95% conﬁdence limit of time for the
ﬁrst peak ULH and the highest peak ULH (the quantities
of ULH and the ratio of ULH concentrations/Cr) were,
respectively, 4h∼6.2h and 7.2h∼9.5h. And the number
(median) of peaks and the upper 95% conﬁdence limit
were 3 peaks and 4 to 4.75 peaks, respectively. (2) The
correlation coeﬃcient between the peak UGn and serum
peak gonadotropin: The correlation coeﬃcient between
serum peak LH (PLH) and the ﬁrst peak quantities of ULH
was 0.927, and between serum PLH and the the highest
peak quantities of ULH 0.856, and between serum PLH
and the ﬁrst peak ratio of ULH concentrations/Cr 0.851,90 International Journal of Pediatric Endocrinology
and between serum PLH and the highest peak ratio of
ULH concentrations/Cr 0.826. The correlation coeﬃcient
between serum PLH/peak FSH (PFSH) and (the ﬁrst
peak quantities of ULH)/(quantities of UFSHs) was 0.845
(UFSHs was the quantities of urinary FSH in the same
ﬁrst peak ULH sample), and between serum PLH/PFSH
and (the highest peak quantities of ULH)/(quantities of
UFSHs) 0.878, and between serum PLH/PFSH and (the ﬁrst
peak ratio of ULH concentrations/Cr)/(the ratio of UFSHs
concentrations/Cr) 0.861, and between serum PLH/PFSH
and (the highest peak ratio of ULH concentrations/Cr)/(the
ratio of UFSHs concentrations/Cr) 0.843. (3) Consecutive
UGn determinations in overnight urine: The correlation
coeﬃcient between serum PLH and the ratio of ULH con-
centrations/Cr in overnight urine before injecting triptorelin
was 0.482, and for the ratio of ULH concentrations/Cr in
ﬁrst overnight urine after injecting triptorelin 0.797, for
the one in second overnight urine 0.653, for the one in
third overnight urine 0.212. And there was the highest
median for the ratio of ULH concentrations/Cr in the ﬁrst
overnighturineamongallovernighturinesamples,thenthat
in the second overnight urine decreased to the level that
was same as in overnight urine before injecting triptorelin
(P>. 05). Conclusions. Our data suggest that there was
good correlation between consecutive timed UGn and serum
peak Gn determined by ICMA during GnRHa stimulation
testing in children. The eﬀectiveness of triptorelin on
pituitary almost disappears in 48h after injecting triptorelin
in children.
The CirculatingLevels of NTproCNP inGirls
withIdiopathic CentralPrecociousPuberty
Yanan Zhang, Yalei Pi, Xue Yan, and Huifeng Zhang
The Department of Pediatrics, the Second Hospital,
Hebei Medical University, Shijiazhuang, 050000, China
Background. The features of plasma NTproCNP and the
relationship between NTproCNP, IGF-I and estrogen in
girls with idiopathic central precocious puberty. Methods.
A total of 16 cases of girls with ICPP were set as ICPP
group, while the control group involved 16 of healthy
girls with age matched. Physical detection indices such
as height, body weight and bone age were determined.
The bone age was measured with TW-method, through
evaluating the ossiﬁcation center of the left hand and
wrist. Plasma NTproCNP and IGF-I were measured by
ELISA, while estrogen (E2) were determined by chemolu-
minescence assay. Results. (1) Compared with the control
group, plasma NTproCNP level (18.92 ± 8.62pmol/ml
versus 21.74 ± 13.12pmol/ml, z =− 2.34), P<. 05),
serum IGF-I level (522.41 ± 228.33ng/ml versus 867.50 ±
318.15ng/ml, (t =− 3.59, P<. 05) and serum estro-
gen level (19.00 ± 4.5pg/ml versus 37.19 ± 16.08pg/ml,
z =− 2.58, P<. 05) in ICPP group were signiﬁcantly
higher. (2) In control group, plasma IGF-I level had
signiﬁcant positive correlation with both age and bone
age (r = 0.65, P<. 01; r = 0.66, P<. 01), whereas no such
correlation existed in ICPP group. In both ICPP group
and control group, plasma NTproCNP level had no cor-
relation with neither age nor bone age; Moreover, plasma
NTproCNP had no correlation with IGF-I; No correlation
was found between NTproCNP, IGF-I and estrogen. Con-
clusion. NTproCNP may play a role in the acceleration
process of longitudinal growth of bone in the girls with
ICPP.
LongitudinalEstimatesof
PubertalDevelopment inGirlsMaturating
at Different Ages
YanHong Li, HuaMei Ma, HongShan Chen, Zhe Su,
YuFen Gu, and MinLian Du
The First Aﬃliated Hospital of Sun Yat-Sen University,
GuangZhou 510080, China
Objective. To investigate pubertal growth pattern in relation
to the timing of onset of puberty in healthy Cantonese girls.
Method. 320 normal Cantonese schoolgirls, recruited at age
of 7.24 ± 0.38 years (6.25 to 8.83 years), were followed
up annually for 9 years (from 1992 to 2001). Physical
examinations included height, weight and pubertal stages.
Children were subdivided into 4 groups according to the
ages at the onset of puberty (B2): group 1: onset less than
9y e a r s ,g r o u p2 :o n s e tb e t w e e n9t o1 0y e a r s ,g r o u p3 :
onset between 10 to 11 years, group 4: onset later than 11
years. Results. 274 girls (85.6%) had submitted menarche,
250 girls (78.1%) had reached ﬁnal adult height (FAH).
Girls with earlier puberty reached menarche at earlier ages
(11.39 ± 1.38 years, 12.08 ± 1.25 years, 12.77 ± 1.14 years,
13.45 ± 1.09 years, P<. 001), but exhibited longer durations
from B2 to peak height velocity (PHV) (1.52 ± 1.01 years,
1.23 ± 0.80 years, 0.74 ± 0.61 years, 0.52 ± 0.36 years,
P<. 001) and from menarche to FAH (2.36 ± 1.16 years,
2.18 ± 1.31 years, 1.90 ± 0.99 years, 1.48 ± 1.11 years, P =
.014),however,intervalsfromPHVtomenarcheweresimilar
to the late maturers (2.10 ± 1.25 years, 1.83 ± 1.18 years,
1.82 ± 1.06 years, 1.99 ± 0.94 years, P = .405). In girls
with early puberty, height Z-score at B2, PHV (cm) and the
height attained from menarche to FAH were higher than
those matured later: (0.24 ± 0.99, 0.25 ± 0.69, −0.28 ± 0.82,
−0.20 ± 0.85, P = .003), (8.60 ± 0.90cm, 8.31 ± 0.92cm,
8.12 ± 1.12cm, 7.60 ± 0.97cm, P<. 001), (6.69 ± 4.04cm,
6.07±4.00cm, 5.24±3.82cm, 4.04±3.41cm, P = .029), but
no diﬀerences of FAH were found between groups (158.58 ±
6.44cm, 158.09 ± 5.73cm, 158.59 ± 6.05cm, 159.24 ±
5.93cm, P = .857). Conclusions.P u b e r t a lg r o w t hp a t t e r n s
depend on the timing of the onset of puberty in healthy
Cantonese girls. Although menarche may occur earlier, girls
matured at early age exhibit the compensatory pubertal
development, comprising longer duration of puberty growth
and higher peak height velocity, namely the increased total
heightattainmentduringpuberty,andthushaveunimpaired
FAH.International Journal of Pediatric Endocrinology 91
Miscellaneous
Self-Esteem,Behavior,andSocialFunctioning
in Girlswith TurnerSyndrome
Mei-Chyn Chao,1,2 Cheng-Yu Liao,1
and Sa-Chin Guan3
1Division of Genetics, Endocrinology and Metabolism,
Department of Pediatrics, Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan
2Department of Medical Genetics, College of Medicine,
Kaohsiung Medical University, Kaohsiung, Taiwan
3Department of Psychology, Kaohsiung Medical University,
Kaohsiung, Taiwan
TS is a sex-chromosome disorder which is caused by the
total or partial absence of one X chromosome in some
or all cells. The principal features are short stature and
dysfunctional gonads, resulting in a lack of sex hormones,
incomplete pubertal development and impaired fertility.
Previous studies from other countries indicated that girls
with TS are at higher risk of having social and behavioral
problems than the general population. Besides, parents of
girls with TS have rated them as having signiﬁcantly more
behavioral problems and lower social competence than did
parents in a normative sample, and girls with TS have rated
themselves as having social problems, and have reported
being dissatisﬁed with their physical appearance. The objec-
tive of this study is to describe self-esteem, behavior and
social functioning in all known girls with Turner syndrome
(TS), 7–16 years of age. Participants are recruited from the
Department of Pediatrics of Chung-Ho Memorial Hospital,
Kaohsiung Medical University. Forty girls with TS (range,
7–16 years) participate in a cross-sectional study using the
Rosenberg Self-esteem Scale (RSE) and the Child Behavior
Checklist (CBCL). Students t-test are used to compare the
RSE scores with normative data, and the Mann-Whitney
test are used to compare CBCL scores with normative data.
Spearmans rank correlation coeﬃcient (rs) are used to
examine the relationship between age, RSE scores and CBCL
scores. Descriptive statistics are given as means and standard
deviations (SD) for the RSE, and as raw scores for the CBCL.
The results from this study may support previous studies
from other countries that girls with TS are at higher risk
of having social and behavioral problems than the general
population. These may also help us understanding the self-
esteem in TS and these problems should be considered when
providing further clinical care.
EndocrineDysfunctionafter
Bone MarrowTransplantationduring
Childhood and Adolescence
Hye-Young Jin, Jin-Ho Choi, Ho-Joon Im,
Jong-Jin Seo, and Han-Wook Yoo
Department of Pediatrics, Asan Medical Center Children’s
Hospital, University of Ulsan College of Medicine, Seoul,
Korea
Purpose. Several complications can occur in patients who
received bone marrow transplantation (BMT) during child-
hood and adolescence. This study aims to investigate
endocrine dysfunctions after BMT so that better care can be
provided to care for long-term survivors of BMT. Methods.
One hundred patients (61 males, 39 females) were included
in this study. Clinical parameters such as initial diagnosis,
age at BMT, conditioning regimen, presence of graft-versus-
host disease (GVHD), growth pattern, thyroid function, and
pubertal status were retrospectively reviewed to evaluate
risk factors associated with endocrine dysfunction. Results.
Height standard deviation score (SDS) at BMT, after 1
year of BMT, and at the last visit were 0.08 ± 1.04,
−0.09 ± 1.02, and −0.27 ± 1.18, respectively, (P = .001).
Height SDS signiﬁcantly decreased in patients who received
total body irradiation (TBI) (P = .017). One of the
patients who received TBI demonstrated growth hormone
deﬁciency. Thirty (31.9%) of 94 patients had compensated
hypothyroidism. Incidence of compensated hypothyroidism
was higher among those who had GVHD (odds ratio 2.82,
P = .025). Of the 32 patients (17 males, 15 females)
w h ow e r eo v e r1 4y e a r si nm a l ea n d1 3y e a r si nf e m a l e
at the last visit, 16 (3 males, 13 females) had increased
luteinizing hormone (LH) or follicle-stimulating hormone
(FSH).AbnormalelevationofLHorFSHwasmorecommon
in females (odds ratio 30.3, P = .001). Conclusion. The most
common endocrine dysfunction was ovarian insuﬃciency.
Regular checkup for endocrine function needs to be required
due to high incidence of endocrine dysfunction in patients
with BMT.
Differences in the Anthropometric and
Endocrine Characteristicsof Children
Conceived after the Transfer of a Fresh or
ThawedEmbryoComparedtoNaturally
Conceived Controls
Mark Green,1 Frances Mouat,1 Harriet Miles,1
Sarah Hopkins,1 Paul Hofman,1 John Peek,2
and Wayne Cutﬁeld1
1The Liggins Institute, University of Auckland, Auckland,
New Zealand
2Fertility Associates, Auckland, New Zealand
Objectives. To determine whether anthropometric or endo-
crine characteristics diﬀer in IVF children; conceived via
fresh or thawed embryo transfer, compared to naturally
conceived controls. Methods. Healthy prepubertal children
(3.5 to 11 years) born at term after a singleton pregnancy
were evaluated. Naturally conceived controls (CON; n =
94) were compared to IVF children conceived via the
transfer of a fresh (IVFF; n = 72) or thawed (IVFT;
n = 43) embryo. Anthropometric characteristics and
body composition (DEXA) were assessed, as well as fasting
metabolic (glucose and insulin) and endocrine (IGF-I,-II
andBP3)hormonesmeasured.Allanthropometricdatawere
standardised (SD scores) and adjusted for parental size.92 International Journal of Pediatric Endocrinology
Data were analysed by linear regression and mixed model
ANOVA with appropriate covariates. All data are reported
as means ±SEM. Results. IVFF children were lighter at
birth (P<. 001) than CON and IVFT. After adjustment
for parental size, IVFF children were taller (P<. 05)
than both CON and IVFT contemporaries. Although no
diﬀerences in corrected BMI were evident, IVFT children
had lower (P<. 05) percent body fat compared to CON
but not IVFF children. All hormones were positively (P<
.05) correlated with height and percent fat. No diﬀerences
were found in glucose or insulin concentrations. IGF-I was
higher (P<. 05) in IVFF than the other two groups. In
contrast, IGF-II was higher (P<. 05) and IGFBP3 lower
(P<. 01) in the IVFT children compared to CON, and
CON and IVFF children, respectively. Conclusion. Subtle
diﬀerences exist between IVFF (taller with higher IGF-I
concentrations) and IVFT (leaner with higher IGF-II and
lower IGFBP3 concentrations) children, in addition to those
identiﬁed between IVF and CON children. The divergent
anthropometric and biochemical characteristics of the two
IVFgroupsmaybeexplainedbyacombinationofdiﬀerences
in embryo selection, in vitro processing, or the transfer
of an embryo to a uterus exposed to ovarian IVF super-
stimulation regimes. However, the underlying mechanisms
involved are yet to be elucidated and are the focus of
continued research.
PolyuriainanInfantCausedby
PrimaryPolydipsia
Muhammad Faizi, Bagus Samsu Tri Nugroho,
Achmad Yuniari Heryana, and Netty Harjantien
Division of Endocrinology, Department of Child Health,
Faculty of Medicine, University of Airlangga/Dr. Soetomo
Hospital, Surabaya
Background. Excessive and persistent ﬂuid intake or com-
monly called primary polydipsia is one of causes of polyuria
in children, beside nephrogenic diabetes, diabetes mellitus
and diabetes insipidus. Undiagnosed and untreated polyuria
cancausesuﬀeringandresultinfailuretothrive,hyperosmo-
lar state, severe dehydration, irreversible brain damage and
death. Objective. To report a case of polyuria in an infant
caused by primary polydipsia. Case Report. A 2-month-old
boy was referred with suspicion of diabetes insipidus. He
came with frequent urination for 7 days, spent 4 dozen
of cloth diapers a day. He got frequent breast feeding.
His mother was told by a previous health caregiver to
feed the baby frequently because of his prematurity and
low birth weight. Urine production was 10.1cc/kg/hour
(polyuria >4cc/kg/hour). Laboratory tests revealed ran-
dom blood glucose was 85mg/dL, creatinine serum was
0.4mg/dL, BUN was 9mg/dL, urine speciﬁc gravity (SG)
was 1.005 (N: 1.010) and plasma osmolarity (POsm) was
277.9 mOsm (N: 282–295 mOsm). Results of head CT-
scanand kidney ultrasoundwere normal. Waterdepriviation
test was done to distinguish DI and primary polydipsia.
After the test, urine production decreased to 3.27cc/kg/hour,
POsm 295.79 mOsm/L (<300mOsmL), SG 1.010. He had
primary polydipsia. Polyuria was improved by feeding
reschedule according to his daily requirement. Conclusions.
Inappropriatefeedingbehavior(excessivefeeding)maycause
polyuria. Water deprivation test can be used to diﬀeren-
tiate polyuria caused by primary polydipsia or diabetes
insipidus.
MandibuloacralDysplasiawith
Type A Partial Lipodystrophy: A Case Report
Ganesh Jevalikar, Ambrish Mithal,
and Abhimanyu Garg
Department of Endocrinology,
Indraprastha Apollo Hospital, New Delhi, India
Background. Mandibuloacral dysplasia is a rare autosomal
recessive disorder associated with lipodystrophy which is
an uncommon cause of oligomenorrhea. Case Report.A
nineteen year old girl presented with irregular menses and
excessivescalphairlosssincemenarchewhichwasat11years
of age. She had a mottled cutaneous pigmentation. She had
mild hirsutism and acne. She was receiving metformin and
oral contraceptives for above complaints. She had dispro-
portionate fat distribution in the form of presence of fat in
truncal region and lack of fat from the extremities. There
was no intake of androgenic medications. Family history was
unremarkable. On examination her weight was 47kg and
height was 149.7cm. Her blood pressure was 130/86mm
of Hg. She had muscular appearance of upper limbs with
paucity of fat and excess truncal fat. Her ﬁngers and toes
were short and thin with bulging of terminal phalanges.
She had small pointed nose, small mandible and narrow
shoulders. There was mottled pigmentation of neck, trunk
and elbow ﬂexures. Acanthosis was absent. Thyroid was
normally palpable. Systemic examination was unremarkable.
Her serum testosterone was 0.68nmol/L. Thyroid proﬁle,
serum prolactin and 17-hydroxyprogesterone levels were
normal. She had fasting hyperinsulinemia (243.6pmol/L)
and impaired glucose tolerance (2 hours post glucose
load blood glucose −7.7mmol/L). Her fasting lipid proﬁle
showed total cholesterol of 4.88mmol/L, LDL cholesterol
of 2.86mmol/L and triglyceride of 2mmol/L. X-ray of
the hands showed osteolysis of terminal phalanges and X-
ray of the shoulders revealed destruction of the clavicle.
The echocardiogram was normal. She was managed with
dietary advice, lifestyle modiﬁcation. Oral contraceptives
and metformin were continued. Discussion. Mandibuloacral
dysplasia is a rare autosomal recessive disorder caused
by mutations in LMNA gene and zinc metalloproteinase
(ZMPSTE24) gene. Mutations result in apoptosis and pre-
mature cell death of adipocytes. It is associated with two
distinct patterns of lipodystrophy. Type A involves the loss
of subcutaneous fat from the arms and legs but normal
or excess deposition of fat in the face and neck, and type
B is characterized by a more generalized loss of subcuta-
neous fat. Some of the patients may not have mutationsInternational Journal of Pediatric Endocrinology 93
in both of the above genes suggesting presence of other
loci.
ACaseofImmune-Dysregulation,
Polyendocrinopathy, Enteropathy, X-Linked
(IPEX)Syndrome PresentingasPure
Red CellAplasia andPosterior Reversible
Encephalopathy Syndrome
Hye-Young Jin,1 Keun Wook Bae,1 Jin-Ho Choi,1
Jong Jin Seo,1 Young Seo Park,1 Gu-Hwan Kim,2
and Han Wook Yoo1,2
1Department of Pediatrics, Asan Medical Center Children’s
Hospital, University of Ulsan College of Medicine, Seoul,
Korea
2Medical Genetics Clinics and Laboratory,
Asan Medical Center, Seoul, Korea
Background. The syndrome of immune-dysregulation, poly-
endocrinopathy, enteropathy, X-linked (IPEX) is a rare
X-linked recessive disorder, usually manifesting as multi-
systemic autoimmune disorders during infancy. Most
patients have been reported to die within the ﬁrst 2 years
of life due to severe infection or failure to thrive. We
describe here a patient with IPEX syndrome with a novel
splicing mutation of the FOXP3 gene. Case. The patient
was a male child, born healthy at 39 + 2 weeks of
gestation. At 11 months of age, he was diagnosed with
type 1 diabetes mellitus (T1DM). At 39 months of age,
he developed acute anemia with a plasma hemoglobin
concentration of 2.3mg/dL. Direct and indirect Coombs’
test results were 3+ and 1+, respectively, however, hemol-
ysis was not obvious on a peripheral blood smear. Bone
marrow biopsy showed adequate erythropoiesis. He was
diagnosed with pure red cell aplasia (PRCA) and started
on steroid treatment with 2mg/kg/day of prednisolone. A
renal biopsy was performed for evaluation of incidentally
detected albuminuria on routine urinalysis, and conﬁrmed
the diagnosis of membranous glomerulonephritis (MGN).
He was also treated for severe bacterial pneumonia at the
age of 7 years and for bacterial meningitis at the age of 11
years. DNA analysis of the FOXP3 gene identiﬁed a novel
splicing mutation (c.201 + 1G > A). The same mutation
was found in his mother’s FOXP3 genes as a heterozygote.
Four months after recovery from meningitis, he developed
posterior reversible encephalopathy syndrome (PRES) with
severe hypertension after taking a vaccine against pandemic
inﬂuenza A H1N1 virus. Following antihypertensive therapy,
his neurological ﬁndings returned to normal, and he was
discharged without any symptoms after two weeks. He has
been treated with a very low dose of prednisolone and
intensive insulin regimen. Conclusion. This patient presented
with unusual clinical characteristics, including pure red cell
aplasia, membranous glomerulonephropathy, and posterior
reversible encephalopathy syndrome associated with sud-
den severe hypertension after vaccination. Although IPEX
syndrome is usually a disease of infancy, it should not
be ruled out solely on the basis of age. Its presentations
are so variable that IPEX should be suspected in a male
child with one or more autoimmune disorders and severe
infections.
Evaluationof Growth and Gonadal Maturity
in Children and Adolescents on Treatment for
LupusNephritisClass III/IV
Sophy Korula, Indira Agarwal, and Anna Simon
Department of Child Health, Christian Medical College,
Vellore
Objective. To determine the risk of growth retardation and
gonadal toxicity in children treated for Class III/IV Lupus
nephritis. Design And Setting. Concurrent cohort study.
Methodology. 22 Children with SLE nephritis class III/IV
were enrolled into the study over an 18 month period from
April 2008–October 2009. 14 received cyclophosphamide
(CYC) and 8 received mycophenolate (MMF). All received
steroids and hydroxychloroquine. All of them had the
routine investigations at followup including Anti-Ds Dna, Se
complement and Se Creatinine. Growth delay was assessed
by growth velocity measurement and correlation with the
midparental height centile. Se vit D level, Se calcium, Se
phosphorus were also checked for those with growth delay.
Gonadal maturation was assessed by SMR staging. Gonadal
toxicity was evaluated based on presence of amenorrhea, ele-
vated FSH, LH levels and decreased ovarian size/endometrial
thickness on ultrasound. Results. 22 children were included
(3 were males). Mean age at study was 13.6 years (range 8–19
years). Mean duration of therapy was 35.07mns (range 11–
62) in CYC group, 16.06mns (range 6–33) in MMF group.
Average cumulative dose of CYC was 11.4 gm/m2. ∗7/22
(31.8%) had growth delay. Of these 3 of them had high
disease activity and 4 had low Se vit D levels. The mean Se
vit D level was 21.9ng/ml in those with growth delay. ∗Of
the 19 girls, 11 attained menarche and had SMR breast stage
3. Three of them had sustained amenorrhea (>4 months). Of
these 3, severe disease was noted in 2. One was on MMF and
2o nC Y C( P = .99, mean dose of 10.6 gm/m2). Among the
remaining 8 girls-5 were prepubertal, 3 were ≥12 years. Of
these3girls-2haddevelopedthelarche(breaststage2)andin
1 there was family history of maturational delay. There were
3 boys in this study, 2 were in early puberty based on SMR.
No child had elevated FSH, LH levels. Conclusions.G r o w t h
delay was a cause of concern in children with lupus nephritis
class III/IV. This was probably caused by a combination of
the severe disease activity and vit D deﬁciency. Sustained
amenorrhea was seen in 3/11 girls (27%) and was probably
related to the disease severity rather than drug toxicity.
None of the children had hormonal proﬁle to qualify for
premature gonadal failure during the period of study. A
follow up of these patients will be necessary to conﬁrm the
same.94 International Journal of Pediatric Endocrinology
Glucose Homeostasis and
Body Composition inSurvivorsof
Childhood Acute Lymphoblastic Leukemia
Alisa Kulpiya,1 Preamrudee Poomthavorn,1
Pat Mahachoklertwattana,1 Suradej Hongeng,1
Samart Pakakasama,1 Chanika Sritara,2
and Patcharin Khlairit1
1Department of Pediatrics,
2Department of Radiology, Faculty of Medicine,
Ramathibodi Hospital, Mahidol University, Bangkok10400,
Thailand
Background. Improvement in the treatment of childhood
acute lymphoblastic leukemia (ALL) has led to a growing
number of survivors. ALL survivors are at increased risks of
obesity, abnormal body composition and insulin resistance
as a result of the treatment modalities and hormonal
disorders. We aimed to study glucose homeostasis and
body composition in survivors of childhood ALL. Methods.
Childhood ALL survivors who had been in remission for at
least 1 year were enrolled in the study. They were excluded
if they had syndromic obesity or medications aﬀecting
glucose metabolism. Auxological data and history of ALL
treatmentwereobtained.Oralglucosetolerancetest(OGTT)
with plasma glucose and insulin levels measurement was
undertaken in all patients. Insulin sensitivity indices derived
from the obtained glucose and insulin levels were calculated.
All patients underwent dual energy X-ray absorptiometry
(DXA) for body composition analysis. Data are presented
in mean (SD). Results. There were 34 patients, aged 15.6
(3.8) years enrolled in the study. There were 21 (61.8%)
males. Twenty-nine (85.3%) patients had already entered
puberty. Age at diagnosis of ALL was 5.9 (3.1) years. All
of them were treated with standard ALL chemotherapy
protocol with 9 of them (26.5%) had prophylactic cranial
irradiation. They had been in remission for 6.6 (3.0) years.
Weight and height Z-scores at enrollment were 0.9 (1.8)
and 0 (0.8), respectively. BMI was 21.0 (4.2)kg/m2and BMI
Z-score was 0.0 (1.3). Waist circumference (WC) and WC
percentile were 74.3 (11.4)cm and 46.3 (33.9), respectively.
Percentages of body fat and lean mass were 30.2 (11.0)
and 66.3 (10.4), respectively. Of 34 patients, 15 (44%) had
an abnormal OGTT result with 13 of them had hyperin-
sulinemia, that is, insulin resistance and 2 had impaired
glucose tolerance. Homeostatic model assessment of insulin
resistance (HOMA-IR) and whole body insulin sensitivity
index (WBISI) were 1.6 (1.2) and 7.0 (4.9), respectively.
In comparison with patients having normal OGTT results,
patients with abnormal OGTT results had greater HOMA-
IR (2.2 (1.3) versus 1.1 (0.7); P = .007) and less WBISI (4.0
(1.6) versus 9.4 (5.3); P<. 001). However, percentage of
body fat was not diﬀerent between patients with abnormal
and normal OGTT results (32.6 (10.2) versus 28.4 (11.6)%;
P = .276). Conclusions. Childhood ALL survivors have an
increased risk of insulin resistance despite being non-obese.
This ﬁnding may be partly caused by relatively increased fat
mass found in this group of patients.
Impact of Intravenous Immunoglobulins on
theEndocrinologicMilieuinKawasakiDisease
Kenichi Miyako, Naohiro Suga, Tomoko Hidaka,
Hiroshi Koga, and Noboru Takahashi
Beppu Medical Center
Kawasaki disease is a systemic vasculitis syndrome that
usually develops in very young children. Options for treat-
ment include aspirin and intravenous immunoglobulins.
Immunoglobulin preparations are plasma derivatives from
which blood-borne pathogens have been safely eliminated.
However, remnants of endocrine substances have not been
closely studied. We have found relatively high levels of fT3
and E2 in several lots of immunoglobulin preparations.
To evaluate the impact of intravenous immunoglobulin
preparations, we examined changes in serum hormone
concentrations after a 2-g/kg/24 hours dose in children
with Kawasaki disease (n = 4; age, 8 months—2 years 8
months). Changes in mean concentrations were as follows:
fT3 1.96→2.56pg/ml (P = .08), fT4 1.21→1.31ng/dl
(P = .67), TSH 1.88→3.99μIU/ml (P = .01), LH
0.10→0.12mIU/ml (P = .39), FSH 0.55→0.57mIU/ml
(P = .86), and E2 42.0→16.5pg/ml (P = .19). Analyses
after adjustment by hemoglobin or creatinine levels showed
similar trends. Changes in thyroid function test results
in an infant treated with only aspirin were as follows:
fT3 2.7→3.7pg/ml, fT4 1.03→1.28ng/dl, and TSH 1.39→
2.38μIU/ml. No change in any variable of thyroid function
test was clinically signiﬁcant. Because the infant treated
with aspirin showed similar trends, changes in serum
thyroid hormone levels may reﬂect the recovery phase of
euthyroid sick syndrome. Although there was no elevation
of E2 level, stimulation of the gonadotropin axis should be
considered in patients with other diseases who repeatedly
receive intravenous immunoglobulins. We are continuing
our studies in additional patients.
Report of Two Cases of ABCC8 Gene Mutation
withOpposing Phenotypes:Neonatal Diabetes
and Congenital Hyperinsulinism
Hooi Leng Ooi and Loo Ling Wu
Paediatric Endocrinology Unit, Department of Paediatrics,
University Kebangsaan Malaysia Medical Centre,
Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras,
Kuala Lumpur, Malaysia
Introduction. KATP channel in the pancreatic b-cell is
an important gateway to regulation of glucose-dependent
insulin secretion. Activating mutation of KCNJ11 or ABCC8
genes which encode Kir6.2 and SUR1 subunit, respectively,
in the KATP channel results in severe inhibition of insulin
secretion manifesting as neonatal diabetes whereas loss of
function mutations in the same genes can cause oversecre-
tion of insulin and results in congenital hyperinsulinism.
We report two cases of neonatal diabetes and congenitalInternational Journal of Pediatric Endocrinology 95
hyperinsulinism due to opposite mutations involving the
ABCC8 gene. Case 1. TXY, 12-month old girl was delivered
at term with birth weight of 2.5kg. She presented with severe
diabetic ketoacidosis at ﬁve weeks of life. There were three
episodes of seizures documented at presentation. Investiga-
tions showed negative pancreatic autoantibodies and normal
pancreas on ultrasound. Genetic study revealed de novo het-
erogyzous activating missense mutation, Q211K, in exon 5
of the ABCC8 gene. She was weaned oﬀ insulin and switched
to glibenclamide at 8.5 months old. Currently she required
glibenclamide 1.1mg/kg/day with marked improvement in
g l y c e m i cc o n t r o la n ds t a b l eb l o o dg l u c o s ep r o ﬁ l e .T h el a t e s t
HbA1c was 6.2% with no hypoglycaemia. She remained
well and seizure free but had mild delay in gross motor
development.Case 2.MA,9-montholdboywasbornatterm
with birth weight of 4.1kg. He was the ﬁfth progeny of a ﬁrst
cousin marriage. The elder two siblings died in early infancy
due to hypoglycemia. MA had recalcitrant hypoglycaemia
since birth but referred only at two months old. He did not
response to diazoxide but maintained normoglycemia with
glucagoninfusionandsubcutaneousoctreotideinjection.He
underwent 95% subtotal pancreatectomy at three months
oldhoweverhypoglycaemiarecurredtwoweeksaftersurgery.
Parents refused further operation and patient continued on
octreotide injection. He had delayed development with poor
sucking reﬂex. Genetic study revealed a novel homozygous
frameshift mutation A736fs in exon 16 of the ABCC8 gene
resulting in a premature termination codon. Both parents
are heterozygous carriers of the same mutation. Conclusion.
The identiﬁcation of ABCC8 gene mutation in patients
with neonatal diabetes and congenital hyperinsulinism not
only conﬁrmed the diagnosis but also had implications for
treatment. For neonatal diabetes, oral sulphonylureas should
be tried. Autosomal recessive congenital hyperinsulinism
usually a diﬀuse disease and until further novel intervention
available, subtotal pancreatectomy remains the mainstay of
treatment.
GrowthMonitoringinPrimarySchoolChildren
Voraluck Phatarakijnirund
and Suttipong Wacharasindhu
Paediatric Endocrine Unit, Department of Paediatrics,
Faculty of Medicine, King Chulalongkorn Memorial
Hospital, Chulalongkorn University, Bangkok, Thailand
Background. Growth monitoring is a part of child health
supervision program in many countries worldwide. The aim
of the program is to identify the growth disorder in an early
stage of disease. In Thailand, there is no consensus guideline
ofgrowthmonitoringprograminschoolandtheroleofthese
has never been studied. Objective. To study the prevalence
of growth disorder and to establish the role of growth
monitoring for identiﬁcation of growth disorder in primary
schoolchildren.Method.Across-sectionalstudyofgrade3–6
children from 2 primary schools was conducted during July
2009–January 2010. The program consists of measuring of
individual height and weight in all children. Short, and Tall
statures were deﬁned by either height below 3rd percentile
or >2 major percentile below target height, and height above
97rd percentile or >2 major percentile above target height
using Thai standard children growth charts, respectively.
Obesity was diagnosed in children with ideal weight for
height >120%. Children who met one of these criteria were
completely examined to determine the deﬁnite cause of
growth disorder. Result. Total number of subjects was 993
(523 boys and 470 girls. Prevalence of obesity, short and
tall stature was 13.0%, 7.3%, and 4.3%, respectively. Among
short stature group, 80.6% of children diagnosed according
to their height below target height. Fifty children (80.6%) in
short stature group were completely examined. There was 1
new case of GHD, who had height above 3rd percentile but
below target height, 1 child with known Turner syndrome
and 1 diagnoses of malnutrition therefore the detect rate of
growth disorder is 1:281. In tall stature group, 60.5% of
children had height above 97rd percentile. Seven children
(17.9%) in tall stature group were completely examined
and no new case of growth disorder was found. Within the
obesity group, more than half of children (60.8%) had mild
obesity. Fifty-two children (47.3%) in obesity group were
examined, 11 of them had sign of insulin resistance and
one, who was severe obesity, had hypertension. Conclusion.
The results of the study have highlighted on the role of
growth monitoring to detecting growth disorder in general
children.Thedetectionrateofshortstature-relateddisorders
is higher than previous report due to limit number of study
population while the prevalence of obesity was similar to the
previous report in Thailand over the past 10 years.
ClinicalSigniﬁcance of
SerumNT-proCNP, BAP, andOC in
New Borns of Different Gestation Ages
Pi Ya-lei, Zhang Hui-feng, Yan xue,
and Zhang Ya-nan
Department of Pediatric, the Second Hospital of
Hebei Medical University, Shijiazhuang, Hebei 050000,
China
Objective. To determine the serum concentration of NT-
proCNP, BAP, OC in newnatals of diﬀerent gestational
ages. To investigate their clinical signiﬁcance in evaluating
bone growth. Methods. 80 newborns without congenital
and metabolism disease, serious hypoxia or infections were
chosed and divided into group A(26 newborns, gestational
age ≤ 32 week, mean 29.2 week), B(28 newborns, 32 week
< gestational age < 37 week, mean 34.1 week) and C(26
newborns, 37 week ≤ gestational age < 42 week, mean 38.1
week). Body length and birth weight of all the newborns
were determinded immediately after birth. Intravenous
blood samples were collected within 24 hours after birth.
Calcium and phosphor were measured by biochemistric
method. Serum NT-proCNP, BAP, OC were measured by
ELISA. Result. (1) There were no correlations between NT-
proCNP levels and birth weight, body length, BAP or OC
levels. (2) There were negative correlations between BAP96 International Journal of Pediatric Endocrinology
and gestational age, birth weight, body length. (3) There
were positive correlations between OC and gestational age,
birth weight, body length. Conclusion.( 1 )T h e r ei sn o
correlation between NT-proCNP levels and fetus growth and
development. (2) With the gestational age growth, the bone
grows slower and the mineralization becomes stronger.
AF ull - B l o wnCas eo fW o l f ramS ynd r o m ein
aYoungChinese Girl
Grace Poon,1 Ivan Lo,2 Tony Tong,2 Pik To Cheung,1
Anne Kwok,1 Joanna Tung,1 and Louis Low1
1Department of Paediatrics and Adolescent Medicine,
Queen Mary Hospital, The University of Hong Kong
2Clinical Genetic Service, Department of Health,
The Government of the HKSAR
Introduction. Wolfram Syndrome is a rare autosomal
recessive neurodegenerative disease, characterised by dia-
betes insipidus, diabetes mellitus, optic atrophy, deafness
(DIDMOAD) and various other clinical manifestations
including neurological symptoms, renal tract abnormalities,
psychiatric manifestations, gastrointestinal dysmotility and
gonadal disorders. Juvenile-onset diabetes mellitus and optic
atrophy tend to present early at a median age of 6 years
and 11 years, respectively. Cranial diabetes insipidus and
sensorineural deafness often present in the second decade,
whilst renal tract abnoramlaities present in the third decade,
followed by neurological complications in the fourth decade.
This progressive disorder often results in death before the
age of 50 years and aﬀected individuals lead an impaired
quality of life due to neurological and urological compli-
cations. Case Report. A young Chinese girl was diagnosed
to have non-autoimmune insulin-deﬁcient diabetes mellitus
at the age of 5 years. She complained of poor vision
with gradually decreasing visual acuity since the age of 3
years and was diagnosed to have bilateral optic atrophy
at the age of 9 years. MRI showed no signiﬁcant lesions
along the visual pathway. She was further diagnosed to
have central diabetes insipidus and later with additional
detrusor sphincter dyssynergia around her 10th birthday.
MRI brain and pituitary gland were normal. Ultrasound
showed bilateral distended pelvicalyceal system with dilated
ureters despite treatment with DDAVP. She was put on
Detrusitol and Imipramine with improvement. BAEP at 10
years showed bilateral click thresholds at 40dB, signifying
mild hearing impairment bilaterally. She was also diagnosed
to have agoraphobia without panic attack in the same year
requiring psychotherapy and psychiatric followup. Genetic
Analysis. PCR-based cycle sequencing of all 8 exons of the
WFS1 gene was performed on peripheral blood leucocyte-
derived DNA from the proband. Three diﬀerent heterozy-
gous mutations were detected: two missense mutations
R456H and G736S and one nonsense mutation Q667X. Both
G736S and Q667X mutations are well reported in patients
with Wolfram syndrome and are likely to be the cause
of the proband’s disease. The R456H mutation has been
reported to be signiﬁcantly associated with type 1 diabetes
mellitus and may have a modifying eﬀect. Parental genetic
testing is underway. Conclusion. It is becoming apparent that
not all diabetes presenting in childhood is type 1 and rare
syndromic forms, such as Wolfram syndrome, have been
identiﬁed in Hong Kong Chinese. Paediatricians should have
a high index of suspicion of Wolfram syndrome when a
childpresentswithjuvenile-onsetdiabetesmellitusandoptic
atrophy.
TheMolecularMechanismofInsulinResistance
inIntrauterineGrowth RetardationRats
Qianqi Liu, Lin Zhang, Xing Shi, Shining Ni, Wei Gu,
and Ziyang Zhu
Nanjing Children Hospital Aﬃliated to
Nanjing Medical University, Nanjing 210008, China
Objectives. (1) To investigate the expression of Insulin/
FoxO1/Pdx1/MafA genes and microRNA (miRNA) during
pancreatic development in the intrauterine growth retarda-
tion (IUGR) rats. (2) To study the molecular mechanism
of insulin resistance in IUGR rats. Methods. (1) Estab-
lishment of rat model: Female and male SD rats were
copulated by 1:3, then the pregnant rats were divided
into the following two groups: IUGR group and normal
group. The former were treated by 50% calorie com-
pared with normal group from gestational day 1 until
term. (2) Collection of the samples: Pancreas of rat in
embryonic day 14.5(E14.5), 19.5(E19.5) and new born were
dissected under microscope, respectively. (3) Expression of
Insulin/FoxO1/Pdx1/MafA genes: After abstraction of total
RNA, the technique of RT-PCR was used to study the
expression of insulin/FoxO1/Pdx1/MafA genes. (4) Expres-
sion of Pdx1/MafA protein: Western blotting was used to
study the expression of Pdx1/MafA protein. (5) Expression
of miRNA: Total RNA were harvested using TRIzol and
RNeasy mini kit according to manufacturer’s instructions.
The samples were labeled using the miRCURY Hy3/Hy5
Power labeling kit and hybridized on the miRCURY LNA
Array (v.11.0). (6) Conﬁrmation of the results: The real-
time PCR was used to conﬁrm the miRNA array results.
Results. (1) Insulin/FoxO1/Pdx1/MafA genes mRNA began
to be expressed from E14.5, and the expression of Insulin
and MafA were increased as the fetes grew while FoxO1
and Pdx1 were decreased. (2) The expressions of FoxO1
and MafA were lower than normal rats (P<. 05) while
Insulin and Pdx1 had no evident change. (3) Compared
with the normal, the expressions of MafA protein were
lower (P<. 05) while Pdx1 protein had no evident
change in IUGR group. (4) In the normal group, comparing
with embryonic day 14.5, 48 miRNAs of embryonic day
1 9 . 5w e r eu p - r e g u l a t e dw h i l e2 8w e r ed o w n - r e g u l a t e d ;6 4
miRNAs of new born were up-regulated while 55 were
down-regulated. Comparing with embryonic day 19.5, 40
miRNAs of new born were up-regulated while 52 were
down-regulated. Comparing with the normal group, in
the IUGR model, 10 were up-regulated while 26 were down-
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while 15 were down-regulated in embryonic day 19.5,
9 were up-regulated while 13 were down-regulated in
new born. (5) The expression of miR-124let −7d∗ mRNA
were be chosen to conﬁrm the miRNA array results: in
normal group, miR-124 of the new born was increased
comparing with embryonic day 14.5 and embryonic day
14.5 (FoldChange >=1.5), and let −7d∗ was increased as
the fetes grew (FoldChange >=1.5); in IUGR group, miR-
124 had no evident change comparing with the normal
group (0.67 < FoldChange < 1.5), while let −7d∗ was down-
regulated in embryonic day 19.5 and new born (FoldChange
<= 0.67). The real-time PCR results were consistent with
miRNA array results. Conclusions. (1) The expression of
Insulin/FoxO1/Pdx1/MafA and miRNA in pancreas were
eﬀected by intrauterine growth retardation. (2) The molecu-
lar changes in IUGR rats pancrease could play an important
role in adult insulin resistance which result from intrauterine
growth retardation.
Are Children Conceived with
MaternalClomiphene Physically or
Metabolically Different?
Tim Savage,1 Mark Green,1 Paul Hofman,1
John Peek,1 and Wayne Cutﬁeld2
1The Liggins Institute, University of Auckland
2Fertility Associates, Auckland
Background.ClomipheneCitrateiswidelyusedtoaidfertility
as it causes ovarian stimulation leading to increased oocyte
numberanddiﬀeringoocytemorphology.Aims.Toassessthe
growth and metabolism of children conceived with mater-
nal clomiphene compared to naturally conceived children.
Methods. Pre-pubertal children aged 3.5 to 10 years each had
height, weight, pubertal assessment and body composition
assessment by DEXA scan to determine fat mass percentage.
Linear regression analysis compared their results to naturally
conceived children of the same age, ethnicity and socio-
economic groups. Results. Interim analysis of preliminary
data of 34 clomiphene conceived children compared to 94
naturally conceived children revealed the following results.
Mean age of clomiphene conceived children and controls
was 7.3 (S.E. 0.33) and 6.8 (SE 0.22) years, respectively.
There was no signiﬁcant diﬀerence in weight, BMI, fat
percentage or height SDS when comparing the two groups.
When children’s height SDS was corrected for midparental
height SDS, there was a trend of clomiphene conceived
children being 0.4 SDS taller than naturally conceived
children (P = .07). Conclusion. Interim data analysis reveals
a trend towards taller stature in clomiphene conceived
children when corrected for genetic height. It appears
that clomiphene treatment of mothers may be partially
responsible for the increase in height seen in IVF oﬀspring.
This suggests that fertility medications may cause imprinting
changes leading to taller stature in clomiphene conceived
children.
PhysicalGrowthand EndocrineProﬁle of
Thalassemic Childrenatan IndianTertiary
CareHospital
Rajni Sharma, Anju Seth, and Jagdish Chandra
Department of Pediatrics, Kalawati Saran Children’s
Hospital and Lady Hardinge Medical College, New Delhi,
India
India has a large number of patients with transfusion
dependent thalassemia major and there are few studies on
physical growth and endocrinal proﬁle of these children.
We are presenting our experience of managing children
with thalassemia major with a focus on growth and
endocrine issues. This is a cross-sectional study of patients
enrolled at the Thalassemia Day Care Centre at Kalawati
Saran Children Hospital, Lady Hardinge Medical College,
New Delhi. We evaluated the growth, pubertal status and
endocrinal proﬁle of patients aged 10–18-years (n = 58).
Clinical and laboratory parameters included weight, height,
sexual maturity ratings, general and systemic examina-
tion. Laboratory parameters were average pretransfusion
hemoglobin, periodic serum ferritin and tests for viral
markers HIV, Hepatitis B and C, liver function tests, blood
sugar (fasting and post-prandial), calcium, phosphate and
alkaline phosphatise (PTH in cases with hypocalcemia),
thyroid proﬁle, bone age and gonadotropins with gonadal
hormones in patients with delayed puberty. Z scores for
weight, height, body mass index were calculated using
WHO reference data. Pretransfusion haemoglobin was well
maintained (mean 9.2g/dl 95% CI 9.06–9.36) but the mean
serum ferritin levels were approximately 3 times the desired
value despite the patients being on regular chelation with
deferiprone (72%) or deferasirox (25%). 86.2% of the
patients had short stature. Delayed puberty or pubertal
arrest was seen in 82.3% (42/51) of patients at or beyond
the age of normal puberty. Diabetes mellitus/impaired
glucose tolerance, hypothyroidism and hypoparathyroidism
was seen in 6.8%, 8.6% and 12% patients, respectively.
In conclusion, there is a high prevalence of growth and
endocrine abnormalities in Indian children with thalassemia
major.
Thyroid Hormone Proﬁle in Children with
Sepsisand ItsCorrelationwithPelodScore as
aPrognosticParameter inSepsis
Agung Tanurahardjaa, Antonius Pudjiadib,
Risma Kaban, Husein Alatas, Pramita Gayatri,
and Aman Pulunganc
Department of Child Health,
Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Background. Thyroid hormones dysfunction can be found in
sepsis, known as euthyroid sick syndrome or nonthyroidal
illness. Aims. To evaluate the thyroid hormones dysfunction
proﬁle in children with sepsis and its correlation with98 International Journal of Pediatric Endocrinology
PELOD score, outcome and PCT. This study also aimed to
know the correlation between PELOD score and outcome.
Methods. This is a cross sectional design. Subjects were
children age 1–18 year old with sepsis admitted in PICU.
PELOD score and blood examinations were taken once
during the ﬁrst 24 hours of PICU admission. Results.
Thirty subjects were included. Median of T3, free T4 and
TSH was 45 (17–133)ng/dL, 0.81 (0.3–1.57)ng/dL and 1.36
(0.05–7.78)μIU/L, respectively. T3, free T4 and TSH was
decreased in 97%, 50% and 40% subject. There were no
correlation between decreased thyroid hormone and PELOD
score (P = .218), outcome (P = .55) and PCT (P =
.694). The risk of death increased by 15 times among the
subject with PELOD score >20 compare to PELOD score
<20 (P = .012; OR = 15 (95% CI = 1.535–146.545)).
Conclusions. Thyroid hormones were decreased in septic
children with the majority of low T3. PELOD score can
be used as a prognostic parameter for septic children at
PICU.
Kabuki Syndrome: One Case Report
Xuejing Yang and Feng Xiong
Children’s Hospital of Chongqing Medical University
Kabuki syndrome (KS) is also known as Kabuki make-
up syndrome, Niikawa-Kuroki syndrome. The exact cause
of the syndrome and the pathogenesis is still unknown.
Attractive hypothesis is that KS belong to micro-deletion
syndrome.Thediagnosis basedonthefollowingﬁvecardinal
manifestations. These included a “peculiar face” (eversion
of the lower lateral eyelid, arched eyebrows with the lateral
one-thirddispersedorsparse,depressednasaltip,prominent
ears and abnormal tooth morphology) in 100% of their
patients,skeletalanomalies(deformedspinalcolumnwithor
without sagittal cleft vertebrae, and brachydactyly V) in 92%
oftheirpatients,mildtomoderatementalretardationin92%
of their patients, dermatoglyphic abnormalities (ﬁngertip
pads, absence of digital triradius c and/or d, and increased
digital ulnar loop and hypothenar loop patterns) in 93% of
their patients and growth deﬁciency in 83% of their patients
(Postnatal growth retardation, but even more signiﬁcantly
with age. Complete or partial deﬁciency of growth hormone
had ever reported). There have also been a number of less
frequent ﬁndings reported in Kabuki syndrome, including
visceral abnormalities, premature breast development in
females,andsusceptibilitytofrequentinfections,Diaphragm
abnormality, deaf. A boy, 4 years old, product of noncon-
sanguineous marriage, presented with retardation in growth
and mental. He had facial dysmorphism with high arched
eyebrows sparse laterally, long palpebral ﬁssures with everted
lower eyelids, blue sclera and long eyelash. His nose was
broad with depressed tip, and ears were prominent and
protruding, transverse palm-ar creases, persistent fetal ﬁnger
pads.Auxiliaryexaminationsshowsthepatienthasmoderate
mental retardation, growth hormone deﬁciency, Atrial septal
defect, moderate hearing loss. Karyotype done on peripheral
lymphocytes was normal. He was diagnosed as Kabuki make
up syndrome due to clinical ﬁndings. The patient was
treated successfully with an ASD repair, and subcutaneous
injections of growth hormone 0.1U/Kg/day. The patient
has grown 4cm after 5 months. Because Kabuki syndrome
is not associated with severe medical complications, it is
presumed that the prognosis for survival into adulthood is
good.
Research on Body Proportions Reference
Chartsof 0–18 YearsChildren andAdolescents
inChina
Zhang Yaqin and Li Hui
Department of Growth and Development,
Capital Institute of Pediatrics, Beijing 100020, China
Objective. To know the status of body proportions of 0–18
years Chinese children and adolescents in 2005, analyze
secular changes of body proportions during 1985–2005,
and obtain the reference charts of body proportions to
provide reference data for doctors and researchers in related
ﬁelds. Methods. Subjects were healthy han nationality chil-
dren and adolescents in nine provinces (cities) from two
national representative cross-sectional surveys in “2005”.
The evaluation index of body proportions was the ratio of
sitting height and leg length (SH/LL). Sitting height and
height were obtained by measuring and Leg length was
obtained by subtracting sitting height from height. Reference
charts of SH/LL were formulated by LMS methods. Results.
(1) SH/LL was decreased gradually with age, for example,
SH/LL of newborn infants, 1 years, 3 years, 6 years children
was, respectively, 2.0, 1.68, 1.43, 1.25 in both boys and
girls. It reached the lowest at 12-13 years in boys and 10-
11 years in girls (the minimum of boys and girls was,
respectively, 1.11, 1.13). Then SH/LL increased slightly and
ﬁnally unchanged after 17 years, the ﬁnal SH/LL of boys
and girls was, respectively, 1.16, 1.18. (2) Before 11 years,
there was not gender diﬀerence in SH/LL, and after that
SH/LL of girls was higher slightly than boys’ SH/LL. The
gender diﬀerence became largest in 13 years (diﬀerence value
was 0.04). SH/LL of urban and rural children was similar
before 7 years, after that SH/LL of rural children was higher
slightly than urban children (maximum diﬀerence value was
0.02), while the ﬁnal SH/LL wasnot urban-rural diﬀerence.
The SH/LL charts were almost coincident in diﬀerent areas.
(3) The ﬁnal SH/LL was not changes during 1985–2005.
While the age that reached the lowest point was advanced
1 year in 2005. Conclusions. SH/LL regularly changed with
age in 0–18 years Chinese children and adolescents. There
wasnot gender diﬀerence in prepubertal children, and SH/LL
of girls was higher slightly than boys’ SH/LL after post-
pubertal. There were not urban-rural diﬀerence, regional
diﬀerence and secular changes in SH/LL in China. Reference
charts of SH/LL in this study were suitable as evaluated
standards of body proportions of Chinese children and
adolescents.International Journal of Pediatric Endocrinology 99
Relationship between Genetic Polymorphisms
Involved in Folate/Homocysteine Metabolic
PathwayandRisk of Down Syndrome
Juan Ye and XP Luo
Department of pediatrics, Tongji Hospital,
Tongji Medical College, Huazhong University of
Science and Technology, Wuhan, Hubei 430030, China
Objective. to investigate the possible links between six
common genetic polymorphisms involved in folate/homo-
cysteine metabolic pathway and risk of Down syndrome
in Han nationality. Methods. 34 mothers who had ever
gestatedorgivenbirthtochildrenwithDownsyndromewere
retrieved as case group and 60 mothers of normal children
as control group. The age of all mothers at the time of
conception was less than 35 years and they were Han nation-
ality.Genomic DNA was extracted from peripheral blood
by using RelaxGene Blood DNA System kit. The genotypes
of MTHFR 677C→T, MTR 2756A→G, RFC-1 80A→G
were detected by PCR-RFLP and all genetic polymorphisms
weredetectedbyGenomeLabSNP-PrimerExtensionKit.The
fast plasma homocysteine level was measured by HPLC
with ﬂuorescence. SPSS 15.0 assessed the statistical risk
of these genotypes. Results. We found that frequence of
MTHFR 677 C→T mutation was more prevalent among
morthers of children with DS than among the control group,
with an OR of 2.60 (95% CI 1.04–6.49). Moreover, the
mutation of CBS 833 T→C wasnot found and no signiﬁcant
diﬀerence in other polymorphisms was observed between
these two groups. The mean homocysteine concentration
had no diﬀerence between case group (8.51 ± 2.55μmol/l)
and control group (8.41±1.42μmol/l). Conclusion.M a t e rn a l
mutation of MTHFR 677 C→T may be the risk factor for
DS child without changing of homocysteine level in Han
nationality.
One Case Report of Idiopathic Syndrome of
InappropriateAntidiureticHormone
SecretionandReview
Yi Gu, Chunxiu Gong, Jin Zhou, and Xuejun Liang
Beijing Children’s Hospital, Capital Medical University
Objective. Approach the clinical characteristic, diagnosis
and treatmnet of idiopathic syndrome of inappropriate
antidiuretic hormone secretion in order to improve the
cognition and treatment of this disease. Method. Summarize
one case of idiopathic inappropriate antidiuretic hormone
secretion in Beijing Children Hospital, analyze clinical
manifestation, laboratory examination, diagnosis and ther-
apeutic method of this case combining with literatures.
Meanwhile review literatures to gain relevant knowledge and
progression of idiopathic inappropriate antidiure hormone
secretion. Result. Clinical manifestations of this patient were
respiratory infection with convulsion, severe polydipsia and
diuresis greater than 3000ml/24h during the treatment.
Laboratory examination showed that sodium and osmotic
pressure of blood serum decreased obviously. No signiﬁ-
cant eﬀect with administration high tension sodium (5.5–
8.5mmol/kg). Speciﬁc gravity and electrolyte excretion of
urine increased obviously simultaneously. (sodium of blood
serum 119.3mmol/L, osmotic pressure of blood serum 250∼
270mmol/L, SG 1.030, sodium of urine 920mmol/24hr,
osmotic pressure of urine 626mmol/L). Finally, the restric-
tion of water 1000ml/m2 gained signiﬁcant eﬀect in this
patient. MRI of head and pituitary were normal, exclud-
ing BSWS simultaneously. Diagnosis of this patient was
idiopathic syndrome of inappropriate antidiuretic hormone
secretion. The growth and development was normal in two
years followup of this patient. Referring to the literature
of domestic and abroad: little reports of inappropriate
antidiuretichormonesecretionofchildrenandnoidiopathic
inappropriate antidiuretic hormone secretion of children.
Conclusion. The diagnosis of this patient was clinically based.
Idiopathic inappropriate antidiuretic hormone secretion is
very rare in pediatrics patients. It is easily neglected because
of the insuﬃciecy cognition or its positive process by
paediatricians. Diﬀerentiated from BSWS. This paper clues
on that paediatricians should pay attention to discover
and treat idiopathic inappropriate antidiuretic hormone
secretion, with taking appropriate therapy of this disease.
CardiovascularDiseases inTurnerSyndrome
Jirina Zapletalova,1 Eva Klaskova,1
Jaroslav Wiedermann,1 and Marta Snajderova2
1Department of Pediatrics, Palacky University and
University Hospital, Olomouc, Czech Republic
2Department of Pediatrics, Charles University and
University Hospital, Prague-Motol, Czech Republic
Objective. To evaluate the prevalence of cardiovascular
abnormalities in Turner syndrome (TS). Background.T S
is the most common chromosomal abnormality, aﬀecting
1/2000 live female birth. Congenital heart disease (CHD)
aﬀects approximately 50% of TS individuals and it is the
major cause of premature morbidity and mortality in TS
adults. Recent data report an association of TS with a
generalised vasculopathy and aortic abnormalities such as
aortic dilatation (AoDil) and dissection. The higher risk
of CHD is associated with severe dysmorphic features.
Bicuspid aortic valve (BAV), aortic coarctation (CoA), aortic
root dilatation (ARD) and arterial hypertension (AH) are
the risk factors for aortic dissection. Risk of the aortic
dissection is increased in young women particularly during
pregnancy. Accurate data on prevalence of aortic valve
abnormalities, AH and ARD are not available yet. Methods.
Forty four individuals with TS (18 with karyotype 45, X)
age 7.4 (0.1 to 19.0) years underwent complete cardiologic
examination including ECG, echocardiography, 24 hours
monitoring of arterial blood pressure and 38 of them also
magnetic resonance imaging (MRI). The median of age at
ﬁrst cardiologic evaluation was 12.3 (0.1–19.0) years. Results.
BAV or dysplastic aortic valve was found in 29% of subjects,100 International Journal of Pediatric Endocrinology
CoA was found in 2% of patients, aortic stenosis in 2%
of subjects, AoDil in 18% and AH in 11% of subjects.
Ascending/descendingaorticdiameterratio>95thpercentile
wasfoundin21%individuals.Thecardiacabnormalitieshad
61% of all TS patients, but 78% of 45, X. Conclusion.O n e
third of our patients had at least one risk factor for aortic
dissection, but 44, 5% in the group of 45, X individuals.
Our data conﬁrm the high risk for cardiovascular diseases
in TS. The patients should be carefully examined just after
diagnosis of TS to detect the cardiovascular abnormalities
and to identify many asymptomatic individuals with risk
factors. Regularly followup by experienced cardiologist is
necessary for early detection of cardiac abnormalities. MRI
is helpful for early detection of AoDil in all TS girls at an
age when the study may be performed without sedation to
prevent cardiovascular morbidity and mortality.
TrendinOverweightandObesityPrevalence
and Body Mass Index among Children and
Adolescents Aged 6–18 YearsOld in
Two Districtsof Shanghai
Miao-Ying Zhang,1 L u oF e i - H o n gL u o , 1
Shui-Xiana Shen,1 Hong Xia,2 Yue-Zhen Tu,3
Feng-Xia Guo,4 Ting-Ting Huang,4 Di-Jing Zhi,1
Zhu-Hui Zhao,1 Rong Ye,1 Ruo-Qian Cheng,1
and Xiao-Jing Li1
1Department of Endocrinology and Metabolism,
Children’s Hospital, Fudan University, Shanghai 201102,
China
2Public Health Bureau, Minhang District,
Shanghai 201100, P. R. China
3Minhang District Center for Disease Control and
Prevention, Shanghai 201100, China
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Background. It is unclear how is the trend of overweight and
obesity prevalence and the trend of body mass index among
children and adolescents in Shanghai. Objective. The aim
of this survey was to establish baseline data on the trend
in overweight and obesity prevalence and body mass index
among children and adolescents in Shanghai. Design.W e
selected two districts in Shanghai in 2003, randomly, one
in urban area and the other in suburb area. All students
in the primary schools, junior and senior high schools of
the two districts were screened in 2003 and 2008. Body
composition was estimated by using BMI. Result.( 1 )T h e
prevalence of overweight increased from 13.67% to 15.41%
and the prevalence of obesity increased from 3.72% to 4.58%
during the study periods. (2) The overall prevalence of
obestiy and overweight in all children and adolescents (6–
18 years) rose signiﬁcantly between 2003 and 2008 (P<. 01).
The standard prevalence of overweight and obesity increase
signiﬁcantly in each group (P<. 01). (3) The mean BMI
was signiﬁcantly higher in male students than that of female
students (P<. 01). (4) Compared with data in 2003, the
mean BMI of 2008 was signiﬁcantly higher (P<. 01).
Conclusion. The prevalence of obesity and overweight in
children and adolescents had increased over time in two
districts of Shanghai. The distribution of BMI also showed
diﬀerences between the sexes and between 2003 and 2008.